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I.  Abstract/Zusammenfassung 
 
Multikomponentenreaktionen sind Eintopfreaktion in denen drei oder mehr 
Komponenten zu einem Produkt reagieren, welches Teile aller 
Ausgangskomponenten enthält. Folglich lassen sich hierbei mehrere chemische 
Bindungen und strukturell komplexere Reaktionsprodukte in nur einem synthetischen 
Schritt darstellen. 
In der vorliegenden Arbeit wurde der Einsatz von Multikomponentenreaktionen im 
Hinblick auf Datenspeichersysteme untersucht. In einem ersten Ansatz wurde die Ugi-
Vierkomponenten-Reaktion von perfluorierten Säuren genutzt, um eine exemplarische 
Datenbank, bestehend aus 130 kommerziell erhältlichen Komponenten, zu erstellen. 
Betrachtet man alle möglichen Permutationen, so kann dieser Ansatz bis zu 500.000 
Moleküle generieren, die jeweils in einem einzigen Schritt synthetisiert werden. 
500.000 Permutationen entsprechen ca. 18 Bits pro Molekül. Die hier erstmals 
beschriebenen perfluorierten Ugi-Reaktionsprodukte wurden in Kombination mit 
Advanced Encryption Standard Kryptographie und molekularer Steganographie als 
molekulare Schlüssel eingesetzt. Diese molekularen Schlüssel dienen als Passwörter 
für verschlüsselte Daten und wurden auf versteckten und nicht-digitalen Kanälen 
übertragen, z.B. adsorbiert auf einem festen Trägermaterial oder aufgelöst in einer 
Flüssigkeit. Die Rückgewinnung und Aufreinigung der molekularen Schlüssel wurde 
durch die perfluorierten Seitenketten erleichtert. Mittels hochauflösender Tandem-
Massenspektrometrie wurde anschließend die molekulare Struktur eindeutig aufklärt 
und somit der versteckte Schlüssel zur Entschlüsselung geheimer Nachrichten 
bestimmt. Zum einfacheren Auslesen der Massespektren wurde ein eigens 
programmiertes Computerskript benutzt. Die Verschlüsselung und Entschlüsselung 
von Nachrichten oder Daten wurde mit einem unabhängigen Programm durchgeführt. 
In einem weiteren Ansatz wurde die Biginelli-Reaktion mit der Passerini-Reaktion in 
einem sequentiellen Multikomponenten-Reaktionssystem verknüpft. Nach der 
Bewertung der möglichen Linker-Moleküle und der Etablierung eines geeigneten 
Lösungsmittelsystems wurden diverse Dihydropyrimidon-α-acyloxycarboxamid-
Strukturen in guten bis ausgezeichneten Ausbeuten dargestellt. In einem ersten 
Reaktionsschritt wurden dazu unterschiedliche Biginelli-Säuren synthetisiert und 
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daraufhin in einer Passerini-Reaktion eingesetzt. Durch die Variation der 
Komponenten wurde eine Bibliothek strukturell vielseitiger Moleküle synthetisiert. 
Darüber hinaus wurde erstmalig eine Biginelli-Passerini-Eintopf-Tandem-Reaktion 
demonstriert, wobei fünf Komponenten in einem Schritt im selben Reaktionsprodukt 
vereint werden. 
In einem dritten Ansatz wurden sequenzdefinierte und informationscodierende 
Makromoleküle, welche potentiell als Datenspeichermaterialien geeignet sind, 
dargestellt. Für diese Untersuchung wurde die zuvor erarbeitete Kombination der 
Passerini- und Biginelli-Reaktion angewandt, um unterschiedliche bifunktionelle 
Monomere zu synthetisieren. Das Datenspeichersystem basiert auf der Variation von 
sechs Komponenten pro Wiederholeinheit, wobei aus einer eigens erstellten 
Datenbank von über 100 unterschiedlichen Komponenten gewählt werden kann. Diese 
strukturelle Diversität ermöglicht eine Datenspeicherdichte von ca. 24 Bits pro 
Wiederholeinheit. Die molekulare Information wurde mittels Tandem-
Massenspektrometrie ausgelesen, wobei drei wesentliche Fragmentationsmuster 
identifiziert wurden. 
 
Schlagwörter: Sequenzdefinierte Makromoleküle, Multikomponentenreaktionen, 
Biginelli-Reaktion, Passerini-Reaktion, Ugi-Reaktion, molekulare Datenspeicher, 
digitale Polymere, molekulare Kryptographie.
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II.  Abstract 
 
Multicomponent reactions are one-pot reactions wherein three or more components 
react to a product containing parts of all precursors. Thus, several new chemical bonds 
and structurally more complex reaction products are obtained in a single synthetic step. 
In the present thesis, the utilization of multicomponent reactions for data storage 
devices was investigated. In a first approach, the Ugi four-component reaction of 
perfluorinated acids was utilized to establish an exemplary database consisting of 130 
commercially available components. Considering all permutations, this combinatorial 
approach can in principle provide 500,000 molecules, in only one synthetic step per 
molecule. The 500,000 permutations translate into approximately 18 bits per molecule. 
The herein firstly described perfluorinated Ugi compounds were employed as 
molecular keys by combining Advanced Encryption Standard cryptography with 
molecular steganography. Molecular keys serve as passwords for encrypted data and 
were transferred via concealed nondigital channels, e.g. by adsorption onto solid 
supports or by dissolution in liquids. Re-isolation and purification from these disguises 
was simplified by the perfluorinated sidechains of the molecular keys. Analysis via high 
resolution tandem mass spectrometry enabled the determination of the molecular 
structure and thus the identity the hidden key, for decryption of encoded messages. 
For straight-forward readout of the mass spectra a custom programed computer script 
was employed. The encoding and decoding of messages or data was performed by an 
independent software. 
In another set of experiments, the Biginelli reaction was combined with the Passerini 
reaction in a sequential multicomponent reaction approach. After evaluation of all 
possible linker components and a suitable solvent system, several dihydropyrimidone–
α-acyloxycarboxamide compounds were obtained in good to excellent yields. In a first 
reaction step, different Biginelli-acids were synthesized and subsequently employed in 
a Passerini reaction. By variation of the components in both multicomponent reactions, 
a library of structurally diverse compounds was synthesized. In addition, a one-pot 
Biginelli-Passerini tandem reaction was demonstrated, herein five components were 
incorporated in a single reaction step in one product. 
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In a third approach, sequence-defined and information-coding macromolecules, 
suitable for data storage materials, were synthesized. For this investigation, the 
previously established combination of the Passerini reaction with the Biginelli reaction 
was applied for the synthesis of bifunctional monomers. The data storage system is 
based on the variation of six different components per repeating unit, choosing from a 
herein comprised database of more than 100 components. This structural variety offers 
an information density of ca. 24 bits per repeating unit. The structural information was 
read out via tandem mass spectrometry, wherein three predominant fragmentation 
processes were identified. 
 
Keywords: Sequence-defined macromolecules, multicomponent reactions, Biginelli 
reaction, Passerini reaction, Ugi reaction, molecular data storage, digital polymers, 
molecular cryptography. 
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1 Initial situation & problem analysis 
 
Information is a major driving force for human evolution. Therefore, humans try to 
memorize, store and access increasing amounts of information in as little time and 
space as possible. Generally, the term information is directly linked to data. When data 
is processed, organized, structured and interpreted in a certain context it becomes 
information. A wise quote stated “An ounce of information is worth a pound of data. An 
ounce of knowledge is worth a pound of information. An ounce of understanding is 
worth a pound of knowledge”[1] (1 pound = 16 ounces). 
When humans in the prehistoric age realized the significance of data storage, they 
started to preserve their observations through cave paintings and stone engravings. 
Starting from rocks, wood, bones, clay tablets, papyri, metal tablets, paper and 
punched cards, humanity moved on to magnetic tapes, celluloid films, gramophone 
records, floppy disk, and many more. A major breakthrough was witnessed in 1928, 
when Fritz Pfleumer invented the magnetic tape, enabling the concentration of data 
into compact space.[2] In 1958, Jack Kilby introduced the first integrated circuit, a 
computer chip made out of the semiconductor germanium.[3] Only a few months later 
Robert Noyce created a more efficient silicon-based chip.[4] The evolving computer 
technology made increasingly capacious and efficient data storage devices possible. 
Modern methods of data storage are e.g. optical discs, such as CDs, DVDs, and 
Blu-ray discs or hard drives and flash drives. 
Today, the total digital data amounts to approximately 4.4 zettabytes (= 4.4 × 109 TB 
= 3.52 × 1022 bits) globally and is expected to reach 3 × 1024 bits, at a presumed 
consistent exponential rate of growth, by 2040.[5] However, data storage on magnetic 
tapes which are currently employed to maintain large-scale permanent archives begin 
to deteriorate within 20 – 30 years. To meet the demand for data storage devices, ca. 
109 kg silicon wafers would be necessary, however, the estimated supply only 
accounts to ca. 107–108 kg.[4] Silicon has limited data storage ability[6] and comes along 
with other concerns, such as human health hazards[7] and environmental pollution. For 
instance, a typical chip manufacturing site produces around 2 million chips per month 
and consumes about 75 million liters of water, while the production of a single 32 MB 
chip weighing ca. two grams requires about 1600 g of secondary fossil fuel and 700 g 
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of nitrogen gas are consumed.[4] In addition the production for one square centimeter 
of a silicon wafer consumes about 1.5 kWh of energy (5.4 MJ).[4,8] 
To face future problems of data storage, scientist currently discuss the utilization of 
DNA as means of data storage.[9] Claiming that the entire current global data of 
(3.52 × 1022 bits) could be packed in a 0.00352 m3 box (less than three 1.5 liter bottles) 
and yet around 1 kg of DNA would be sufficient to address the worlds storage 
requirement in 2040 (3 × 1024 bits).[4] In contrast to the binary system (2n, encoding 
data in “1” or “0”), DNA is capable of encoding in a quaternary system (4n, encoding 
with the four nucleobases). The synthetic and analytic technologies associated with 
DNA are already well established and developed.[10] Nevertheless, data storage 
applications of DNA have inherent disadvantages, such as limited long term 
stability,[11,12] the current inability to synthesize long DNA homopolymers,[13] various 
sequencing errors,[14,15] nucleobase mutations,[16,17] etc. It should also be considered 
that DNA is the information storage of life, which can lead to the problem that data 
encoded in DNA might accidentally (or even on purpose) encode virus sequences 
acting as pathogens to living organisms (a computer virus has already been encoded 
in DNA).[13] 
In order to introduce additional concepts for data storage devices, non-natural 
sequence-defined macromolecules are discussed. These sequence-defined 
macromolecules were described to be one of the biggest goals in polymer science and 
are thus challenging to synthesize.[18] However, non-natural systems enable the use of 
different chemistry protocols,[19] offering new perspectives and opportunities for 
synthetic and analytic methods, and might therefore overcome the limitations of DNA-
based data storage systems.[20] 
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2 Theory 
 
2.1 Multicomponent reactions 
 
Parts of this chapter and following subchapters were adapted from previous passages 
written by the author.[21–24] 
In a multicomponent reaction (referred to as MCR), three or more components react to 
a product containing parts of all precursors in a one-pot reaction. MCRs have steadily 
gained importance in synthetic organic chemistry and recently also in polymer 
science.[24] Because of the capability to form several chemical bonds and thus complex 
products in a single operation, MCRs are highly convergent, modular and versatile 
synthetic tools. MRCs also offer many other advantages, such as operational 
simplicity,[25] facile automation,[26,27] reduction in the number of work-up steps and 
hence minimized waste production (Scheme 1).[28] One-pot reactions in general 
shorten the time required for a synthetic procedure and can provide higher overall 
yields compared to multiple-step syntheses.[29] Due to a reduction in the use of 
material, energy and manpower, one-pot MCRs render chemical transformations as 
more sustainable processes.[30–34] 
 
Scheme 1. Conventional synthesis in comparison to one-pot MCRs.[21]  
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By minimizing the number of synthetic operations, while maximizing the buildup of 
structural and functional complexity, these highly step- and atom economical 
reactions[35] are particularly appealing in the context of target-oriented synthesis.[36,37] 
In 2000, Dömling and Ugi introduced a classification system categorizing three types 
of MCRs based on the respective reaction mechanisms (see Table 1).[38] 
 
Table 1. Three basic types of MCRs.[38] 
MRC type Mechanistic aspects Exemplary reaction scheme 
I 
Mobile equilibrium 
 
II Irreversible in the last step 
 
III Irreversible elementary reactions 
 
According to this classification, MCRs exclusively consisting of equilibrium reaction 
pathways are referred to as Type I. MCRs of type II include an irreversible last reaction 
step and are thus more favorable than type I reactions. The irreversible last step shifts 
the previous equilibria and can therefore achieve higher yields of the desired reaction 
product P. In many cases, Type II reactions include a strong chemical driving force in 
the last step such as: an exothermic reaction, for instance an oxidation (i.e. isocyanide 
carbon atoms from CII to CIII), the condensation of small and stable molecules (i.e. 
water in the Biginelli reaction), an irreversible ring-closing reaction or the formation of 
an aromatic system. Type III MCRs consist of irreversible elementary reactions and 
can be found in biochemical (enzymatic) reaction systems. However, the MCR 
classification system is only valid for ideal model reactions and many MCRs cannot be 
categorized in this fashion.[39] 
A selection of important and well-known examples for MCRs is presented in Scheme 2 
(in chronologic order), including the Strecker amino acid synthesis (1850, 
Scheme 2 a), the Hantzsch dihydropyridine synthesis (1882, Scheme 2 b), the 
Biginelli dihydropyrimidone synthesis (1891, Scheme 2 c), the Mannich reaction 
(1912, Scheme 2 d), the Passerini three-component reaction (1921, Scheme 2 d), 
and the Ugi four-component reaction (1959, Scheme 2 e). 
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Scheme 2. Selected examples for multi component reactions. a, Strecker synthesis.[40] b, Hantzsch 
pyridine synthesis.[40–42] c, Biginelli reaction.[43] d, Mannich reaction.[40,42,44] e, Passerini reaction.[45–47] f, 
Ugi reaction.[48] 
The Strecker synthesis (Scheme 2 a) was discovered in 1850 and describes the 
reaction between an aldehyde, a cyanide and a nitrogen source, such as ammonium 
chloride (or primary/secondary amines). The Strecker reaction is considered a 
milestone in the field of MCRs and was furthermore the first method for the direct 
synthesis of α-amino acids.[49,50] Although the classical Strecker synthesis results in a 
racemic product mixture, many asymmetric methods in which enantioinduction is 
achieved e.g. utilizing chiral auxiliaries[51–53] or chiral catalysts[54] have been described. 
a 
b 
c 
d 
e 
f 
1 
2 
1 3 
4 
5 
6 
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In the Hantzsch dihydropyridine synthesis (Scheme 2 b), an aldehyde (aliphatic or 
aromatic) reacts with two equivalents of an acetoacetate (β-keto ester) 1 and a nitrogen 
donor (ammonia or primary aliphatic amines).[55] The initially formed reaction product 
is a 1,4-dihydropyridine (DHP) 2, which can subsequently be oxidized to the 
corresponding aromatic pyridine derivate.[41,56] Some DHP compounds display 
pharmacologic activities and can be applied, for instance, as calcium channel blockers 
(e.g. nifedipine, amlodipine or nimodipine).[57,58] The Biginelli reaction (illustrated in 
Scheme 2 c) involves the reaction between an aldehyde (preferably aromatic), a urea 
and an acetoacetate 1 under acidic conditions. The heterocyclic reaction product is a 
so-called 3,4-dihydropyrimidin-2(1H)-one (DHMP) 3. DHMPs 3 were also utilized in 
medicinal chemistry.[59] In the Mannich reaction (Scheme 2 d), an acidic proton in 
α-position to a carbonyl functional group (acting as a carbon nucleophile) is amino 
alkylated in the presence of formaldehyde and amines (or ammonia).[60] The β-amino 
carbonyl products 4 of the Mannich reaction (also called Mannich-Bases) can be 
synthesized with high optical purity via different asymmetric methods e.g. proline 
organo-catalysis.[61–63] The Passerini three-component reaction (Scheme 2 e) is an 
example for an isocyanide-based MCR. The Passerini reaction is formally an addition 
reaction between a carboxylic acid, a carbonyl component and an isocyanide forming 
an α-acyloxycarboxamide 5 in 100% atom economy.[35] Nowadays, the Passerini 
reaction has been successfully introduced to numerous fields of chemistry including 
combinatorial chemistry for drug discovery,[64] natural product synthesis[65] and polymer 
science.[24] In the field of isocyanide-based MCRs, the Ugi four-component reaction 
(Ugi-4CR) (Scheme 2 f) is another well-known example. Herein, the reaction of four 
components (carboxylic acid, amine, carbonyl compound and isocyanide) leads to the 
formation of a bis-amide product 6 via previous imine condensation of the aldehyde 
and the amine.[38] As for many other MCRs, the Ugi reaction has also been applied in 
the fields of combinatorial chemistry and polymer science.[66,67] 
Polymer material properties highly depend on their functionality, topology and 
macromolecular architecture. Hence, polymer- and soft-matter science require a 
variety of functionalized polymers specifically designed for novel applications. Macro- 
and microscopic functionality can be introduced e.g. by the precise installation of 
functional groups within a polymer chain or in the side groups. In this context, MCRs 
offer many attractive features and evolved to versatile tools, which have been 
appreciated in polymer science.[68] On the one hand, many MCR benefit from one-pot 
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procedures, but on the other hand a great advantage for polymer chemistry is the high 
diversity of functionality, which can be introduced by variation of the components, 
allowing macromolecular engineering. In the present thesis, three MCRs were utilized 
for the synthesis of novel compounds and sequence-defined macromolecules and will 
therefore be discussed more into detail in the following chapters (chapter 2.1.1 for 
Biginelli; 2.1.2 for Passerini and 2.1.3 for Ugi). 
 
2.1.1 The Biginelli reaction 
 
In 1893, Pietro Biginelli observed the formation of a precipitate in the reaction between 
benzaldehyde, ethyl acetoacetate and urea in the presence of catalytic amounts of 
hydrochloric acid in absolute ethanol. Elemental analysis of this precipitate evidenced 
the incorporation of all starting precursors under the elimination of two equivalents 
water.[69] Biginelli initially proposed the formation of ternary adducts with acyclic (open 
chain) structures and hence did not recognize the novelty of his discovery. However, 
after further investigations, Biginelli evidenced the formation of a heterocyclic 
compound, a so-called 3,4-dihydropyrimidin-2(1H)-one (DHMP) 3.[59] 
The Biginelli reaction is a three-component reaction involving a series of reversible 
reaction steps followed by the irreversible elimination of water. In Scheme 3, a 
proposed mechanism of the Biginelli reaction with respect to the generally accepted 
mechanism of Kappe et al. is illustrated.[70] In the first reaction step, the aldehyde is 
activated by a Lewis- or a Brønsted acid (H+). Subsequently, urea can react as a 
nucleophile and attacks the activated carbonyl with the lone pair of the nitrogen atom 
to form a hemiaminal species 7. Hemiaminals 7 are unstable in acidic conditions and 
can eliminate water to form a reactive N-acyliminium cation 8. In the next step, the N-
acyliminium ion 8 reacts with the nucleophilic α-carbon atom of the acetoacetate 
component 1 (i.e. after keto-enol tautomerization) resulting in an open chain ureide 9. 
Subsequent ring closure forms a six-membered ring. After two proton transfer 
reactions (referred to as P.T.), the cyclic hexahydropyrimidine intermediate 10 is 
obtained. The irreversible elimination of a second equivalent of water results in the 
formation of the thermodynamically favored DHMP product 3. 
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Scheme 3. Proposed mechanism of the Biginelli reaction.[70] Acid-catalyzed condensation of urea with 
the aldehyde affording an hemiaminal 7, which dehydrates to an N-acyliminium ion 8. Subsequently, the 
enol form of the β-keto ester 1 attacks the N-acyliminium ion 8 to generate an open chain ureide 9, 
which readily cyclizes to a hexahydropyrimidine derivative 10 and dehydrates to the DHMP 
product 3.[23,42] 
The accepted mechanism illustrated in Scheme 3 was supported by spectroscopic 
data. However, alternative mechanisms are discussed.[71,72] For instance, the so-called 
enamine mechanism starts with an enamine formation between urea and the 
β-ketoester. Subsequently, the enamine reacts with the aldehyde.[73] A third alternative 
reaction mechanism begins with a Knoevenagel type reaction between the aldehyde 
and the β-ketoester followed by the reaction with urea.[74] 
The scope of accessible DHMP structures was enriched in 1989 by Atwal et al.[75] In 
the so-called Atwal modification unsaturated keto esters are reacted with substituted 
(in this case protected) urea derivatives to yield protected DHMPs, presumably via a 
Michael addition. The protected DHMPs can subsequently be alkylated/acylated in a 
regiospecific manner by various electrophiles.[76] After deprotection of the products, 
functionalized DHMPs are obtained, which would not have been accessible by the 
7 
1 
8 
8 9 
10 3 
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conventional Biginelli reaction. However, the additional reaction steps depart from the 
one-pot reaction convenience.[43] The manifold chemistry of the Biginelli reaction found 
numerous applications including combinatorial and medicinal chemistry, which will be 
discussed hereafter. 
 
2.1.1.1 The Biginelli reaction in combinatorial and medicinal chemistry 
 
In the context of medicinal chemistry, DHMPs can mimic the pharmacologic properties 
of the Nifedipine type Hantzsch dihydropyridine (DHP) drugs (i.e. active calcium 
channel modulators, displayed in Figure 1). The pharmacological scope of DHMPs 
includes calcium channel modulation for the treatment of cardiovascular diseases (e.g. 
hypertension),[58] cardiac arrhythmias[76,77] or angina (see Figure 1, SQ 32926 and 
SQ 32547).[57,58,78–81] Furthermore, DHMPs (e.g. SNAP 6201), can function as 
α1a adrenoceptor-selective antagonists for the treatment of benign prostatic 
hyperplasia (progressive enlargement of the prostate effecting ca. 70% of males older 
than 70 years, resulting in a number of disruptive symptoms).[82] 
 
Figure 1. Structures of selected pharmacological active DHP (Nifedipine) and DHMP compounds. 
Other drug applications include cancer therapy (e.g. Monastrol),[76,83] treatment of 
trachoma viruses,[84] anti-HIV alkaloids (e.g. Batzelladine B,)[85,86] antibacterial activity 
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and fungicidal activity (e.g. 2-thioxo DHMPs against Aspergillus niger and 
Aspergillus ochraceus).[76] The modular nature of the Biginelli reaction also suggests 
an application in combinatorial chemistry. In 1995, Wipf et al. developed a solid phase 
protocol for the Biginelli reaction based on a urea derivate linked to a Wang resin and 
demonstrated the synthesis of ten DHMPs in high yields.[87] A automated, solution-
based and microwave-assisted, combinatorial system was established by Kappe et al. 
and generated an automatically produced library of 48 DHMPs.[27] Other combinatorial 
methods for the preparation of different DHMPs utilized polymer-supported 
catalysts.[88] A review including further examples and detailed descriptions of the 
Biginelli reaction in combinatorial chemistry can be found in literature.[89] 
 
2.1.1.2 The Biginelli reaction in polymer science 
 
The Biginelli reaction proved to be a versatile and efficient reaction for the preparation 
of small molecules but was further employed in polymer chemistry. In 2013, Tao et al. 
utilized the Biginelli reaction for polymer conjugation of two methoxy poly(ethylene 
glycol) (mPEG) chains of different chain lengths equipped with suitable end groups 
(aldehyde 11 and β-acetamide 12). The addition of urea promoted the coupling step 
(see Scheme 4 a).[90] Hence, the Biginelli reaction evolved as a multicomponent 
reaction tool for the preparation of block copolymers. Block copolymers represent a 
class of interesting materials, because different physical and/or chemical properties 
can be combined in the same polymer (for applications as surfactants or thermoplastic 
elastomers, etc.).[91] In other experiments, the Biginelli reaction was employed for 
polymer side group modification (a post-polymerization modification), wherein a 
polymethacrylate backbone bearing acetoacetate side chains was reacted with urea 
and benzaldehyde.[92] Some of the DHMP sidechain polymers were utilized as 
water-soluble adhesives.[93] Moreover, the Biginelli reaction was combined with a 
reversible addition–fragmentation chain transfer polymerization (RAFT) of an 
acetoacetate functionalized methacrylate 13 in a one-pot reaction with urea and 
benzaldehyde (illustrated in Scheme 4 b).[94] 
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Scheme 4. Selected examples of the Biginelli reaction in polymer chemistry. a, polymer conjugation, 
two mPEG chains with suitable end groups (11 and 12) coupled via the Biginelli reaction. b, one-pot 
combination of the Biginelli reaction with RAFT polymerization.[90] c, Biginelli polycondensation of a AB-
type monomer.[95] d, Biginelli polycondensation of renewable AA- and BB-type monomers.[22] 
Under optimized conditions, the Biginelli reaction proved to be very efficient, hence 
suggesting the application of the Biginelli reaction as a step-growth multicomponent 
polymerization method. In 2015, AB type monomers, displaying an acetoacetate and 
aldehyde functional group 14, were polymerized in the presence of urea via a Biginelli 
polycondensation (Scheme 4 c).[95] In another study, the Biginelli polycondensation 
was utilized to polymerize AA- and BB-type monomers (dialdehydes and 
diacetoacetates) derived from renewable resources. The respective polymers 
(polyDHMPs), with molar masses of up to 20 kDa, showed interesting thermal 
properties such as high glass transition temperatures (Tg up to 203°C) and high thermal 
stability.[22] This concept was further extended by investigating different AA- and 
a 
b 
12 
11 
13 
c 
d 
14 
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BB-type monomers (eight diacetoacetates, four dialdehydes and two urea derivates) 
in a combinatorial high throughput screening approach for different glass transition 
temperatures.[96] If thiourea is applied in Biginelli reactions, the respective 
dihydropyrimidin-2(1H)-thiones can be functionalized at the sulfur atom e.g. via 
alkylation. This concept was also utilized as a post-polymerization modification method 
for poly(dihydropyrimidin-2(1H)-thiones).[97] Acetoacetates and aldehydes can also 
participate in other chemical transformations such as the Hantzsch reaction (see 
Scheme 2 b), which enabled the preparation of copolycondensates via simultaneous 
Hantzsch and Biginelli polymerization.[98] In conclusion, the Biginelli reaction was 
developed as a versatile tool for polymer science and enabled the synthesis of 
interesting and functional materials. 
 
2.1.2 The Passerini reaction 
 
The Passerini reaction (discovered in 1891 by Mario Passerini) is an isocyanide-based 
three-component reaction involving a carboxylic acid, a carbonyl compound and an 
isocyanide.[99] In most cases, the Passerini reaction is very efficient if performed in 
aprotic polar solvents like dichloromethane. The proposed mechanism of the Passerini 
reaction is illustrated in Scheme 5. In the first step, a six-membered cyclic hydrogen 
bonded adduct 15 is formed between the carboxylic acid and the carbonyl component 
(now two out of three reacting components are in the same place at the same time). 
Subsequently, the isocyanide reacts with the loosely bound H-bonded adduct 15, in a 
so-called α-addition. Remarkably, in the α-addition the isocyanide displays nucleophilic 
and electrophilic reactivity simultaneously. The consequently formed intermediate 16 
(proposed as seven-membered ring) has not been isolated and characterized yet, 
because 16 immediately undergoes an irreversible rearrangement reaction, affording 
the final Passerini α-acyloxycarboxamide adduct 5.[72,100] The above presented and 
commonly accepted mechanism was supported by kinetic experiments.[101,102] An 
alternative mechanism proposes the protonation of the isocyanide in the first step and 
confirms the observation that Passerini reactions are accelerated in the presence of 
inorganic mineral acids.[103] 
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Scheme 5. Proposed mechanism of the Passerini reaction. First, the carboxylic acid and the carbonyl 
compound form a hydrogen bonded adduct 15. Subsequently the isocyanide attacks the H-bonded 
adduct 15 in in a concerted fashion (so-called α-addition). The respectively formed seven-membered 
transition state 16 undergoes a rearrangement to the final α-acyloxycarboxamide Passerini product 5. 
In addition, Passerini and Ugi reactions can be accelerated in the presence of water 
and upon the addition of salts.[104] However, quantum mechanical calculations suggest 
a mechanism, in which a second carboxylic acid molecule functions as an 
organo-catalyst.[105,106] The Passerini reaction is classically leading to racemic product 
mixtures, however asymmetric methods were investigated for instance by utilizing 
chiral components (isocyanides,[107] carboxylic acids,[108] aldehydes[109,110]) or Lewis 
acids with chiral ligands, achieving up to 98% enantiomeric excess (ee).[111,112] 
 
2.1.2.1 The Passerini reaction in combinatorial and medicinal chemistry 
 
The modular nature of the Passerini reaction provides combinatorial access to a large 
variety of reaction products, of which some have found their application as drugs, e.g. 
Passerini depsipeptides.[113,114] Bicalutamide is the pharmacologically active substance 
in Casodex® and can be synthesized via a Passerini reaction with water as acid 
component (see Scheme 6). Casodex® is a nonsteroidal selective antiandrogen for 
the treatment of prostate cancer by inhibition of the androgen receptor.[115] The 
Passerini reaction was also employed for the synthesis of a molecule targeting the HI 
virus via inhibition of the enzyme HIV-1 protease (displayed in Scheme 6 b).[116,117] 
15 
16 5 
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Scheme 6. Selected examples of the Passerini reaction in medicinal chemistry.[118] a, synthesis of 
Bicalutamid via a Passerini reaction.[118] b, HIV-1 protease inhibitor.[116,117] c, general structure for a 
library of Passerini molecules screened as EPO hormone mimics.[119] 
For targeting neuromuscular and neurodegenerative diseases via calpain inhibition, a 
large library (containing hundreds of compounds) based on the Passerini reaction was 
synthesized and tested. In vivo experiments revealed that several compounds 
exhibited potent activity and sufficient metabolic stability in mice, with no prominent 
adverse effects.[120] In another combinatorial approach, three libraries of 88 
compounds each were prepared utilizing the Passerini reaction of dicarboxylic acids 
(Scheme 6 b) and Ugi reactions of dicarboxylic acids or diamines in order to screen 
for compounds mimicking the hormone erythropoietin (EPO).[119] In a screening 
approach of the crude reaction mixtures, several promising compounds were identified. 
Reviews including further examples of the Passerini reaction in medicinal and 
combinatorial chemistry are present in literature.[115,118,121,122] 
 
2.1.2.2 The Passerini reaction in polymer science 
 
An early example of the Passerini reaction applied in polymer science was reported by 
Meier et al. in 2011.[123] For instance, the Passerini reaction was employed to 
synthesize several α,ω-diene monomers (Scheme 7 a) derived from undec-10-enoic 
acid (obtained from ricinoleic acid, a renewable fatty acid from castor oil). These 
monomers were subsequently utilized in an acyclic diene metathesis polymerization 
(ADMET) to obtain the corresponding polymers. Additionally, the Passerini reaction 
a 
b c 
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can be used as a multi component-step-growth polycondensation of dicarboxylic acids, 
dialdehydes and isocyanides (AA- and BB-type monomers, see Scheme 7 c).[68,123] 
Besides AA- and BB-type monomers, AB-type monomers were also employed in the 
Passerini polyaddition. Therefore, a bifunctional monomer equipped with a carboxylic 
acid and an aldehyde functional group (prepared via thiol-ene addition of 
undec-10-enal and 3-mercaptopropionic acid) was polymerized upon the addition of 
an isocyanide.[46] 
 
Scheme 7. Early examples of the Passerini reaction in polymer synthesis. a, for monomer synthesis. b, 
as post-polymerization modification tool. c, Passerini step-growth polymerization employing diacids, 
dialdehydes and isocyanides.[68,123] 
The Passerini step-growth polymerization of sequence-defined macromonomers was 
reported by Li et al.[124] The Passerini reaction also allowed post-polymerization 
modification reactions (Scheme 7 b) on polymers equipped with carboxylic acid side 
chains (via the reaction with isocyanides and aldehydes).[123] Meier and coworkers 
further utilized the Passerini and Ugi reaction for the synthesis of α,ω-diene monomers 
employing 2-(2,2-dimethoxyethyl)phenyl isocyanide (a so-called convertible 
isocyanide), which can be converted into an indole-substituted active amide, thus 
enabling post-polymerization modifications. The active indole amides were reacted 
with different nucleophiles to obtain e.g. carboxylic acids (by hydrolysis in 
tetrahydrofuran/water 10:1), esters (by alcoholysis in tetrahydrofuran/methanol 8:5), 
secondary and tertiary amides (by aminolysis in xylene via triazabicyclodecene (TBD) 
a 
b 
c 
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catalysis), and thioesters (by reaction with thiols) as polymer side groups.[125] Another 
example of monomer synthesis via the Passerini reaction utilizing a convertible 
isocyanide (N-acylindole) was reported by Gianneschi et al.[126] The resulting 
α-hydroxy carboxylic acid monomers were converted to side chain-functionalized 
hemilactides and subsequently copolymerized with dilactide to poly(α-hydroxy acid)-
copolymers.[126] Meier, Hoogenboom, et al. postmodified poly(2-oxazoline)s by 
Passerini and Ugi reactions in order to tune the lower critical solution temperature 
(LCST) of the resulting polymers in water.[127] The Passerini reaction also enabled the 
synthesis of star-shaped block copolymers with various side chains and arm 
lengths[128] and the preparation of dendrimers.[129] Amphiphilic copolymers for potential 
applications in the biomedical field were synthesized by Passerini polymerization in the 
group of Xie.[130] Li et al. described the synthesis of poly(ε-caprolactone)s via Passerini 
multicomponent polymerization of 6-oxohexanoic acid with five different isocyanides 
yielding water-soluble polymers, bearing oligo ethylene glycol side chains.[131] 
Polyacrylates, incorporating a limonene derived sidechain, originating from a 
limonene-based aldehyde (by catalytic oxidation), were prepared by a Passerini 
reaction of the limonene aldehyde with acrylic acid and subsequent free radical 
polymerization of the Passerini acrylate monomers.[132] Another monomer-based 
approach utilized styrene monomers, produced by the reaction of 3-vinylbenzaldehyde 
with different isocyanides and carboxylic acids resulting in a series of 15 different 
(meth)acrylic- and styrene monomers which were subsequently polymerized via 
RAFT.[133] Comprehensive reviews of the Passerini reaction in polymer science can be 
found in literature.[24,25] 
 
2.1.3 The Ugi reaction 
 
The Ugi reaction (discovered 1959 by Ivar Ugi) is another isocyanide-based MCR and 
utilizes, in comparison to the Passerini reaction, an amine as fourth component.[134,135] In 
the Ugi four-component reaction (see Scheme 8) a carbonyl component reacts with 
an amine and initially forms an imine 17. The imine (Schiff base) 17 is activated via 
protonation from the carboxylic acid and then reacts with the isocyanide in an 
α-addition to from an acylated isoamide 18. The intermediate 18 undergoes an 
irreversible Mumm rearrangement[136] to from the thermodynamically favored bis-amide 
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Ugi product 6 displaying four defined side chains, introduced by the four starting 
components. The variation of the precursor components creates molecular diversity 
with minimal synthetic effort.[137] Compared to Passerini products, the Ugi products 
display two amide bonds instead of one ester and one amide bond. Hence, the Ugi 
products are chemically and thermally more stable against hydrolysis than Passerini 
products (due to the amide resonance stabilization). Since the Ugi reaction is assumed 
to proceed via an ionic mechanism, the utilization of polar protic solvents, such as 
methanol, is favorable in terms of reaction efficiency and yields. 
 
 
Scheme 8. Proposed mechanism of the Ugi reaction. Amine and aldehyde from an imine 17, which is 
subsequently protonated. The subsequent α-addition of the isocyanide results in the formation of 18. 
Mumm rearrangement of 18 results in the irreversible formation of the Ugi bis-amide product 6. 
The addition of Lewis acids can promote the Ugi reaction via activation of the imine.[138] 
Experimental evidence for the generally accepted mechanism presented in Scheme 8 
was observed by in situ ESI-MS/MS experiments of Ugi reactions in methanol.[139,140] 
Furthermore, the acylated isoamide intermediate 18 could be isolated.[141] However, 
alternative mechanisms are described in literature. For instance, the α-addition is 
discussed to proceed in a stepwise manner instead of proceeding in a concerted 
fashion, thus allowing two plausible pathways (see Scheme 9): i. first the protonated 
imine reacts with the isocyanide to a nitrilium ion, followed by subsequent addition of 
the carboxylic acid; ii. the carboxylic acid reacts with the activated imine first to a 
hemiaminal, followed by insertion of the isocyanide. Density functional theory (DFT) 
quantum mechanical modelling suggested a protic mechanism in methanol, wherein 
methanol also promotes the Mumm rearrangement. In toluene, a non-ionic mechanism 
18 
17 
6 
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is proposed.[142] Furthermore, a second carboxylic acid molecule was proposed to 
catalyze the rearrangement reaction, similar postulations were previously mentioned 
for the Passerini reaction.[105,106] The aforementioned pathway ii. via the hemiaminal, 
was calculated to be favored for toluene as solvent.[142] Investigations on 
stereoselective Ugi reactions indicated that the reaction of the iminium ion with the 
carboxylic acid is probably the stereo directive step.[107] 
 
Scheme 9. Stepwise α-addition proceeding via an ionic or non-ionic mechanism. 
The utilization of chiral isocyanides, carboxylic acids or carbonyl components did not 
significantly induce enantio- or stereoselectivity. However, chiral glycosylamines 
enable stereoselective Ugi reactions, allowing the synthesis of non-natural 
(R)-α-amino acids.[113,143] Chiral ferrocenylalkylamines could also be employed for 
stereoselective Ugi reactions.[144] Later improvements of this procedure enabled 
reisolation of the chiral auxiliary after mild hydrolysis[145] and heterogenization on a 
solid support.[146] Considering the amine-component, primary and secondary amines, 
hydroxylamines and hydrazine derivatives can be employed.[135] Besides the classical 
four components, a variety of subsidiary components can be employed for Ugi 
reactions (see Scheme 10). In this context water, cyanates, thiocyanates, or 
hydrogensulfides can react in Ugi type reactions (as substitute for the carboxylic acid), 
enabling the preparation of versatile product scaffolds.[135,147] In the so-called Ugi 
five-component reaction (Scheme 10 b) carbamates can be obtained while the acidic 
component is formed in situ by applying carbon dioxide pressure to an alcohol.[148] This 
reaction was reported to be most effective for low molar mass alcohols (e.g. methanol, 
ethanol, trifluoromethanol, allyl alcohol). If higher alcohols were employed, yields 
decreased.[149] The scope of the Ugi five-component reaction was extended to the use 
of carbonyl sulfide (COS) yielding carbamate-thioamides and carbon disulfide (CS2) 
resulting in α-aminothioamides.[149] The utilization of isocyanic acid derivatives leads 
to the formation of hydantoin analogues (Scheme 10 c).[150] In the so-called Ugi-Smiles 
18 
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reaction (Scheme 10 d), phenols substituted with electron withdrawing groups 
(increasing the acidity, e.g. o-nitrophenols) can participate as carboxylic acid 
substitutes.[151] Furthermore, the Ugi-Smiles reaction was described with pyridine and 
quinoline derivatives.[152] In the Ugi-Smiles reaction mechanism, the last step is a 
Smiles-rearrangement instead of a Mumm-rearrangement. 
 
Scheme 10. Variations of the Ugi reaction. a, conventional Ugi reaction. b, Ugi five-component reaction 
employing carbon dioxide or carbonyl sulfide. c, Ugi reaction of isocyanic acid derivatives resulting in 
hydantoins. d, Ugi-Simles reaction of substituted phenols. EWG = electron withdrawing group e, Ugi 
reaction of thiocarboxylic acids. f, Ugi reaction of hydrazoic acid resulting in tetrazoles. 
The Smiles-rearrangement (discovered in 1931) was initially described as a 
rearrangement reaction of hydroxy sulphones to the corresponding sulphinic acids.[153] 
If thiocarboxylic acids (Scheme 10 e) are employed, thioamides can be obtained. The 
reaction of hydrazoic acids (reacting in analogy to carboxylic acids) with isocyanides, 
carbonyl components and amines leads to the formation of 1,5-substituted tetrazoles 
(Scheme 10 f).[154]  
a 
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2.1.3.1 The Ugi reaction in combinatorial and medicinal chemistry 
 
Similar to many other multicomponent reactions, also the Ugi reaction was applied as 
a versatile tool for combinatorial and medicinal chemistry. For instance, 
pyridine-4-carboxy and pyrazine carboxy pharmacophores (also present in the 
antibiotics isoniazid and pyrazinamide, Figure 2) were employed in the Ugi reaction 
as carboxylic acid components. Two libraries of 192 compounds each were produced, 
and the crude materials were tested directly against M. tuberculosis after evaporation 
of the solvents. Compounds with more than 90% inhibition efficiency were 
resynthesized, purified and evaluated again with respect to their minimum inhibitory 
activity (MIC) and cytotoxicity (IC50) against M. tuberculosis.[155] The two best 
candidates of the screening are presented in Figure 2 a. 
 
Figure 2. Selected examples of the Ugi reaction in medicinal chemistry.[118] a, most potent Ugi 
antituberculotic compounds (MIC = 3.13 µg⋅mL-1 for both, IC50 = 31.1 µg⋅mL-1 for left compound and 
27.9 µg⋅mL-1 for the right compound).[155] b, Ugi compound targeting the cowpox virus and Leishmania 
parasites.[156] c, Ugi compounds derived from dicarboxylic acids or diamines mimicking the EPO 
hormone.[119] 
In another Ugi approach, 5-formyl-20-deoxyuridine was employed as aldehyde 
component, resulting in a library of 25 different 20-deoxyuridine Ugi compounds, which 
were tested as antiviral agents (against cowpox) and against protozoa parasites of the 
Leishmania type.[156] A promising compound discovered in this screening is shown in 
Figure 2 b. Furthermore, quinoline containing Ugi compounds were evaluated as anti-
malarial drugs.[157] Dömling et al. synthesized two libraries comprising 88 Ugi 
compounds each, utilizing bifunctional components (dicarboxylic acids or diamines, 
a b 
c 
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see Figure 2 c).[119] This approach was previously described for the Passerini reaction 
in chapter 2.1.2.1. Reviews describing the Ugi reaction in medicinal and combinatorial 
chemistry can be found in literature.[115,118,121,122] 
 
2.1.3.2 The Ugi reaction in polymer science 
 
The Ugi reaction allows the precise installment of four different side chains, which was 
not only appreciated in combinatorial chemistry, but also in synthetic polymer 
chemistry. Due to the modular nature of the Ugi reaction, the properties of monomers 
and the respective polymers can be tuned. Similar to the Passerini reaction, the Ugi 
reaction was utilized to prepare α,ω-diene monomers for ADMET polymerization, 
resulting in highly functionalized polyamides.[48] In addition, the Ugi reaction was 
utilized to prepare functionalized acrylamide monomers, each displaying three different 
side chains.[158] Performing the Ugi reaction with acrylic acid (and different carbonyl 
components, amines and isocyanides) resulted in 14 different monomers, which were 
successfully polymerized via free radical polymerization.[47] Tao et al. employed the 
Ugi reaction under mild conditions for the synthesis of middle-functional block 
copolymers.[67] Similar to other multicomponent reactions, the Ugi reaction was also 
employed as step-growth polymerization method (in this case the polymerization is 
described as a polycondensation due to the imine formation). Meier et al. optimized 
the Ugi polymerization conditions and evaluated different combinations of bifunctional 
and monofunctional components (the Ugi polymerization offers six possible 
combinations of AA- and BB-type monomers e.g. diisocyanide + dialdehyde, diamine 
+ diisocyanide, etc.).[66] Despite the fact that Ugi reactions usually provide the best 
results in methanol, a mixture of tetrahydrofuran/methanol was necessary to prevent 
precipitation of the growing oligomers during the polymerization. Luxenhofer et al. 
investigated Ugi polymerization with respect to the six above-mentioned combinations 
of components for polymers with aromatic moieties, utilizing N-methyl-2-pyrrolidone 
(NMP) as polar aprotic solvent (Scheme 11 a).[159] Besides a classical Ugi four-
component polycondensation, a Ugi five-component polycondensation enabling the 
incorporation of carbon dioxide into the respective polymers was reported 
(see Scheme 11 c).[160] The resulting polymers could subsequently be converted into 
the corresponding poly(hydantoin)s upon treatment with a potassium hydroxide 
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solution, resulting in a decrease of the glass transition temperature (from 37 to 0 °C in 
one example).[160] The direct polymerization of levulinic acid (which otherwise needs to 
be modified prior to polymerization) was reported by Becer et al. utilizing the Ugi 
polycondensation (Scheme 11 b). 
 
Scheme 11. Selected examples of the Ugi reaction in polymer chemistry.[24] a, Ugi polymerization of 
aromatic monomers.[159] b, direct Ugi polycondensation of levulinic acid.[161] c, Ugi five-component 
polycondensation with CO2 and post-polymerization modification to obtain polyhydantoins.[160] 
Levulinic acid can be obtained from renewable resources and displays two functional 
groups participating in Ugi reactions (carboxylic acid and ketone), hence reacting as 
an AB-type monomer in the Ugi polymerization.[161] Another type of AB-type monomers 
in the Ugi reaction was exploited by utilizing natural amino acids resulting in 
polypeptoid structures. In this investigation it was found, that the reaction of α-amino 
acids, such as glycine or alanine, leads to the formation of six-membered rings. 
Nevertheless, lysine (containing an ε-amino group), enabled direct polymerization 
(after α-amino protection with tert-butyloxycarbonyl (BOC)). After the polymerization, 
the BOC protecting groups were cleaved.[162] As for the Passerini reaction, also several 
Ugi approaches were applied for dendrimer synthesis.[163,164] Comprehensive reviews 
on the Ugi reaction in polymer science have already been published.[24,25] 
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2.2 Tandem multicomponent reactions 
 
Tandem reactions (or cascade[37] and domino reactions[165]) are chemical 
transformations involving at least two independent reactions with different functional 
groups participating in either one of the reactions (via distinct or orthogonal chemical 
reactivities).[166–169] Remarkably, in literature the term tandem reaction is not entirely 
used in consistence with the initial definition by Tieze et al.[165] In literature, only a few 
examples of multicomponent tandem reactions are described.[28,170] For instance, 
Portlock et al. described a Petasis-Ugi tandem reaction, forming products with six 
different side chains.[171,172] The group of Al-Tel et al. combined Passerini or Ugi 
reactions with the Groebke-Blackburn reaction in a sequential one-pot procedure.[173] 
Up to eight components were reacted by the combination of three multicomponent 
reactions by Orru et al.[174] In 2010, Westermann et al. combined the Ugi reaction and 
the Ugi-Smiles reaction.[175] Wipf et al. synthesized a library of twelve Biginelli 
compounds and subsequently reacted them with suitable Ugi components under reflux 
in methanol to yield 30 different DHMP amides in 5 – 51% yield.[176] The Biginelli 
reaction has been applied in a multicomponent step-growth polymerization combined 
with the Hantzsch reaction resulting in copolycondensates.[98] Furthermore, the Ugi 
reaction was combined with the Biginelli reaction by Brodsky et al.[177] 
 
2.3 Perfluoroalkyls and fluorous solid phase extraction (F-SPE) 
 
Perfluorocarbon alkyl chains exhibit remarkably different properties if comparison to 
the respective alkane equivalents. The special nature of these perfluoroalkyl chains 
originates from the numerous C-F-bonds. Generally, the C-F-bond is the most 
stable carbon-heteroatom single bond in organic chemistry[178] (C-F-bond energy: 
489 kJ⋅mol-1, C-H-bond energy: 413 kJ⋅mol-1).[179] C-F bonds are dominated by the high 
electronegativity of fluorine, the slightly larger Van-der-Waals radius, the smaller 
polarizability and a higher ionization potential of fluorine compared to hydrogen. 
Furthermore, hydrocarbon chains are likely to form “zick-zack” structures, while in 
contrast, perfluoroalkyl chains are less flexible and tend to adapt helical 
conformations.[180] Hence, perfluoroalkyl chains occupy more space than equivalent 
alkanes (e.g. the volume required for a CF2-group is approximately 38 Å3, whereas the 
Chapter    2    Theory 
 
24  
volume of the CH2 group is ca. 27 Å3).[181] Due to the low polarizability of fluorine, the 
Van-der-Waals interactions between fluorinated chains are comparably weak. 
Consequently, fluorocarbons are characterized by low dielectric constants, high vapour 
pressure and compressibility, low surface tension, high gas solubility and high surface 
activity in aqueous solutions. Perfluorinated substrates do not favour intermolecular 
interactions via Van-der-Waals forces[181] and thus display very weak interactions with 
other molecules. In multi-phasic systems, nonfluorinated solvents preferably interact 
with themselves instead of the perfluorinated molecule (hydrophobic effect, in this case 
entropy is balanced or overcome by enthalpy). Thus, fluorocarbons exhibit the 
interesting property of being both hydrophobic and lipophobic, which leads to the 
formation of triphasic systems. The unique properties of perfluorinated substrates were 
also utilized in the so-called fluorous solid phase extraction method (F-SPE, see 
Scheme 12). 
 
Scheme 12. F-SPE employing fluorous silica gel e.g. FluoroFlash® (-SiMe2(CH2)2C8F17) for the 
purification of F-tagged compounds.[182] 
F-SPE enables the separation of perfluorinated substances based on the concept of 
fluorophilicity (vice versa meaning hydro- and lipophobicity). Fluorophilicity is defined 
as the partition coefficient (ln P) of a substance between equal volumes of 
perfluoromethylcyclohexane (CF3C6F11) and toluene.[183] F-SPE chromatography 
separation protocols were categorised into standard F-SPE and reverse F-SPE. The 
standard F-SPE employs silica gel equipped with perfluorinated alkyl chains as 
stationary phase and non-fluorinated solvents as mobile phase. On the contrary, the 
reverse F-SPE technique utilizes unmodified silica gel as stationary phase and the 
fluorous components are eluted with a perfluorinated eluent (e.g. perfluorohexane or 
perfluorobutyl-methyl ether sometimes blended with ethyl acetate).[184] In the present 
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thesis, standard F-SPE was utilized for the purification of perfluoroalkyl-substituted Ugi 
compounds and is therefore explained in more detail. The fluorous silica gel for 
standard F-SPE is commercially available under several trade names e.g. 
FluoroFlash® or SiliaBond® (synthesized from silica gel and dimethyl[2-
(perfluorohexyl)ethyl]silyl chloride).[185] In standard F-SPE, a mixture containing 
fluorous and a non-fluorous components is separated by first eluting organic non-
fluorous compounds with fluorophobic eluents. Fluorophobic eluents are, e.g. mixtures 
of organic solvents and small amounts of water to reduce the fluorophilicity. Prominent 
examples are methanol/water (4:1), acetonitrile/water (3:2) or pure dimethyl sulfoxide 
(utilized in case a of water sensitive components). This first elution step is called the 
“fluorophobic pass” (illustrated in Scheme 12) and elutes the organic non-fluorous 
fraction. In a following step, the “fluorophilic pass”, the perfluorinated compounds, so-
called fluorous-tagged molecules (F-tag), can be obtained by eluting with a fluorophilic 
solvent (e.g. pure methanol, acetonitrile or tetrahydrofuran), resulting in a fluorous 
fraction. In general, the F-SPE procedure is robust, straight-forward, offers operational 
simplicity, is time efficient and can be implemented in automated systems without great 
effort.[186] 
 
2.4 Sequence-defined macromolecules 
 
Parts of this chapter and following subchapters were adapted from previous passages 
written by the author.[19,21,24] 
Sequence-defined macromolecules are uniform[187] (monodisperse) compounds, 
consisting of different monomers, arranged in exactly defined positions. In nature, 
highly precise sequence-defined macromolecular structures e.g. DNA, proteins, 
enzymes, etc. are essential for life.[188] Hence, non-natural synthetic sequence-defined 
macromolecules are inspired by nature and gained significant scientific interest 
recently, since the properties of polymeric substances directly correlate to their 
molecular structure, composition and molar mass.[19] Precise control allows to achieve 
and adjust new features and functions of synthetic macromolecular architectures, 
facing the increasing demand for tailored materials in polymer science and 
engineering.[189] Sequence-defined macromolecules can potentially exhibit manifold 
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properties, e.g. self-assembly,[190–192] catalytic activity,[193] molecular recognition or 
self-replication,[194] offering numerous possible applications, for instance in data 
storage,[20,195] cell signaling,[196] biocatalysis,[197] and life sciences.[198] Hitherto, the 
synthesis of artificial sequence-defined macromolecules is considered one of the major 
challenges in polymer chemistry.[18] An extensive review on sequence-defined 
macromolecules can be found in literature, wherein different synthetic approaches 
(e.g. liquid phase, solid-phase, fluorous-phase and polymer-tethered synthesis), also 
including conjugated macromolecules, are discussed.[19] Selected examples are also 
presented here. 
Du Prez et al. reported a solid support approach towards sequence-defined oligomers 
based on iterative and thiolactone chemistry (Scheme 13).[199] Two thiolactone 
building blocks and a second isocyanato thiolactone building block were synthesized. 
A 2-chlorotrityl chloride resin (solid support) was functionalized with a thiolactone 
moiety in a coupling efficiency of 53%. 
 
Scheme 13. Macromolecules prepared via thiolactone chemistry. Aminolytic ring-opening of the 
thiolactone releases a thiol, which is subsequently reacted in a thia-Michael addition with an acrylate. 
Chain-extension was achieved by reacting the hydroxyl group with the isocyanato group of the 
thiolactone building block.[199] 
The iterative synthetic cycles employ ring-opening of the immobilized thiolactone using 
an amino alcohol (e.g. ethanolamine or 4-amino-1-butanol) in the first step, releasing 
a thiol group. The thiol functionality is then reacted in situ with an acrylamide or an 
acrylate in a thia-Michael addition. In the second step, chain extension is achieved via 
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the reaction of the hydroxyl group (introduced by the amino alcohol) with the isocyanato 
group of the thiolactone building block. The current strategy enabled the synthesis of 
several sequence-defined decamers, which were prepared by hand manually and by 
automated processes. Compared to the manual approach, the decamers from the 
synthesizer contained small impurities, for instance nonamers or degraded decamers 
(missing the thiolactone unit). The macromolecules were characterized by NMR 
spectroscopy, LC-ESI-MS and HRMS. 
Barner-Kowollik et al. investigated a bidirectional, photochemical approach towards 
sequence-defined macromolecules.[200] A first monomer, equipped with a ortho-methyl 
benzaldehyde (photoenol) and a sorbyl ester group as well as a second monomer, 
equipped with a phenacyl sulfide group and a protected maleimide group, were 
prepared in yields of 59% and 54%, respectively (see Scheme 14 c). 
 
Scheme 14. a & b, Photochemical reactions utilized by Barner-Kowollik et al. for the synthesis of 
sequence-defined macromolecules.[200] c, monomer structures. d, bidirectional growth synthetic strategy 
utilizing reactions a and b. 
A symmetric core unit equipped with two terminal maleimides was reacted with the 
photoenol-sorbyl ester monomer (see Scheme 14 a). The terminal sorbyl ester was 
subsequently reacted with a photochemically activated phenacyl sulfide (second 
monomer) (see Scheme 14 b). The phenacyl sulfide monomers were further equipped 
with a furan-protected maleimide. The furan protective group was removed in a retro-
Diels-Alder reaction, resulting in a terminal maleimide group for further synthetic cycles 
(see Scheme 14 d). A sequence-defined decamer was obtained in seven steps in an 
a 
b 
c 
d 
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overall yield of 1% and analyzed via SEC and MALDI-ToF-MS. The structural variation 
using the afore described photochemical approach was demonstrated by the same 
group utilizing of a set of different monomers.[201] The resulting sequence-defined 
macromolecules were characterized by NMR spectroscopy, UV/Vis spectroscopy, ESI-
MS, SEC and sequenced by MALDI-ToF-ToF-MS. 
An example for sequence-defined macromolecules purified via fluorous separation 
was demonstrated by Anderson et al.[202] In this work, hydroxyproline monomers 
coupled to a F-tag were utilizing in an iterative approach (see Scheme 15). A variety 
of different hydroxyproline blocks were employed in consecutive carbonyldiimidazole-
mediated carbamate formation reactions. 
 
Scheme 15. Fluorous supported synthesis of sequence-defined hydroxyproline macromolecules by 
Anderson et al.[202] CDI: Carbonyldiimidazole. 
Using an automated system and FSPE technique, 14 sequence-defined oligomers with 
three repeating units each were obtained in yields between 14% and 97% and purities 
between 73% and 100% (determined via HPLC). The oligomers were characterized by 
LC-MS and NMR spectroscopy. Moreover, four sequence-defined macromolecules 
with six repeating units were synthesized (91% purity is reported for one representative 
example) and characterized via LC-MS.[202] 
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2.4.1 Sequence-defined macromolecules via multicomponent reactions 
 
This chapter mainly focuses on sequence-defined macromolecules synthesized via 
multicomponent reactions. Multicomponent reactions (MCRs) already proved to be 
very suitable reactions for the preparation of sequence-defined macromolecules and 
contributed to a great extent in this field. MCRs offer the great advantage of introducing 
different defined side chains into a macromolecule by variation of one reacting 
component. The other reacting components allow chain growth utilizing so-called 
iterative approaches, wherein each monomer unit is installed after another, in a 
stepwise fashion (see Scheme 16 a for a three-component reaction, utilizing the 
functional groups A+B+C). 
 
Scheme 16. Iterative step-growth polymerizations via multicomponent strategies for the synthesis of 
sequence-defined macromolecules. a, general reaction scheme of the multicomponent reaction A+B+C. 
b, activation-based approach where the growing chain is reacted with a bifunctional substrate displaying 
an orthogonal reactive site and functional group B. Sequence-definition is achieved by introducing 
different side chains Rx, through variation of the component with functional group C. c, protective group-
based approach. In order to propagate the growing chain, the protective group needs to be removed to 
release functional group B. 
a 
b c 
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For instance, bifunctional monomers equipped with the reactive functional groups A or 
B can be reacted with a third component bearing functional group C (utilizing A and B 
for chain growth, while C introduces different side chains). By variation of components 
(different Rx), sequence definition is achieved, while the degree of 
polymerization/molar mass depends on the number of iterative reaction steps/cycles. 
Iterative approaches require the implementation of orthogonal reactions via e.g. an 
activation step (Scheme 16 b) or a protective group strategy (Scheme 16 c). If a 
synthesis employing more than three components is utilized, additional side chains can 
be introduced within the same reaction step and architectures of higher complexity can 
be generated. In iterative step growth approaches, high yields for the individual 
reaction step are an important benchmark for efficient chain growth, scalability and 
applicability of the overall strategy. Thus, suggesting the use of optimized reaction 
conditions and selective MCRs e.g. the Passerini reaction along with robust purification 
protocols. 
In 2014, Meier et al. introduced an iterative activation-based approach towards the 
synthesis of sequence-defined macromolecules based on iterative Passerini and 
subsequent thiol–ene additions (Scheme 17 a).[45] For the Passerini reactions, 
undec-10-enal was utilized as aldehyde component, which carries a terminal double 
bond enabling orthogonal thiol-ene reactions. Variation of the isocyanide component 
introduced several defined side chains. After each Passerini step, the terminal double 
bond of the unsaturated aldehyde side chain was reacted in a thiol-ene addition with 
3-mercaptopropionic acid, for the introduction of another carboxylic acid to the growing 
chain. After the next Passerini reaction with undec-10-enal and another isocyanide 
component, the iteration of one cycle is completed. Stearic acid was chosen as starting 
acid. After seven steps and purification via column chromatography (after Passerini 
steps) or recrystallization (after thiol–ene additions), a sequence-defined tetramer (four 
different side chains) was obtained in an overall yield of 26% (120 mg, see 
Scheme 17 c).[45] An alternative approach in terms of purification was conducted 
utilizing a soluble poly(ethylene glycol) support equipped with a carboxylic acid 
functional group as starting component. This polymer support enabled simple 
precipitation of the crude reaction mixtures into a solvent with poor solubility for the 
polymer-tethered macromolecules (e.g. cold diethyl ether) for purification (more time 
efficient than column chromatography). This strategy introduced five sequence-defined 
repeating units, in 34% overall yield after nine reaction steps.[45] 
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In another work, an iterative strategy utilizing the Ugi reaction was exploited 
(Scheme 17 b).[203] Due to the application of an amine as fourth component, the Ugi 
reaction enabled the installation of a second side chain to the growing macromolecule 
within the same reaction step. Hence, in every repeating unit, a so-called dual side 
chain control was achieved. 
 
Scheme 17. Activation-based approaches towards sequence-defined macromolecules via 
multicomponent strategies. a, by iterative Passerini and thiol-ene reactions.[45] b, by iterative Ugi and 
thiol-ene reactions.[203] c, structures of the respective macromolecules. 
The first Ugi reaction was conducted with stearic acid as starting point, tert-butyl 
isocyanide and undec-10-enal (again enabling subsequent thiol-ene reactions on the 
terminal double bond) in combination with varying amine components. After each Ugi 
step, the terminal double bond of the unsaturated side chain was reacted with 
3-mercaptopropionic acid in a thiol–ene addition to introduce another carboxylic acid 
moiety. A sequence-defined tetramer with four sequence-defined side chains (derived 
a b 
c 
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from the varying amine components) was synthesized in an overall yield of 15% 
(purification was analogous to the Passerini approach). In a similar approach, both the 
amine and the isocyanide components were varied in each Ugi step (Scheme 17 b), 
resulting in a sequence-defined pentamer equipped with ten defined side chains in an 
overall yield of 15% (Scheme 17 c).[203] The aforementioned deprotection-based 
approach (Scheme 16 c) was explored via combining iterative Passerini- and benzyl 
ester deprotection reactions.[204] For this approach, a monoprotected, linear AB-type 
monomer comprising on the one terminus a benzyl-protected carboxylic acid and on 
the other terminus an isocyanide functional group was employed. The AB-type 
monomer was synthesized in three steps starting from commercially available 
11-aminoundecanoic acid in an overall yield of 63%. The isocyanide-benzyl ester 
monomer was employed in Passerini reactions with varying aldehyde components in 
each iterative cycle, introducing sequence-defined side chains into the growing 
macromolecule (Scheme 18 a). The respective Passerini reaction products (equipped 
with a terminal benzyl ester) were subsequently deprotected by hydrogenolysis with 
hydrogen gas and a heterogeneous palladium catalyst immobilized on activated 
charcoal to obtain a terminal free carboxylic acid (enabling further Passerini reactions). 
The products after each Passerini step were purified via column chromatography on 
silica gel, while the hydrogenolysis products were simply isolated by filtering off the 
heterogeneous catalyst. A sequence-defined macromolecule with ten different side 
chains (decamer, structure in Scheme 18 b), synthesized in 19 steps was obtained in 
an overall yield of 44%. In the Passerini step, an unsaturated aliphatic side chain was 
introduced via the aldehyde component for a subsequent self-metathesis reaction, 
resulting in a sequence-defined symmetric icosamer.[204] 
In 2017, Meier and Du Prez et al. combined the activation-based Passerini/thiol-ene 
approach with the thiolactone strategy described previously. In this approach, a 
thiolactone-carboxylic acid monomer was employed as starting material for iterative 
Passerini/thiol-ene reactions, resulting in a set of four different sequence-defined 
trimers. The thiolactone terminated trimers were subsequently subjected to an 
aminolytic ring opening reaction and reacted in situ with an acrylate-isocyanide 
monomer, to from four different sequence-defined pentamers. 
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Scheme 18. Protecting group- and monomer-based approach towards sequence-defined 
macromolecules via multicomponent strategies. a, iterative Passerini and hydrogenolytic benzyl ester 
deprotection reactions. b, structure of the respective macromolecule (decamer).[204] 
These isocyanide-acrylate terminated pentamers acted as a modular building blocks 
for the previously described Passerini/thiol-ene system, resulting in a macromolecule 
displaying 15 sequence-defined side chains.[205] Besides the activation or protecting 
group approaches described in Scheme 16, other orthogonal strategies can be 
employed for the synthesis of macromolecules. A selective Passerini approach utilizing 
4-formylbenzoic acid and 4-isocyanobenzoic acid with aliphatic isocyanides and 
aldehydes was reported in 2017. The concept is based on a kinetic “chemoselectivity” 
claiming that aliphatic aldehyde and isocyanide groups react faster than aromatic 
analogs in Passerini reactions.[206] In 2018, Becer et al. investigated the Ugi reaction 
for sequence-defined peptide–peptoid hybrid structures synthesized on a solid 
support. Amongst other methods, the resulting macromolecules were analyzed via 
high resolution mass spectrometry and fragmented via tandem-MS.[207] 
 
a b 
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2.5 Data storage and encryption methods in combination with chemistry 
 
Parts of this chapter and following subchapters were adapted from previous passages 
written by the author.[24,208,209] 
 
2.5.1 Data storage devices utilizing molecular architectures 
 
In nature, deoxyribonucleic acid (DNA), proteins, special oligosaccharides and other 
sequence-defined macromolecules fulfill many different purposes essential for life. 
DNA carries the genetic code, encoded in form of nucleobases, and can be considered 
as a biological information storage system. Every form of life known has a similar set 
of four nucleobases (adenine, cytosine, guanine and thymine for DNA or uracil instead 
of thymine for RNA) combined into macromolecular strands. The distinct sequence of 
nucleobases acts as the information storage (Figure 3 b). In contrast to nature, today’s 
information technology utilizes the binary system (originating from switches, whereby 
1 triggers on and 0 off). Common (and historical) employed electronic information 
storage systems such as e.g. hard drives or optical storage media, utilize the binary 
system to store information in sequences of 0 or 1 (Figure 3 a). In general aspects, 
data storage systems (natural and electronic) share common characteristics, for 
instance, systematic repeating units (1 and 0, or the four nucleobases) are combined 
to longer sequences in order to store information. For a comparison of different data 
storage systems, the total number of permutations is an important benchmark, taking 
the following considerations into account: a sequence of eight binary digits = 1 byte = 
8 bits = 28 = 256 permutations; storing 256 permutations in a DNA molecule (coding 
with four nucleobases in a quaternary system 4n) would theoretically require a 
sequence of only four nucleobases (44 = 256). However, the so-called Shannon 
information capacity[210] of one nucleotide is lower than two bits and equals 
approximately 1.83 bits, due to the fact that not all possible combinations of nucleotides 
can be realized (e.g. long DNA homopolymers such as poly(adenine) or DNA 
macromolecules containing a high content of repetitive guanine or cytosine units are 
currently challenging to synthesize and analyze).[13] Sequence-defined 
macromolecules are attractive candidates for information storage and were 
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investigated utilizing DNA.[5,10,13] In 2017, Erlich et al. reported a so-called DNA 
fountain data storage architecture encoding 2.1 MB (featuring 72,000 oligo-
nucleotides, 32 byte each, coding 1.57 bits per nucleotide). DNA storage systems 
highly benefit for the well-established amplification methods, such as the polymerase 
chain reaction (PCR),[211,212] as well as from highly developed analytical readout 
methods.[213–215] The human genome in comparison consists of approximately three 
billion base pairs, equaling six billion bits (assuming two bits per nucleotide) leading to 
a storage capacity of 715 MB (which is surprisingly low).[216] This value does of cause 
not represent the complexity of human life in any means (a tomato genome for instance 
features 900 billion base pairs which equal approximately 1.07 GB).[217] Even though 
DNA features many advantages for data storage, there are also certain drawbacks as 
for example long term stability, because DNA can degrade in the presences of 
nucleophiles, electrophiles, water, metal ions, etc.[11,12] Another jet theoretical problem 
concerns the choice of the DNA (the information storage of life): the data encoded in 
DNA can accidentally (or even on purpose) encode virus sequences, which might not 
only affect computer systems[13] but also be pathogenic to living organisms. 
Non-natural sequence-defined macromolecules enable the use of different chemistry 
protocols offering new perspectives and opportunities for synthetic and analytic 
methods, thus overcoming the limitations of DNA-based data storage systems. In 
literature, non-natural information-coding macromolecules employing either two 
varying components (Figure 3 c, coding in a binary system, providing one bit per 
repeating unit)[218–222] or four varying monomers[201] (two bits per repeating unit) were 
described (Figure 3 d). In 2017, Lutz et al. demonstrated the synthesis and readout of 
a macromolecule encoding 64 bits in total. The read out was performed via mass 
spectrometry and simplified by so-called inter-byte fragmentation mediated by exactly 
positioned mass tags.[218] In another approach, the same group prepared digital 
macromolecules via orthogonal iterative pathways based on successive 
phosphoramidite and radical-radical coupling steps. In this fashion digital 
poly(alkoxyamine phosphodiesters) were obtained, coding 16 bits in total. The readout 
for data-extraction was simplified by favoring the formation of MS/MS fragments 
containing two bits instead of one.[223] Additional approaches also employed non-
natural sequence-defined macromolecules,[201,218–222,224–226] polymeric materials[227] or 
molecular memory and processing devices[228] as potential data storage devices. The 
Passerini reaction is a versatile tool in polymer chemistry[24] (see chapter 2.1.2.2) and 
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was also utilized for the synthesis of sequence-defined macromolecules (see 
chapter 2.4). In the Passerini approach described in Scheme 18, one varying 
component per repeating unit was introduced, while choosing from ten different 
aldehyde components. Formally, the respective repeating units encode three bits, 
however, the macromolecules were not sequenced/read out or regarded in the context 
of data storage at that time.[204] 
 
Figure 3. Comparison of selected macromolecules and the theoretical information content per repeating 
unit. a, the binary system. b, DNA/RNA coding within sequences of four different nucleobases, each 
nucleobase theoretically encodes two bits. c, non-natural macromolecules[222] with one varying 
component per repeating unit: left,[218,219] middle,[220] and right.[221] d, non-natural macromolecules 
utilizing four monomers.[201] e, sequence-defined macromolecules synthesized via the Passerini reaction 
utilizing ten varying components, each repeating unit formally encodes three bits, however, the 
sequences were not read out.[204] The theoretical bits per repeating unit were calculated by: Log(Number 
of possible permutations)/Log(2). The theoretical storage capacity of a macromolecule is calculated as 
follows: bits per repeating unit × total number of repeating units. 
The Ugi approach described in Scheme 17 led to sequence-defined macromolecules 
with two varying components per repeating unit, while choosing from five different 
isocyanides and five different amine components (in total ten components, thus also 
a 
b 
c 
d 
e 
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encoding three bits per repeating unit, however the macromolecules were not read out 
or considered for data storage at that time).[229] 
 
2.5.2 Secret communication via molecules 
 
In today’s digital world, data security, in all facets ranging from every day applications, 
professional environments to espionage, is of great importance. Even though the goal 
of ultimate security is unreachable, constant progress and advances in the fields of 
cryptography and steganography, evolving with the possibilities and demands of new 
technologies on the one hand and the steadily increasing capabilities of adversaries 
trying to hack data on the other hand, is required. The term cryptography is a 
composition of κρυπτός (Greek) [kryptós], meaning “hidden, secret" and γράφειν 
[graphein] "writing". Today, cryptography is referred to as the science and art of secure 
coding and decoding of information. A main purpose of cryptography is encryption, i.e. 
to convert messages or data in readable form into unintelligible ciphertexts that can 
only be decrypted by a person possessing the dedicated decryption key (see 
Scheme 19). Cryptography can be dated back to ancient Egypt (3000 BC), where 
standard hieroglyphs where simply replaced by a different and unusual hieroglyphic 
writing system, which only selected persons could read, thus concealing the 
information.[230] The ancient Greeks used ciphers for coding messages and the Spartan 
military utilized a first encryption/decryption device: the Scytale.[231] 
 
Scheme 19. Schematic representation of symmetric cryptography. 
The term steganography originates from στεγανός [steganos], meaning "covered, 
concealed, or protected" and γράφειν "writing" (see also above). Steganography, in 
contrast to cryptography, hides the fact that a message is being transmitted: only the 
sender and the receiver know that the message even exists. A major drawback of 
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steganography is that whenever an adversary reveals the fact that steganography has 
been used and knows how to apply the decoding, he is able to obtain the secret 
information.[232,233] Considering cryptography, several state-of-the-art symmetric 
encryption schemes, such as the Advanced Encryption Standard (AES, also known as 
Rijndael),[234] Serpent, or Blowfish can protect data reliably (practicably “unbreakable”), 
but require a secret key (password) for their operation. Practicably “unbreakable”, 
means that the encoded data cannot be accessed, due to today’s physical limitations 
in computing power (if the password is long enough, consisting of random characters 
and remains a secret). An even higher degree of safety is provided by the so-called 
One-time pad (OTP), which is mathematically perfectly secure, and thus also secure 
against hypothetical quantum computers.[235] If used correctly, the OTP crypto system 
cannot be breached, even if the adversary has unlimited computing power and an 
unlimited amount of time. In practice, the OTP encrypts every letter/sign of the initial 
document with an individual substitution code,[236] leading to a key document with the 
same length/number of characters as the secret message. For long messages or large 
files, this generates long keys requiring electronic storage. If the correct key is applied, 
the original message can be decoded, but if not, every other possible combination of 
characters (including any other text with a completely different meaning, but of the 
same length as the initial code) can be generated, rendering the OTP a perfectly 
secure algorithm. This can be illustrated by the following example: the text “Let’s meet 
at 5” has 15 characters. The correct key will generate the correct information, but within 
the space of false keys any other text with 15 characters i.e. “Let’s meet at 1” or also 
“Hi how are you?” can be obtained. A major weak spot of cryptographic systems is the 
key itself, i.e. the storage of the key in an electronic document as well as the 
transportation/distribution of the key. The secret key (i.e. the password) must be known 
by both the encryptor and the decryptor and be chosen uniformly at random. An 
adversary trying to decrypt the hidden information can steal the key, copy the key, or 
even restore information from an allegedly erased or even destroyed digital storage. 
Thus, the password/key is one of the most vulnerable parts in modern encryption 
systems, leaving room for improvements. Secret encryption keys are typically short 
(e.g. 128 bits), but it is not a priori clear how encryptor and decryptor exchange/receive 
common secret keys. The methods utilized to distribute secret keys today involve 
asymmetric cryptography e.g. the Diffie-Hellman key exchange scheme, or key 
transport based on the Rivest–Shamir–Adleman cryptosystem (RSA).[237] Asymmetric 
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cryptography is considerably less efficient than symmetric cryptography. Furthermore, 
state-of-the-art asymmetric encryption schemes require specific algebraic structures, 
and are thus potentially more prone to attacks via structured cryptanalysis.[237] For a 
higher degree of data security, decryption keys can be concealed by steganography 
and be hidden i.e. via chemicals.[232,238,239] The general idea to employ chemicals for 
secret communication dates back to the first uses of secret inks.[240] Nowadays, more 
sophisticated methods for chemical secret communication systems are discussed, e.g. 
fluorescent materials[241–247] or multi-analyte fluorescent molecular sensors.[238,248–250] 
In 2015, Margulies et al. presented an inspiring system based on two fluorescent 
molecules (one example is displayed in Figure 4) that can act as a sensor to “chemical 
input” (i.e. addition of different chemicals at different concentrations).[238] The authors 
demonstrated that messages can be encrypted by sequentially adding various 
chemicals to the fluorescent molecules, thereby analyzing characteristic emission 
patterns recorded between 500 to 700 nm. The chemicals modulated the emission 
pattern by interactions with certain functionalities in the cis-amino proline molecule 
displayed in Figure 4 e.g. the three spectrally overlapping fluorophores: nile blue 
(Figure 4 a), sulforhodamine B (Figure 4 e) and fluorescein (Figure 4 g), serving as 
fluorescence resonance energy transfer (FRET) donor/acceptor system. 
 
Figure 4. Molecular cis-amino proline scaffold sensor. a, solvatochromic nile blue; b, boronic acid; c, 
dipicolylamine; d, sulfonamide; e, sulforhodamine B; f, thiourea and g, pH-sensitive fluorescein. 
The fluorescein emission is highly pH dependent,[251] whereas deprotonation of the 
fluorescein moiety can enable the phenolic ligand to coordinate metal ions.[252] 
a 
b 
c 
d 
e 
f 
g 
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Solvatochromic sulforhodamine B can interact with DNA and non-polar analytes.[253] In 
addition, the sensor molecule includes various other chemical recognition elements 
e.g. boronic acid (Figure 4 b) and dipicolylamine (Figure 4 c) groups. The boronic 
acid provides an affinity e.g. towards saccharides[254] and dipicolylamine to metal 
ions,[255] respectively. Moreover, dipicolylamine–metal ion complexes are known to 
interact with phosphate anions.[256] The thiourea (Figure 4 f) and sulfonamide 
functionalities (Figure 4 g) can additionally serve as metal ion-recognition sites,[257–259] 
but also as anion and hydrogen-bonding motifs.[260–262] Additional chemical recognition 
sites in the sensor molecule could be formed after binding of certain analytes and 
supplementary interactions may include hydrogen bonding (e.g. of the amides or 
carboxylic acid functional groups) and hydrophobic interactions (π-stacking of aromatic 
system). The general idea to utilize fluorescent compounds or materials for data 
encryption has also been investigated by others.[241–247] In addition, DNA was utilized 
for secure communication.[263–267] Molecular logic gates,[268–273] molecular computing 
systems[274–276] and systems for authorizing password entries[277–286] also contributed 
to the filed. Other investigations employed NMR chemical shifts,[287] microorganism 
colonies,[288] antibodies,[289] 3D photonic crystals[290] and molecular tags.[291] 
 
2.6 Mass spectrometry and ESI-MS 
 
The history of mass spectrometry dates to the late 19th century when Thomson first 
described the e/me determination via a cathode ray experiment.[292] For his 
contributions to the nature of the electron by “theoretical and experimental 
investigations on the conduction of electricity by gases”, he was awarded the Noble 
Prize in physics in 1906.[293] The first mass spectrometers developed in the early 20th 
century were utilized to measure the mass of atoms and prove the existence of 
isotopes.[294] In 1918, Dempster invented the first electron impact source,[295] in 1946 
Stephens introduced the time-of-flight analyzer (TOF),[296] while in 1953 Paul first 
utilized a quadrupole mass filter and quadrupole ion trap.[297] Later, in 1978, Yost and 
Enke described triple-quadropol mass analyzers and selected ion fragmentation[298] 
and in 1981 Barber developed fast atom bombardment ionization (FAB).[299,300] In the 
1980s, mass spectrometry was well established for the analysis of small organic 
compounds. However, most methods known in the early times of mass spectrometry 
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did not allow the analysis of larger macromolecules such as proteins, carbohydrates, 
oligonucleotides or polymers, mainly due to the ionization methods (requiring 
gas-phase collisions between the analyte and charged species). The challenge of 
transferring larger particles into the gas-phase without decomposition or fragmentation 
was encountered in 1988/89 by electrospray ionization (ESI), developed by Fenn,[301] 
and matrix-assisted laser desorption/ionization (MALDI), developed by Tanaka,[302] 
almost simultaneously. Both methods were honored with the Nobel prize in chemistry 
2002 “for their development of soft desorption ionisation methods for mass 
spectrometric analyses of biological macromolecules". Today, mass spectrometry is 
amongst the most sensitive and most developed analytical methods. In this thesis, 
ESI-MS and ESI-MS/MS experiments were of particular interest and therefore ESI-MS 
be described more into detail. The experimental setup of the utilized Thermo 
ScientificTM Q Exactive PlusTM orbitrap mass spectrometer is illustrated in Figure 5. 
 
Figure 5. Schematic representation of a Thermo Fisher Q-Exactive ESI-MS mass spectrometer. 
First, the sprayer (heated electrospray ionization probe) produces the ions (ionization 
mechanism will be discussed later). The ions enter the heated ion transfer capillary 
trough the sweep cone and subsequently enter the S-lens, where the ions are 
captured, focused into an ion beam and transmitted for increased sensitivity, utilizing 
a variety of electromagnetic lenses arranged in different distances. The injection 
flatapole again focuses the ion beam and partly separates neutrals from ions, thus 
acting as a kind of pre-filter. The bent flatapole enables active beam guiding in order 
to prevent neutral species from entering the quadrupole and hence enhances 
operational robustness. The quadrupole mass filter allows precursor selection 
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(isolation widths down to 0.4 amu) and parallel data acquisition, improving sensitivity 
and selectivity. The higher-energy collisional dissociation (HCD) cell is an ion-routing 
multipole, enabling HCD fragmentation experiments at adjustable preselected collision 
energies through collisions of the precursor ions with neutral inert gases such as 
nitrogen, further facilitating parallel analysis through accumulation and routing of 
ions.[303] Despite the name higher-energy, the collision energies are comparably mild 
in range of 10 – 50 eV. The C-trap focuses the ions, stabilizes their movement 
(sometimes also referred to cooling down the ion speed) and injects them into the 
orbitrap mass analyzer. The ultra-high-field orbitrap mass analyzer offers a resolution 
of up to 450 k (at m/z = 200) and scan speeds of up to 12 Hz for high data quality. In 
the orbitrap, the ions are captured in an orbital motion circulating around the analyzer 
geometry (parallel outer electrode and spindle like inner electrode) in an axial fashion. 
The frequency of rotations (frequency of radial oscillations i.e. distance of the ions to 
the middle spindle electrode, frequency of axial oscillation i.e. velocity of the ions 
moving axially along the spindle electrode and frequency of rotation) are related to the 
m/z via a Fourier transformation (FTMS) of the image current generated by the axial 
oscillation of the ions.[304,305] 
For ionization, the analyte solution is distorted into a Taylor cone that emits a fine spray 
(usually assisted by a coaxial gas flow) producing droplet radii in the micrometer range 
(see Figure 6 a). The fine dust of highly charged micro aerosol droplets evaporates 
rapidly in the present conditions of high temperatures and externally applied gas flow. 
In positive mode, the droplets are positively charged mainly due to the presence of 
excess cations that, for instance, include H+ (originating from acidic media and/or 
generated at the metal to solution interface inside the capillary via reactions, such as 
e.g. 2 H2O → 4 H+ + 4 e− + O2), Na+, K+, NH4+, etc. The charge density of the micro 
droplets steadily increases due to shrinking of their volume until the Coulombic 
repulsion is balanced by surface tension (so-called Rayleigh limit). Disruptions of this 
equilibrium state cause spontaneous droplet fission. Repetitive cycles of droplet 
evaporation and fission ultimately lead to the generation of nano-sized droplets 
enabling final analyte ionization. The exact electrospray ionization mechanism, i.e. ions 
escaping the micro droplets into the gas-phase, is not fully understood yet, but 
plausible explanations can be found in literature.[306–315] Three plausible mechanisms 
are presented in Figure 6 b – d. Low molar mass analytes are considered to follow the 
so-called ion evaporation model (IEM) where the cationic charge typically results from 
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protonation in solution. Molecular dynamic simulations suggested that the electric field 
emanating from a Rayleigh-charged ESI nanodroplet is sufficiently high to induce 
ejection of small solvated ions from the droplet surface. During the ejection process, 
the cations remain shortly connected to the droplet by a bridge of solvent molecules 
(Figure 6 b middle). The primary IEM product is assumed to be a tiny gas-phase atom 
cluster, consisting of the analyte cation and a few residual solvent molecules, which 
are subsequently removed via collisions with other species e.g. background gas 
(Figure 6 e). 
 
Figure 6. Proposed ESI ionization mechanisms. a, schematic illustration of the electrospray process of 
droplet formation, the blue bended arrow illustrates the generation of ions in the gas-phase. b, small 
analyte ion ejection from a charged nanodroplet into the gas-phase (IEM). c, release of a globular 
macromolecule ion (i.e. protein) into the gas-phase through evaporation of all solvent molecules (CRM). 
d, ejection of an unfolded macromolecule into the gas-phase (CEM). e, collision-induced dissociation of 
a gaseous multianalyte/analyte solvent complex. 
Larger, globular species e.g. folded proteins can ionize via the so-called charged 
residue model (CRM). In CRM, the surrounding solvent molecules of Rayleigh-charged 
ESI nanodroplets, containing globular analyte cations, evaporate completely. Hereby, 
the positive charge of the nanodroplet is transferred to the analyte. Experimental 
evidence for CRM originates from the observation that ESI of globular proteins 
produces cations with compositions close to [M + n H]n+, where n is the Rayleigh 
charge of the corresponding nanodroplets.[309,311,316,317] The folding behavior of 
macromolecular species in solution is determined by intra molecular interactions vs. 
intermolecular interactions of the macromolecules with solvent molecules. The latter 
effect depends on several factors such as polarity, pH, hydrogen bonding capabilities 
b 
c 
d 
e 
a 
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and other intermolecular interactions leading to folded globular macromolecular 
species or unfolded macromolecular species. The ionization of unfolded, disordered 
macromolecular conformations is proposed to follow the so-called chain ejection model 
(CEM) from Rayleigh-charged nanodroplets (see Figure 6 d). The following 
considerations were suggested by molecular dynamic simulations.[318,319] The unfolded 
macromolecule firstly migrates to the droplet surface. Subsequently, a chain terminus 
exits the nanodroplet and is expelled into the vapor phase (Figure 6 d middle), 
followed up by sequential ejection of the remaining macromolecular segments, 
resulting in complete ionization.[306] 
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3 Goals/Aims 
 
The main objective of this investigation was the conceptional and practical application 
of multicomponent reactions as tools for the preparation of potential molecular data 
storage devices. This thesis has three main foci: 
 
● Investigation of perfluoro-tagged Ugi compounds, evaluation of their storage 
capacity, analysis via tandem-MS and application as molecular cryptography 
keys. 
● Method development for the combination of the Biginelli and the Passerini 
reaction and subsequent synthesis of compounds incorporating up to five 
varying components. 
● Synthesis of bifunctional AB-type monomers via sequential Biginelli and 
Passerini reactions and the establishment of a chemical test system for the 
application of these monomers. Subsequently, the monomers were employed 
for the synthesis of sequence-defined, data encoding macromolecules via an 
iterative step-growth polymerization. High resolution tandem mass 
spectrometric analysis of the macromolecules in order to determine their 
chemical structure and thus read out the information. 
 
The chapters in the following results and discussion part were ordered according to 
increasing synthetic complexity: moving from one multicomponent reaction to the 
combination of two multicomponent reactions and finally to sequence-defined 
macromolecules.  
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4 Results and discussion 
 
4.1 Molecular cryptography: Multicomponent reactions are the key 
 
Parts of this chapter and following subchapters were adapted from previous passages 
written by the author.[208] 
 
Figure 7. Graphical abstract for the investigation presented in chapter 4.1.[208] 
As previously described in chapter 2.5.2, hiding of secret cryptography 
keys/passwords by steganography i.e. via chemicals leads to a higher degree of 
security.[232,238,239] Chemical compounds utilized as cryptographic keys are referred to 
as molecular keys, respectively. Although the number of chemical compounds known 
today is tremendously large and steadily growing, the application of a chemical 
compound as molecular key is limited considering the following requirements: for the 
chemical design of molecular keys a systematic synthetic protocol should be 
employed, providing compounds with high structural complexity. Furthermore, simple, 
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robust and reproducible procedures should be applied. The molecular keys should be 
chemically and thermally insensitive and designed for simple isolation, purification and 
analysis. Multicomponent reactions (MCR) represent highly suitable synthetic tools to 
provide molecular keys, fulfilling these criteria. The Ugi reaction was especially 
appealing, since four components are combined to a single reaction product in a one-
pot reaction (offering all advantages presented in chapter 2.1).[100] The respective Ugi 
products display four individually defined side chains (R1-4, introduced by the four 
starting components), which can be easily varied in order to create molecular diversity 
with minimal synthetic effort (previously utilized for combinatorial approaches, see 
chapter 2.1.3.1).[48,137,320] 
 
Scheme 20. General reaction scheme of the Ugi reaction and the scope of possible Ugi compounds 
considering all permutations. The number of all permutations is calculated as follows: number of possible 
carboxylic acid components (a) × number of possible amines (b) × number of possible aldehydes (c) × 
number of possible isocyanides (d). 
A hypothetical library consisting of the Ugi compounds derived from ten varying 
carboxylic acids, ten aldehydes, ten isocyanides and ten amines would comprise 10 × 
10 × 10 × 10 = 10,000 different compounds in all permutations. The 10,000 
permutations equal approximately 13 bits (calculation: Log(104)/Log(2)=13.29). 
However, in order to convert the chemical information (combination of starting 
components introducing different side chains to the respective Ugi compounds) into 
processable alphanumerical codes, a procedure was required. The assignment of 
chemical information (i.e. reacting components of the Ugi reaction introducing the side 
chains of the respective molecular keys) to alphanumerical codes (i.e. systematic 
combinations of letters, numbers and special characters) is performed with a table, 
called the list of components. In the list of components, every functional group 
participating in the Ugi reaction is assigned to a letter (e.g. aldehydes → letter A; 
isocyanides → letter B, etc.). The different side chains within the same category of 
functional groups are counted with arbitrary numbers e.g. benzaldehyde → A(001), 
butyraldehyde → A(003), …; tert-butyl isocyanide → B(001), …). This assignment 
system, comprised in the list of components, is highly flexible and the alphanumerical 
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assignment can be exchanged or adjusted if necessary, which is highly beneficial in 
the field of secret communication. An exemplary short list of components can be found 
in Table 2. The full list is provided as supplementary information in the corresponding 
publication[208] and also provided in the digital from with the submitted thesis. 
 
Table 2. Selected entries from an exemplary list of components 
Name Structure Formula 
Alphanumerical 
code 
Monoisotopic 
mass [Da] 
Perfluoropentanoic 
acid 
 
C5H1F9O2 A(001) 263.98328 
Perfluorononanoic 
acid  
    C9H1F17O2 A(005) 463.97051 
Isopropyl isocyanide 
 
C4H7N1 B(001) 83.07350 
Pentylamine 
 
C5H13N1 C(007) 87.10480 
Benzaldehyde 
 
C7H6O1 D(007) 106.04186 
Additional information, such as e.g. a SMILES code for visualizing the molecular structures, or a 
chemical supplier can be added. The full list of components can be found as supplementary information 
along with the previously published work[208] and is also included in the electronic version of this thesis. 
For exploring the synthetic potential of the Ugi reaction, an evaluation based on 
previously reported literature was performed in order to identify suitable components 
for the list of components. Regarding possible side reactions (and modifications of the 
Ugi reaction discussed in chapter 2.1.3), a set of limitations considering the reacting 
components was established. In this context, aldehydes were chosen as carbonyl 
species exclusively, because of the higher carbonyl activity and better reactivity in Ugi 
reactions compared to ketones. Nevertheless, the scope of carbonyl components 
reported for Ugi reactions potentially allows to utilize many more components than the 
aldehydes selected for this investigation. Generally, the reacting components need to 
fulfill further requirements which are illustrated in Figure 8. The components should 
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display only one functional group participating in the Ugi reaction (e.g. a carboxylic acid 
and an aldehyde functional group should not be combined in the same component, 
otherwise polymerization might occur, see 2.1.3.2). The components should also not 
contain moieties which are highly redox sensible, photosensitive, hydrolyzed or 
decomposed under the conditions of the Ugi reaction or in the presence of protic 
solvents like methanol or water. Functional groups prone to cause side reactions with 
the other substances/solvents involved in the Ugi reaction were also avoided. 
Furthermore, electron-poor phenols (i.e. nitro-substituted) were avoided due to the 
potential Ugi-Smiles reaction (acidic phenol reacts as an acid component).[151] 
 
Figure 8. Limitations that should be considered when setting up a list of components.[208] 
As the analytical method of choice, high-resolution mass spectrometry (see chapter 
2.2) in combination with tandem-MS fragmentation experiments was selected and 
thus, the components in the same category of functional groups should not include 
isomers (same monoisotopic mass).[321] In principle, isotope labeled components can 
be beneficial for MS experiments, but were also excluded from the list of components. 
Considering the literature survey and the requirements stated above, an exemplary list 
of components, including ten perfluorinated carboxylic acids, 50 aldehydes, 50 amines 
and 20 isocyanides, was compiled. All components chosen for this list are 
commercially available and selected in order to react selectively to the desired Ugi 
products. These 130 components can potentially be combined to 10 × 50 × 50 × 20 = 
500,000 different molecular keys. This virtual library of 500,000 permutations formally 
corresponds to an information density of approximately 18 bits per molecule 
(Log(500,000)/Log(2)=18.93). The possible number of components for the list of 
components are theoretically only limited by the availability of components suitable for 
the Ugi reaction and can therefore easily be extended beyond the set of commercially 
available compounds.  
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4.1.1 Ugi reactions of perfluorinated acids  
 
Considering the molecular design, the molecular keys were equipped with a 
perfluorinated side chain (also called F-Tag), enabling a highly simplified purification 
via Fluorous Solid Phase Extraction (F-SPE, see chapter 2.3).[186,322] F-SPE retains 
perfluoro-tagged molecules selectively and can hence separate the molecular keys 
from contaminations and/or matrix materials. The F-tags were introduced via the 
utilization of perfluorinated acid components in the Ugi reaction. For performing the Ugi 
reactions of perfluorinated acids, methanol was chosen as solvent because Ugi 
reactions are reported to proceed efficiently in methanol and moreover because 
methanol is readily dissolving perfluorinated acids (methanol is also utilized for 
collecting the fluorous fractions in F-SPE). A reaction optimization of the Ugi reaction 
presented in Scheme 21 revealed that it is efficient to perform the imine condensation 
prior to the addition of the other components. For the imine condensation, 
equistoichiometric amounts of aldehyde and amine were stirred for one hour over 
sodium sulfate (in order to remove the water formed during the condensation process). 
 
Scheme 21. Optimization of the Ugi reaction of perfluorononanoic acid, benzaldehyde, tert-butyl 
isocyanide and butylamine resulting in compound 19. 
Subsequently, the perfluoro acid dissolved in a minimal amount of methanol, was 
added to the imine and the resulting mixture was stirred for 2 min. The isocyanide was 
added last into the stirring reaction mixture. The reaction progress was followed by 
TLC. Further optimization revealed that an excess of components provides higher 
yields (best results were achieved employing 1.70 eq. of aldehyde, amine and 
isocyanide with respect to 1.00 eq. of perfluoro acid). The purity of the isolated material 
after chromatography was confirmed by GC-MS (Figure 9 a).  
19 
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Figure 9. a, GC-MS, chromatogram of a representative molecular key (compound 19). The respective 
MS data of the intense signal at 11.5 min retention time (99%) are displayed in c. The MS data of the 
weak signal at 10.6 min retention time (1%) are displayed in b. b, MS spectrum of the weak signal (1%) 
at 10.6 min retention time, the m/z species are assigned in d. c, MS spectrum of the intense signal 
(99%) at 11.5 min retention time, the m/z species are assigned e. d, fragment assignment of the weak 
signal at 10.6 min indicates the presence of a Ugi compound with a shorter perfluorinated side chain. 
This impurity (originating from a shorter perfluorinated acid) was already present in the starting material 
and did not interfere with other analytical methods and the readout. e, fragment assignment of the 
intense signal at 11.5 min.[208]  
< 
a 
b  (assigned in d) c  (assigned in e) 
 
d 
e 
see b 
see c 
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The intense signal at 11.5 minutes retention time corresponds to the desired Ugi 
compound 19, the relative integral is 99%. The small impurity (1%) at 10.6 minutes 
retention time originates from a species with a shorter perfluorinated sidechain 
(5 × CF2 instead of 7 × CF2). This impurity was formed because a shorter 
perfluorinated acid component was present in the precursor material (ordered and 
used as received). The respective MS data and the assignment of the m/z species is 
presented in Figure 9 b - e. However, since the amount of impurity is small, no 
interference with other analytical methods or the tandem-MS readout was observed. 
The chemical identity of the reaction product was confirmed via 1D and 2D NMR 
spectroscopy. 
 
Figure 10. Representative NMR analysis of 19. a, 1H-NMR, the respective signal assignment was 
performed with respect to additional information obtained from 2D NMR experiments. b, 19F-NMR stack 
of the precursor perfluorononanoic acid (top) and the Ugi compound (bottom). The expansion magnifies 
the two AB signals of the CF214 group (two species caused by restricted rotation) next to the newly 
formed amide bond.[208] 
The 1H- and 19F-NMR spectra showed an interesting signal splitting, probably due to 
restricted rotation (analogous to peptides). The restricted rotation theory was further 
supported by nuclear Overhauser enhancement and exchange spectroscopy 
(NOESY), indicating chemical exchange of the rotamers in solution.[208] In the 1H-NMR 
spectrum (Figure 10 a), split signals can be observed for the protons on the CH1 and 
NH6 positions resulting in a split signal between 5 – 6 ppm, with a relative integral of 
two, that does not couple to other protons, as indicated in the correlated spectroscopy 
experiment (COSY, Figure 11 b). Regarding the stacked 19F-NMR spectra 
(Figure 10 b) of the molecular key (bottom) compared to the 19F-NMR spectrum of the 
precursor perfluorononanoic acid (top), the molecular key displays two new AB signals 
(magnified in the expansion view). The AB signals originate from the CF214 group next 
to the newly formed amide bond. The 13C-NMR (Figure 11 b, bottom) signal for the 
quaternary C12 is weak in intensity compared to the C5, probably due to 3J(C-F) coupling 
a b 
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with the vicinal CF214. The 13CF signals of the perfluorinated chain are also weak in 
intensity and barely visible, due to the numerous C-F couplings. The distortionless 
enhancement by polarization transfer experiments (DEPT90 and DEPT135, see 
Figure 11 b) confirm the proposed signal assignment. The heteronuclear single 
quantum coherence spectroscopy experiment (HSQC) displays all carbon bonded 
protons via 1J(C-H) correlations (Figure 11 c). The heteronuclear multiple bond 
correlation spectrum (HMBC, Figure 11 d) displays correlations between carbons and 
protons that are separated by two, three and sometimes even four bonds (i.e. in 
conjugated systems). The HSQC and HMBC experiments were both utilized in order 
to elucidate and confirm the molecular structure. 
 
 
Figure 11. Representative NMR analysis of 19. a, Top: DEPT135 experiment: CH and CH3 positive, 
CH2 negative. Middle: DEPT90 experiment CH positive. Bottom: 13C-NMR. b, COSY experiment. c, 
HSQC experiment confirming the structure. d, HMBC experiment confirming the signal assignment for 
the carbon and proton signals.[208] 
Subsequent to the identification of the reaction product 19 and understanding of the 
split NMR signals, the scope of possible components was investigated. As proof of 
principle, a sub-library of different molecular keys was synthesized. In this 
investigation, the reacting components, chosen from the list of components, were on 
one hand selected randomly an on the other hand systematically. The systematic 
a b 
c d 
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variation of the different reacting components is illustrated in Figure 12. The axes in 
Figure 12 represent three varying components and thus the side chains of the Ugi 
compounds. The variation is presented in a 3D plot (amines in yellow, isocyanides in 
red and aldehydes in green) for one of the applied perfluorinated acids (here 
perfluorononanoic acid). Each point in the 3D plot represents a synthesized Ugi 
compound. Two systematic component variations are represented in the expansions 
(Figure 12 c, d). 
 
Figure 12. Molecular keys synthesized with perfluorononanoic acid. a, schematic representation of the 
general reaction equation. b, 3D plot of a subset of compounds. The three axes represent the different 
functional groups. The numbers on the axes assign the different components and side chains, 
respectively. c and d, expansions of the two systematic component variations, enlarged views of the 
red and blue box in b.[208] 
The variation of perfluorinated acids was examined for the shortest and longest 
member of the list of components and is summarized in Table 3. Comparison of the 
results obtained indicated a clear trend towards higher yields for shorter perfluorinated 
acid components, probably due to better solubility of the shorter perfluorinated acids 
in methanol. In the case of long perfluorinated acid components (Table 3 entry 3), 
tetrahydrofuran was added after 30 minutes reaction time because a precipitate was 
formed during the reaction, in order to re-homogenize the reaction mixture. 
  
a 
d 
c 
b 
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Table 3. Ugi reaction with perfluorinated acids of different chain length 
# Ugi compound Yield [%] №  
1 
 
85 20 
 
2 
 
55 19 
 
3 
 
18a 21 
 
Conditions: Reaction in methanol at r.t. for 3 d, 1.70 eq. of aldehyde, amine and isocyanide with respect 
to 1.00 eq. of acid.a During the reaction a precipitate was formed; in order to homogenize the reaction 
mixture, tetrahydrofuran was added. 
The herein investigated variation of components resulted in a library comprising 28 Ugi 
compounds, the results are summarized in Table 4. The respective molecular keys 
were analyzed via 1D and 2D NMR spectroscopy, high resolution mass spectrometry 
(HRMS) and infrared spectroscopy to confirm their chemical identity (the respective 
experimental procedures and analytical data can be found in chapter 6.2). The yields 
reported in Table 4 varied from 85 – 3 %. This discrepancy is correlated to the 
individual combination of components, a well-known phenomenon of Ugi reactions.[323–
325] However, the poor yields for the compounds 22, 36 and 38 were also caused by 
unexpected complications which occurred during purification: these compounds were 
very challenging to visualize on TLC. In this context several staining reagents 
(Seebach, permanganate, iodine, vanillin reagent, etc.) were tested. However, the 
spots on the TLC plates were only barely visible and disappeared very fast. Hence, the 
identification of product containing fractions was complicated. Therefore, the overall 
product recovery after purification was probably incomplete. 
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Table 4. Molecular keys. 
# R1 R2 R3 R4 Yield [%] № 
1 C8F17 C4H9 Ph tBu 55 19 
2 C4F9 C4H9 Ph tBu 85 20 
3 C13F27 C4H9 Ph tBu 18 21 
4 C4F9 C4H9 C4H9  6 22 
5 C8F17 C4H9 C6H13  19 23 
6 C4F9 C4H9 Ph  68 24 
7 C8F17   
cHex 56 25 
8 C8F17    
65 26 
9 C8F17    
40 27 
10 C8F17    
23 28 
11 C8F17   
cHex 34 29 
12 C8F17  Ph 
cHex 15 30 
13 C8F17 C5H11 
 
cHex 25 31 
14 C8F17 C5H11 C4H9 cHex 31 32 
15 C8F17 C5H11 cHex cHex 36 33 
16 C8F17 C5H11 C4H9 tBu 16 34 
17 C8F17 C5H11 Ph cHex 42 35 
18 C8F17 cHex C4H9 tBu 7 36 
19 C8F17 cHex 
 
tBu 19 37 
20 C8F17 cHex 
 
C5H11 3 38 
21 C8F17 cHex 
 
cHex 11 39 
22 C8F17 cHex 
 
Bn 19 40 
23 C8F17   
cHex 69 41 
24 C8F17 C8H17 Ph cHex 14 42 
25 C8F17 C7H15 
 
cHex 25 43 
26 C8F17 tBu C4H9 tBu 17 44 
27 C8F17 Bn C11H23 C5H11 18 45 
28 C8F17 
  
tBu 17 46 
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The variation of components demonstrated the applicability of perfluorinated acids in 
the Ugi reaction. Furthermore, the combination of the Ugi reaction with the list of 
components allowed to encode information into the Ugi compounds. However, a 
method was required to read out the information encoded via the side groups of the 
respective molecular keys. 
 
4.1.2 Tandem-MS analysis of the molecular keys 
 
Analytical chemistry offers a many different methods for the identification of organic 
molecules and thus for the readout of Ugi-type molecular keys. The molecular structure 
of the Ugi compounds is unambiguously solved when the four sidechains (R1-4) 
originating from the starting components: perfluorinated acid (blue, R1), amine (orange, 
R2), aldehyde (green, R3), and isocyanide (red, R4) are determined. In mathematical 
terms, a four-dimensional problem needs to be solved using four different 
conditions/parameters (similar to solving matrices in linear algebra). The four 
parameters can be for instance obtained via four different molar masses from high 
resolution mass spectrometry fragmentation experiments e.g. the monoisotopic mass 
of the intact molecule and the masses of three fragments (obtained via collision 
experiments). Tandem-MS is a well-established and developed technique and has 
many unique advantages e.g., the detection limits are very small and thus only minimal 
amounts of substance are required. Moreover, tandem-MS can be applied universally, 
and minimal sample preparation is required. The herein employed ESI-MS/MS 
experimental setup was previously discussed in chapter 2.6. Exemplary ESI-MS 
spectra are presented in Figure 13. ESI-MS provides the monoisotopic mass (full scan 
mode 200 – 2000 m/z). The predominant signals arise from the intact analyte 
molecule + sodium: [M + Na]+ and two analyte molecules + sodium: [2 M + Na]+ . The 
sodium was introduced on purpose by utilizing a doped solvent mixture during the ESI 
sample preparation. 
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Label Resolution m/z(exp) m/z(theo) Δm/z   Formula Structure 
1 in a ⚫ 77000 731.1541 731.1537 0.0004 C25H25O2N2F17Na1 
 
2 in a ◼ 56000 1439.3219 1439.3181 0.0038 C50H50O4N4F34Na1 [2 M + Na]+ 
3 in b ⚫ 90000 531.1669 531.1665 0.0004 C21H25O2N2F9Na1 
 
4 in b ◼ 66000 1039.3451 1039.3437 0.0014 C42H50O4N4F18Na1 [2 M + Na]+ 
5 in c ⚫ 93000 595.1615 595.1619 0.0004 C25H25O3N2F9Na1 
 
6 in c ◼ 66000 1167.3384 1167.3341 0.0043 C50H50O6N4F18Na1 [2 M + Na]+ 
7 in d ⚫ 83000 739.1238 739.1229 0.0009 C42H50O4N4F18Na1 
 
8 in d ◼ 59000 1455.2600 1455.2561 0.0039 C52H42O4N4F34Na1 [2 M + Na]+ 
Figure 13. ESI-MS of four molecular keys (a-d). Table (bottom): assignment of the respective m/z 
species presented above. The resolution was obtained by the Xcalibur software from Thermo Fisher.[208] 
The next step towards the readout of a molecular key is to isolate the intact molecule 
([M + Na]+ m/z) and fragment via collisions employing ESI-MS/MS. For this purpose, 
mild conditions (low fragmentation energy) were first used. Subsequently, the energy 
was gradually increased to higher fragmentation energy levels (see Figure 14 a). For 
the first evaluation, a spectrum with many fragment peaks occurring in a wide range of 
molar masses (high information density) was chosen and regarded in detail, i.e. the 
b a 
c d m/z m/z 
m/z m/z 
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30 eV spectrum (Figure 14 b). The 30 eV spectrum provides a high information 
density, because many fragments and the unfragmented molecule at 595 m/z can be 
observed). The heavier/larger fragment species were observed at small fragmentation 
energies (less fragmentation of fragments). In case of Figure 14 it is possible to 
observe numerous fragments and hence extract the information required for structure 
elucidation from one single tandem-MS spectrum. 
However, for other Ugi compounds, two tandem-MS spectra at different fragmentation 
energies are necessary to observe the relevant fragments utilized for readout. In 
Figure 15, two tandem-MS spectra of the same species (731 m/z) recorded at 35 eV 
(Figure 15 a) and at 50 eV (Figure 15 b) are displayed. Herein, the heavier fragments 
❖ and  can only be observed in the 35 eV energy spectrum (Figure 15 a, expansion). 
The lighter fragments ● and ◄ can exclusively be observed in the 50 eV spectrum 
(Figure 15 b). 
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Entry Label Resolution m/z(exp) m/z(theo) Δm/z Formula Structure 
1  89000 595.1612 595.1619 0.0007 C25H25O3N2F9Na1 
 
2 ▼ 97000 446.1137 446.1142 0.0009 C17H18O1N1F9Na1 
 
3 ❖ 112000 375.0274 375.0282 0.0008 C12H7O1N1F9Na1 
 
4 ● 125000 325.1911 325.1916 0.0005 C20H25O2N2 
 
5  135000 262.0839 262.0840 0.0001 C15H13O2N1Na1 
 
6  162000 176.1435 176.1439 0.0004 C12H18N1 
 
7 ◼ 202000 104.0499 104.0500 0.0001 C7H6N1 
 
Figure 14. a, Fragmentation energy screening, stacked tandem-MS spectra of a single charged species 
at 595 m/z () in positive mode with different higher-energy collision dissociation (HCD) energy levels 
in the range from 50 – 750 m/z. b, Tandem-MS of a single charged species at 595 m/z (). Recoded in 
positive mode with an HCD energy of 30 eV in the range from 50 – 650 m/z. The expansion visualizes 
the fragment ion (▼). Table (bottom): peak assignment of the ESI-MS/MS spectrum presented in b.[208]  
a b 
m/z m/z 
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Entry Label Resolution m/z(exp) m/z(theo) Δm/z Formula Structure 
1  ► 82000 731.1534 731.1542 0.0008 C25H25O2N2F17Na1 
 
a: 35 eV top 
2 in a  82000 675.0910 675.0916 0.0006 C21H17O2N2F17Na1 
 
3 in a ❖ 93000 575.0148 575.0154 0.0006 C16H7O1N1F17Na1 
 
4 in a  157000 184.1098 184.1102 0.0004 C11H15N1Na1 
 
b: 50 eV bottom 
5 in b ◄ 169000 162.1278 162.1283 0.0005 C11H16N1 
 
6 in b ● 208000 106.0660 106.0657 0.0003 C7H8N1 
 
Figure 15. a, Tandem-MS of a single charged species at 731 m/z (►). Recoded in positive mode with 
an HCD energy of 35 eV. b, with an HCD energy of 50 eV. The expansions visualize the range from 
550 – 700 m/z. The heavier fragments (❖and) are exclusively observed in the lower energy spectrum 
(a) and the smaller fragments (●and◄) exclusively in the higher energy spectrum (b). Table (bottom): 
peak assignment of the ESI-MS/MS spectra in a and b.[208] 
  
b a 
m/z m/z 
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After evaluating the data of numerous spectra, the most probable fragments were 
identified (see Figure 16) and applied for the subsequent readout of molecular keys. 
Interestingly, similar fragmentation patterns were observed in FAB-MS and in GC-MS 
(see Figure 9) for several compounds. 
 
Figure 16. Four sidechains require four parameters. The parameters are determined via four masses. 
The mass of the intact molecule and the three fragments were utilized for readout of molecular keys.[208] 
 
4.1.2.1 Differentiation of isomers 
 
Tandem-MS fragment analysis is also capable of distinguishing between isomers of 
molecular keys (molecules with the same mass but different structures). In Figure 17, 
two isomeric molecular keys are displayed. These isomers cannot be distinguished by 
regarding the molar mass of the intact molecule (►) nor the isomer fragments. It is 
necessary to evaluate the lighter fragments (● and ■), which are unambiguously 
different. The respective ESI-MS/MS spectra are displayed in Figure 17 b (isomer 2) 
and Figure 17 c + d (isomer 1). Unique fragmentation patterns allow differentiation of 
isomeric molecular keys, if the list of components is known and does not include 
isomers for the same component (as stated in the criteria for the list of components, 
see Figure 8). 
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Figure 17. Differentiation of isomers via ESI-MS/MS. a, two isomeric molecular keys and their 
respective fragments. b, ESI-MS/MS of a single charged species at 737 m/z (►) (Isomer 1). c and d, 
ESI-MS/MS of a single charged species at 737 m/z (►) (Isomer 2). HCD energy = 25 eV (c) and 50 eV 
(d). The larger fragment (▼) is observed in the 25 eV spectrum (c) and the smaller fragments (and●) 
in the 50 eV spectrum (d). Table 5 (below), includes fragment assignment.  
a 
b 
c 
d 
m/z m/z 
m/z 
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Table 5. Fragment assignment for the m/z species in Figure 17 b – c. 
Entry Label Resolution m/z(exp) m/z(theo) Δm/z Formula Structure 
1 in c ► 75000 737.2000 737.2011 0.0011 C25H31O2N2F17Na1 
 
2 in c ▼ 124000 291.2405 291.2412 0.0007 C16H32O1N2Na1 
 
3 in c ● 172000 142.1591 142.1596 0.0005 C9H20N1 
 
4 in d  252000 72.0815 72.0813 0.0002 C4H10N1 
 
5 in b ► 78000 737.2000 737.2011 0.0011 C25H31O2N2F17Na1 
 
6 in b  86000 655.1220 655.1229 0.0009 C19H21O2N2F17Na1 
 
7 in b ❖ 117000 318.2402 318.2401 0.0001 C18H33O2N1Na1 
 
8 in b  137000 269.2588 269.2593 0.0005 C16H32O1N2 
 
9 in b ■ 177000 154.1592 154.1596 0.0004 C10H20N1 
 
10 in 
b ◄ 247000 72.0815 72.0813 0.0002 C7H8N1 
 
 
Regarding the fragmentation spectra of the above mentioned examples, some of the 
masses employed for readout out are comparably weak in intensity, complicating the 
analysis. In order to simplify the analysis a custom made computer script, providing 
the masses of the expected fragments, was employed. The function and application of 
this so-called analysis script is described later, in chapter 4.1.2.3. 
 
4.1.2.2 Influence of stereochemistry 
 
In the course of the Ugi reaction, a new chiral center is formed which was not controlled 
in the present protocol. Hence, if racemic mixtures of precursor components are 
utilized, diastereomeric product mixtures will result after the Ugi reaction. In order to 
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study if diastereoisomers have an influence on either the separation protocol or the 
ESI-MS/MS fragmentation behavior, a model compound mixture consisting of four 
diastereoisomers (see Figure 18) was synthesized, purified via F-SPE and fragmented 
via ESI-MS/MS. 
 
Figure 18. Model compound for investigating the influence of stereochemistry on the ESI-MS/MS 
readout. The molecular key presented above was synthesized from racemic mixtures of precursor 
components. The reaction Ugi reaction will thus form a mixture of four different diastereoisomers. 
The F-SPE separation protocol retains perfluorinated compounds selectively and is 
therefore unselective towards the separation of diastereoisomers. This characteristic 
of F-SPE was utilized in the field of so-called fluorous mixture synthesis (FMS).[326] 
FMS separation was applied for the synthesis of diastereomer mixtures, wherein 
F-tagged diastereomers were synthesized stepwise and separated from 
non-fluorinated contaminations via F-SPE.[327] If a diastereomeric mixture is subjected 
to tandem-MS experiments, it can be assumed that the required fragments for the 
readout will still be observed. Even if theoretically different fragmentation pathways 
may occur, the favored fragments presented in the manuscript will still be observed, at 
least for some of the pathways (perhaps with a lower probability, but still detectable). 
The observed m/z of the fragments is independent from the stereochemical 
information. The fragmentation behavior of diastereoisomers in tandem-MS methods 
was previously studied, confirming that the fragmentation leads to a different intensity 
distribution pattern but all relevant fragments were observed.[328,329] In Figure 19 the 
fragmentation of the diastereomeric product mixture is illustrated, indicating that 
diastereomeric mixtures of molecular keys can be read out in the same manner as 
described before. In conclusion, diastereomeric mixtures of molecular keys can be 
synthesized, purified and read out respectively, employing the herein established 
protocols. 
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Entry Label Resolution m/z(exp) m/z(theo) Δm/z Formula Structure 
1  73800 829.2633 829.2638 0.0005 C32H39O2N2F17Na1 
 
2 ▼ 71000 759.1846 759.1850 0.0004 C27H29O2N2F17Na1 
 
3 ❖ 106000 383.3034 383.3033 0.0001 C23H40O1N2Na1 
 
4 ◼ 122000 296.1987 296.1985 0.0002 C18H27O1N1Na1 
 
5 ● 124000 282.2189 282.2192 0.0003 C18H29N1Na1 
 
6  165000 188.1435 188.1434 0.0001 C13H18N1 
 
Figure 19. Top: Fragmentation of a molecular key diastereomeric mixture. ESI-MS/MS of a single 
charged species at m/z = 829 (). HCD energy = 35 eV. Table (bottom): fragment assignment of the 
spectrum above.[208]  
● 
 
▼ 
❖ 
◼ 

● 
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4.1.2.3 Computer assisted readout for tandem-MS spectra 
 
The analysis of tandem-MS spectra at different energies turned out to be time 
consuming. At this point a computer script becomes a very useful tool for providing 
pre-calculated masses of the most probable fragments after the input of the 
monoisotopic mass of the respective molecular key. The script was conceptionally 
designed by the author and discussed with Kevin Reiter (cooperation partner). The 
computer programming and refinement was subsequently performed by Kevin Reiter. 
The script operates as follows: the database of components is the basis for the 
alphanumerical coding (e.g. aldehydes → letter A; benzaldehyde → A(003), etc.), the 
chemical formula, the corresponding exact masses and SMILES codes for visualizing 
the molecule; e.g. A(003) | benzaldehyde | C7H6O1 | 106.04186 g⋅mol-1 | SMILES: 
[H]C(C1=CC=CC=C1)=O. The script is capable of calculating the molar masses of all 
possible Ugi compounds with respect to the reaction equation, by adding the molar 
masses of all components and subtracting the molar mass of water i.e. 
M(Ugi product) = M(carboxylic acid) + M(aldehyde) + M(isocyanide) - M(water). This 
calculation is performed for all 500,000 permutation and stored in a separate list. 
The script uses the input of the monoisotopic mass and then searches for all possible 
permutations of component combinations within a certain mass range (reduction of 
possibilities is illustrated in Figure 20). The monoisotopic mass [M + Na]+ is entered 
with four decimals e.g. 567.5678 and an appropriate ΔM threshold e.g. ΔM = 0.02 Da. 
The resulting possibilities are again listed by the script and the masses of probable 
fragments are directly displayed (the fragment masses are calculated with respect to 
the general fragment structures displayed in Figure 16). For small ΔM thresholds the 
remaining possibilities are reduced several orders of magnitude, e.g. if ΔM = 0.001 Da, 
the initial 500,000 permutations are reduced to a maximum of around 60 possibilities. 
This reduction can be visualized by comparing the height of a human to the height of 
Mount Everest. After entering fragments to the script, the resulting possibilities are 
further reduced and refined until the structure is determined. The fragment masses are 
entered with two decimals (e.g. 123.45). If accidentally a wrong digit was entered, the 
REDO command will return to the initial selection of possibilities after entering the 
[M + Na]+ mass.  
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Figure 20. Database evaluation of the list of components, regarding the occurring masses within certain 
thresholds: a, ΔM = 0.001 Da. b, ΔM = 0.005 Da. c, ΔM = 0.01 Da. d, ΔM = 0.05 Da. e, ΔM = 0.1 Da. f, 
ΔM = 0.5 Da. This analysis was provided by a cooperation partner: Kevin Reiter.[208] 
After entering enough fragments (in most cases two fragments are sufficient 
information; in case of isomers, three fragments are required), the distinct molecular 
structure is obtained, and the script generates the alphanumerical code of the 
molecular key e.g. A(005)-B(002)-C(004)-D(007). The script also offers the possibility 
to display more detailed information about the molecular key via the PRINT command. 
After selecting the print command, a SMILES code for the target molecule and all 
a   ΔM = 0.001 Da b   ΔM = 0.005 Da 
c   ΔM = 0.01 Da d   ΔM = 0.05 Da 
e   ΔM = 0.1 Da f   ΔM = 0.5 Da 
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precursor components (on basis of the list of components) is displayed. The SMILES 
code of the Ugi compounds are generated employing a generalized SMILES code for 
Ugi bis-amides with four different variables for the four sidechains (introduced by the 
four components). $acid$N($amine$)C($aldehyde$)C(N$isocyanide$)=O. 
The variables (between the $ signs) were then substituted by the corresponding 
SMILES coded associated with the sidechains obtained from the list of components. 
The SMILES code of the Ugi products generated by the script can be copied e.g. to 
ChemDraw® (insert with Alt+Crtl+P) for visualization of the respective molecular 
structure. The evaluation and assignment of ESI/MS/MS fragments can clearly 
determine the structure of the molecular keys. In principle, further analytical methods 
could be introduced for the readout (i.e. quantitative 19F-NMR spectroscopy for R1 in 
combination with three masses from tandem-MS). The analysis script can be 
downloaded from the supplementary information of reference[208] and is also included 
in the electronic version of this thesis (on the CD). In addition, the electronic version 
includes the tandem-MS spectra of three molecular keys for testing the analysis script. 
 
4.1.3 Cryptography integration of the molecular keys 
 
As described previously, the 500,000 permutations equal approximately 18 bits. In 
order to provide a possible application for the molecular keys and their respective data 
storage capacity, a cryptography integration is suggested herein. The cryptographic 
system is based on a secret communication channel employing molecular keys, which 
can be easily hidden in various media, transferred nondigitally, isolated via F-tags and 
unambiguously read out via ESI-MS/MS. Considering cryptography, the well-
established Advanced Encryption Standard (AES) algorithm was combined with an 
effective hiding and transportation of the encryption key. The herein presented 
molecular keys based on Ugi compounds provide a robust steganographic channel 
that can be used to transport i.e. cryptographic keys. An AES key with 100 bits or more 
can be considered as physically unbreachable (due to limited computing power), hence 
the AES key should be encoded on six to seven molecular keys (6 × 18 bits = 108 bits). 
An exemplary way of key transmission is illustrated in Figure 21. The sender and 
recipient first meet to exchange details on how to secretly communicate in the future 
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(Figure 21 a). They need to agree on how the molecular key will be transferred (e.g. 
adsorbed on paper, dissolved in a perfume, etc.), whether the AES decryption key will 
be fragmented onto several molecular keys, and if so, how many individual molecular 
keys will be used. Additionally, the list of components, is exchanged and the analytical 
methods are preselected (tandem-MS). These initially communicated details should 
remain secret, however, if an adversary reveals one or some of the discussed details, 
the adversary is still not able to decrypt the message without knowing the other 
information, the list of components and most importantly the molecular keys. 
 
Figure 21. Cryptography integration of molecular keys. a, sender and recipient exchange the list of 
components and discuss details about their secret communication. b, from left to right: the sender 
synthesizes one or several molecular keys and determines the alphanumeric code associated with the 
chemical structures according to the list of components. The alphanumeric code e.g. A(005)-B(013)-
C(007)-D(027) is serving as encryption key/password. The molecular key is concealed and transferred 
to the recipient via a steganographic channel. The recipient isolates the key and elucidates the molecular 
structure for decryption. c, hierarchical levels of security and knowledge an adversary needs for 
decryption.[208] 
The molecular keys can hardly be recognized, because i. an adversary does not know 
that a key is hidden in a molecule; ii. only the recipient knows where the molecular 
keys are located/stored (i.e. adsorbed on paper, dissolved in perfume, etc., see below) 
and in which order they should be readout; iii. an adversary needs information on how 
to extract and analyze the molecule, convert the chemical structure into digital 
information and apply the necessary decryption. iv. Since the keys are transferred 
a 
b 
c
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physically, an attacker cannot rely on computing power alone. Molecular keys can be 
hidden and transferred in many creative ways. Since the molecular keys are fluoro-
tagged compounds, they can be isolated from various types of surrounding media. The 
main requirement to the surrounding environment or the matrix material is the absence 
of any perfluorinated alkyl chains. Furthermore, the extraction of the molecular key 
should be possible with reasonable effort. 
The following extraction examples were performed with the molecular key 19. As a first 
transportation example adsorption onto paper was chosen (see Figure 22). Therefore, 
4.0 mg of the molecular key were dissolved in 0.5 mL methanol and subsequently 
transferred dropwise onto the top right corner of an envelope. Intermediately, the drops 
were quickly evaporated by gently blow-drying with a heat gun. For further protection 
and disguising, a stamp was placed above the covered area (see Figure 23). 
 
Figure 22. Transportation and extraction of a molecular key. The molecular key is dissolved and placed 
in the top right corner of the envelope and covered with a stamp. After the letter reached its destination, 
the molecular key is extracted and purified via F-SPE prior to analysis.[208] 
For later extraction, the part of the paper doped with the molecular key (here the area 
around the stamp) was cut into pieces and extracted in an ultrasonic bath with 15 mL 
methanol for 15 minutes three times and subsequently three times with 10 mL 
dichloromethane. The extracts were combined, concentrated under reduced pressure 
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and purified via F-SPE. In this protocol 3.5 mg (90%) of the molecular key were 
recovered. In another experiment, hiding of molecular keys in solution was 
demonstrated. Therefore, a molecular key was dissolved in a commercial perfume. 
4.0 mg of the molecular key were dissolved in 0.5 mL ethanol and transferred into the 
same amount of a commercial perfume (see Figure 23 l - o). The resulting solution is 
more diluted than the initial perfume, but the dilution cannot be easily recognized by a 
change of appearance or smell. The molecular key proved to remain in solution 
throughout the investigated time of more than 14 days. It can be assumed, that the 
molecular key will not precipitate or phase-separate, because a diluted system is used. 
For the extraction of the molecular key, the perfume solution was evaporated under 
reduced pressure and subjected to F-SPE. In this protocol, 3.7 mg (93%) of the 
molecular key were recovered. Another example was demonstrated by adsorption onto 
instant coffee powder, tea or sugar (see Figure 23 f - h): 4.0 mg of the molecular key 
were dissolved in 0.5 mL dichloromethane and added dropwise onto 1 g of the 
substrate powder, each drop was placed onto a different spot and allowed to evaporate 
separately. For the extraction, the powder was ground with a mortar and stirred three 
times in 5 mL dichloromethane for 3 minutes. The combined extracts were filtered over 
celite®. The filtrate was washed with 10 mL water, twice. The combined aqueous 
phases were reextracted with 5 mL dichloromethane, twice. The combined organic 
phases were washed with 5 mL brine, dried over sodium sulfate, evaporated under 
reduced pressure and purified via F-SPE. Extraction yields: from instant coffee powder 
3.4 mg (85%), from green tea 3.6 mg (90%), from sugar 3.4 mg (87%), of the molecular 
key were recovered. For the extraction from sugar, no further purification via F-SPE 
was necessary, because sugar is a fully water-soluble substrate and was removed 
during the washing procedure. In order to demonstrate a challenging extraction 
example for the herein presented F-tagged molecular keys from complex biological 
media, pig blood was chosen as carrier substrate. Extraction from biological media 
would be far more challenging for cryptographic keys encoded in DNA or other 
biomolecules. 5.0 mg of the molecular key were dissolved in 0.5 mL ethanol and 
concentrated under reduced pressure until a transparent film of the molecular key with 
a minimized amount of ethanol was obtained. 5 mL of pig blood were added into the 
vial and gently stirred for 5 min. For stability reasons, the blood should be stored and 
transported under cooling. For later extraction, the blood sample was diluted with 
10 mL water and extracted with 20 mL dichloromethane three times. After the second 
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extraction, an emulsion was formed, hence the second and third organic extracts were 
combined and treated separately. The organic extracts were washed separately with 
10 mL water, twice. The organic phases were dried over sodium sulfate. The emulsion 
broke upon drying and a clear solution was obtained. This solution was evaporated 
under reduced pressure and purified via F-SPE. In this protocol, 4.5 mg (91%) of the 
molecular key were recovered. 
 
Figure 23. Hiding of molecular keys. a, 4.0 mg of powdered molecular key on a scale. b, envelope 
before application. c, envelope after adsorption of the molecular key (the black box indicates the treated 
area, the adsorbed molecular key was not visible with bare eyes). d, envelope containing the molecular 
key cut in pieces e, before the extraction with methanol. f, molecular key adsorbed onto instant coffee 
powder. g, molecular key adsorbed on green tea. h, adsorption onto sugar. i, in this vial the molecular 
key was previously dissolved in ethanol. The solvent was evaporated until a transparent film was 
obtained, before mixing with blood. j, mixing with pig blood. k, re-extraction of the molecular key from 
blood. l, empty perfume bottle. m, the left vial (yellow liquid) contains the original perfume, right vial 
(colorless liquid) contains the molecular key dissolved in methanol. n, resulting solution after mixing the 
perfume with the dissolved molecular key. o, transferred into the perfume bottle. Although the mixture 
is now more diluted, it cannot be easily distinguished from the original perfume with bare eyes or by the 
smell. p, typical F-SPE column for the purification of molecular keys.[208] 
In principle, for MS analysis, even smaller amounts of substance are sufficient for the 
readout. However, the herein employed masses of several milligrams were sufficient 
to further conduct TLC, GC-MS and 1H-NMR experiments for purity determination. 
h 
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After the molecular key is isolated and purified, (tandem-)MS-spectra are measured 
and employed to readout the molecular keys. The alphanumerical codes can be 
employed directly as AES encryption keys e.g. A(005)-B(002)-C(004)-D(007) is the 
password for encrypting secret data. If several molecular keys were utilized, they are 
entered one after the other. 
 
Figure 24. a, Schematic illustration of molecular encryption encryption/decryption process which is 
conducted by an independent symmetric encryption scheme e.g. the molecular encryption script. b, 
Schematic illustration of the analysis script. The alphanumerical codes obtained from the list of 
components serve as AES keys (passwords).[208] 
 
Inspired by the idea to incorporate even more varying components into one molecule, 
in order to achieve higher storage capacities, the combination of two multicomponent 
reaction was investigated (presented in the following chapter 4.2).  
  
a 
b 
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4.2 Combining the Biginelli and Passerini reaction 
 
Parts of this chapter and following subchapters were adapted from previous passages 
written by the author.[23] 
 
Figure 25. Graphical abstract for the investigation presented in chapter 4.2.[23] 
Multicomponent tandem reactions (previously described in chapter 2.2.) are powerful 
synthetic tools in order to introduce multiple varying components into a distinct reaction 
product with minimal synthetic effort. In this context, the Biginelli reaction was 
combined in a sequential tandem approach with the Passerini reaction for the first time. 
In addition, both reactions were combined in a one-pot tandem procedure employing 
five different components at once. 
For the herein described Biginelli-Passerini sequential tandem reactions, the Biginelli 
reaction was performed first, in order to avoid undesired transesterification reactions 
(of the ester groups in the Passerini products) due to the acidic conditions of the 
Biginelli reaction.[174] A challenge, which had to be faced while combining both 
reactions, was the choice of solvent and the selection of bifunctional components, 
which can interlink the Biginelli and the Passerini reaction. In the earlier-reported 
Biginelli-Ugi tandem reaction of Wipf et al.,[176] methanol could be used. However, as 
previously mentioned in chapter 2.1.2, the solvent of choice for the Passerini reaction 
is dichloromethane. The DHMP Biginelli products employed herein, however, were in 
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most cases insufficiently soluble in dichloromethane. A screening of several solvents 
and solvent mixtures finally identified a mixture consisting of dichloromethane with a 
small amount of dimethyl sulfoxide (polar but aprotic) to successfully promote the 
combination of both chemistries. The possible bifunctional components for the 
Biginelli-Passerini combination are represented in Figure 26. 
 
Figure 26. Bifunctional components evaluated for combining the Biginelli and Passerini reaction.[23] 
Linkers of the B1- and C1-type were employed in this investigation. 
Evaluation of the combinations considering pervious reports from literature allowed a 
pre-selection of bifunctional linker molecules; A3, B3 and C3 display an isocyanide 
functionality, which could hydrolyze under the acidic conditions for the Biginelli 
reaction.[330] Components A2, B2 and C2 carry an aldehyde functional group for the 
Passerini reaction, but aldehydes can also react in the Biginelli reaction. Hence, A2, 
B2, C2 as well as A3, B3, C3 were excluded from this investigation. The remaining 
possible components A1, B1 and C1 seemed most promising for combining the 
Biginelli and Passerini reaction. The components featuring A1, B1 and C1 structures 
tested in synthetic experiments were: C1: 4-formylbenzoic acid; B1: 
N-carbamoylglycine, A1: benzyl acetoacetate (for the Biginelli reaction and 
subsequent hydrogenolytic deprotection to the corresponding acid). 
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In the first sequential step, the Biginelli reactions were performed in dimethyl sulfoxide 
at 110 °C in order to remove the water formed in course of the condensation reaction. 
The aldehyde was employed as limiting component, the urea and acetoacetate 
component were employed in 1.20 eq. excess with respect to the aldehyde. 
4-Methylbenzenesulfonic acid (p-TSA) was added as catalyst. After a straight-forward 
washing procedure (described in 6.2.2), the desired Biginelli acids 47 – 52 were 
obtained in 63 – 92% yields (see Table 6). Compared to literature known procedures, 
the herein established Biginelli protocol is simple, utilizes p-TSA as a cheap catalyst, 
provides high yields and can be used for the preparation of various Biginelli acids, 
employing different bifunctional linkers. Aliphatic aldehydes were not reactive under 
the present conditions, even after longer reaction periods of up to six days. 
Table 6. Biginelli reactions for the preparation of Biginelli acids. 
 
# R1 R2 R3 Yield [%] Product № 
1 Ph H Bn 91 47 
2a Ph H CO2H 93 48 
3 Ph CH2CO2H Et 63 49 
4 Ph CH2CO2H Bn 77 50 
5 
 
H Et 90 51 
6 
 
H Bn 91 52 
Conditions: 0.10 eq. p-TSA, 110 °C, 8 - 48 h in dimethyl sulfoxide. a Obtained via hydrogenolytic 
deprotection of product 47 (Entry #1). Conditions: H2 (balloon), 10 wt.% Pd/C, solvent mixture of acetic 
acid/ethanol (1:3), 50 °C, 15 h. 
For the subsequent Passerini reactions, the Biginelli acids were dissolved in the 
previously described mixture of dichloromethane with dimethyl sulfoxide as co-solvent. 
The aldehyde and isocyanide component were added in 1.5 fold excess with respect 
to the Biginelli acid. After three days reaction time at room temperature and subsequent 
purification via column chromatography, the Biginelli-Passerini products 53 – 61 were 
obtained in 22 – 99% yields. The results are summarized in Table 7.  
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Table 7. Passerini reactions utilizing Biginelli acids. 
 
# 
Biginelli 
acid № 
R1 R2 R3 R4 R5 
Yield 
[%] 
Product 
№ 
1 51 
 
H Et C6H13 tBu 67 53 
2 52 
 
H Bn C6H13 tBu 22 54 
3 51 
 
H Et 
 
cHex 98 55 
4 49 Ph 
 
Et iPr tBu 76 56 
5 49 Ph 
 
Et C10H19 tBu 99 57 
6 49 Ph 
 
Et C7H15 Bn 76 58 
7 49 Ph 
 
Et C7H15 
 
39 59 
8 49 Ph 
 
Et 
 
C5H11 78 60 
9a 
not 
isolated  
 
Et 
 
C5H11 41 61 
Conditions: room temperature, 3 d reaction time in dichloromethane/dimethyl sulfoxide. a one-pot 
multicomponent tandem procedure, the Biginelli acid was not isolated.  
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Regarding the yields reported in Table 7, the products for entry #3 and #5 were 
obtained in quantitative yields. The lower yield for compound 59 (39%) is presumably 
due to the presence of the tertiary amine structure of the morpholinoethyl sidechain. 
On the one hand, this tertiary amine can act as a base and disrupt the Passerini 
reaction by deprotonating the acid component, and on the other hand substrate 59 
required a different and more complex purification. During the synthesis of compound 
54, the reaction mixture was not completely homogenous, which is assumed to be 
responsible for the lower yield of 22%. For the other reactions presented in Table 7, 
the Passerini protocol proved to be robust and very effective, providing very good to 
quantitative yields. Considering the column chromatographic purification on silica gel, 
substrates employing a linker molecule of type B1 (ureido-carboxylic acids, Figure 26) 
could be separated better than molecules employing linkers of type C1 (aromatic 
aldehyde-carboxylic acids). The C1 type molecules displayed a strong tailing effect, 
which is most probably correlated to the additional NH (polar and hydrogen bond 
donor) causing stronger interference with the polar stationary phase.[331] 
In Figure 27, a representative 1H-NMR spectra comparison between the Biginelli 
acid 51 (Figure 27 a) and the Biginelli-Passerini product 53 (Figure 27 b) is displayed. 
The CO2H proton at 12.9 ppm is not observed after the Passerini reaction, while all 
other DHMP signals, i.e. the NHCH at 9.2 ppm, the CHNH at 5.2 ppm or the CCH3 at 
2.3 ppm, are still observable and did not shift significantly. Furthermore, in Figure 27 b 
the characteristic signals for the NHCH at 4.9 ppm, the C(CH3)3 at 1.2 ppm and the 
terminal CH2CH3 methyl group at 0.8 ppm strongly indicate the formation of the 
Biginelli-Passerini product. 
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Figure 27. Stacked 1H-NMR spectra and the respective signal assignment. a, Biginelli acid 51. b, 
Biginelli-Passerini product 53.[23] 
Besides the sequential Biginelli-Passerini reactions, both reactions were conducted in 
a one-pot tandem reaction (see Scheme 22). Therefore, the Biginelli reaction was 
performed with a three-fold excess of the aldehyde component in a minimal amount of 
dimethyl sulfoxide. After completion of the Biginelli reaction, the crude reaction mixture 
was cooled to room temperature and diluted with dichloromethane. Subsequently, the 
isocyanide component was added to the mixture and enabling the Passerini reaction 
with the exceeding aldehyde. 
 
Scheme 22. Biginelli-Passerini one-pot tandem reaction. 
The resulting one-pot tandem product 61 was obtained in 41% yield after column 
chromatographic purification without intermediate workup of the Biginelli acid (Table 7, 
entry #9). However, the structural diversity in the one-pot tandem procedure is more 
limited if compared to the previously described two-step approach (including isolation 
a 
b 
61 
53 
51 
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of Biginelli acid) because in the one-pot procedure the same aldehyde component is 
participating in both multicomponent reactions. Compared to previously described 
combinations of multicomponent reactions (see chapter 2.2), the herein described 
sequential strategy combined the Biginelli and Passerini reaction while utilizing several 
bifunctional linker components. Interestingly, the 1H- and 13C-NMR spectra of the 
Biginelli-Passerini tandem products displayed split signals which are illustrated for 
compound 55 in Figure 28. 
 
  
Figure 28. Phase sensitive HSQC spectrum of Biginelli-Passerini compound 55, expansions and signal 
assignment for two asymmetric carbon atoms. a, diastereomeric signal splitting in 1H-NMR spectrum 
exclusively. b, diastereomeric splitting in both 1H- and 13C-NMR spectra.[23] 
Most of the split signals were located either next to chiral centers in the molecule or in 
the six membered DHMP core. In order to identify the cause of this peak splitting, high 
b 
a 
b a 
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temperature NMR experiments at 40 °C, 60 °C and 80 °C were conducted. Even at 
higher temperatures the peak splitting was still observed, evidencing that the splitting 
was not caused by rotational barriers (as described for the perfluorinated Ugi 
compounds in chapter 4.1.1) or conformational effects. The signal splitting was not 
observed for the Biginelli acids, hence a diastereomeric effect was assumed. The 
Biginelli and Passerini reaction both from a new chiral center, which was not controlled 
in the present protocols, leading to racemic product mixtures in every multicomponent 
reaction step. Thus, after the Passerini reactions, four different stereoisomers (RR, RS, 
SR, SS) are obtained. The homo (RR, SS) and hetero pairs (RS, SR) are 
diastereomers with slightly different physical properties (causing different chemical 
shifts in the NMR spectra). However, the diastereoisomers could not be separated by 
chromatography or crystallization (nor by slow vapor diffusion crystallization). In order 
to separate the diastereoisomers chiral chromatography could be tested. 
In conclusion, the Biginelli reaction was successfully combined with the Passerini 
reaction for the synthesis of highly functionalized DHMP heterocyclic products. 
Different Biginelli acids were prepared by variation of the components and the 
bifunctional linker. The Biginelli acids were employed in a Passerini reaction utilizing a 
dichloromethane/dimethyl sulfoxide solvent mixture. Furthermore, a one-pot Biginelli-
Passerini reaction without intermediate workup was demonstrated. All compounds of 
this investigation were carefully characterized via NMR (1D and 2D) spectroscopy, IR 
spectroscopy and HRMS (see chapter 6.2.2). The herein presented strategy was 
further developed for the preparation of sequence-defined macromolecules, which will 
be described in the following chapter 4.2. 
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4.3 Macromolecules derived from two multicomponent reactions 
 
Parts of this chapter and following subchapters were adapted from previous passages 
written by the author.[209] 
 
Figure 29. Graphical abstract for the investigation presented in chapter 4.3.[209] 
Sequence-defined macromolecules represent highly ordered structures and were 
already discussed in the context of data storage in chapter 2.5.1. In chapter 4.1, it was 
demonstrated that multicomponent reactions can be employed to build up a large 
variety of molecular structures which can be translated into computer processable 
codes. In the Ugi approach described previously, a virtual library comprising 500,000 
permutations translated into approximately 18 bits of storage capacity (for one 
individual Ugi compound). In addition, a system that allows to utilize even more varying 
components via the combination of the Biginelli reaction and the Passerini reaction 
was investigated and described in chapter 4.2. In the present chapter, the Biginelli and 
Passerini reaction were employed to synthesize bifunctional monomers which can be 
subsequently combined to information-coding macromolecules suitable for data 
storage materials. 
 
4.3.1 Monomer design and a qualitative reactivity test system  
 
The bifunctional monomers were designed in order to react in iterative Passerini and 
hydrogenolytic deprotection steps, inspired by the strategy described in chapter 2.4, 
which was reported previously by Meier et al.[204] The most generalized structure of the 
selected design is presented in Figure 30 a; one terminus of the molecule is equipped 
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with an isocyanide for Passerini reactions, the other terminus bears a benzyl ester for 
subsequent hydrogenolytic deprotection. This bifunctional combination was chosen for 
practical reasons i.e. according to the relative stability of the functional groups 
participating in the Passerini reaction against degradation. The degradation stability of 
the functional groups was qualitatively sorted as follows: carboxylic acid > isocyanide 
> aldehyde (isocyanides hydrolyze under acidic conditions[330] and aldehydes oxidize 
to the corresponding carboxylic acids). The growing chain is considered the most 
valuable substrate of the whole strategy and furthermore the terminal end group 
(allowing chain growth) was regarded as the most critical position. Hence, the terminal 
end group allowing iterative growth via Passerini reactions was equipped with the most 
stable functional group, the carboxylic acids (obtained after hydrogenolytic 
deprotection of the corresponding benzyl esters, see Figure 30 a). 
 
Figure 30. Monomer design chosen for the present investigation. 
Considering the results from chapter 4.2, substituted urea components were employed 
in the Biginelli reactions because chromatographic separation on silica gel is simplified 
if the additional NH (polar and hydrogen bond-donor resulting in challenging 
separation) is blocked via substitution with e.g. an alkyl chain. The resulting DHMP 
structures were therefore integrated as shown in Figure 30 b into the monomers. For 
testing the stability of the internal double bond of the DHMP core unit in hydrogenolysis 
reactions, a stability experiment was performed. In this experiment, the DHMP 
containing Biginelli-Passerini substrate 56 was dissolved in ethyl acetate and 20 wt.% 
of palladium on activated charcoal were added. The mixture was stirred at 40 °C for 
three days in an autoclave system applying 20 bar of H2 gas. TLC indicated no 
conversion. After filtration over celite® and evaporation of the solvent the residue was 
analyzed via 1H- and 13C-NMR, confirming the initial structure. Furthermore, high-
resolution mass spectrometry confirmed the molecular mass of the precursor, 
evidencing that the DHMP core is stable against hydrogenolysis under the present 
conditions. The final monomer design is presented in Figure 30 c; the aldehyde 
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components introducing Rx and Ry were commercially available, the other 
(bifunctional) components were either commercial or synthesized herein. Regarding 
the monomers structure, five different components are combined in the same 
monomer, enabling to leverage the high structural variety of two multicomponent 
reactions. Thus, for a theoretical data storage system the information is encoded via 
the variation of six different components per repeating unit (five per monomer); 
choosing from a list of components. In analogy to the previous considerations of 
chapter 4.2, bifunctional components are required in order to link the Passerini and 
Biginelli reaction (illustrated in Figure 26). Since not many of the required bifunctional 
components were commercially available, a set of bifunctional components was 
synthesized. The synthetic strategies for the bifunctional components starting from 
commercially available chemicals, are summarized in Figure 31. 
 
Figure 31. Synthesis of bifunctional components a, synthesis of acetoacetate-benzyl esters (AB-type) 
in two reaction steps via a ring opening oligomerization of ε-caprolactone, chromatographic separation 
of the oligomers and subsequent acetoacetylation with diketene acetone adduct 67. b, synthesis of 
diisocyanides (AA-type) in two reaction steps starting from diamines which are firstly reacted to 
diformamides and subsequent dehydration with phosphorus oxychloride in triethylamine. c, synthesis of 
ureido-carboxylic acids in one step (AB type) via transamidation of amino acids with urea.[209]  
The acetoacetate-benzyl esters were prepared in a two-step procedure (Figure 31 a). 
First, ε-caprolactone was ring-opened by dropwise addition into an excess of benzyl 
alcohol with the non-nucleophilic base diazabicycloundecene (DBU) as catalyst. The 
product mixture contained discrete oligomers (62 – 66), which were separated by 
column chromatography. The respective 1H-NMR spectra are stacked in Figure 32. 
a 
b 
c 
62 – 66 
 
(n=1) 68, (n=5) 69 
67 
X 
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Figure 32. 1H-NMR spectra stack of the oligo alcohol-benzyl esters (monomer – pentamer), measured 
in DMSO-d6. The blue arrow illustrates the increasing number of the methylene group next to the oxygen 
atom of the ester marked with the blue cycle. 
The (oligo) alcohol-benzyl esters 62 and 66 were reacted in an acetoacetylation 
reaction with diketene acetone adduct 67, to obtain acetoacetate-benzyl esters 68 and 
69, respectively. The diisocyanides were synthesized according to a modified 
procedure reported earlier, starting from diamines (Figure 31 b).[66] The diamines were 
converted into the corresponding diformamides upon reaction with ethylformate or 
trimethyl orthoformate. The diformamides were dehydrated by phosphorous 
oxychloride in the presence of diisopropylamine. After purification via column 
chromatography, typical yields of 40 – 80% were achieved. 
In the stacked 1H-NMR spectra of the formamide precursor and the isocyanide product 
(see Figure 33), the disappearance of the formamide signals, and a shift of the 
methylene protons next to the functional groups (green vs. blue box) was clearly 
observed. 
62 
66 
65 
64 
63 
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Figure 33. 1H-NMR stack of hexane-1,6-diformamide (top) and hexane-1,6-diisocyanide (bottom) 
measured in DMSO-d6. The expansion visualizes the signal of the methylene group next to the 
isocyanide functional group (triplet of triplets). The formamide signals in the red box are not observed 
for the isocyanide product. 
Ureido-carboxylic acids were prepared by a straight-forward transamination reaction 
of amino acids with urea at 120 °C in dimethyl sulfoxide and slow addition of 
hydrochloric acid obtaining typical yields of 70 – 90% after washing or recrystallization 
(Figure 31 c). The synthetic procedures along with characterization for all bifunctional 
components prepared for this investigation can be found in chapter 6.2.3. 
With the herein utilized protocols, a library of different components can be prepared. 
In analogy to the Ugi approach described in chapter 4.1, a list of components was 
established considering limitations reported in literature for choosing the components 
(see Table 8). Again, the later read out of the sequences is conducted by tandem-MS 
and hence no isomers should be chosen for the same category of components. In 
addition to the previous considerations from Figure 8, no hydrogenolysis-sensitive 
side chains should be present (except for the acetoacetate-benzyl ester, where later 
deprotection is desired). 
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Table 8. Selected entries from an exemplary list of components 
Structure Formula 
Alphanumerical 
code 
Monoisotopic mass 
[Da] 
 
C3H6N2O3 A(001) 118.03784 
 
C13H26N2O3 A(011) 258.19434 
 
C11H12O3 B(001) 192.07864 
 
C17H22O5 B(002) 306.14672 
 
C37H58O11 B(006) 678.39791 
 
C7H6O1 C(001) 106.04186 
 
C7H12O1 D(009) 112.08882 
 
C8H12N2 E(005) 136.10005 
 
C10H8N2 E(012) 156.06875 
A: ureido-carboxylic acids. B: acetoacetate-benzyl esters. C: aldehydes for Biginelli reactions. D: 
aldehydes for Passerini reactions. E: diisocyanides. The full list of components can be found as 
supplementary information along with the previously published work and included in the electronic 
version of this thesis.[209] 
The herein compiled list of components comprised 116 varying components; eleven 
ureido–carboxylic acids, 18 aldehydes for the Biginelli reaction (aromatic aldehydes 
only), six acetoacetate–benzyl esters, 29 diamines and 26 aldehydes for the Passerini 
reaction (the 26 aldehydes can be employed for monomer synthesis and iterative 
Passerini coupling reactions). The variation of ureido-carboxylic acids was 
demonstrated for the longest spacers (b = C10H20, Table 9 entry #1 – #4, 70 – 73) an 
intermediate length (b = C5H10, Table 9 entry #5, 74) and shortest spacer (b = CH2, 
Table 9 entry #6 – #14, (50, 75 – 80) included in the list of components. Hence, it can 
be assumed that the present strategy is also applicable for all intermediate spacer 
lengths (b = C2H4 – C9H18). The respective variation generates a number of 11 different 
urea components. Following the same argumentation, the variation of acetoacetate-
benzyl ester components (red) was demonstrated for the shortest spacer (benzyl 
acetoacetate, commercially available) an intermediate spacer (a = (CH2)5O(C=O)CH2, 
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68) and the longest spacer (a = [(CH2)5O(C=O)CH2]5, 69). The variation of 
diisocyanides was demonstrated for cycloaliphatic (Table 9 entry #9, 83), aromatic 
(Table 9 entry #10, 84), and aliphatic spacers (all other entries in Table 9). The 
aldehydes, either for Biginelli or Passerini reactions, included in the list of components 
are commercially available and were selected in order to react effectively and 
selectively, considering previously reported experiments from literature[23,27,89,332] and 
the results from chapter 4.2. For the aromatic aldehydes of the Biginelli reaction (blue, 
Rx), six different components were demonstrated and nine for the Passerini reaction 
(orange, Ry). These experiments indicate that the components can be varied according 
to the list of components and that the anticipated structural diversity of the 
monomers-NC (83 – 96), which translates into data storage density, can be achieved. 
The permutations are calculated by multiplication of the different component sub 
libraries: 11 × 18 × 6 × 29 × 26 × 26 = 23,289,552 permutations. The respective 
information content for one repeating unit can be calculated by the number of possible 
permutations: Log(number of possible permutations)/Log(2), hence approximately 
24 bits (Log(23,289,552)/Log(2)=24.47) can be encoded per repeating unit. If multiple 
repeating units are combined into longer sequences, the storage capacity of the 
respective macromolecule is calculated by: bits per repeating unit × number of 
repeating units. In is noteworthy, that the single step Ugi approach described in chapter 
4.1 resulted in a higher storage capacity per reaction step, since a repeating unit 
structure was not necessary.[208] However, if compared to the iterative approaches of 
the sequence defined macromolecules discussed herein, the overall storage capacity 
of the macromolecules can be much larger and mainly depends on the length of the 
sequence (see Figure 34). 
The synthesis of the monomers-NC (Scheme 23 a) starts with a Biginelli reaction 
involving an ureido-carboxylic acid (green, spacer b), an aromatic aldehyde (blue, Rx) 
and an acetoacetate-benzyl ester (red, spacer a) yielding a so-called Biginelli acid. The 
Biginelli reactions were performed in dimethyl sulfoxide with a high concentration of 
the reactants at 110 °C overnight employing an 1.20 equivalent excess of ureido-
carboxylic acid and acetoacetate-benzyl ester with respect to the aldehyde component 
under acidic conditions (10 mol.-% p-TSA as catalyst) obtaining typical yields of 50 – 
80% (according to the methods established in chapter 4.2). The Biginelli acids were 
subsequently employed in a Passerini reaction with an aldehyde (orange, Ry) and a 
diisocyanide (dark purple, spacer c) to from the monomer-NC. 
Chapter    4    Results and discussion 
 
90  
 
Figure 34. Theoretical information content per repeating unit of the herein described approach utilizing 
two multicomponent reactions – the variation of all components can potentially provide 24 bits per 
repeating unit. Bits per repeating unit were calculated as follows: Log(number of possible 
permutations)/Log(2). The storage capacity of a macromolecule is calculated by: bit per repeating unit 
× number of repeating units.[209] 
The monomer-NC syntheses were performed in a solvent mixture of dichloromethane 
and a few droplets of dimethyl sulfoxide (required in order to solubilize the Biginelli 
acids) at room temperature, while employing 5.00 equivalents of diisocyanide and 2.00 
equivalents of aldehyde, obtaining typical yields of 50 – 90% (the exceeding 
diisocyanide could be recovered via column chromatographic purification). In 
Figure 35 representative stacked 1H-NMR spectra of the Biginelli acid 77, hexane-1,6-
diisocyanide and the monomer-NC product 93 are displayed. Many of the precursor 
signals can also be found (slightly shifted) in the product spectra (see colored boxes 
in Figure 35). 
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Figure 35. 1H-NMR spectra stack of Biginelli acid 77 (top), hexane-1,6-diisocyanide (middle) and the 
resulting monomer-NC 93 (bottom). The colored boxes illustrate the origin of the product signals. 
The disappearance of the acid signal at 13.0 ppm in the blue spectrum of the Biginelli 
acid and the incorporation of the aromatic region 7.5 – 6.5 ppm and the aliphatic region 
1.5 – 1.0 ppm indicates the formation of the desired Passerini product. For 
demonstrating the variability of the approach described herein, a subset of 14 different 
monomers (monomer-NC) was synthesized and evaluated in a test reaction system 
(see Scheme 23 b). This qualitative monomer-NC test system (Scheme 23 b), 
consists of a first Passerini step employing 1.50 equivalents of stearic acid and 2.00 
equivalents of octanal to prove the reactivity of the isocyanide end group in Passerini 
reactions. In a subsequent deprotection step, the reactivity of the benzyl ester towards 
hydrogenolysis was tested. Except for entry #7 in Table 9, all monomers passed the 
test system. The test system experiments for entry #7 in Table 9 illustrate that the 
Passerini step C was successful, however the hydrogenolytic deprotection D failed. 
Hence, monomer-NC 91 should only be used in order to terminate a macromolecule 
because further iterations would require a free carboxylic acid functionality. 
  
93 
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Scheme 23. a, synthesis of monomers-NC. A: Biginelli reaction; B: Passerini reaction. b, test system. 
C: Passerini reaction; D: hydrogenolytic deprotection. The results are summarized in the table below.[209] 
 
Table 9. Monomers for sequence-defined information-coding macromolecules, chosen to 
achieve large structural variety, and their performance in a Passerini/deprotection test system. 
# Rx a b 
Yield A 
[%] (№) 
Ry c 
Yield B 
[%] (№) 
Yield C 
[%] (№) 
Yield D 
[%] (№) 
1 Ph CH2 C10H20 45 (70) C7H15 C6H12 97 (85) 77 (108) 99 (123) 
2 
 
CH2 C10H20 39 (71) 
 
C6H12 83 (86) 96 (109) 99 (124) 
3 
 
CH2 C10H20 45 (72)  
C6H12 65 (87) 94 (110) 98 (125) 
4 Ph 
 
C10H20 67 (73) C6H13 C6H12 81 (88) 78 (111) 97 (126) 
5 Ph CH2 C5H10 55 (74) C4H9 C6H12 84 (89) 81 (112) 99 (127) 
6 Ph CH2 CH2 78 (50) CH3 C6H12 59 (90) 80 (113) 99 (128) 
7 
 
CH2 CH2 62 (75) C11H23 C6H12 50 (91) 75 (114) 0
a 
8 
 
CH2 CH2 61 (76) 
 
C6H12 51 (92) 42 (115) 92 (129) 
9 Ph CH2 CH2 78 (50) C7H15 
 
59 (83) 78 (116) 94 (130) 
10 Ph CH2 CH2 78 (50) C7H15 
 
76 (84) 98 (117) 96 (131) 
11 
 
CH2 CH2 45 (77) 
 
C6H12 42 (93) 95 (118) 99 (132) 
12 
 
CH2 CH2 63 (78) C7H15 C6H12 69 (94) 75 (119) 99 (133) 
13 
 
CH2 CH2 68 (79) 
 
C6H12 43 (95) 71 (120) 98 (134) 
14 
 
CH2 CH2 58 (80) C7H15 C6H12 61 (96) 52 (121) 93 (135) 
a Hydrogenation did not occur, even in an autoclave system at 40 bar H2 gas pressure at 40 °C or under 
homogenous conditions utilizing Wilkinson’s catalyst, no significant conversion was observed.  
b 
a 
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In Figure 36, two representative IR spectra (recorded in transmittance), of 
monomer-NC 84 and benzyl ester 117 are stacked. In the IR spectra, the isocyanide 
vibration band at ~2100 cm-1 clearly disappeared after reacting the monomers-NC in 
the first Passerini step of the test system. In addition, the C-H vibration region around 
2900 cm-1 increased in intensity, due to the introduction of two aliphatic chains. 
 
Figure 36. IR stack of monomer-NC 84 and benzyl ester 117. The isocyanide vibration band (red box) 
clearly disappeared. 
In addition to the monomers described in Table 9, a stereochemically different 
monomer-NC 97 (obtained from Biginelli acid 52) was synthesized and subjected to 
the test system (see Scheme 24). In order to solubilize the Biginelli acid 52, more 
dimethyl sulfoxide was required, leading to longer reaction times and a decrease in 
reaction efficiency. In the test system, compound 97 passed the Passerini step but was 
not converted under the hydrogenolytic conditions utilized herein. 
 
Scheme 24. Synthesis and evaluation of a stereochemically different monomer-NC 97. Monomer-NC 
reacted in the Passerini step of the test system but not in the hydrogenolytic deprotection step. 
52 
97 
122 
117 
84 
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Furthermore, the hydrogenation was tested in an autoclave system applying 40 bar of 
hydrogen gas, palladium on activated charcoal as catalyst while stirring at 40 °C for 
three days and under homogeneous conditions employing Wilkinson’s catalyst. 
However, no significant conversion could be achieved. In conclusion, testing new 
monomers for reactivity in both critical steps (see Scheme 23, steps C and D) before 
their utilization for iterative chain growth is feasible and should be performed prior to 
building up of larger macromolecules. 
 
4.3.2 Synthesis and analysis of information-coding macromolecules 
 
The herein employed iterative reaction strategy is based on a protective group 
approach and illustrated in Scheme 25. The monomers-NC can be polymerized by 
consecutive Passerini reactions, upon addition of an aldehyde (purple, Rz) and a 
carboxylic acid (black, R1 for the first reaction sequence), utilizing a modified procedure 
reported earlier.[204] 
 
Scheme 25. Synthesis of sequence-defined macromolecules via the Biginelli and the Passerini 
multicomponent reactions. In the Biginelli reaction, an ureido-carboxylic acid (spacer b), an aromatic 
aldehyde (with sidechain Rx) and an acetoacetate-benzyl ester (with spacer a) are reacted to yield a 
Biginelli acid, which subsequently reacts with an aldehyde (sidechain Ry) and a diisocyanide (spacer c) 
to from an isocyanide monomer (monomer-NC). The monomers-NC are polymerized iteratively by 
consecutive Passerini reactions, adding an aldehyde (sidechain Rz) and a carboxylic acid. After 
hydrogenolytic benzyl deprotection, the growing macromolecule bears a free terminal carboxylic acid, 
allowing the addition of the next monomer-NC in a further Passerini step.[209] 
Chapter    4    Results and discussion 
 
  95 
In a first test reaction, compound 98 was reacted with Biginelli acid 49 in a Passerini 
reaction (Scheme 26). The desired product 99 was isolated in 73% yield, and utilized 
in a subsequent hydrogenolytic deprotection, obtaining the corresponding carboxylic 
acid 100 in 97% yield. However, the compounds 99 and 100 did not feature a clear 
repeating unit structure (i.e. one DHMP core is in a different orientation than the other, 
as illustrated in Scheme 25) and were therefore not employed for further iterative 
cycles but regarded as a proof of principle. 
 
Scheme 26. First test reaction resulting in an asymmetric reaction product. 
For the subsequent syntheses, an aliphatic diacid (sebacic acid) was chosen as 
starting component to achieve bidirectional growth (see Figure 37 b). Nevertheless, 
instead of bifunctional components, mono- or multifunctional core units can potentially 
be applied, resulting in different macromolecular architectures. The reasons for 
choosing a bidirectional growth leading to symmetric macromolecules was: i. regarding 
SEC analysis: The differences in molar mass between each iterative cycle is greater 
than for unidirectional approaches and hence the shift in retention times in SEC 
analysis is greater; ii. regarding purification: Chromatographic separation of e.g. 
tetramers from dimers proved to be more efficient, than separation of tetramers from 
trimers; iii. the tandem-MS readout benefits from symmetry (due to the presence of 
both symmetric and asymmetric fragments vs. asymmetric fragments exclusively for 
non-symmetric macromolecules). The iterative Passerini polymerizations were 
conducted in dichloromethane at room temperature employing 1.50 equivalents of 
monomer-NC and 2.00 equivalents of aldehyde per carboxylic acid group. The reaction 
progress was monitored via size-exclusion chromatography (see Figure 37 a, for the 
reaction monitoring of the reaction between monomer-NC 90, sebacic acid and 
heptanal obtaining the symmetric dimer 101). The reaction mixture was purified by 
column chromatography on silica gel, obtaining typical yields of 70 – 95%. The 
exceeding monomer-NC could be partly recovered. 
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Figure 37. a, SEC reaction monitoring of the Passerini reaction presented in b, the monomer-NC 90 is 
marked by the arrow in red, the intermediately formed monofunctionalized product is marked with the 
green box and the desired difunctionalized macromolecule 101 is marked with the blue arrow. b, reaction 
equation for the synthesis of a sequence-defined symmetric dimer. c, HRMS analysis of the isotope 
pattern of 101.[209] 
After hydrogenolytic benzyl deprotection, the growing macromolecule is equipped with 
a terminal free carboxylic acid functional group, allowing the addition of the next 
monomer-NC in a subsequent Passerini reaction. The hydrogenolytic benzyl ester 
deprotection reactions were performed via heterogenous catalysis utilizing hydrogen 
gas and palladium on activated charcoal as catalyst. After simple filtration of the 
heterogenous catalyst and drying in high vacuum, the carboxylic acid terminated 
macromolecules were obtained in quantitative yields. Noteworthy, the herein selected 
monomer design is fully compatible with the previously reported iterative Passerini 
polymerization for sequence-defined macromolecules, potentially allowing the 
incorporation of chemically different monomers.[333,334] However, in comparison to the 
previously described approach (illustrated in Scheme 18 ), synthesis of the individual 
monomers-NC is required, thus enabling to encode more information per repeating 
c 
a b 
90 
101 
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unit, albeit requiring additional synthesis and purification steps. A summary of all 
macromolecules synthesized for this investigation can be found in Figure 38. 
 
Figure 38. Structures of the macromolecules synthesized for the present investigation. 
The macromolecules prepared herein were analyzed via size-exclusion 
chromatography (see Figure 39), indicating uniform species and high purity. The 
structural identity of the macromolecules was investigated via 1D and 2D nuclear 
magnetic resonance spectroscopy and further confirmed by high resolution mass 
spectrometry (including analysis of the isotope pattern, see Figure 37 c) and 
ESI-MS/MS collision experiments (see chapter 4.3.3). 
  
R = Bn: 101  R = H: 102 
R = Bn: 105  R = H: 106 
107 
R = Bn: 103  R = H: 104 
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Figure 39. a, Size-exclusion chromatography traces and schematic representation of the iterative 
growth of the sequence-defined macromolecule 106. b, ESI-MS of 106 recorded in positive mode. The 
signal at m/z = 1449 corresponds to the double charged bis-sodium adduct, the signal at m/z = 973 
corresponds to the triple charged tris-sodium adduct.[209] 
The symmetric and narrow peak shape of the size-exclusion elugrams (Figure 39 a) 
indicates the high purity of the obtained substances. The shoulders for the blue and 
green curve towards shorter retention times account for an amount of approximately 
1% monofunctionalized chains (trimers), which could not be fully separated via column 
chromatography. However, the monofunctionalized chains did not interfere with the 
later readout. NMR analysis of the macromolecules (see Figure 40) was complicated 
due the aforementioned diastereomers (see Figure 28). Signal splitting caused by the 
presence of diastereomers was observed for monomers and the respective polymers 
displaying a short ureido-carboxylic acid spacer (i.e. a = CH2), possibly due to the 
shorter distance of the chiral centers and the more fixed geometry of the substrates. 
Compounds derived from longer spacers (a = C5H10 or C10H20) did not display split 
signals. However, careful analysis of 2D NMR spectra (i.e. multiplicity edited HSQC in 
Figure 40 a and b, or via HMBC Figure 40 c) and comparison with the spectra of the 
precursor compounds, clearly identified the reaction products.  
b a 
106 
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Figure 40. NMR analysis of macromolecule 105 displaying additional diastereomeric signal splitting. a, 
multiplicity edited HSQC. b, Expansion of the box in a visualizing the CH region. For position 8 and 76 
split signals are observed in the proton spectrum. Signal 76 further overlaps with 25. Positions 1 and 40 
or 22 and 73 are too close to each other to be clearly distinguished. c, HMBC, employed to further 
confirm the signal assignment.   
a 
b c 
b 
105 
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4.3.3 Readout via distinct fragmentation pathways  
 
In the perspective of data storage materials, it is essential to read out the previously 
stored information. In the present investigation, several symmetric sequence-defined 
dimers (101, 102, 103 and 104) were synthesized and sequenced via ESI-MS/MS. The 
ESI-MS samples were prepared in solvent mixtures doped with sodium trifluoroacetate 
in order to predominantly observe the sodium adducts in positive mode. The 
ESI-MS/MS collision experiments were conducted at different fragmentation energies 
ranging from 10 – 50 eV. ESI-MS/MS analysis of the macromolecules revealed that 
the complex macromolecular structures are predominantly fragmenting in distinct and 
repetitive positions along the backbone chain of the macromolecule, such as the ester 
or amide bonds. This systematic fragmentation allows full sequencing of the structures 
(considering a limited subset of possible components as proposed in the list of 
components). After evaluating of the fragmentation patterns of several sequence-
defined dimers, three dominant fragmentation patterns were identified: 
decarboxylation, Mc Lafferty rearrangements and isocyanide formation (see 
Figure 41). Subsequently, different symmetric tetramers (107, 105 and 106) were 
sequenced accordingly, employing the afore identified fragmentation patterns to 
predict the fragment masses. 
 
Figure 41. Fragmentation pathways occurring along the chain, utilized to sequence the structures. 
In order to reconstruct the molecular structure form the MS readout, the monoisotopic 
mass of the intact molecule is considered first. As previously described in Figure 20, 
preselection of the monoisotopic mass already significantly reduces the remaining 
possibilities according to the list of components. Fragmentation of the macromolecules 
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at different fragmentation energies and comparison of the fragmentation spectra with 
the above described and predominant fragmentation patterns successively narrows 
the remaining possibilities until the molecular structure is solved and thus the sequence 
re-established. 
 
Figure 42. ESI-MS/MS fragmentation of a double charged species at m/z = 1449 (106) recorded in 
positive mode at higher-energy collision dissociation of 30 eV. Fragmentation processes are denoted 
as follows: ax: decarboxylation at position x; bx: Mc Lafferty rearrangement of the ester bonds forming a 
carboxylic acid (by) and an enamide (bz); cx: Amide bond fragmentation forming an isocyanide. The 
fragments are labeled accordingly: [axcy+2Na]2+ → a doubly charged bis-sodium adduct formed by 
decarboxylation on position x and isocyanide formation on position y.[209] A comprehensive description 
of each fragment can be found in supplementary information of the open access publication[209] and in 
the electronic version of this thesis. 
Utilizing the above-mentioned fragmentation patterns in combination with the list of 
components, the position of each component within the macromolecule can be 
determined (see Figure 43) by the analysis of overlapping fragments (in analogy to 
protein[335,336] or DNA sequencing via tandem-MS).[337] 
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Figure 43. Conceptional reconstruction of the molecular structure via the analysis of overlapping 
fragments. After considering the mass of the intact molecule (determined via ESI/MS) and a multitude 
of fragments (via ESI-MS/MS) the molecular structure can be determined precisely. The sequence is 
subsequently transferred into a systematic component-based notation utilizing the list of components 
and can be further processed into binary codes.[209] 
The investigated symmetric tetramers formally encoded 97 bits each 
(4 × 24.47 = 97.89), generated by the list of components. Translation of this 
component-based alphabet back into binary numerical system can be achieved 
through conversion of the positional notation. If longer sequences are synthesized 
and/or more compounds are included in the list of components, the storage capacity 
of the macromolecules can potentially be much higher. However, the herein presented 
strategy is currently limited in the length of sequences for two reasons: 
i. chromatographic separation on silica gel becomes challenging due to the increasing 
amount of polar dihydropyrimidone rings and ii. the readout of longer sequences 
generates a large number of fragments. This information needs to be processed and 
analyzed and would require a computer assisted system (as presented in 4.1.2.3). 
However, both limitations could be overcome with further development. 
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5 Conclusions and outlook 
 
The main objective of this thesis was the application of multicomponent reactions in 
novel data storage systems. Herein, the Ugi reaction of perfluorinated acids in 
combination with a list of components (comprising 130 commercially available 
components for evaluating the possible permutations and further assigning chemical 
information to alphanumeric codes for computer processing) was introduced. The 
structural variety resulted in 500,000 permutations and hence 18 bits information 
density within one Ugi compound (so-called molecular key). The herein investigated 
molecular key strategy allows secure steganographic key distribution in combination 
with a flexible and adaptable data safety protocol. The molecular keys were 
synthesized in a straight-forward, one-pot reaction procedure. The molecular 
structures were analyzed by a combination of tandem-MS fragmentation and computer 
assisted readout. Readout of the molecular keys was simplified by a custom 
programed computer script, provided by a cooperation partner. The respective 
molecular structures served as decryption keys (passwords) for AES encrypted 
messages or data files. In principle, the herein presented keys could also be used for 
other applications, e.g. as identification or anti-counterfeit tags (for the identification of 
trademark products). The encryption/decryption was performed by a second computer 
script (based on AES). In future research, the synthesis of molecular keys (probably 
also purification and analysis) could be performed by a robotic system. The 
investigation of molecular keys with even higher data storage capacities will be of great 
interest in order to overcome current limitations of the system. Furthermore, it will be 
important to refine the list of components by synthesizing and testing many 
permutations by systematic component variations, identify unexpected complications 
and remove components that caused problems. In this refining, additional components 
(non-commercial) can be added to the list of components in order to increase the 
storage capacity of the individual compounds. 
Inspired by the idea to utilize even more varying components, the Biginelli reaction was 
successfully combined with the Passerini reaction to obtain highly functionalized 
heterocyclic products. For this purpose, different Biginelli acids were prepared by 
variation of the components and the bifunctional linker. The Biginelli acids were 
subsequently reacted with different aldehydes and isocyanides in a Passerini reaction. 
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The combination of both reactions was enabled by a dichloromethane/dimethyl 
sulfoxide solvent mixture. The respective Biginelli-Passerini reaction products enabled 
the variation of five components and were obtained in good to excellent yields. 
Furthermore, a one-pot Biginelli-Passerini tandem reaction without intermediate 
workup was demonstrated. In future experimental work it will be interesting to evaluate 
the Biginelli-Passerini compounds towards their pharmacological properties. 
In order to leverage the Biginelli-Passerini system, a monomer-based strategy towards 
sequence-defined macromolecules was established. First, several bifunctional 
components were prepared and a list of components (for generating the permutations 
and assigning sidechains to alphanumeric codes) was compiled. Secondly, the 
bifunctional components were employed in consecutive Biginelli and Passerini 
reactions for the synthesis of highly functionalized isocyanide-benzyl ester monomers. 
Thirdly, these monomers were evaluated in a qualitative test system consisting of a 
Passerini reaction in the first step and a hydrogenolytic benzyl ester deprotection in 
the second step. Finally, the monomers were polymerized via iterative Passerini and 
benzyl deprotection reactions, resulting in symmetric sequence-defined 
macromolecules, formally encoding 24 bits per repeating unit (generated through the 
variation of six components per repeating unit). The macromolecules were sequenced 
by tandem-MS. Sequencing was enabled via the identification of three predominant 
fragmentation processes occurring along the chain. 
The herein presented concepts demonstrate several key advantages contributing to 
the rapid development of molecular data storage materials: i. the number of varying 
monomers/components can be much higher than for biomacromolecules such as 
DNA/RNA offering the key benefit of achieving high data storage density within few 
synthetic steps.; ii. DNA/RNA and other biomacromolecules can potentially be 
pathogenic by coincidentally containing biologically relevant sequences (for instance 
of viruses in the biological sense). iii. different chemical methodologies can be 
employed or even combined for the preparation of sequence-defined 
macromolecules.[205,334] Generally, synthetic and non-natural molecules can be 
designed to be chemically more stable than DNA analogs (for instance, the herein 
described macromolecules do not contain phosphate esters, which are prone to 
hydrolysis). However, the long term stability of the herein presented macromolecules 
should be evaluated under different conditions in future experiments. The combination 
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of all benefits can promote sequence-defined macromolecules to serve for special 
applications such as data storage materials, cryptographic keys or anti-counterfeit 
tags.[242,338] Since the macromolecules in the present investigation are symmetric 
structures, not every permutation of a corresponding bit sting can be encoded. In future 
work, it will thus be interesting to synthesize non-symmetric macromolecules in order 
to also encode non-symmetric bit strings of data. In addition, the Shannon information 
capacity[210] for the present multicomponent system should be evaluated (as already 
performed for DNA),[13] in order to prove how many permutations can be practically 
realized (i.e. how many permutations can be synthesized and read-out). Nevertheless, 
automated synthesis of long sequences and automated analysis (combined with a 
suitable software) will be crucial for potential applications.  
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6 Experimental part 
 
The experimental design and logic of all experiments was kept minimalistic in order to 
be simple, comprehensible and reproducible. Synthetic strategies were planned in 
convergent routes and compared with each other to achieve high reaction efficiency. 
Procedures of increasing synthetic complexity were only applied if simpler approaches 
did not provide satisfying results. Many synthetic procedures included herein were 
successfully reproduced in undergraduate organic chemistry laboratory courses, by 
supervised bachelor or “Vertiefer” students (specialization subject) or apprentices 
(chemical laboratory technicians). 
All synthesized and subsequently utilized substances were characterized via 
complementary methods (1H-, 13C-NMR spectroscopy, IR spectroscopy, HRMS). 
Structural characterization and elucidation was carried out via 2D NMR methods, 
enabling assignment of 1H-NMR and 13C-NMR signals. Displayed NMR spectra, 
tandem-MS fragmentation spectra, etc. are not included in the printed version of this 
thesis but can be found in the electronic version (stored on the CD) and in the 
supplementary information of the respective peer-reviewed publications (open 
access). References to the respective publications are provided at the beginning of the 
corresponding chapters in the experimental part. 
 
6.1 Methods section 
 
6.1.1 Chemical reagents and solvents 
 
All technical solvents were used, if not explicitly described without further purification. 
Ethyl acetate, hexanes, tetrahydrofuran, dichloromethane and acetone were pre-
distilled. If necessary, solvents were additionally dried via standard procedures. All 
commercially available chemicals were used, unless otherwise stated, without further 
purification and purchased from SIGMA ALDRICH. Aldehydes were tested for 
oxidative contaminations (carboxylic acids) before use via TLC and 1H-NMR. If 
carboxylic acids were present, the aldehyde was purified via distillation (for low boiling 
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liquids), column chromatography (for high boiling liquids) or recrystallization (for solids) 
before use. The substances described in chapter 6.2 were synthesized by the author 
himself or students/apprentices under supervision of the author. Flash column 
chromatography[339] was performed utilizing Merck SiO2 60 (230 − 400 mesh). 
 
6.1.2 Thin-layer chromatography 
 
For thin-layer chromatography (TLC) analysis precoated aluminum foils with 
fluorescence indicator from MERCK (TLC Silica gel 60, F254, layer thickness: 0.25 mm) 
were employed as stationary phase. The analyte substances were spotted onto the 
TLC plates with a thin capillary, subsequently the plates were set into a TLC chamber 
filled and presaturated with eluent solvent mixture, the solvent ratios were reported in 
(volume:volume). The spots were firstly visualized by fluorescence quenching under 
UV-light (λ = 254 and 365 nm), fluorescence (λ = 365 nm) and afterwards by staining 
with Seebach reagent solution. Preparation of Seebach reagent: 6.25 g ammonium 
heptamolybdate tetrahydrate (NH4)6Mo7O24·4H2O) and 2.50 g cerium(IV) sulfate 
tetrahydrate (Ce(SO4)2·4H2O), were stirred in 225 mL water and 25.0 mL concentrated 
sulfuric acid were added slowly while stirring and cooling. In some cases, staining with 
potassium permanganate was more efficient. Preparation of permanganate staining 
reagent: solution of 3.00 g potassium permanganate (KMnO4), 20.0 g potassium 
carbonate (K2CO3) and 5.00 mL of a 5 wt.% sodium hydroxide (NaOH)-solution in 
300 mL water. For some of the perfluorinated Ugi compounds a vanillin staining 
reagent was the best choice. Preparation of vanillin staining reagent: 15 g of vanillin 
were dissolved in 250 mL ethanol, subsequently 2.5 mL of concentrated sulfuric acid 
were slowly added while stirring and cooling. 
 
6.1.3 Nuclear magnetic resonance spectroscopy 
 
1H- and 13C-nuclear magnetic resonance (NMR) spectra were recorded on BRUKER 
Avance DPX spectrometers (Billerica, MA) with a 5-mm dual proton/carbon probe 
(operating at 300 MHz or 400 MHz for 1H-NMR spectra and 75.5 MHz for 13C-NMR 
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spectra) or on a Bruker Avance III with a 5 mm z-gradient cryogenically cooled probe 
head operating at 600 MHz for 1H- and 75.5 MHz for 13C-NMR) or on a 500 MHz WB 
Bruker Avance I spectrometer with a proton frequency of 499.97 MHz. 13C-NMR 
spectra were measured at a frequency of 125.72 MHz on an 8 mm TXI probehead with 
actively shielded z-gradients (at Θ =0°) and on a 4 mm triple HCX MAS probehead (at 
ca. Θ = 65°) at 298 K, regulated with a Bruker VTU-3000. Unless otherwise stated, all 
spectra were measured at ambient temperature. The chemical shift for 1H-NMR 
spectra was reported in parts per million (ppm) referenced to to TMS (0 ppm) or to 
characteristic solvent signals of partly deuterated solvents e.g. CDCl3 at 7.26 ppm or 
the centroid peak of the DMSO-d6 quintet at 2.50 ppm. 13C-NMR spectra were reported 
in ppm relative to characteristic signals of partly deuterated solvents, e.g. the centroid 
peak of the CDCl3 triplet at 77.00 ppm or the DMSO-d6 septet at 39.52 ppm. All 13C-
NMR spectra are decoupled from 1H signals. The signals were listed from low field 
(large ppm) to high filed (small ppm) with the following notation: NMR-active nucleus 
(frequency [MHz], deuterated solvent): δ [ppm] = chemical shift (spin multiplicity, scalar 
coupling constant J [Hz], integral/number of nuclei, assignmentAtom position). The spin 
multiplicity and corresponding signal patterns were abbreviated as follows: s = singlet, 
d = doublet, t = triplet, q = quartet, quint. = quintet, m = multiplet, br s = brought singlet. 
Coupling constants J were noted in Hz. Furthermore, 2D NMR methods e.g. 
heteronuclear multiple quantum coherence (HMQC) or heteronuclear single quantum 
coherence (HSQC), heteronuclear multiple bond correlation (HMBC) and correlated 
spectroscopy (COSY) or nuclear Overhauser enhancement spectroscopy (NOESY) 
were carried out, if necessary, for signal assignment and structure elucidation. 
 
6.1.4 Fourier transform infrared spectroscopy 
 
Infrared spectra (IR) were recorded on a BRUKER Alpha-p instrument in a range from 
3997 to 374 cm-1 applying ATR-technology. The signal shape and intensity was 
reported relative to the most intense signal in the spectrum and abbreviated in the 
following pattern: br = brought, vs = very strong, s = strong, m = medium, w = weak, 
vw = very weak. The signals were noted from large to smaller wavenumbers with the 
following notation: IR (type of measurement)  [cm-1] = wave number (signal intensity, 
proposed molecular oscillation assignment). 
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6.1.5 Fast-atom-bombardment and electron ionization 
 
Fast-atom-bombardment (FAB) and electron ionization (EI) mass spectra were 
recorded utilizing a Finnigan MAT 95 mass spectrometer. The signal of the molecule 
singly charged cation was referred to as [M]+, the protonated singly charged cation of 
the molecule was referred to as [(M+H)]+. Molecule fragmentations observed in FAB 
or EI measurements were illustrated in a figure below the text and were formally 
denoted as homolytic bond cleavage to allow a simple illustration of the observed m/z 
species, but a radical mechanism (or formation) was not proven. 
 
6.1.6 Electrospray ionization – mass spectrometry 
 
Electrospray ionization – mass spectra (ESI-MS and ESI-MS/MS) were recorded on a 
Q Exactive (Orbitrap) mass spectrometer (Thermo Fisher Scientific, San Jose, CA, 
USA) equipped with a HESI II probe. Calibration was carried out in the m/z range 
74-1.822 using premixed calibration solutions (Thermo Fisher Scientific). A constant 
spray voltage of 4.7 kV and a dimensionless sheath gas of 5 were employed. The S-
lens RF level was set to 62.0, while the capillary temperature was set to 250 °C. All 
samples were dissolved at a concentration range of 0.05 – 0.01 mg⋅mL−1 in a mixture 
of THF and MeOH (3:2) doped with 100 μmol sodium trifluoroacetate and injected with 
a flow of 5 μL⋅min−1. 
 
6.1.7 Size-exclusion chromatography – mass spectrometry 
 
Size-exclusion chromatography – Mass spectrometry (SEC-ESI-MS) was performed 
by coupling the above-mentioned Q Exactive (Orbitrap) mass spectrometer to an 
UltiMate 3000 UHPLC System (Dionex, Sunnyvale, CA, USA) consisting of a pump 
(LPG 3400SD), autosampler (WPS 3000TSL), and a thermostated column department 
(TCC 3000SD). Separation was performed on two mixed bed size-exclusion 
chromatography columns (Polymer Laboratories, Mesopore 250 × 4.6 mm, particle 
diameter 3 μm) with precolumn (Mesopore 50 × 4.6 mm) operating at 30 °C. THF at a 
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flow rate of 0.30 mL·min-1 was used as eluent. The mass spectrometer was coupled to 
the column in parallel to a RI-detector (RefractoMax520, ERC, Japan). In this setup 
0.27 mL·min-1 of the eluent were directed through the RI-detector and 30 μL·min-1 
infused into the electrospray source after postcolumn addition of a 100 μM solution of 
sodium iodide in methanol at 20 μL·min-1 by a micro-flow HPLC syringe pump 
(Teledyne ISCO, Model 100DM). A 20 μL aliquot of a analyte solution with a 
concentration of 1 mg·mL-1 was injected onto the HPLC system. 
 
6.1.8 Size-exclusion chromatography 
 
Size-exclusion chromatography (SEC) was conducted on a Varian 390-LC system 
equipped with a LC-290 pump (Varian), a refractive index detector (24 °C), a PL AS 
RT GPC-autosampler (Polymer laboratories) and a Varian Pro Star column oven 
Model 510, operating at 40 °C. For separation two SDV 5 μm linear S columns (8 × 
300 mm) and a guard column (8 × 50 mm) were used. Detection was performed by a 
differential refractive index detector operating in THF (flow rate 1.0 mL·min-1). For 
calibration linear poly(methyl methacrylate) standards (Agilent) ranging from 875 Da to 
1677 kDa were used. Samples were prepared in a concentration of 1 mg·mL-1 in THF. 
Determinations of molecular weights of polymers insoluble in tetrahydrofuran were 
performed on a Tosoh EcoSEC HLC-8320 SEC system with hexafluoro isopropanol 
(HFIP) containing 0.1 wt.% potassium trifluoroacetate as the solvent. The solvent flow 
was 0.40 mL·min-1 at 30 °C. The analysis was performed on a three column system: 
PSS PFG Micro precolumn (3.0 × 0.46 cm, 10,000 Å), PSS PFG Micro (25.0 × 0.46 cm, 
1000 Å) and PSS PFG Micro (25.0 × 0.46 cm, 100 Å). The system was calibrated with 
linear poly(methyl methacrylate) standards (Polymer Standard Service, Mp 102 – 
981 000 Da). For sample preparation a mass of approximately 2 mg was stirred in 
1 mL of solvent until a solution was obtained. 
 
6.1.9 Differential scanning calorimetry 
 
Differential scanning calorimetry (DSC) experiments were carried out with a METTLER 
TOLEDO DSC stare system DSC821e calorimeter measuring in nitrogen atmosphere, 
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employing a sample mass of approximately 5 mg. The melting temperature, Tm, is 
recorded as the minimum (endothermic transitions are represented downwards) of the 
endothermic melting peak with the following method. The glass transition temperature 
Tg is reported as the curves inflection point (first derivative equals zero) using the 
following method: heating from 25 °C to 240 °C at 15 °C·min-1, cooling from 240 °C to 
0 °C at 15 °C·min-1 and heating from 0 °C to 260 °C at 15 °C·min-1. All values were 
recorded on the second heating cycle to ensure equal thermal history for all samples. 
 
6.1.10 Gas chromatography – mass spectrometry 
 
Gas Chromatography – Mass Spectrometry (GC-MS) (electron impact (EI)) analyses 
were conducted using a Varian 431-GC instrument with a capillary column 
FactorFourTM VF-5ms (30 m × 0.25 mm × 0.25 μm) and a Varian 210-MS ion trap mass 
detector. Scans were performed from 40 to 650 m/z at rate of 1 scan per second. The 
oven temperature program applied during the analysis was: initial temperature 95 °C, 
hold for 1 min, ramp at 15 °C∙min-1 to 200 °C, hold for 2 min, ramp at 15 °C∙min-1 to 
300 °C, hold for 5 min. The injector transfer line temperature was set to 250 °C. 
Measurements were performed in the split-split mode (split ratio 50:1) using helium as 
carrier gas (flow rate 1.0 mL∙min-1). 
 
6.1.11 Microwave reactor 
 
Microwave-assisted syntheses were performed in a CEM EXPLORER 12 HYBRID 
microwave reactor using a dynamic program at 150 W. The reaction mixture was pre-
stirred with a magnetic stir bar for 30 s at medium speed in 10 mL or 35 mL glass 
vessels sealed with a PTFE rubber band.  
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6.2 Synthetic procedures 
 
6.2.1 Synthetic procedures for chapter 4.1 
 
Additional data such as displayed NMR spectra and tandem-MS mass spectra can be 
found in the supplementary information of the previous publication and are included in 
the electronic version of this thesis on the CD.[208] 
 
6.2.1.1 Ugi reactions of perfluorinated acids 
 
 Ugi reaction of perfluorononanoic acid, benzaldehyde, 
tert-butylisocyanide and butylamine 19 
 
In a 25 mL round bottom flask benzaldehyde (50.0 µL, 52.0 mg, 490 µmol, 1.30 eq.) 
was dissolved in 1.5 mL methanol, subsequently butylamine (48.5 µL, 35.9 mg, 
490 µmol, 1.30 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards, the mixture was filtrated. The solid was washed with 10 mL 
methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, tert-butylisocyanide (51.2 µL, 37.6 mg, 453 µmol, 
1.20 eq.) was added to the stirring mixture. The reaction was stirred for 18 h at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was concentrated and the residue was adsorbed onto celite® and purified via 
column chromatography employing silica gel and eluting with a gradual solvent mixture 
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of ethyl acetate and c-hexane (0:1 → 1:1) to yield the Ugi product 19 as a pale highly 
viscous oil (59.4 mg, 83.7 µmol, 22.2%). 
Rf = 0.50 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3320.6 (w, 𝜈(N-H)), 2968.3 (w, 𝜈(C-H)), 1675.7 (m, 𝜈(C=O)), 
1654.1 (m, 𝜈(C=O)), 1553.5 (m), 1477.9 (vw), 1453.2 (w), 1429.2 (w), 1369.4 (w), 
1330.5 (w), 1234.3 (m), 1202.1 (vs), 1148.3 (vs), 1111.3 (m), 987.4 (w), 968.1 (vw), 
928.5 (w), 806.6 (vw), 772.64 (vw), 736.7 (w), 697.8 (w), 655.0 (m), 631.3 (m), 611.6 
(w), 564.8 (w), 519.9 (s), 496.1 (w), 439.3 (vw). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.64 – 7.31 (m, 5 H, CHAr23-27), 5.74 – 5.36 
(m, 2 H, NH5 + CH2), 3.78 – 3.00 (m, 2 H, CH28), 1.47 – 1.18 (m, 9 H, CH318,28,29), 
1.14 – 0.96 (m, 4 H, CH219,20), 0.67 (t, J = 7.2 Hz, 3 H, CH321). 
13C-NMR (101 MHz, CDCl3): δ [ppm] = 166.17 (s, CONR4), 157.98 (s, CONR17), 132.94 
(s, CAr22), 132.64 (s, CHAr), 128.59 (s, CHAr), 128.11 (s, CHAr), 128.05 (s, CHAr), 64.86 
(s, CH2), 51.17 (s, C6),47.15 (s, CH28), 30.85 (s, CH220 or 19), 27.86 (s, CH318, 28, 29), 
27.48 (s, CH318, 28, 29), 18.87 (s, CH220 or 19), 12.28 (s, CH321). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.11 (t, J = 10.3 Hz, 3 F, CF39), AB-signal 
(δA = -113.09, δB = -114.08, JAB = 297.4 Hz, A and B are split into t, J = 13.1 Hz, CF216a), 
AB-signal (δA = -115.56, δB = -116.60, JAB = 291.8 Hz, CF216b, additional coupling not 
resolved, signals broadened), -124.62 (s, CF2), -126.11 (s, CF2), -127.05 (s, 
CF2), -130.44 (s, CF210). Total integral of CF2 region normalized with respect to the 
CF39 group = 14.  
FAB – MS [m/z] (relative intensity): 709.2 (35%) [M + H]+, 637.1 (40%) [Fragment A – 
H]+, 608.1 (55%) [Fragment A – CO]+, 552.1 (20%) [Fragment A – CO – C5H9]+, 191.1 
(12%), [Fragment B + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C251H2616O214N219F17, 709.1717; found, 
709.1715; Δ = 0.19 mmu. 
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 Ugi reaction of perfluoropentanoic acid benzaldehyde, 
tert-butylisocyanide and butylamine 20 
 
In a 25 mL round bottom flask benzaldehyde (115 µL, 119 mg, 1.12 mmol, 1.70 eq.) 
was dissolved in 1.5 mL methanol, subsequently butylamine (114 µL, 82.4 mg, 
1.12 mmol, 1.70 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards, the mixture was filtrated and the solid was washed with 
10 mL methanol three times. Subsequently, the filtrate was concentrated under 
reduced pressure. Perfluoropentanoic acid (175 mg, 663 µmol, 1.00 eq.) dissolved in 
1 mL methanol was added to the imine at room temperature and the resulting mixture 
was stirred for 2 min. Subsequently, tert-butylisocyanide (127 µL, 93.7 mg, 1.12 mmol, 
1.70 eq.) was added to the stirring mixture. The reaction was stirred for 3 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
remaining perfluoro acid was removed with a short silica gel filter column, eluting with 
c-hexane/ethyl acetate (3:1) to yield the Ugi product 20 as a yellow powder (259 mg, 
562 µmol, 85.1%). 
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Rf = 0.50 in c-hexane/ethyl acetate (5:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3317.9 (w, 𝜈(N-H)), 2963.9 (w, 𝜈(C-H)), 1679.7 (m, 𝜈(C=O)), 
1654.9 (s, 𝜈(C=O)), 1556.6 (m), 1475.8 (w), 1454.4 (w), 1429.8 (m), 1355.4 (w), 
1305.9 (w), 1233.5 (s), 1214.1 (s), 1187.4 (s), 1137.4 (s), 1125.2 (w), 1110.5 (w), 
1029.5 (w), 959.2 (w), 869.7 (w), 855.6 (w), 805.5 (w), 787.1 (w), 764.8 (w), 748.8 (w), 
728.1 (w), 699.2 (w), 648.3 (m), 634.3 (s), 610.4 (w), 522.6 (s), 498.2 (w), 435.9 (w). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 7.67 – 7.06 (m, 5 H, CHAr19-23), 6.09 – 5.59 (m, 
2 H, CH2 + NH5), 3.72 – 2.94 (m, 2 H, CH28), 1.33 (d, J = 15.2 Hz, 9 H, CH314,24,25), 
1.03 – 0.76 (m, 4 H, CH215 + 16), 0.68 – 0.55 (m, 3 H, CH317). 
13C-NMR (126 MHz, CD3OD): δ [ppm] = 168.75 (s, CONR4), 158.04 (s, CONR13), 
134.19 (s, CAr18), 130.23 (s, CHAr), 129.58 (s, CHAr), 128.87 (s, CHAr), 128.75 (s, CHAr), 
128.58 (s, CHAr), 64.24 (s, CH2), 50.96 (s, C6), 45.82 (s, CH28), 32.09 (s, CH215 or 16), 
28.96 (s, CH314, 24, 25), 27.28 (s, CH314, 24, 25), 19.45 (s, CH215 or 16), 12.25 (s, CH317). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -82.77 (dt, J = 23.6, 11.7 Hz, 3 F, CF39), AB-
signal (δA = -110.63, δB = -111.89, JAB = 240.9 Hz, A and B are split into t, J = 14.0 Hz, 
CF212a), AB-signal (δA = -112.48, δB = -113.57, JAB = 235.3 Hz, A and B are split into t, 
J = 14.4 Hz, CF212b), -122.01 – -122.31 (m, CF2), -124.75 (s, CF2), -125.33 (s, CF2), -
125.44 (s, CF210). Total integral of CF2 region normalized with respect to the CF39 
group = 6.  
ESI-MS [m/z]: [M + Na]+ calculated for 12C211H2516O214N219F923Na1, 531.1665; found, 
531.1669, Δ = 0.42 mmu. 
ESI-MS [m/z]: [2 M + Na]+ calculated for 12C421H5016O414N419F1823Na2, 1039.3437; 
found, 1039.3450, Δ = 1.29 mmu.  
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 Ugi reaction of perfluorotetradecanoic acid, benzaldehyde, 
tert-butylisocyanide and butylamine 21 
 
In a 25 mL round bottom flask benzaldehyde (97.2 µL, 101 mg, 952 µmol, 1.70 eq.) 
was dissolved in 1.5 mL methanol, subsequently butylamine (94.1 µL, 69.6 mg, 
952 µmol, 1.70 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Perfluorotetradecanoic acid (400 mg, 560 µmol, 1.00 eq.) dissolved in 
1 mL methanol was added at room temperature and the resulting mixture was stirred 
for 2 min. Subsequently, tert-butylisocyanide (108 µL, 79.2 mg, 952 µmol, 1.70 eq.) 
was added to the stirring mixture. After 4 h a precipitate was formed, and 2 mL 
tetrahydrofuran were added to homogenize the reaction mixture. The resulting solution 
was stirred for 5 d at room temperature. The crude reaction mixture was dried under 
reduced pressure. The residue was adsorbed onto celite® and purified via column 
chromatography employing silica gel and eluting with a gradual solvent mixture of ethyl 
acetate and c-hexane (1:10 → 1:3) to yield the Ugi product 21 as a yellow solid 
(98.7 mg, 103 mmol, 18.4%). 
Rf = 0.50 in c-hexane/ethyl acetate (5:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3321.1 (w, 𝜈(N-H)), 2968.1 (w, 𝜈(C-H)), 1679.5 (s, 𝜈(C=O)), 1654.5 
(s, 𝜈(C=O)), 1553.7 (m), 1452.7 (w), 1429.0 (w), 1363.3 (w), 1021.7 (vs), 1149.1 (vs), 
1113.3 (s), 1095.2 (m), 1042.1 (m), 987.1 (w), 968.3 (w), 938.3 (w), 873.6 (w), 827.5 
(m), 761.6 (m), 729.6 (m), 699.6 (m), 645.8 (s), 549.9 (s), 524.9 (s), 436.8 (w). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.79 – 7.25 (m, 5 H, CHAr24-28), 5.83 – 5.10 
(m, 2 H, NH5 + CH2), 3.79 – 3.16 (m, 2 H, CH29), 1.43 (s, 1 H, CH220a), 1.40 – 1.22 (m, 
9 H, CH319,29,30), 1.16 – 0.82 (m, 3 H, CH220b + CH221), 0.77 – 0.56 (m, 3 H, CH322). 
13C-NMR (101 MHz, CDCl3): δ [ppm] = 166.16 (s, CONR4), 159.78 (s, CONR18), 132.56 
(s, CAr23), 129.43 (s, CHAr), 128.58 (s, CHAr), 127.55 (s, CHAr), 64.79 (s, CH2a), 62.05 
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(s, CH2b), 50.81 (s, C6), 46.33 (s, CH29), 30.81 (s, CH220 or 21), 27.38 (s, CH318, 29, 30), 
18.72 (s, CH220 or 21), 12.28 (s, CH322). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -80.78 (t, J = 9.7 Hz, 3 F, CF335), AB-signal 
(δA = -108.81, δB = -109.78, JAB = 237.2 Hz, A and B are split into t, J = 13.1 Hz, CF217a), 
AB-signal (δA = -111.27, δB = -112.34, JAB = 233.4 Hz, CF217b, additional coupling not 
resolved, signals broadened), -120.31 (s, CF2), -121.76 (s, CF2), -122.77(s, CF2), -
126.18 (s, CF234). Total integral of CF2 region normalized with respect to the CF335 
group = 24.  
FAB – MS [m/z] (relative intensity): 959.1 (25%) [M + H]+, 886.0 (27%) [Fragment A]+, 
858.0 (43%) [Fragment B]+, 802.0 [Fragment B – C4H9]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C301H2616O214N219F27, 959.1558; found, 
959.1557; Δ = 0.09 mmu. 
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 Ugi reaction of perfluoropentanoic acid valeraldehyde, 
4-methoxyphenylisocyanide and butylamine 22 
 
In a 25 mL round bottom flask valeraldehyde (83.2 mg, 966 µmol, 1.70 eq.) was 
dissolved in 1.5 mL methanol, subsequently butylamine (108 µL, 70.6 mg, 966 µmol, 
1.70 eq.) was added and the resulting mixture was stirred for 60 min over sodium 
sulfate. Afterwards, the mixture was filtrated and the solid was washed with 10 mL 
methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluoropentanoic acid (150 mg, 568 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, 4-methoxyphenylisocyanide (108 µL, 129 mg, 
966 µmol, 1.70 eq.) was added to the stirring mixture. The reaction was stirred for 3 d 
at room temperature. The crude reaction mixture was dried under reduced pressure 
and purified via column chromatography employing FluoroFlash® silica gel. The 
fluorous fraction was tested for purity via TLC and concentrated under reduced 
pressure. The remaining perfluoro acid was removed with a short silica gel filter 
column, eluting with c-hexane/ethyl acetate (3:1) to yield the Ugi product 22 as a yellow 
powder (18.4 mg, 34.1 µmol, 6.01%). 
Rf = 0.48 in c-hexane/ethyl acetate (5:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 2957.5 (m, 𝜈(C-H)), 2929.3 (s, 𝜈(C-H)), 2858.8 (m, ), 1795.3 (m), 
1718.9 (s, 𝜈(C=O)), 1606.3 (vs, 𝜈(C=O)), 1506.0 (m), 1464.9 (m), 1351.9 (m), 1292.8 
(vs), 1234.4 (vs), 1136.6 (s), 1099.4 (s), 1036.6 (s), 894.2 (m), 835.9 (s), 793.9 (m), 
742.8 (m), 725.7 (m), 691.5 (m), 575.6 (w), 527.3 (w), 435.6 (w). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 7.47 – 7.35 (m, 2 H, CHAr16,20), 6.94 – 6.80 (m, 
2 H, CHAr17,19), 4.75 (t, J = 7.6 Hz, 1 H, CH2), 3.76 (s, 3 H, OCH322), 3.67 – 3.47 (m, 2 
Chapter    6    Experimental part 
 
  119 
H, CH29), 2.15 – 2.00 (m, 1 H, CH28a), 1.94 – 1.76 (m, 1 H, CH28b), 1.72 – 1.57 (m, 2 
H, CH2), 1.45 – 1.22 (m, 6 H, CH2), 1.02 – 0.81 (m, 6 H, CH324,27). 
13C-NMR (126 MHz, CD3OD): δ [ppm] = 169.96 (s, CONR4), 169.44 (s, CONR14), 
158.29 (s, CAr18), 132.15 (s, CAr6), 123.58 (s, CHAr16,20), 115.01 (s, CHAr17,19), 62.45 (s, 
CH2), 55.84 (s, OCH322), 47.15 (s, CH29), 33.77 (s, CH2), 29.74 (s, CH28), 29.56 (s, 
CH2), 23.51 (s, CH2), 21.06 (s, CH2), 14.25 (s, CH324 or 27), 13.91 (s, CH324 or 27).  
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.25 (t, J = 10.5 Hz, 3 F CF310), -123.93 (s, 
CF213), -125.69 – -127.15 (m, CF2), -133.18 (s, CF2), -133.32 (s, CF2), -134.92 (s, 
CF211). Total integral of CF2 region normalized with respect to the CF310 group = 6. 
FAB – MS [m/z] (relative intensity): 538.3 (28%) [M + H]+, 523.3 (34%) [M – CH3]+, 
220.2 (28%) [Fragment A]+, 122.1 (53%) [Fragment B]+. 
HRMS – FAB [m/z]: [M]+ calculated for 12C221H2716O314N219F9, 538.1872; found, 
538.1870; Δ = 0.26 mmu. 
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 Ugi reaction of perfluorononanoic acid, heptanal, 
4-methoxyphenylisocyanide and butylamine 23 
 
In a 25 mL round bottom flask heptanal (71.0 µL, 56.0 mg, 490 µmol, 1.30 eq.) was 
dissolved in 1.5 mL methanol, subsequently butylamine (48.5 µL, 35.9 mg, 490 µmol, 
1.30 eq.) was added and the resulting mixture was stirred for 60 min over sodium 
sulfate. Afterwards, the mixture was filtrated and the solid was washed with 10 mL 
methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, 4-methoxypehnylisocyanide (50.4 µL, 60.3 mg, 
453 µmol, 1.20 eq.) was added to the stirring mixture. The reaction was stirred for 3 d 
at room temperature. The crude reaction mixture was dried under reduced pressure 
and purified via column chromatography employing FluoroFlash® silica gel. The 
fluorous fraction was tested for purity via TLC and concentrated under reduced 
pressure. The remaining perfluoro acid was removed with a short silica gel filter 
column, eluting with c-hexane/ethyl acetate (3:1) to yield the Ugi product 23 as a highly 
viscous yellow oil (53.9 mg, 70.3 µmol, 18.6%). 
Rf = 0.45 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3320.9 (br, 𝜈(N-H)), 2959.5 (m, 𝜈(C-H)), 2932.7 (w, 𝜈(C-H)), 2861.1 
(w, 𝜈(C-H)), 1794.9 (w, 𝜈(C=O)), 1665.5 (s), 1605.3 (w), 1511.7 (m), 1466.2 (s), 1414.5 
(m), 1298.9 (m), 1236.4 (vs), 1205.4 (vs), 1147.3 (vs), 1037.6 (s), 936.0 (w), 829.4 (m), 
722.4 (m), 703.9 (m), 659.9 (m), 559.0 (m), 528.0 (m). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 8.25 (s, 1 H, NH5), 7.53 – 7.27 (m, 2 H, CHAr20,24), 
7.13 – 6.68 (m, 2 H, CHAr21,23), 4.69 (t, J = 7.5 Hz, 1 H, CH2), 3.79 (s, 3 H, OCH326), 
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3.63 – 3.28 (m, 2 H, CH29), 2.42 – 1.68 (m, 2 H, CH28), 1.64 – 1.42 (m, 2 H, CH219), 
1.39 – 1.19 (m, 10 H, CH2), 1.02 – 0.77 (m, 6 H, CH328 + 33). 
13C-NMR (126 MHz, CDCl3): δ [ppm] = 167.73 (s, CONR4), 160.32 (s, CONR18), 156.77 
(s, CAr22), 130.74 (s, CAr6), 121.79 (s, CHAr20,24), 114.33 (s, CHAr21,23), 62.04 (s, CH2), 
55.62 (s, OCH326), 45.61 (s, CH29), 31.69 (s, CH2), 29.09 (s, CH2), 27.84 (s, CH28), 
26.13 (s, CH2), 22.64 (s, CH2), 20.12 (s, CH2), 14.11(s, CH333 or 28), 13.58 (s, CH333 or 28). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.08 (t, J = 9.9 Hz, 3 F, CF310), -112.11 – -
113.63 (m, CF217a), AB-signal (δA = -115.34, δB = -115.68, JAB = 331.3 Hz, A and B are 
split into t, J = 12.8 Hz, CF217b), -124.74 (s, CF2), -126.11 (s, CF2), -127.03 (s, CF2), -
130.42 (s, CF211). Total integral of CF2 region normalized with respect to the CF310 
group = 14. 
FAB – MS [m/z] (relative intensity): 766.3 (50%) [M]+, 617.2 (85%) [Fragment A + H]+. 
HRMS – FAB [m/z]: [M]+ calculated for 12C281H3116O314N219F17, 766.2058; found, 
766.2058; Δ = 0.04 mmu. 
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 Ugi reaction of perfluoropentanoic acid benzaldehyde, 
4-methoxyphenylisocyanide and pentylamine 24 
 
In a 25 mL round bottom flask benzaldehyde (115 µL, 119 mg, 1.12 mmol, 1.70 eq.) 
was dissolved in 1.5 mL methanol, subsequently butylamine (114 µL, 82.4 mg, 
1.12 mmol, 1.70 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards, the mixture was filtrated and the solid was washed with 
10 mL methanol three times. Subsequently, the filtrate was concentrated under 
reduced pressure. Perfluoropentanoic acid (175 mg, 663 µmol, 1.00 eq.) dissolved in 
2 mL methanol was added to the imine at room temperature and the resulting mixture 
was stirred for 2 min. Subsequently, tert-butylisocyanide (127 µL, 93.7 mg, 1.12 mmol, 
1.70 eq.) was added to the stirring mixture. The reaction was stirred for 4 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing fluoro flash silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
remaining perfluoro acid was removed with a short silica gel filter column, eluting with 
c-hexane/ethyl acetate (3:1) to yield the Ugi product 24 as a colorless powder (258 mg, 
451 µmol, 68.1%). 
Rf = 0.29 in c-hexane/ethyl acetate (4:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3307.9 (br, 𝜈(N-H)), 2962.1 (m, 𝜈(C-H)), 2932.8 (m, 𝜈(C-H)), 
1673.9 (vs, 𝜈(C=O)), 1657.4 (s, 𝜈(C=O)), 1599.4 (m), 1544.4 (s), 1513.9 (w), 1494.6 
(w), 1477.9 (m), 1463.6 (m), 1452.6 (m), 1431.4 (m), 1417.4 (m), 1381.8 (w), 1353.1 
(m), 1298.5 (m), 1284.8 (m), 1262.9 (m), 1234.3 (s), 1211.9 (vs), 1197.1 (vs), 1185.5 
(s), 1175.2 (s),1136.8 (vs), 1126.6 (s), 1110.5 (vs), 1034.0 (s), 974.4 (w), 950.7 (s), 
931.0 (w), 870.8 (w), 849.6 (w), 829.7 (s), 812.4 (s), 802.4 (s), 760.1 (m), 745.8 (m), 
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722.2 (m), 704.7 (vs), 632.3 (m), 612.4 (m), 574.9 (w), 548.1 (m), 524.7 (m), 512.3(s), 
474.4 (m), 436.9 (w). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.44 (d, J = 2.6 Hz, 5 H, CHAr26-30), 7.31 (d, J = 
9.0 Hz, 2 H, CHAr16,20), 6.79 (d, J = 8.9 Hz, 2 H, CHAr17,19), 5.74 (s, 1 H, CH2), 
3.88 – 3.66 (m, 3 H, OCH322), 3.58 – 3.25 (m, 2 H, CH29), 1.57 (d, J = 58.6 Hz, 2 H, 
CH2), 1.19 – 0.91 (m, 4 H, CH2), 0.75 (t, J = 7.0 Hz, 3 H, CH325). 
13C-NMR (126 MHz, CDCl3): δ [ppm] = 166.60 (s, CONR4), 159.65 (s, CAr18), 157.11 
(s, CONR14), 133.39 (s, CAr8), 130.81 (s, CAr6), 130.14 (s, CHAr), 129.93 (s, CHAr), 
129.73 (s, CHAr), 122.32 (s, CHAr16,20), 114.51 (s, CHAr17,19), 66.56 (s, CH2), 55.89 (s, 
OCH322), 48.23 (s, CH29), 29.92 (s, CH2), 29.12 (s, CH2), 22.33 (s, CH2), 14.22 (s, 
CH325). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.38 (t, J = 9.9 Hz, 3 F, CF310), AB-signal 
(δA = -113.13, δB = -114.21, JAB = 301.20 Hz, A and B are split into t, J = 12.3 Hz, 
CF213a), AB-signal (δA = -115.78, δB = -116.72, JAB = 291.8 Hz, A and B are split into t, 
J = 12.4 Hz, CF213a), -125.48 (s, CF2), -128.89 (s, CF211). Total integral of CF2 region 
normalized with respect to the CF310 group = 6. 
ESI-MS [m/z]: [M + Na]+ calculated for 12C251H2516O314N219F923Na1, 595.1614; found, 
595.1615, Δ = 0.13 mmu. 
ESI-MS [m/z]: [2M + Na]+ calculated for 12C501H5016O614N419F1823Na1, 1167.3335; 
found, 1167.3348, Δ = 1.32 mmu. 
 
 Ugi reaction of perfluorononanoic acid, p-anisaldehyde, 
cyclohexylisocyanide and propargylamine 25 
 
In a 25 mL round bottom flask p-anisaldehyde (77.9 µL, 87.3 mg, 641 µmol, 1.70 eq.) 
isobutyraldehyde and propargylamine (41.4 µL, 35.3 mg, 641 µmol, 1.70 eq.) were 
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added. The resulting mixture was stirred for 60 min over sodium sulfate. 
Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol 
was added to the imine at room temperature and the resulting mixture was stirred for 
2 min. Subsequently, cyclohexylisocyanide (79.7 µL, 70.0 mg, 641 µmol, 1.70 eq.) was 
added to the stirring mixture. The reaction was stirred for 3 d at room temperature. The 
crude reaction mixture was dried under reduced pressure and purified via column 
chromatography employing FluoroFlash® silica gel. The fluorous fraction was tested 
for purity via TLC and concentrated under reduced pressure. The remaining 
perfluorononanoic acid was removed with a short silica gel filter column, eluting with 
c-hexane/ethyl acetate (3:1) to yield the Ugi product 25 as a yellow oil (158 mg, 
212 µmol, 56.3%). 
Rf = 0.36 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3314.9 (m, 𝜈(N-H)), 2937.2 (m, 𝜈(C-H)), 2862.0 (w), 1687.5 (vs, 
𝜈(C=O)), 1655.8 (vs), 1612.7 (m), 1550.2 (s), 1518.1 (s), 1440.1 (s), 1405.5 (m), 
1368.2 (m), 1326.9 (m), 1307.5 (m), 1286.6 (s), 1243.1 (s), 1021.5 (s), 1150.3 (s), 
1119.4 (vs), 1079.4 (vs), 1034.4 (vs), 1011.4 (vs), 986.9 (s), 939.2 (m), 894.0 (m), 
874.4 (m), 838.6 (m), 776.3 (m), 755.3 (m), 736.6 (m), 707.6 (m), 653.7 (vs), 642.8 (s), 
629.0 (vs), 618.8 (vs), 560.0 (s), 527.0 (vs), 441.5 (w), 424.2 (m).  
1H-NMR (500 MHz, CD3OD): δ [ppm] = 7.41 – 7.19 (m, 2 H, CHAr21,25), 7.03 – 6.81 (m, 
2 H, CHAr22,24), 5.91 (s, 1 H, CH2), 4.40 – 4.18 (m, 2 H, CH29), 3.80 (s, 3 H, CH334), 3.69 
(s, 1 H, CH6), 3.34 – 3.25 (m, 1 H, CH20), 1.94 – 1.10 (m, 10 H, CH2). 
13C-NMR (126 MHz, CD3OD): δ [ppm] = 172.97 (s, CONR4), 169.96 (s, CONR18), 
161.98 (s, CAr23), 133.13 (s, CHAr21,25), 132.10 (s, CAr8), 115.32 (s, CHAr22,24), 61.53 (s, 
CH2), 55.81 (s, CH334), 50.00 (s, CH6 or CH20), 50.03 (s, CH6 or CH20), 36.89 (s, CH29), 
33.51 (s, CH2), 33.46 (s, CH2), 26.99 (s, CH2), 26.58 (s, CH2), 26.00 (s, CH2). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.24 (t, J = 10.3 Hz, 3 F, CF310), AB-signal 
(δA = -116.45, δB = -117.92, JAB = 301.2 Hz, A and B are split into t, additional coupling 
not resolved, signals broadened, CF217a), AB-signal (δA = -117.79, δB = -119.06, JAB = 
293.6 Hz, A and B are split into t, additional coupling not resolved, signals broadened, 
CF217b), -126.39 – -127.61 (m, CF2), -128.66 (s, CF2), -129.62 (s, CF2), -133.16 (s, 
CF211). Total integral of CF2 region normalized with respect to the CF310 group = 14. 
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FAB – MS [m/z] (relative intensity): 747.2 (25%) [M – H]+, 621.0 (30%) [Fragment A + 
H]+, 620.0 (45%) [Fragment A ]+, 582.0 (34%) [Fragment A + H – C3H3]+, 247.1 (33%) 
[Fragment B + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C271H2416O314N219F17, 747.1510; found, 
747.1509; Δ = 0.06 mmu. 
 
 
 Ugi reaction of perfluorononanoic acid, p-anisaldehyde, 
4-methoxyphenyl-isocyanide and propargylamine 26 
 
In a 25 mL round bottom flask p-anisaldehyde (77.9 µL, 87.3 mg, 641 µmol, 1.70 eq.) 
and propargylamine (41.1 µL, 35.3 mg, 641 µmol, 1.70 eq.) were added. The resulting 
mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid (175 mg, 
377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
4-methoxyphenyl-isocyanide (85.4 mg, 641 µmol, 1.70 eq.) was added to the stirring 
mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure and purified via column chromatography 
employing FluoroFlash® silica gel. The fluorous fraction was tested for purity via TLC 
and concentrated under reduced pressure. The remaining perfluorononanoic acid was 
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removed with a short silica gel filter column, eluting with c-hexane/ethyl acetate (3:1) 
to yield the Ugi product 26 as a yellow oil (190 mg, 247 µmol, 65.4%). 
Rf = 0.30 in c-hexane/ethyl acetate (4:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3299.7 (br, 𝜈(N-H)), 1680.0 (s, 𝜈(C=O)), 1656.2 (s), 1606.8 (m), 
1549.2 (m), 1510.5 (vs), 1462.2 (m), 1418.1 (m), 1300.9 (m), 1202.6 (vs), 1143.7 (vs), 
1034.2 (s), 1004.1 (m), 945.7 (m), 828.0 (s), 781.1 (m), 719.5 (m), 657.6 (s), 632.1 (s), 
526.1 (s), 441.3 (w).  
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.59 – 7.29 (m, 4 H, CHAr25,32,28,33), 6.93 (d, J = 
8.7 Hz, 2 H, CHAr22,24 or 29,31), 6.81 (d, J = 8.4 Hz, 2 H, CHAr22,24 or 29,31), 6.00 (s, 1 H, 
CH2), 4.45-4.32 (m, 2 H, CH29), 3.89 (s, 1 H, CH20), 3.83 (s, 3 H, CH327 or 35), 3.77 (s, 3 
H, CH327 or 3). 
13C-NMR (101 MHz, CDCl3): δ [ppm] = 171.35 (s, CONR4), 166.24 (s, CONR18), 160.77 
(s, CAr23 or 30),156.94 (s, CAr23 or 30), 131.97 (s, CHAr25,32 or 28,33), 130.26 (s, CAr8), 123.88 
(s, CAr6), 122.04 (s, CHAr25,32 or 28,33), 114.76 (s, CHAr22,24 or 29,31), 114.29 CHAr22,24 or 29,31), 
64.04 (s, CH2), 55.59 (s, CH327 or 3), 55.49 (s, CH327 or 3), 36.02 (s, CH29). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.13 (t, J = 9.9 Hz, 3 F, CF310), AB-signal (δA = 
-113.30, δB = -114.73, JAB = 299.3 Hz, additional coupling not resolved, signals 
broadened, CF217a), AB-signal (δA = -115.21, δB = -116.14, JAB = 293.6 Hz, additional 
coupling not resolved, signals broadened, CF217b), -124.78 (s, CF2), -126.13 (s, CF2), 
-127.07 (s, CF2), -130.46 (s, CF211). Total integral of CF2 region normalized with 
respect to the CF310 group = 14. 
FAB – MS [m/z] (relative intensity): 771.2 (33%) [M + H]+, 770.1 (65%) [M]+, 620.1 
(65%) [Fragment A ]+, 271.1 (33%) [Fragment B + H]+. 
HRMS – FAB [m/z]: [M]+ calculated for 12C281H1916O414N219F17, 770.1068; found, 
770.1070; Δ = 0.22 mmu. 
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 Ugi reaction of perfluorononanoic acid, p-anisaldehyde, 
2,6-dimethylphenyl-isocyanide and propargylamine 27 
 
In a 25 mL round bottom flask p-anisaldehyde (77.9 µL, 87.3 mg, 641 µmol, 1.70 eq.) 
and propargylamine (41.1 µL, 35.3 mg, 641 µmol, 1.70 eq.) were added. The resulting 
mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid (175 mg, 
377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
2,6-dimethylphenyl-isocyanide (84.1 mg, 641 µmol, 1.70 eq.) was added to the stirring 
mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure and purified via column chromatography 
employing FluoroFlash® silica gel. The fluorous fraction was tested for purity via TLC 
and concentrated under reduced pressure. The remaining perfluorononanoic acid was 
removed with a short silica gel filter column, eluting with c-hexane/ethyl acetate (3:1) 
to yield the Ugi product 27 as a yellow oil (114 mg, 149 µmol, 39.5%). 
Rf = 0.30 in c-hexane/ethyl acetate (4:1). Visualized via fluorescent quench and 
Seebach staining solution. 
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IR (ATR):  [cm-1] = 3330.2 (m, 𝜈(N-H)), 1694.4 (m), 1665.2 (s), 1609.3 (w), 1534.7 
(m), 1513.8 (m), 1426.0 (w), 1362.7 (w), 1205.8 (w), 1178.3 (vs), 1144.8 (vs), 1109.7 
(vs), 1072.8 (s), 1027.5 (m), 1003.6 (s), 937.2 (s), 920.3 (m), 831.6 (m), 802.9 (m), 
771.0 (m), 765.8 (m), 703.0 (s), 663.7 (vs), 633.2 (s), 587.1 (m), 559.7 (m), 559.7 (s), 
525.1 (s), 444.7 (w).  
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.51 (d, J = 9.5 Hz, 2 H, CHAr25,32), 7.11 – 7.01 
(m, 3 H, CHAr29,30,31), 6.97 (d, J = 8.7 Hz, 2 H, CHAr22,24), 5.99 (s, 1 H, CH2), 4.32 (s, 2 
H, CH29), 3.85 (s, 3 H, CH337), 2.16 (s, 6 H, CH334,35). 
13C-NMR (101 MHz, CDCl3): δ [ppm] = 166.72 (s, CONR4), 160.85 (s, CAr23), 135.64 
(s, CAr8 or 6), 132.17 (s, CHAr25,32), 128.40 (s, CAr8 or 6), 127.76 (s, CHAr29,30,31), 114.70 (s, 
CHAr22,24), 55.52 (CH327), 35.96 (s, CH29), 18.55 (CH334,35). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.10 (t, J = 9.9 Hz, 3 F, CF310), AB-signal (δA = 
-112.63, δB = -114.35, JAB = 297.4 Hz, additional coupling not resolved, signals 
broadened, CF217a), AB-signal (δA = -115.23, δB = -116.38, JAB = 293.6 Hz, additional 
coupling not resolved, signals broadened, CF217b), -124.82 (s, CF2), -126.13 (s, CF2), 
-127.06 (s, CF2), -130.44 (s, CF211). Total integral of CF2 region normalized with 
respect to the CF310 group = 14.  
FAB – MS [m/z] (relative intensity): 769.1 (60%) [M + H]+, 620.1 (85%) [Fragment A]+. 
HRMS – FAB [m/z]: [M]+ calculated for 12C291H2216O314N219F17, 769.1353; found, 
769.1355; Δ = 0.18 mmu.  
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 Ugi reaction of perfluorononanoic acid, p-anisaldehyde, 
ethyl-2-isocyanoacetate and propargylamine 28 
 
In a 25 mL round bottom flask p-anisaldehyde (77.9 µL, 87.3 mg, 641 µmol, 1.70 eq.) 
and propargylamine (41.1 µL, 35.3 mg, 641 µmol, 1.70 eq.) were added. The resulting 
mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid (175 mg, 
377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
ethyl-2-isocyanoacetate (82.6 µL, 72.5 mg, 641 µmol, 1.70 eq.) was added to the 
stirring mixture. The reaction was stirred for 3 d at room temperature. The crude 
reaction mixture was dried under reduced pressure and purified via column 
chromatography employing FluoroFlash® silica gel. The fluorous fraction was tested 
for purity via TLC and concentrated under reduced pressure. The remaining 
perfluorononanoic acid was removed with a short silica gel filter column, eluting with 
c-hexane/ethyl acetate (3:1) to yield the Ugi product 28 as a yellow oil (65.8 mg, 
87.8 µmol, 23.3%). 
Rf = 0.30 in c-hexane/ethyl acetate (4:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3269.5 (m, 𝜈(N-H)), 2924.6 (w, 𝜈(C-H)), 1746.7 (s, 𝜈(C=O)), 1691.8 
(s), 1666.2 (s), 1613.2 (w), 1563.9 (m), 1514.8 (m), 1449.1 (m), 1412.8 (m), 1200.9 
(vs), 1145.4 (vs), 1106.1 (s), 1036.6 (m), 1004.3 (m), 950.1 (m), 828.4 (m), 768.2 (m), 
702.4 (s), 672.2 (s), 636.9 (s), 558.2 (s), 529.1 (s), 430.2 (w), 390.0 (w). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.39 (d, J = 8.2 Hz, 2 H, CHAr25,32), 6.93 (d, J = 
8.7 Hz, 2 H, CHAr22,24), 5.92 (s, 1 H, CH2), 4.46 – 3.96 (m, 6 H, CH234,6,9), 3.89 (s, 1 H, 
CH20), 3.83 (s, 3 H, CH337), 1.42 – 1.09 (m, 3 H, CH335). 
Chapter    6    Experimental part 
 
130  
13C-NMR (101 MHz, CDCl3): δ [ppm] = 169.44 (s, CONR4), 164.76 (s, CONR18), 160.74 
(s, CAr23), 132.14 (s, CHAr25,32), 129.61 (s, CAr8), 114.69 (s, CAr22,24), 61.83 (s, CH2), 
55.73 (s, CH20), 55.50 (s, OCH337), 41.77 (s, CH26), 35.98 (s, CH29), 14.23 (CH335). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.10 (t, J = 9.9 Hz, 3 F, CF310), AB-signal (δA = 
-113.26, δB = -114.63, JAB = 297.4 Hz, additional coupling not resolved, signals 
broadened, CF217a), AB-signal (δA = -115.22, δB = -116.19, JAB = 291.8 Hz, additional 
coupling not resolved, signals broadened, CF217b), -124.84 (s, CF2), -126.12 (s, CF2), 
-127.05 (s, CF2), -130.44 (s, CF211). Total integral of CF2 region normalized with 
respect to the CF310 group = 14. 
FAB – MS [m/z] (relative intensity): 750.1 (90%) [M]+, 620.1 (17%) [Fragment A]+, 250.1 
(33%) [Fragment B]+, 120.1 [Fragment C]+. 
HRMS – FAB [m/z]: [M]+ calculated for 12C291H1916O514N219F17, 750.1017; found, 
750.1018; Δ = 0.13 mmu. 
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 Ugi reaction of perfluorononanoic acid, 4-hydroxybenzaldehyde, 
cyclohexylisocyanide and propargylamine 29 
 
In a 25 mL round bottom flask 4-hydroxybenzaldehyd (59.6 mg, 489 µmol, 1.30 eq.) 
was dissolved in 1.5 mL methanol, subsequently propargylamine (31.4 µL, 27.0 mg, 
490 µmol, 1.30 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards, the mixture was filtrated. The solid was washed with 10 mL 
methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, cyclohexylisocyanide (56.3 µL, 49.4 mg, 453 µmol, 
1.20 eq.) was added to the stirring mixture. The reaction was stirred for 1 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
Ugi product 29 was obtained as a yellow oil (93.9 mg, 128 µmol, 34.1%). 
Rf = 0.66 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3301.6 (br, 𝜈(N-H)), 3103.4 (br, 𝜈(O-H)), 2928.2 (w, 𝜈(C-H)), 
2855.1 (w, 𝜈(C-H)), 1650.1 (m, 𝜈(C=O)), 1614.5 (w), 1598.5 (w), 1566.03 (m), 1514.2 
(m), 1452.4 (w), 1425.6 (w), 1367.3 (w), 1347.2 (w), 1200.5 (s), 1149.3 (vs), 988.9 (w), 
945.4 (m), 891.3 (w), 864.1 (w), 837.2 (w), 821.1 (w), 806.3 (w), 806.3 (w), 769.8 (w), 
712.8 (m), 678.2 (m), 638.9 (s), 558.5 (m), 544.7 (m), 515.6 (s), 451.2 (w), 440.3 (w), 
415.3 (w). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 7.20 (dd, J = 25.7, 7.3 Hz, 2 H, CHAr22,24), 6.86 
(d, J = 7.3 Hz, 2 H, CHAr21,25), 5.89 (d, J = 17.6 Hz, 1 H, CH2), 4.41 – 3.93 (m, 2 H, 
CH29), 3.77 – 3.57 (m, 1 H, CH6), 1.97 – 1.06 (m, 11 H, CH20 + CH2). 
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13C-NMR (126 MHz, CD3OD): δ [ppm] = 170.13 (s, CONR4), 159.80 (s, CONR18), 
141.03 (s, CAr23), 133.21 (s, CHAr22, 24), 125.03 (s, CAr8), 116.69 (s, CHAr21, 25), 73.04 (s, 
C19), 64.48 (s, CH2), 48.79 (s, CH6), 36.94 (s, CH29), 33.48 (s, CH2), 26.58 (s, 2 CH2), 
26.01 (s, 2 CH2), 24.39 (s, CH20). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -86.69 (t, J = 10.3 Hz, 3 F, CF310), AB-signal 
(δA = -114.86, δB = -116.45, JAB = 286.1 Hz, A and B are split into t, CF217a, additional 
coupling not resolved, signals broadened), AB-signal (δA = -116.24, δB = -117.50, JAB 
= 293.6 Hz, A and B are split into t, CF217b, additional coupling not resolved, signals 
broadened), - 125.00 (s, CF2), -125.59 (m, CF2), -127.10 (s, CF2), -128.07 (s, CF2), -
131.60 (s, CF211). Total integral of CF2 region normalized with respect to the CF310 
group = 14. 
FAB – MS [m/z] (relative intensity): 733.2 (65%) [M + H]+, 606.0 (75%) [Fragment A]+, 
568.0 (22%) [Fragment A + H – C3H3]+, 232.1 (83%) [Fragment B]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C261H2216O314N219F17, 733.1353; found, 
733.1352; Δ = 0.14 mmu. 
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 Ugi reaction of perfluorononanoic acid, benzaldehyde, 
cyclohexylisocyanide and propargylamine 30 
 
In a 25 mL round bottom flask benzaldehyde (65.4 µL, 68.0 mg, 641 µmol, 1.70 eq.) 
and propargylamine (41.4 µL, 35.3 mg, 641 µmol, 1.70 eq.) were added. The resulting 
mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid (175 mg, 
377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
cyclohexylisocyanide (79.7 µL, 70.0 mg, 641 µmol, 1.70 eq.) was added to the stirring 
mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure and purified via column chromatography 
employing FluoroFlash® silica gel. The fluorous fraction was tested for purity via TLC 
and concentrated under reduced pressure. The remaining perfluorononanoic acid was 
removed with a short silica gel filter column, eluting with c-hexane/ethyl acetate (3:1) 
to yield the Ugi product 30 as a yellow oil (41.3 mg, 57.8 µmol, 15.3%). 
Rf = 0.43 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3292.6 (m, 𝜈(N-H)), 2937.3 (m, 𝜈(C-H)), 2857.2 (w, 𝜈(C-H)), 1681.4 
(s, 𝜈(C=O)), 1645.5 (m, 𝜈(N-H)), 1549.9 (m), 1494.1 (w), 1456.2 (m), 1421.6 (m), 
1365.9 (m), 1329.4 (m), 1202.6 (vs), 1147.9 (vs), 1081.6 (m), 1029.4 (s), 1002.3 (m), 
940.7 (m), 926.3 (m), 895.4 (w), 870.3 (w), 805.7 (m), 789.9 (m), 769.1 (s), 744.5 (s), 
699.2 (vs), 669.8 (s), 633.2 (s), 559.7 (s), 520.3 (vs), 464.3 (w). 
1H-NMR (500 MHz, CD3OD): δ [ppm] = 7.40 (s, 5 H, CHAr22-26), 5.99 (s, 1 H, CH2), 4.52 
– 4.20 (m, 2 H, CH29), 4.09 – 3.85 (m, 1 H, CH6), 3.77 – 3.53 (m, 1 H, CH20), 1.92 – 
1.54 (m, 4 H, CH2), 1.40 – 1.06 (m, 6 H, CH2). 
13C-NMR (126 MHz, CD3OD): δ [ppm] = 169.61 (s, CONR4), 157.51 (s, CONR18), 
131.73 (s, CAr8), 130.71 (s, CHAr), 130.32 (s, CHAr), 129.96 (s, CHAr), 64.15 (s, CH2), 
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53.36 (s, CH6), 50.04 (s, CH20), 36.64 (s, CH29), 33.51 (s, CH2), 33.43 (s, CH2), 26.99 
(s, CH2), 26.57 (s, CH2), 25.99 (s, CH2). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.26 (t, J = 10.2 Hz, 3 F, CF310), AB-signal 
(δA = -116.51, δB = -117.81, JAB = 301.2 Hz, A and B are split into t, CF217a, additional 
coupling not resolved, signals broadened), AB-signal (δA = -117.81, δB = -119.02, JAB 
= 295.5 Hz, A and B are split into t, CF217b, additional coupling not resolved, signals 
broadened), -126.28 – -127.72 (m, CF2), -128.68 (s, CF2), -129.64 (s, CF2), -133.18 (s, 
CF211). Total integral of CF2 region normalized with respect to the CF310 group = 14. 
FAB – MS [m/z] (relative intensity): 717.2 (87%) [M + H]+, 591.0 (17%) [Fragment A + 
H]+, 590.0 (60%) [Fragment A ]+, 552.0 (15%) [Fragment A + H – C3H3]+, 217.1 (23%) 
[Fragment B + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C261H2216O214N219F17, 717.1403; found, 
717.1404; Δ = 0.11 mmu. 
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 Ugi reaction of perfluorononanoic acid, isobutyraldehyde, 
cyclohexylisocyanide and pentylamine 31 
 
In a 25 mL round bottom flask isobutyraldehyde (83.6 µL, 66.0 mg, 916 µmol, 1.70 eq.) 
and pentylamine (106 µL, 79.8 mg, 916 µmol, 1.70 eq.) were added and the resulting 
mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid (250 mg, 
539 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the imine at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
cyclohexylisocyanide (114 µL, 100 mg, 916 µmol, 1.70 eq.) was added to the stirring 
mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure. The residue was adsorbed onto celite® and 
purified via column chromatography employing silica gel as stationary phase and 
eluting with a gradual solvent mixture of ethyl acetate and c-hexane (1:10 → 1:3) to 
yield the Ugi product 31 as a yellow oil (95.1 mg, 133 mmol, 24.7%). 
Rf = 0.54 in c-hexane/ethyl acetate (6:1). Visualized via permanganate staining 
solution. 
IR (ATR):  [cm-1] = 3303.7 (br, 𝜈(N-H)), 2927.3 (s, 𝜈(C-H)), 2855.9 (m), 1764.4 (w), 
1707.2 (s, 𝜈(C=O)), 1673.4 (m), 1626.5 (s), 1538.8 (m), 1451.3 (m), 1429.5 (s), 1378.9 
(m), 1239.5 (vs), 1211.9 (vs), 1146.6 (s), 1088.2 (m), 891.7 (w), 726.2 (w), 626.7 (m), 
557.7 (w), 529.1 (w), 481.3 (w), 402.1 (w). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 3.71 – 3.30 (m, 2 H, CH1 + CH18), 3.27 – 3.21 
(m, 2 H, CH26), 2.88 – 2.79 (m, 2 H, CH2), 2.00 – 1.70 (m, 3 H, CH5 + CH2), 1.67 – 1.53 
(m, 2 H, CH2), 1.50 – 1.16 (m, 12 H, CH2), 1.06 (d, J = 6.8 Hz, 3 H, CH328, 29), 0.97 – 
0.77 (m, 6 H, CH328, 29 + CH327).  
13C-NMR (101 MHz, CD3OD): δ [ppm] = 166.95 (s, CONR2), 162.79 (s, CONR15), 51.75 
(s, CH1), 50.15 (s, CH18), 42.48 (s, CH26), 40.70 (s, CH2), 33.08 (s, CH5), 32.50 (s, 
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CH2), 30.86 (s, CH2), 30.50 (s, CH2), 30.10 (s, CH2), 29.57 (s, CH2), 28.78 (s, CH2), 
25.47 (s, CH2), 25.42 (s, CH2), 19.97 (s, CH328, 29), 19.94 (s, CH328, 29), 14.28 (s, CH327). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -86.72 (t, J = 10.3 Hz, 3F, CF37), -122.25 (t, 
J = 12.5 Hz, CF214), -126.96 (s, CF2), -127.28 (s, CF2), -127.92 (s, CF2), -128.12 (s, 
CF2), -131.66 (s, CF28). Total integral of CF2 region normalized with respect to the CF37 
group = 14. 
ESI-MS [m/z]: [M + Na]+ calculated for 12C251H3116O214N219F1723Na1, 737.2011; found, 
737.2006, Δ = 0.42 mmu. 
 
 Ugi reaction of perfluorononanoic acid, valeraldehyde, 
cyclohexylisocyanide and pentylamine 32 
 
In a 25 mL round bottom flask valeraldehyde (52.1 µL, 42.2 mg, 490 µmol, 1.30 eq.) 
was dissolved in 1.5 mL methanol, subsequently pentylamine (56.6 µL, 42.7 mg, 
490 µmol, 1.30 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards, the mixture was filtrated and the solid was washed with 10 
mL methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, cyclohexylisocyanide (56.3 µL, 59.4 mg, 453 µmol, 
1.20 eq.) was added to the stirring mixture. The reaction was stirred for 4 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
remaining perfluoro acid was removed with a short silica gel filter column, eluting with 
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c-hexane/ethyl acetate (3:1) to yield the Ugi product 32 as a colorless solid (86.0 mg, 
118 µmol, 31.4%).  
Rf = 0.40 in c-hexane/ethyl acetate (6:1). Visualized via Seebach staining solution. 
IR (ATR):  [cm-1] = 3325.5 (br, 𝜈(N-H)), 2933.4 (m, 𝜈(C-H)), 2859.3 (m, 𝜈(C-H)), 
1651.9 (s, 𝜈(C=O)), 1534.7 (m), 1452.3 (m), 1367.9 (w), 1237.4 (vs), 1203.2 (vs), 
1146.7 (vs), 1054.4 (w), 965.9 (w), 890.9 (w), 777.3 (m), 735.3 (m), 703.5 (m), 656.3 
(m), 557.8 (m), 528.9 (m). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 4.59 (t, J = 7.6 Hz, CH1a), 4.50 (t, J = 7.2 Hz, 
total integral of CH1 = 1 H, CH1b), 3.69 – 3.43 (m, 3 H, CH26 or 5 + CH18), 2.03 – 1.60 
(m, 10 H, CH2), 1.43 – 1.15 (m, 12 H, CH2), 0.92 (t, J = 7.2 Hz, 6 H, CH327,30). 
13C-NMR (101 MHz, CD3OD): δ [ppm] = 170.35 (s, CONR2), 159.72 (s, CONR15), 62.03 
(s, CH1a), 61.39 (s, CH1b), 50.06 (s, CH18), 47.19 (s, CH26 or 5), 33.55 (s, CH2), 33.38 
(s, CH2), 31.97 (s, CH2), 31.41 (s, CH2), 30.42 (s, CH2), 30.01 (s, CH2), 29.62 (s, CH2), 
29.50 (s, CH2), 28.38 (s, CH2), 26.58 (s, CH2), 26.04 (s, CH2), 23.46 (s, CH2), 23.26 (s, 
CH2), 14.30 (s, CH327 or 30), 14.23 (s, CH327 or 30).  
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.27 (t, J = 10.4 Hz, 3 F, CF37), AB-signal 
(δA = -116.17, δB = -116.99, JAB = 301.2 Hz, A and B are split into t, J = 12.4 Hz, CF214a), 
AB-signal (δA = -118.12, δB = -118.63, JAB = 293.6 Hz, A and B are split into t, 
J = 12.3 Hz CF214b), -126.20 (s, CF2), -126.78 (s, CF2), -127.15 (s, CF2), -128.74 (s, 
CF2), -129.66 (s, CF2), -133.17 (s, CF28). Total integral of CF2 region normalized with 
respect to the CF37 group = 14.  
FAB – MS [m/z] (relative intensity): 729.3 (55%) [M + H]+, 631.2 (10%) [Fragment A]+, 
630.2 (28%) [Fragment A – H]+, 281.3 (7%) [Fragment B]+, 197.2 (16%) [Fragment C 
+ H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C261H3416O214N219F17, 729.2343; found, 
729.2342; Δ = 0.16 mmu. 
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 Ugi reaction of perfluorononanoic acid, 
cyclohexancarboxaldehyde, cyclohexylisocyanide and pentylamine 33 
 
In a 25 mL round bottom flask cyclohexancarboxaldehyde (59.4 µL, 55.0 mg, 
490 µmol, 1.30 eq.) was dissolved in 1.5 mL methanol, subsequently pentylamine 
(56.6 µL, 42.7 mg, 490 µmol, 1.30 eq.) was added and the resulting mixture was stirred 
for 60 min over sodium sulfate. Afterwards, the mixture was filtrated and the solid was 
washed with 10 mL methanol three times. Subsequently, the filtrate was concentrated 
under reduced pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) 
dissolved in 1 mL methanol was added to the imine at room temperature and the 
resulting mixture was stirred for 2 min. Subsequently, cyclohexylisocyanide (56.3 µL, 
59.4 mg, 453 µmol, 1.20 eq.) was added to the stirring mixture. The reaction was stirred 
for 4 d at room temperature. The crude reaction mixture was dried under reduced 
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pressure and purified via column chromatography employing FluoroFlash® silica gel. 
The fluorous fraction was tested for purity via TLC and concentrated under reduced 
pressure. The remaining perfluoro acid was removed with a short silica gel filter 
column, eluting with c-hexane/ethyl acetate (3:1) to yield the Ugi product 33 as a 
colorless solid (103 mg, 137 µmol, 36.3%).  
Rf = 0.45 in c-hexane/ethyl acetate (6:1). Visualized via Seebach staining solution and 
permanganate staining. 
IR (ATR):  [cm-1] = 3317.7 (br, 𝜈(N-H)), 2930.9 (s, 𝜈(C-H)), 2856.6 (m, 𝜈(C-H)), 1653.4 
(s, 𝜈(C=O)), 1536.7 (m), 1451.4 (m), 1351.0 (m), 1237.9 (vs), 1203.5 (vs), 1147.1 (vs), 
1117.8 (s), 1053.5 (m), 962.2 (m), 891.1 (w), 777.5 (m), 735.4 (m), 703.4 (m), 656.3 
(m), 557.6 (m), 528.6 (m). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 4.47 (d, J = 11.0 Hz, CH1a), 4.19 – 3.90 (m, 
total integral of CH1 = 1 H, CH1b), 3.71 – 3.35 (m, 3 H, CH2 + CH18), 2.24 – 1.95 (m, 1 
H, CH5), 1.96 – 1.46 (m, 12 H, CH2), 1.41 – 1.01 (m, 14 H, CH2), 0.92 (t, J = 7.1 Hz, 3 
H, CH327). 
13C-NMR (101 MHz, CD3OD): δ [ppm] = 169.95 (s, CONR2), 160.29 (s, CONR15), 66.46 
(s, CH1a), 65.68 (s, CH1b), 49.88 (s, CH18), 46.34 (s, CH2), 39.02 (s, CH5a), 37.55 (s, 
CH5b), 33.51 (s, CH2), 33.31 (s, CH2), 31.42 (s, CH2), 31.14 (s, CH2), 30.75 (s, CH2), 
30.05 (s, CH2), 27.28 (s, CH2), 26.58 (s, CH2), 25.93 (s, CH2), 23.24 (s, CH2), 14.22 (s, 
CH327). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.27 (t, J = 10.5 Hz, 3 F, CF37), -115.58 (t, 
J = 10.8 Hz, CF214a), AB-signal (δA = -117.67, δB = -118.82, JAB = 293.6 Hz, A and B 
are split into t, J = 12.0 Hz, CF214b), -125.59 (s, CF2), -126.65 (s, CF2), -126.92 (s, CF2), 
-128.72 (s, CF2), -129.66 (s, CF2), -133.20 (s, CF28). Total integral of CF2 region 
normalized with respect to the CF37 group = 14.  
FAB – MS [m/z] (relative intensity): 755.3 (67%) [M + H]+, 629.2 (27%) [Fragment 
A + H]+, 307.3 (8%) [Fragment B]+, 223.2 (23%) [Fragment C + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C281H3616O214N219F17, 755.2501; found, 
755.2500; Δ = 0.14 mmu. 
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 Ugi reaction of perfluorononanoic acid, valeraldehyde, 
tert-butylisocyanide and pentylamine 34 
 
In a 25 mL round bottom flask valeraldehyde (42.2 mg, 490 µmol, 1.30 eq.) was 
dissolved in 1.5 mL methanol, subsequently pentylamine (56.6 µL, 42.7 mg, 490 µmol, 
1.30 eq.) was added and the resulting mixture was stirred for 60 min over sodium 
sulfate. Afterwards, the mixture was filtrated. The solid was washed with 10 mL 
methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, tert-butylisocyanide (51.2 µL, 37.6 mg, 453 µmol, 
1.20 eq.) was added to the stirring mixture. The reaction was stirred for 3 d at room 
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temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was concentrated and the residue was adsorbed onto celite® and purified via 
column chromatography employing silica gel as stationary phase and eluting with a 
gradual solvent mixture of ethyl acetate and c-hexane (0:1 → 1:1) to yield the Ugi 
product 34 as a highly viscous yellow oil (42.7 mg, 60.3 µmol, 16.0%). 
Rf = 0.49 in c-hexane/ethyl acetate (6:1). Visualized via Seebach staining solution and 
permanganate staining. 
IR (ATR):  [cm-1] = 3367.2 (br, 𝜈(N-H)), 2962.9 (m, 𝜈(C-H)), 2875.3 (w), 1661.9 (s, 
𝜈(C=O)), 1532.8 (m), 1456.6 (m), 1366.2 (m), 1204.6 (vs), 1147.5 (vs), 996.7 (w), 778.1 
(m), 735.4 (m), 703.2 (m), 656.5 (m), 558.6 (m), 528.9 (m).  
1H-NMR (400 MHz, CD3OD): δ [ppm] = 7.43 (s, 1 H, NH3), 4.57 (t, J = 7.6 Hz, 1 H, 
CH1), 3.58 – 3.37 (m, 2 H, CH27), 2.04 – 1.85 (m, 2 H, CH26), 1.79 – 1.57 (m, 2 H, 
CH225), 1.40 – 1.19 (m, 17 H, CH310,22,23 + CH2), 0.92 (t, J = 7.2 Hz, 6 H, CH324,28). 
13C-NMR (101 MHz, CD3OD): δ [ppm] = 170.58 (s, CONR2), 159.73 (s, CONR19), 
62.36 (s, CH1), 52.39 (s, C4), 47.12 (s, CH27), 32.09 (s, CH225), 31.48 (s, CH2), 30.42 
(s, CH2), 30.00 (s, CH2), 29.67 (s, CH26), 29.44 (s, CH2), 28.69 (s, CH322,23,10), 23.24 
(s, CH2), 14.30 (s, CH324 or 28), 14.23 (s, CH324 or 28). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.27 (t, J = 10.3 Hz, 3 F, CF311), AB-signal 
(δA = -116.39, δB = -117.10, JAB = 288.0 Hz, A and B are split into t, J = 11.7 Hz, CF218a), 
AB-signal (δA = -118.10, δB = -118.55, JAB = 291.8 Hz, A and B are split into t, J = 12.5 
Hz, CF218b), -126.95 (s, CF2), -128.68 (s, CF2), -129.65 (s, CF2), -133.16 (s, CF212). 
Total integral of CF2 region normalized with respect to the CF311 group = 14. 
FAB – MS [m/z] (relative intensity): 703.2 (65%) [M + H]+, 630.1 (25%) [Fragment A – 
H]+, 560.5 (28%) [Fragment A – C5H11]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C241H3116O214N219F17, 703.2187; found, 
703.2188; Δ = 0.13 mmu. 
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 Ugi reaction of perfluorononanoic acid, benzaldehyde, 
cyclohexylisocyanide and pentylamine 35 
 
In a 25 mL round bottom flask benzaldehyde (56.3 µL, 49.4 mg, 453 µmol, 1.20 eq.) 
was dissolved in 1.5 mL methanol, subsequently pentylamine (56.6 µL, 42.7 mg, 
490 µmol, 1.30 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards, the mixture was filtrated and the solid was washed with 10 
mL methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, cyclohexylisocyanide (56.3 µL, 59.4 mg, 453 µmol, 
1.20 eq.) was added to the stirring mixture. The reaction was stirred for 4 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
remaining perfluoro acid was removed with a short silica gel filter column, eluting with 
c-hexane/ethyl acetate (3:1) to yield the Ugi product 35 as a colorless solid (106 mg, 
140 µmol, 42.3%). 
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Rf = 0.47 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3306.5 (br, 𝜈(N-H)), 2922.9 (m, 𝜈(C-H)), 2851.1 (w), 2186.6 (vw), 
2044.9 (vw), 1971.1 (vw), 1672.8 (s, 𝜈(C=O)), 1654.2 (s, 𝜈(C=O)), 1556.4 (m), 1451.0 
(w), 1428.8 (m), 1369.9 (m), 1234.2 (s), 1193.9 (s), 1145.5 (s), 1119.6 (s), 1062.2 (m), 
975.9 (m), 923.8 (m), 859.2 (w), 762.6 (w), 709.5 (s), 683.4 (m), 666.9 (m), 643.2 (m), 
559.2 (m), 516.4 (m), 463.7 (w), 437.2 (w).  
1H-NMR (400 MHz, CD3OD): δ [ppm] = 7.54 – 7.22 (m, 5 H, CHAr28-32), 5.87 (d, J = 
29.9 Hz, 1 H, CH1), 3.84 – 3.52 (m, 1 H, CH26a), 3.41 – 3.35 (m, 1 H, CH18), 3.24 – 
3.13 (m, 1 H, CH26b), 1.90 – 1.52 (m, 6 H, CH2), 1.44 – 1.24 (m, 4 H, CH2), 1.21 – 1.04 
(m, 4 H, CH2), 1.04 – 0.68 (m, 2 H, CH226), 0.66 – 0.53 (m, 3 H, CH327). 
13C-NMR (101 MHz, CD3OD): δ [ppm] = 169.93 (s, CONR2), 158.75 (s, CONR15), 
135.72 (s, CAr5), 131.66 (s, CHAr), 130.87 (s, CHAr), 130.05 (s, CHAr), 65.47 (s, CH1a), 
64.05 (s, CH1b), 50.03 (s, CH18), 47.29 (s, CH26), 33.45 (s, CH2), 30.34 (s, CH2), 26.58 
(s, CH2), 26.01 (s, CH2), 20.99 (s, CH2), 20.74 (s, CH226), 13.73 (s, CH327). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.27 (t, J = 9.4 Hz, 3 F, CF37), AB-signal 
(δA = -116.01, δB = -117.30, JAB = 299.3 Hz, A and B are split into t, J = 12.8 Hz, CF214a), 
AB-signal (δA = -117.97, δB = -119.28, JAB = 291.8 Hz, A and B are split into t, 
J = 11.3 Hz, CF214b), -126.38 (s, CF2), -127.08 (s, CF2), -128.67 (s, CF2), -129.65 (s, 
CF2), -133.20 (s, CF28). Total integral of CF2 region normalized with respect to the CF37 
group = 14. 
FAB – MS [m/z] (relative intensity): 749.2 [M + H]+ (80%), 552.0 (92%) [Fragment A + 
H]+, 217.1 (68%) [Fragment B + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C281H2916O214N219F17, 749.2030; found, 
749.2032; Δ = 0.17 mmu. 
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 Ugi reaction of perfluorononanoic acid, valeraldehyde, 
tert-butylisocyanide and cyclohexylamine 36 
 
In a 25 mL round bottom flask valeraldehyde (126 mg, 1.46 mmol, 1.70 eq.) was stirred 
with cyclohexylamine (145 mg, 1.46 mmol, 1.70 eq.) for 60 min over sodium sulfate. 
Perfluorononanoic acid (400 mg, 862 µmol, 1.00 eq.) dissolved in 1 mL methanol was 
added to the imine at room temperature and the resulting mixture was stirred for 2 min. 
Subsequently, tert-butylisocyanide (165 µL, 122 mg, 1.46 mmol, 1.70 eq.) was added 
to the stirring mixture. The reaction was stirred for 4 d at room temperature. The crude 
reaction mixture was dried under reduced pressure and purified via column 
chromatography employing FluoroFlash® silica gel. The fluorous fraction was 
concentrated and the residue was adsorbed onto celite® and purified via column 
chromatography employing silica gel as stationary phase and eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (0:1 → 1:1) to yield the Ugi product 36 
as a highly viscous yellow oil (42.2 mg, 61.2 µmol, 7.1%). 
Rf = 0.52 in c-hexane/ethyl acetate (6:1). Visualized via Seebach staining solution and 
permanganate staining. 
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IR (ATR):  [cm-1] = 3337.4 (br, 𝜈(N-H)), 2933.4 (s, 𝜈(C-H)), 2875.3 (m), 1675.6 (s, 
𝜈(C=O)), 1534.8 (s), 1453.0 (m), 1238.8 (vs), 1206.8 (vs), 1148.2 (vs), 1109.0 (s), 
999.9 (w), 896.1 (w), 785.3 (w), 735.0 (m), 702.4 (m), 668.5 (m), 557.5 (m), 528.0 (m). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 4.02 – 3.66 (m, 1 H, CH1), 2.80 – 1.69 (m, 7 H, 
CH2 + CH25), 1.59 – 1.05 (m, 19 H, CH310,22,23 + CH2), 1.00 – 0.83 (m, 3 H, CH324). 
13C-NMR (101 MHz, CD3OD): δ [ppm] = 180.17 (s, CONR2), 171.76 (s, CONR19), 63.54 
(s, CH1a), 59.74 (s, CH1b), 32.50 (s, CH2), 32.20 (s, CH2), 30.60 (s, CH2), 30.48 (s, 
CH2), 30.35 (s, CH25), 28.70 (s, CH2), 28.64 (s, CH310,22,23), 26.79 (s, CH2), 26.61 (s, 
CH2), 25.95 (s, CH2), 23.61 (s, CH2), 14.23 (s, CH324). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -86.69 (t, J = 10.6 Hz, 3 F, CF311), -114.08 – -
114.49 (m, CF218a), AB-signal (δA = -115.38, δB = -116.76, JAB = 293.6 Hz, CF218b, 
additional coupling not resolved, signals broadened), -124.02 – -124.67 (m, CF2), -
124.86 – -125.21 (m, CF2), -125.30 – -125.50 (m, CF2), -126.98 (s, CF2), -127.23 (s, 
CF2), -128.08 (s, CF2), -131.58 (s, CF212). Total integral of CF2 region normalized with 
respect to the CF311 group = 14. 
ESI-MS [m/z]: [M + Na]+ calculated for 12C261H3116O214N219F1723Na1, 737.2006; found, 
737.2008, Δ = 0.20 mmu. 
 
 Ugi reaction of perfluorononanoic acid, isobutyraldehyde, 
tert-butylisocyanide and cyclohexylamine 37 
 
In a 25 mL round bottom flask isobutyraldehyde (83.6 µL, 66.0 mg, 916 µmol, 1.70 eq.) 
and cyclohexylamine (105 µL, 90.8 mg, 916 µmol, 1.70 eq.) were added and the 
resulting mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid 
(250 mg, 539 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution 
at room temperature and the resulting mixture was stirred for 2 min. Subsequently, 
tert-butylisocyanide (104 µL, 76.1 mg, 916 µmol, 1.70 eq.) was added to the stirring 
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mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure. The residue was adsorbed onto celite® and 
purified via column chromatography on silica gel eluting with a gradual solvent mixture 
of ethyl acetate and c-hexane (1:10 → 1:3) to yield the Ugi product 37 as a yellow solid 
(75.0 mg, 102 µmol, 19.1%). 
Rf = 0.54 in c-hexane/ethyl acetate (6:1). Visualized via permanganate staining 
solution. 
IR (ATR):  [cm-1] = 2927.2 (vs, 𝜈(C-H)), 2854.9 (s, 𝜈(C-H)), 1673.1 (s, 𝜈(C=O)), 1596.0 
(m), 1539.9 (m), 1450.7 (s), 1367.1 (m), 1349.4 (m), 1232.6 (vs), 1148.6 (s), 1130.7 
(s), 991.2 (m), 890.6 (w), 802.1 (m), 721.0 (w), 701.0 (m), 660.6 (w), 553.3 (m). 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 3.75 (s, CH1a), 3.66 – 3.50 (m, 1 H, CH6), 3.40 
– 3.33 (m, total integral of CH1 = 1 H, CH1b), 2.38 – 1.98 (m, 1 H, CH5), 1.95 – 1.49 (m, 
8 H, CH2), 1.47 – 1.11 (m, 11 H, CH2 +CH326,27,28), 1.04 – 0.79 (m, 6 H, CH324,25). 
13C-NMR (101 MHz, CD3OD): δ [ppm] =170.15 (s, CONR2), 164.06 (s, CONR15), 57.53 
(s, CH1), 56.28 (s, CH6), 54.77 (s, C23), 34.97 (s, CH1), 34.39 (s, CH2), 31.65 (s, CH2), 
31.55 (s, CH2), 30.76 (s, CH2), 29.23 (s, CH5), 25.51 (s, CH326 - 28 ), 25.30 (s, CH326 - 
28), 22.21 (s, CH2), 18.70 (s, CH324, 25), 18.50 (s, CH324, 25). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.25 (t, J = 10.4 Hz, 3 F, CF37), AB-signal 
(δA = -116.39, δB = -117.11, JAB = 301.2 Hz, A and B are split into t, J = 11.0 Hz, CF214a), 
AB-signal (δA = -118.11, δB = -118.55, JAB = 293.6 Hz, A and B are split into t, J = 12.3 
Hz, CF214b), -126.26 (s, CF2), -126.73 (s, CF2), -127.10 (s, CF2), -128.75 (s, CF2), -
129.64 (s, CF2), -133.22 (s, CF28). Total integral of CF2 region normalized with respect 
to the CF37 group = 14. 
ESI-MS [m/z]: [M + Na]+ calculated for 12C241H2916O214N219F1723Na1, 723.18498; found, 
723.18591, Δ = 1.02 mmu. 
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 Ugi reaction of perfluorononanoic acid, isobutyraldehyde, 
pentylisocyanide and cyclohexylamine 38 
 
In a 25 mL round bottom flask isobutyraldehyde (46.2 mg, 641 µmol, 1.70 eq.) was 
dissolved in 1.5 mL methanol, subsequently cyclohexylamine (674 µL, 63.6 mg, 
641 µmol, 1.70 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards, the mixture was filtrated and the solid was washed with 
10 mL methanol three times. Subsequently, the filtrate was concentrated under 
reduced pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 
0.5 mL methanol was added to the imine at room temperature and the resulting mixture 
was stirred for 2 min. Subsequently, pentylisocyanide (80.6 µL, 62.2 mg, 641 µmol, 
1.70 eq.) was added to the stirring mixture. The reaction was stirred for 6 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
remaining perfluoro acid was removed with a short silica gel filter column, eluting with 
c-hexane/ethyl acetate (3:1) to yield the Ugi product 38 as a highly viscous yellow oil 
(9.1 mg, 12.6 µmol, 3.34%).  
Rf = 0.54 in c-hexane/ethyl acetate (6:1). Visualized via permanganate staining 
solution.  
IR (ATR):  [cm-1] = 3338.2 (br, 𝜈(N-H)), 2930.9 (s, 𝜈(C-H)), 2859.9 (s, 𝜈(C-H)), 1659.8 
(s, 𝜈(C=O)), 1540.8 (m), 1457.7 (m), 1369.4 (m), 1238.5 (vs), 1206.8 (vs), 1148.7 (vs), 
998.0 (m), 777.8 (w), 735.1 (m), 703.1 (m), 656.7 (m), 558.1 (m), 528.8 (w).  
1H-NMR (400 MHz, CD3OD): δ [ppm] = 4.42 (d, J = 11.0 Hz, CH1a), 4.10 (d, J = 7.1 Hz, 
total integral of CH1 = 1 H, CH1b), 3.73 – 3.36 (m, 1 H, CH223a), 3.22 – 3.04 (m, 1 H, 
CH223b), 2.51 – 2.12 (m, 1 H, CH6), 1.93 – 1.49 (m, 6 H, CH2), 1.46 (s, 1 H, CH5), 1.38 
– 1.14 (m, 10 H, CH2), 1.05 – 0.84 (m, 9 H, CH324,25+ CH329). 
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13C-NMR (101 MHz, CD3OD): δ [ppm] = 170.91 (s, CONR2), 67.35 (s, CH1), 46.09 (s, 
CH223a), 40.40 (s, CH223b), 31.41 (s, CH2), 30.90 (s, CH2), 30.16 (s, CH2), 30.08 (s, 
CH5), 29.48 (s, CH2), 28.21 (s, CH2), 23.23 (s, CH2), 20.85 (s, CH6), 19.96 (s, CH324, 
25), 18.73 (s, CH324, 25), 14.25 (s, CH329). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -83.25 (s, CF3), -88.25 (t, J = 10.3 Hz, 3 F, 
CF37), AB-signal (δA = -114.98, δB = -115.37, JAB = 207.1 Hz, A and B are split into A 
and B are split into t, J = 12.0 Hz, CF214a), AB-signal (δA = -117,60, δB = -119,02, JAB = 
293.6 Hz, A and B are split into t, J = 12.6 Hz, CF214b), -125.47 (s, CF2), -126.86 (s, 
CF2), -128.72 (s, CF2), -129.63(s, CF2), -133.14(s, CF28). Total integral of CF2 region 
normalized with respect to the CF37 group = 14.  
ESI-MS [m/z]: [M + Na]+ calculated for 12C251H3116O214N219F923Na1, 737.2006; found, 
737.2013, Δ = 0.66 mmu. 
 
 Ugi reaction of perfluorononanoic acid, isobutyraldehyde, 
cyclohexylisocyanide and cyclohexylamine 39 
 
In a 25 mL round bottom flask isobutyraldehyde (46.2 mg, 641 µmol, 1.70 eq.) was 
dissolved in 1.5 mL methanol, subsequently cyclohexylamine (73.5 µL, 63.6 mg, 641 
µmol, 1.70 eq.) was added and the resulting mixture was stirred for 60 min over sodium 
sulfate. Afterwards, the mixture was filtrated and the solid was washed with 10 mL 
methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 0.5 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, cyclohexylisocyanide (79.9 µL, 70.0 mg, 641 µmol, 
1.70 eq.) was added to the stirring mixture. The reaction was stirred for 6 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
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remaining perfluoro acid was removed with a short silica gel filter column, eluting with 
c-hexane/ethyl acetate (3:1) to yield the Ugi product 39 as a highly viscous yellow oil 
(31.2 mg, 42.9 µmol, 11.4%).  
Rf = 0.64 in c-hexane/ethyl acetate (6:1). Visualized via permanganate staining 
solution. 
IR (ATR):  [cm-1] = 3343.1 (br, 𝜈(N-H)), 2933.8 (m, 𝜈(C-H)), 2856.3 (m, 𝜈(C-H)), 
1675.5 (s, 𝜈(C=O)), 1535.2 (m), 1453.3 (m), 1325.8 (w), 1238.3 (s), 1205.6 (vs), 1148.5 
(vs), 1109.9 (m), 1000.4 (w), 896.2 (w), 785.3 (w), 735.4 (m), 702.4 (m), 668.3 (m), 
556.8 (w), 529.4 (w), 409.9 (w).  
1H-NMR (400 MHz, CD3OD): δ [ppm] = 3.98 – 3.73 (m, 1 H, CH1), 3.72 – 3.59 (m, 1 H, 
CH23), 3.44 (d, J = 11.1 Hz, 1 H, CH6), 3.02 – 2.80 (m, 1 H, CH5), 1.99 – 1.51 (m, 10 H, 
CH2), 1.45 – 1.16 (m, 10 H, CH2), 1.04 – 0.76 (m, 6 H, CH324,25). 
13C-NMR (101 MHz, CD3OD): δ [ppm] = 172.62 (s, CONR2), 160.62 (s, CONR15), 71.64 
(s, CH6), 61.52 (s, CH1), 49.86 (s, CH23), 33.10 (s, CH2), 32.65 (s, CH2), 32.32 (s, CH2), 
27.79 (s, CH5), 26.92 (s, CH2), 26.56 (s, CH2), 25.89 (s, CH2), 25.15 (s, CH2), 20.28 (s, 
CH324, 25), 20.00 (s, CH324, 25). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.29 (t, J = 9.9 Hz, 3 F, CF37), -114.97 (s, 
CF214a), AB-signal (δA = -116.37, δB = -118.34, JAB = 293.6 Hz, A and B are split into t, 
J = 11.3 Hz CF214b), -125.13 (s, CF2), -126.01 (s, CF2), -126.68 (d, J = 73.4 Hz, CF2), 
-128.66 (d, J = 77.4 Hz, CF2), -129.66 (s, CF2), -133.16 (s, CF28). Total integral of CF2 
region normalized with respect to the CF37 group = 14.  
FAB – MS [m/z] (relative intensity): 755.3 (67%) [M + H]+, 600.1 (31%) [Fragment A ]+, 
518.0 (100%) [Fragment A – C6H10]+, 98.1 (15%) [Fragment B – CHO]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C261H3216O214N219F17, 727.2187; found, 
727.2185; Δ = 0.22 mmu. 
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 Ugi reaction of perfluorononanoic acid, undec-10-enal, 
cyclohexylamine and benzylisocyanide 40 
 
In a 25 mL round bottom flask undec-10-enal (97.6 µL, 84.5 mg, 490 µmol, 1.30 eq.) 
was dissolved in 1.5 mL methanol, subsequently cyclohexylamine (56.5 µL, 48.9 mg, 
490 µmol, 1.30 eq.) was added and the resulting mixture was stirred for 60 min over 
sodium sulfate. Afterwards the mixture was filtrated and the solid was washed with 
10 mL methanol three times. Subsequently, the filtrate was concentrated under 
reduced pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) was added at 
room temperature and the resulting mixture stirred for 2 min. Subsequently, 
benzylisocyanide (53.9 µL, 53.0 mg, 453 µmol, 1.20 eq.) was added to the stirring 
mixture. The reaction was stirred for 5 d at room temperature. The crude reaction 
mixture was dried under reduced pressure and purified via column chromatography 
employing silica gel and eluted with a gradual solvent mixture of ethyl acetate and 
c-hexane (0:1 → 1:3) to remove the remaining perfluoro acid. The product containing 
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fractions were collected and further purified via column chromatography employing 
FluoroFlash® silica gel to yield the Ugi product 40 as a highly viscous yellow oil 
(59.4 mg, 71.5 µmol, 19.0%). 
Rf = 0.50 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3324.4 (br, 𝜈(N-H)), 2926.4 (s, 𝜈(C-H)), 2855.8 (m, 𝜈(C-H)), 1663.4 
(s, 𝜈(C=O)), 1528.8 (w, 𝜈(C=C)), 1455.2 (w), 1364.2 (w), 1238.6 (vs), 1208.1 (vs), 
1147.9 (s), 1029.0 (w), 992.2 (w), 909.4 (m), 723.2 (s), 698.2 (s), 655.9 (m), 559.2 (m), 
528.9 (m). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.65 – 6.99 (m, 5 H, CHAr30-34), 6.70 (t, J = 5.7 
Hz, 1 H, NH5), 5.95 – 5.64 (m, 2 H, CH229), 5.11 – 4.83 (m, 1 H, CH28), 4.58 (s, 1 H, 
CH2), 4.50 – 4.26 (m, 3 H, CH26 + CH10), 3.61 – 3.16 (m, 2 H, CH29) 2.17 – 1.94 (m, 4 
H, CH2), 1.88 – 1.42 (m, 4 H, CH2), 1.41 – 1.03 (m, 16 H, CH2).  
13C-NMR (101 MHz, CDCl3): δ [ppm] = 170.40 (s, CONR4), 160.51 (s, CONR19), 140.4 
(s, CH229), 138.63 (s, CAr26), 129.55 (s, CHAr), 128.49 (s, CHAr), 128.41 (s, CHAr), 
115.04 (s, CH28), 62.83 (s, CH2 or 10), 61.85 (s, CH2 or 10), 47.52 (s, CH2), 44.48 (s, CH26), 
34.67 (s, CH2), 32.08 (s, CH2), 30.94 (s, CH2), 30.60 (s, CH2), 30.29 (s, CH2), 30.18(s, 
CH2), 29.93 (s, CH2), 29.54 (s, CH2), 28.70 (s, CH2), 27.71 (s, CH2), 27.36 (s, CH2), 
26.92 (s, CH2). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.11 (t, J = 10.3 Hz, 3 F, CF311), AB-signal 
(δA = -112.77, δB = -113.30, JAB = 299.3 Hz, A and B are split into t, J = 12.7 Hz, CF218a), 
AB-signal (δA = -115.50, δB = -115.86, JAB = 289.9 Hz, A and B are split into t, J = 13.2 
Hz, CF218b), -124.62 (s, CF2), -126.11 (s, CF2), -127.05 (s, CF2), -130.44 (s, CF212). 
Total integral of CF2 region normalized with respect to the CF311 group = 14. 
FAB – MS [m/z] (relative intensity): 831.4 (45%) [M + H]+, 726.3 (73%) [Fragment A + 
H]+, 106.0 (17%) [Fragment B]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C341H4016O214N219F17, 831.2813; found, 
821.2814; Δ = 0.13 mmu. 
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 Ugi reaction of perfluorononanoic acid, p-anisaldehyde, 
cyclohexylisocyanide and allylamine 41 
 
In a 25 mL round bottom flask p-anisaldehyde (77.9 µL, 87.3 mg, 641 µmol, 1.70 eq.) 
and allylamine (48.1 µL, 36.6 mg, 641 µmol, 1.70 eq.) were added. The resulting 
mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid (175 mg, 
377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
cyclohexylisocyanide (79.7 µL, 70.0 mg, 641 µmol, 1.70 eq.) was added to the stirring 
mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure and purified via column chromatography 
employing FluoroFlash® silica gel. The fluorous fraction was tested for purity via TLC 
and concentrated under reduced pressure. The remaining perfluorononanoic acid was 
removed with a short silica gel filter column, eluting with c-hexane/ethyl acetate (3:1) 
to yield the Ugi product 41 as a yellow oil (193 mg, 259 µmol, 68.9%). 
Rf = 0.43 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3286.2 (br, 𝜈(N-H)), 3083.6 (w), 2926.3 (m, 𝜈(C-H)), 2849.5 (m), 
1675.0 (s, 𝜈(C=O)), 1655.9 (s), 1616.8 (m), 1555.6 (s), 1515.9 (s), 1417.2 (m), 1369.6 
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(m), 1330.1 (w), 1308.9 (w), 1248.4 (w), 1195.6 (s), 1143.4 (vs), 1116.4 (vs), 1042.2 
(s), 989.9 (m), 943.3 (m), 927.1 (m), 889.1 (m), 863.4 (m), 840.1 (m), 805.7 (m), 760.8 
(m), 716.6 (m), 681.4 (m), 649.5 (m), 633.9 (m), 615.3 (m), 564.7 (m), 549.9 (s), 519.5 
(s), 481.4 (s), 450.5 (w).  
1H-NMR (400 MHz, CD3OD): δ [ppm] = 7.30 – 7.22 (m, 2 H, CHAr25,32), 6.97 – 6.89 (m, 
2 H, CHAr22,24), 5.90 (s, 1 H, CH2), 5.85 – 5.75 (m, 2 H, CH233), 5.45 – 5.04 (m, 1 H, 
CH19), 4.81 – 4.58 (m, 2 H, CH29), 3.79 (s, 3 H, CH335), 3.77 – 3.60 (m, 1 H, CH6), 1.95 
– 1.01 (m, 10 H, CH2). 
13C-NMR (126 MHz, CD3OD): δ [ppm] = 172.96 (s, CONR4), 170.19(s, CAr23), 161.96 
(s, CONR18), 135.22 (s CAr8), 133.20 (s, CH19), 132.29 (s, CHAr25,32), 116.58 (s, CH29), 
115.16 (s, CAr22,24), 64.94 (s, CH2), 61.53 (s, CH233), 55.81 (s, CH335), 50.05 (s, CH6), 
33.56 (s, CH2), 33.45 (s, CH2), 26.60 (s, CH2), 26.02 (s, CH2), 20.86 (s, CH2). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.26 (t, J = 10.5 Hz, 3 F, CF310), AB-signal 
(δA = -116.14, δB = -117.58, JAB =299.3 Hz, JAB = 297.4 Hz, A and B are split into t, J 
= 12.3 Hz, CF217a), AB-signal (δA = 117.23, δB = -118.91, JAB = 295.5 Hz, A and B are 
split into t, J = 12.6 Hz, CF217b), -126.44 (s, CF2), -126.96 – -127.37 (m, CF2), -128.69 
(s, CF2), -129.65 (s, CF2), -133.16(s, CF211). Total integral of CF2 region normalized 
with respect to the CF310 group = 14.  
FAB – MS [m/z] (relative intensity): 749.1 (25%) [M + H]+, 622.0 (68%) [Fragment A ]+, 
582.0 (52%) [Fragment A + H – C3H5]+, 247.1 (28%) [Fragment B + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C271H2616O314N219F17, 749.1665; found, 
749.1666; Δ = 0.18 mmu. 
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 Ugi reaction of perfluorononanoic acid, benzaldehyde, 
cyclohexylisocyanide and octylamine 42 
 
In a 25 mL round bottom flask benzaldehyde (65.4 µL, 68.0 mg, 641 µmol, 1.70 eq.) 
and octylamine (106 µL, 82.9 mg, 641 µmol, 1.70 eq.) were added. The resulting 
mixture was stirred for 60 min over sodium sulfate. Pefluornonanoic acid (175 mg, 
377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
cyclohexylisocyanide (79.7 µL, 70.0 mg, 641 µmol, 1.70 eq.) was added to the stirring 
mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure and purified via column chromatography 
employing FluoroFlash® silica gel. The fluorous fraction was tested for purity via TLC 
and concentrated under reduced pressure. The remaining perfluorononanoic acid was 
removed with a short silica gel filter column, eluting with c-hexane/ethyl acetate (3:1) 
to yield the Ugi product 42 as a yellow oil (41.8 mg, 52.8 µmol, 14.0%). 
Rf = 0.36 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 2924.8 (s, 𝜈(C-H)), 2853.3 (s, 𝜈(C-H)), 1768.8 (w, 𝜈(C=O)), 1712.5 
(s, 𝜈(C=O)), 1646.9 (s, 𝜈(C=O)), 1450.9 (m), 1375.6 (m), 1240.5 (s), 1214.7 (s), 1150.2 
(m), 753.2 (s), 693.2 (s), 496.5 (w).  
1H-NMR (500 MHz, CDCl3): δ [ppm] = 6.99 – 6.90 (m, 5 H, CHAr25-26), 4.30 (s, 1 H, 
CH2), 3.26 – 3.08 (m, 3 H, CH6 + CH29), 1.28 – 1.16 (m, 4 H, CH2), 0.96 – 0.68 (m, 16 
H, CH2), 0.49 – 0.28 (m, 3 H, CH338). 
13C-NMR (126 MHz, CD3OD): δ [ppm] = 171.58 (s, CONR4), 160.84 (s, CONR18), 
136.48 (s, CAr8), 128.67 (s, CHAr), 128.13 (s, CHAr), 127.44 (s, CHAr), 65.49 (s, CH2), 
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63.40 (s, CH2), 61.96 (s, CH6), 31.99 (s, CH2), 31.06 (s, CH2), 29.84 (s, CH2), 29.56 (s, 
CH2), 29.40 (s, CH2), 27.50 (s, CH2), 26.78(s, CH2), 25.16 (s, CH2), 22.80 (s, CH2), 
14.23 (s, CH38). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.11 (t, J = 9.0 Hz, 3 F, CF310), AB-signal (δA = 
-112.92, δB = -114.05, JAB =295.5 Hz, A and B are split into t, CF217a, additional 
coupling not resolved, signals broadened), AB-signal (δA = -115.47, δB = -116.59, JAB 
= 291.8 Hz, A and B are split into t, CF217b, additional coupling not resolved, signals 
broadened), -123.73 – -124.95 (m, CF2), -126.12 (s, CF2), -127.05 (s, CF2), -130.46 (s, 
CF211). Total integral of CF2 region normalized with respect to the CF310 group = 14. 
FAB – MS [m/z] (relative intensity): 791.3 (40%) [M + H]+, 552.0 (22%) [Fragment A + 
H]+, 118.0 (23%) [Fragment B – H]+, 98.0 (31%) [Fragment C]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C311H3616O214N219F17, 797.2500; found, 
791.2501; Δ = 0.14 mmu. 
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 Ugi reaction of perfluorononanoic acid, p-anisaldehyde, 
cyclohexylisocyanide and heptylamine 43 
 
In a 25 mL round bottom flask p-anisaldehyde (77.9 µL, 87.3 mg, 641 µmol, 1.70 eq.) 
and heptylamine (95.0 µL, 73.8 mg, 641 µmol, 1.70 eq.) were mixed. The resulting 
mixture was stirred for 60 min over sodium sulfate. Perfluorononanoic acid (175 mg, 
377 µmol, 1.00 eq.) dissolved in 0.5 mL methanol was added to the solution at room 
temperature and the resulting mixture was stirred for 2 min. Subsequently, 
cyclohexylisocyanide (79.9 µL, 70.0 mg, 641 µmol, 1.70 eq.) was added to the stirring 
mixture. The reaction was stirred for 3 d at room temperature. The crude reaction 
mixture was dried under reduced pressure and purified via column chromatography 
employing FluoroFlash® silica gel. The fluorous fraction was tested for purity via TLC 
and concentrated under reduced pressure. The remaining perfluorononanoic acid was 
removed with a short silica gel filter column, eluting with c-hexane/ethyl acetate (3:1) 
to yield the Ugi product 43 as a yellow oil (76.9 mg, 95.4 µmol, 25.3%). 
Rf = 0.36 in c-hexane/ethyl acetate (4:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3295.4 (br, 𝜈(N-H)), 2927.7 (m, 𝜈(C-H)), 2853.7 (w, 𝜈(C-H)), 1675.3 
(s, 𝜈(C=O)), 1645.9 (vs, 𝜈(C=O)), 1612.2 (w), 1555.6 (m), 1513.0 (m), 1437.6 (w), 
1200.7 (vs), 1144.6 (vs), 1028.7 (m), 977.1 (m), 918.3 (w), 822.1 (m), 773.1 (m), 703.4 
(m), 662.7 (m), 561.6 (m), 527.0 (s), 443.0 (w).  
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.33 (d, J = 8.7 Hz, 2 H, CHAr25,32), 6.91 (d, J = 
8.8 Hz, 2 H, CHAr22,24), 5.54 (s, 1 H, CH2), 3.83 (s, 3 H, OCH339), 3.81 – 3.75 (m, 1 H, 
CH6), 3.38 (s, 2 H, CH29), 1.94 – 1.84 (m, 2 H, CH2), 1.69 – 1.55 (m, 4 H, CH2), 1.38 – 
0.94 (m, 16 H, CH2), 0.83 (t, J = 7.2 Hz, 3 H, CH337).  
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13C-NMR (101 MHz, CDCl3): δ [ppm] = 167.36 (s, CONR4), 160.34 (s, CAr23), 159.02 
(s, CONR10), 131.34 (s, CHAr25,32), 125.47 (s, CAr8), 114.56 (s, CAr22,24), 64.82 (s, CH2), 
55.47 (s, OCH339), 48.90 (s, CH6), 47.49 (s, CH29), 32.83(s, CH2), 31.65(s, CH2), 29.98 
(s, CH2), 28.60 (s, CH2), 27.06 (s, CH2), 26.66 (s, CH2), 25.59 (s, CH2), 24.88 (s, CH2), 
22.59 (s, CH2), 14.10 (s, CH337). 
19F-NMR (376 MHz, CDCl3): δ [ppm] = -85.11 (t, J = 9.9 Hz, 3 F, CF310), AB-signal (δA = 
-112.88, δB = -114.15, JAB = 295.5 Hz, A and B are split into t, J = 13.3 Hz, CF217a), AB-
signal (δA = -115.47, δB = -116.63, JAB = 291.8 Hz, A and B are split into t, J = 13.7 Hz, 
CF217b), -123.87 – 125.00 (m, CF2), -126.13 (s, CF2), -127.06 (s, CF2), -130.45 (s, 
CF211). Total integral of CF2 region normalized with respect to the CF310 group = 14. 
FAB – MS [m/z] (relative intensity): 807.3 (25%) [M + H]+, 708.1 (23%) [Fragment A 
+H ]+, 681.2 [Fragment B +H ]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C311H3616O314N219F17, 807.2449; found, 
807.2449; Δ = 0.03 mmu. 
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 Ugi reaction of perfluorononanoic acid, valeraldehyde, 
tert-butylisocyanide and tert-butylamine 44 
 
In a 25 mL round bottom flask valeraldehyde (126 mg, 1.46 mmol, 1.70 eq.) and tert-
butylamine (107 mg, 1.46 mmol, 1.70 eq.) were stirred for 60 min over sodium sulfate. 
Perfluorononanoic acid (400 mg, 826 µmol, 1.00 eq.) dissolved in 1 mL methanol was 
added to the imine at room temperature and the resulting mixture was stirred for 2 min. 
Subsequently, tert-butylisocyanide (165 µL, 122 mg, 1.46 mmol, 1.70 eq.) was added 
to the stirring mixture. The reaction was stirred for 5 d at room temperature. The crude 
reaction mixture was dried under reduced pressure and purified via column 
chromatography employing FluoroFlash® silica gel. The fluorous fraction was 
concentrated and the residue was adsorbed onto celite® and purified via column 
chromatography employing silica gel as stationary phase and eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (0:1 → 1:1) to yield the Ugi product 44 
as a highly viscous yellow oil (109 mg, 141 µmol, 17.3%). 
Rf = 0.58 in c-hexane/ethyl acetate (6:1). Visualized via Seebach staining solution and 
permanganate staining. 
IR (ATR):  [cm-1] = 2965.2 (m, 𝜈(C-H)), 1683.9 (s, 𝜈(C=O)), 1509.6 (m), 1456.9 (m), 
1394.9 (m), 1366.9 (m), 1205.7 (s), 1146.3 (s), 1040.6 (w), 985.7 (w), 879.4 (w), 821.3 
(w), 783.1 (w), 735.7 (m), 710.2 (m), 669.4 (m), 635.8 (m), 559.7 (m), 530.2 (m), 473.4 
(w).  
1H-NMR (400 MHz, CD3OD): δ [ppm] = 4.34 (t, J = 6.8 Hz, 1 H, CH1), 2.40 – 2.14 (m, 
1 H, CH26a), 1.86 – 1.66 (m, 1 H, CH26b), 1.55 – 1.05 (m, 22 H, CH28,9 + CH310,22,23,25-
27), 0.95 (t, J = 7.1 Hz, 3 H, CH324). 
13C-NMR (101 MHz, CD3OD): δ [ppm] = 169.54 (s, CONR2), 160.81 (s, CONR19), 62.13 
(s, C4 or 7), 61.30 (s, CH6), 51.25 (s, C4 or 7), 32.17 (s, CH2), 30.03 (s, CH2), 28.25 (s, 
CH310,22,23 or 25-27), 27.24 (s, CH310,22,23 or 25-27), 22.34 (s, CH2), 12.78 (s, CH324). 
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19F-NMR (376 MHz, CD3OD): δ [ppm] = -88.25 (t, J = 10.2 Hz, 3 F, 
CF311), -113.23 – -116.89 (m, CF218), -125.75 (s, CF2), -128.64 (d, J = 64.9 Hz, 
CF2), -129.65 (s, CF2), -133.15 (s, CF212). Total integral of CF2 region normalized with 
respect to the CF311 group = 14.  
ESI-MS [m/z]: [M + Na]+ calculated for 12C231H2916O214N219F1723Na1, 711.1850 found, 
711.18064, Δ = 1.35 mmu. 
 
 Ugi reaction of perfluorononanoic acid, dodecanal, 
pentylisocyanide and benzylamine 45 
 
In a 25 mL round bottom flask dodecyl aldehyde (90.4 mg, 490 µmol, 1.30 eq.) was 
dissolved in 1.5 mL methanol, subsequently benzylamine (56.0 µL, 52.5 mg, 490 µmol, 
1.30 eq.) was added and the resulting mixture was stirred for 60 min over sodium 
sulfate. Afterwards, the mixture was filtrated and the solid was washed with 10 mL 
methanol three times. Subsequently, the filtrate was concentrated under reduced 
pressure. Perfluorononanoic acid (175 mg, 377 µmol, 1.00 eq.) dissolved in 1 mL 
methanol was added to the imine at room temperature and the resulting mixture was 
stirred for 2 min. Subsequently, pentylisocyanide (56.9 µL, 43.9 mg, 453 µmol, 
1.20 eq.) was added to the stirring mixture. The reaction was stirred for 3 d at room 
temperature. The crude reaction mixture was dried under reduced pressure and 
purified via column chromatography employing FluoroFlash® silica gel. The fluorous 
fraction was tested for purity via TLC and concentrated under reduced pressure. The 
remaining perfluoro acid was removed with a short silica gel filter column, eluting with 
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c-hexane/ethyl acetate (3:1) to yield the Ugi product 45 as a highly viscous yellow oil 
(57.1 mg, 68.4 µmol, 18.1%). 
Rf = 0.69 in c-hexane/ethyl acetate (6:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3327.8 (br, 𝜈(N-H)), 2924.6 (m, 𝜈(C-H)), 2854.8 (w, 𝜈(C-H)), 1659.9 
(m, 𝜈(C=O)), 1539.8 (w, 𝜈(N-H)), 1455.2 (w), 1364.5 (s), 1239.1 (s), 1209.2 (vs), 
1148.2 (s), 956.2 (w), 722.9 (m), 699.5 (m), 657.1 (m), 559.4 (w), 529.2 (w), 463.1 (w). 
1H-NMR (400 MHz, CDCl3): δ [ppm] = 7.38 – 7.13 (m, 5 H, CHAr32-36), 6.17 (t, J = 5.5 
Hz, 1 H, NH8), 5.04 – 4.55 (m, 2 H, CH210), 4.43 (t, J = 14.8, 1 H, CH1), 3.34 – 2.92 (m, 
2 H, CH26), 1.96 – 1.67 (m, 2 H, CH29), 1.66 – 1.37 (m, 2 H, CH238 or 29), 1.36 – 1.06 (m, 
22 H, CH2), 0.87 (s, 6 H, CH330 + 39).  
13C-NMR (126 MHz, CDCl3): δ [ppm] = 168.30 (s, CONR4), 159.01 (s, CONR19), 135.90 
(s, CAr31), 127.98 (s, CHAr), 127.27 (s, CHAr), 126.51 (s, CHAr), 60.71 (s, CH1), 40.30 
(s, CH26), 31.55 (s, CH226), 28.41 (s, CH2), 28.25 (s, CH2), 22.33 (s, CH2), 21.94 (s, 
CH2), 13.80 (s, CH330 or 39), 13.59 (s, CH330 or 39). 
19F-NMR (376 MHz, CDCl3) δ [ppm] = -85.10 (t, J = 9.9 Hz, 3 F, CF311), -112.37 – -
114.22 (m, CF218a), AB-signal (δA = -114.15, δB = -115.22, JAB = 291.8 Hz, A and B are 
split into t, J = 13.1 Hz, CF218b), 124.25 (s, CF2), -126.13 (s, CF2), -127.05 (s, CF2), -
130.44 (s, CF212). Total integral of CF2 region normalized with respect to the CF311 
group = 14. 
FAB – MS [m/z] (relative intensity): 835.4 (65%) [M + H]+, 387.3 (10%) [Fragment A]+, 
283.2 (32%) [Fragment B + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C341H4416O214N219F17, 835.3126; found, 
835.3125; Δ = 0.06 mmu. 
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 Ugi reaction of perfluorononanoic acid, cyclamen aldehyde, 
tert-butylisocyanide and 2-pentylamine 46 
 
In a 25 mL round bottom flask cyclamen aldehyde (906 µL, 861 mg, 4.53 mmol, 
3.00 eq.) and 2-pentylamine (493 µL, 394 mg, 4.53 mmol, 3.00 eq.) were stirred for 
60 min over sodium sulfate. The mixture was diluted with 0.5 mL methanol and 
perfluorononanoic acid (700 mg, 1.51 mmol, 1.00 eq.) was added at room temperature. 
Subsequently, tert-butylisocyanide (512 µL, 376 mg, 4.53 mmol, 3.00 eq.) was added 
to the stirring mixture. The reaction was stirred for 4 d at room temperature. The crude 
reaction mixture was dried under reduced pressure and purified via column 
chromatography employing FluoroFlash® silica gel and eluting with 8 mL 
methanol/water (8:2) to elute the organic fraction, subsequently the fluorous fraction 
was eluted with pure methanol. The remaining perfluoro acid was removed with a short 
silica gel filter column, eluting with c-hexane/ethyl acetate (3:1). After drying under 
reduced pressure, the fluoro-tagged product 46 (diastereomer mixture) was obtained 
as a yellow oil (209 mg, 251 µmol, 16.7%). 
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Rf = 0.75 in c-hexane/ethyl acetate (3:1). Visualized via fluorescent quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3305.2 (br, 𝜈(N-H)), 2959.7 (vs, 𝜈(C-H)), 2929.3 (s, 𝜈(C-H)), 2870.8 
(m, 𝜈(C-H)), 2711.1 (m), 1725.1 (vs, 𝜈(C=O)), 1674.4 (s, 𝜈(C=O)), 1512.6 (m), 1457.4 
(m), 1419.9 (w), 1382.2 (w), 1363.0 (w), 1282.5 (w), 1217.7 (m), 1114.2 (s), 1050.7 
(m), 1019.5 (w), 923.8 (w), 879.9 (m), 837.5 (w), 704.4 (w), 548.6 (m). 
1H-NMR (500 MHz, CD3OD): δ [ppm] = 7.20 – 6.95 (m, 4 H, CHAr39-42), 4.87 (s, 1 H), 
4.30 (dd, J = 5.0, 2.3 Hz, 1 H, CH2), 3.04 – 2.50 (m, 5 H, CH219+37 + CH9), 2.31 (ddd, J 
= 13.4, 9.4, 2.6 Hz, 2 H, CH234), 1.94 – 1.80 (m, 2 H, CH38 + CH44), 1.42 – 1.12 (m, 18 
H, CH345,47 + CH327,31,32 + CH333), 1.03 – 0.82 (m, 6 H, CH335+46). 
13C-NMR (126 MHz, CD3OD): δ [ppm] = 147.26 (s, CONR4), 139.32 (s, CONR18), 
139.21 (s, CAr), 130.21 (s, CAr), 127.38 (s, CHAr), 127.09 (s, CHAr), 102.07 (s, CH2), 
42.71 (s, CH38 or 44), 42.39 (s, CH38 or 44), 38.91 (s, CH2), 38.72 (s, CH2), 35.50 (s, CH2), 
34.89 (s, CH9), 24.59 (s, CH3), 24.52 (s, CH3), 14.19 (s, CH335or46), 14.11 (s, CH335or46). 
19F-NMR (376 MHz, CD3OD): δ [ppm] = -86.41 (t, J = 10.4 Hz, 3 F, CF51), -113.47 – -
116.61 (m, CF217), -124.05 – -125.24 (m, CF2), -126.48 (s, CF2), -126.67 – -127.14 (m, 
CF2), -127.72 (d, J = 17.1 Hz, CF2), -127.84 (s, CF2), -130.95 – -131.61 (m, CF250). 
Total integral of CF2 region normalized with respect to the CF351 group = 14. 
ESI – MS [m/z]: [M + Na]+ calculated for 12C321H3916O214N219F17Na1, 829.2638; found, 
829.2636; Δ = 0.19 mmu. 
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6.2.2 Synthetic procedures for chapter 4.2 
 
Additional data such as displayed NMR spectra can be found in the supplementary 
information of the previous publication and are included in the electronic version of 
this thesis on the CD.[23] 
 
6.2.2.1 Biginelli reactions 
 
 Biginelli compound 47 derived from benzaldehyde, benzyl 
acetoacetate and urea 
 
In a tube vial, finely powdered urea (1.50 g, 24.9 mmol, 1.50 eq.) and benzaldehyde 
(1.76 g, 16.6 mmol, 1.70 mL, 1.00 eq.) were suspended in 3.33 mL dimethyl sulfoxide 
(5.00 M for 1.00 eq.). Subsequently, benzyl acetoacetate (3.84 g, 20.0 mmol, 3.45 mL) 
and 4-methylbenzenesulfonic acid (99.9 mg, 833 µmol, 0.05 eq.) were added. The 
resulting mixture was stirred at 110 °C for 24 h. TLC indicated complete conversion of 
benzaldehyde. Subsequently, the crude reaction mixture was added dropwise into 
100 mL water while stirring. The suspension was stirred for 3 h until a precipitate was 
formed. The precipitate was filtered off, crushed, washed with water (3 × 30 mL) and 
dried. Then, the precipitate was washed with and n-hexane (2 × 30 mL) and dried 
under reduced pressure to yield the Biginelli product 47 as a pale yellow solid (4.86 g, 
15.1 mmol, 90.5%). 
IR (ATR):  [cm-1] = 3352.9 (w, 𝜈(N-H)), 3108.6 (br,𝜈(N-H)), 2975.5 (br, 𝜈(C-H), 1701.2 
(s, 𝜈(C=O)), 1684.5 (s, 𝜈(C=O)), 1634.3 (s), 1493.8 (w), 1453.9 (m), 1421.1 (m), 1376.4 
(m), 1320.2 (m), 1292.4 (m), 1221.1 (vs), 1137.0 (w), 1082.1 (vs), 1025.1 (m), 963.5 
(w), 791.7 (w), 750.7 (w), 720.1 (m), 699.0 (s), 660.3 (m), 612.5 (w), 523.0 (w), 488.3 
(m), 385.9 (w). 
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1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 9.28 (s, 1 H, NH19), 7.77 (s, 1 H, NH3), 7.36 
– 7.11 (m, 10 H, CHAr), 5.18 (d, J = 2.7 Hz, 1 H, CH2), AB-signal (δ A = 5.05, δ B = 
5.00, JAB = 13.5 Hz, CH210), 2.28 (s, 3 H, CH312). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 165.10 (s, CO2R7), 152.03 (s, CO4), 149.31 
(s, C5), 144.68 (s, CAr11), 136.54 (s, CAr13), 128.46 (s, CHAr), 128.30 (s, CHAr), 127.74 
(s, CHAr), 127.57 (s, CHAr), 127.35 (s, CHAr), 126.33 (s, CHAr), 98.76 (s, C1), 64.84 (s, 
CH210), 53.96 (s, CH2), 17.89 (s, CH312). 
FAB – MS [m/z] (relative intensity): 323.3 (100%) [M + H]+, 245.1 (30%) [M – C7H7O]+, 
231.0 (35%) [M – C7H7]+, 215.0 (20%) [M – C7H7]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C191H1916O314N2, 321.1390; found, 
323.1388; Δ = 0.19 mmu. 
Spectral data is in accordance to earlier reported.[340] 
 
 Biginelli acid 48 derived from Biginelli benzyl ester 47 
 
In a tube vial equipped with a magnetic stir bar, the Biginelli benzyl ester 47 (800 mg, 
2.48 mmol, 1.00 eq.) was dissolved in 8.00 mL acetic acid/ethanol (1:3). Subsequently, 
palladium on activated charcoal (10 wt.% Pd, 80.0 mg) was added to the solution and 
the vial was placed inside an autoclave. Hydrogen gas (20 bar) was applied and the 
reaction was stirred for 15 h at 50 °C. The crude reaction mixture was concentrated 
under reduced pressure and stirred with 10 mL 1M sodium hydroxide solution for 20 
min. The suspension was filtered, and the yellow filtrate was acidified with hydrochloric 
acid (pH = 1). The white precipitate was filtered off, washed with water (2 × 30 mL), 
diethyl ether (3 × 50 mL) and was subsequently dried under reduced pressure: The 
Biginelli-acid 48 was obtained as a colorless solid (533 mg, 2.29 mmol, 92.5%). 
IR (ATR):  [cm-1] = 3214,7 (br, 𝜈(N-H)), 3087.0 (br, 𝜈(N-H)), 2975.3 (w, 𝜈(C-H), 1700.7 
(s, 𝜈(C=O)), 1643.2 (s, 𝜈(C=O)), 1477.9 (m), 1421.7 (m), 1381.7 (w), 1325.1 (m), 
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1294.5 (w), 1266.7 (w), 1227.9 (vs), 1217.9 (vs), 1106.6 (w), 889.1 (w), 834.0 (w),753.3 
(m), 692.1 (m), 651.8 (s), 613.9 (s), 565.5 (m), 522.6 (w), 483.3 (m), 393.4 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 11.80 (br s, 1 H, CO2H9), 9.09 (s, 1 H, NH17), 
7.68 (s, 1 H, NH3), 7.53 – 7.00 (m, 5 H, CHAr12-16), 5.12 (d, J = 3.0 Hz, 2 H, CH2), 2.24 
(s, 3 H, CH311). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 167.20 (s, CO2H7), 152.46 (s, CO4), 147.78 
(s, C5), 144.85 (s, CAr10), 128.40 (s, CHAr12,16), 127.20 (s, CHAr14), 126.28 (s, CHAr13,15), 
99.85 (s, C1), 54.00 (s, CH2), 17.79 (s, CH311). 
FAB – MS [m/z] (relative intensity): 233.0 (40%) [M + H]+, 155.0 (100%) [M – C6H5]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C121H1316O314N2, 233.0921; found, 
233.0922; Δ = 0.17 mmu. 
1H-NMR data is in accordance to earlier reported.[26] 
 
 Biginelli acid 49 derived from hydantoic acid, benzaldehyde and 
ethyl acetoacetate 
 
In a 50 mL round bottom flask, finely powdered N-carbomoylglycine (1.00 g, 
8.46 mmol, 1.20 eq.) and benzaldehyde (748 mg, 7.06 mmol, 1.00 eq.) were 
suspended in 2.50 mL acetic acid/ethanol (3:1) (2.80 M for 1.00 eq.). Subsequently, 
ethyl acetoacetate (1.10 g, 8.46 mmol, 1.08 mL, 1.20 eq.) and 
4-methylbenzenesulfonic acid (84.7 mg, 706 µmol, 0.10 eq.) were added. The resulting 
suspension was stirred at 40 °C for 1 h and then slowly heated to 80 °C and stirred for 
4 h to obtain a yellow solution. TLC indicated complete conversion of benzaldehyde. 
The crude reaction mixture was added dropwise into 100 mL of water while stirring; 
the slurry was stirred for 1 h until a precipitate was formed, which was filtered off, 
crushed, washed with water (3 × 20 mL), dried and washed with n-hexane (3 × 20 mL). 
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The crude product was dried under reduced pressure yielding Biginelli acid 49 as a 
colorless solid (1.42 g, 5.33 mmol, 63.1%). 
Spectral data is in accordance to earlier reported.[341] 
IR (ATR):  [cm-1] = 3290.5 (br, 𝜈(N-H)), 2979.6 (w, 𝜈(C-H), 1725.4 (s, 𝜈(C=O)), 1701.0 
(s, 𝜈(C=O)), 1631.2 (s, 𝜈(C=O)), 1453.2 (m), 1402.1 (m), 1364.6 (w), 1311.5 (w), 
1279.6 (w), 1233.7 (m), 1213.9 (m), 1181.0 (s), 1120.9 (m), 1058.7 (m), 945.1 (m), 
830.0 (m), 783.9 (m), 747.3 (m), 701.6 (s), 679.9 (m), 623.3 (s), 522.3 (m), 483.3 (m), 
419.1 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 12.90 (s, 1 H, CO2H22), 8.06 (d, J = 3.4 Hz, 
1 H, NH3), 7.40 – 7.17 (m, 5 H, CHAr14-18), 5.19 (d, J = 3.1 Hz, 1 H, CH2), AB-signal (δ 
A = 4.49, δ B = 4.35, JAB = 18.0 Hz, CH220), 4.03 (q, J = 7.1 Hz, 2 H, CH210), 2.40 (s, 3 
H, CH312), 1.10 (t, J = 7.1 Hz, 3 H, CH313). 
13C-NMR (100 MHz, DMSO-d6): δ [ppm] = 171.06 (s, CO2H21), 165.57 (s, CO2R7), 
152.33 (s, CO4), 149.00 (s, C5), 144.18 (s, CAr11), 128.39 (s, CHAr14,18), 127.43 (s, 
CHAr16), 126.54 (s, CHAr15,17), 102.92 (s, C1), 59.66 (s, CH210), 53.13 (s, CH2), 43.95 (s, 
CH220), 15.64 (s, CH312), 14.01 (s, CH313). 
FAB – MS [m/z] (relative intensity): 319.1 (100%) [M + H]+, 241.0 (25%) [M - C6H5]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C161H1916O514N2, 319.1288; found, 
319.1290; Δ = 0.15 mmu. 
 
 Biginelli acid 50 derived from hydantoic acid, benzaldehyde and 
benzyl acetoacetate 
 
In a 25 mL round bottom flask finely powdered N-carbomoylglycine (4.00 g, 33.8 mmol, 
1.20 eq.) and benzaldehyde (2.99 g, 28.2 mmol, 2.88 mL, 1.00 eq.) were suspended 
in 6 mL dimethyl sulfoxide (4.7 M for 1.00 eq.). Subsequently, benzyl acetoacetate 
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(4.40 g, 33.8 mmol, 4.32 mL) and 4-methylbenzenesulfonic acid (169 mg, 1.42 mmol, 
0.05 eq.) were added. The resulting mixture was stirred at 110 °C for 48 h. 
Subsequently, the crude reaction mixture was added dropwise into 300 mL water while 
stirring. The suspension was stirred for 4 h until a precipitate was formed. The 
precipitate was filtered off, crushed and washed with water (4 × 50 mL), dried and 
washed again with n-hexane/ethyl acetate (4:1) (3 × 100 mL) and dried under reduced 
pressure in a desiccator over calcium chloride to yield the Biginelli acid 50 as a 
colorless solid (8.35 g, 21.9 mmol, 77.7%). 
IR (ATR):  [cm-1] = 3258.6 (br, 𝜈(CO2H)), 3077.5 (br, 𝜈(N-H)), 2938.8 (w, 𝜈(C-H), 
1709.2 (s, 𝜈(C=O)), 1649.3 (s, 𝜈(C=O)), 1430.7 (m), 1403.4 (m), 1386.8 (m), 1356.9 
(w), 1315.2 (w), 1277.7 (m), 1239.1 (m), 1222.4 (m), 1205.4 (s), 1181.7 (vs), 1114.2 
(s), 1055.9 (m), 977.8 (w), 830.5 (w), 782.8 (m), 733.0 (w), 694.9 (s), 641.8 (m), 592.4 
(w), 502.6 (w), 461.1 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 12.95 (br s, 1 H, OH22), 8.08 (d, J = 3.5 Hz, 
1 H, NH3), 7.76 – 6.88 (m, 10 H, CHAr), 5.21 (d, J = 3.5 Hz, 1 H, CH2), 5.06 (s, 2 H, 
CH210), AB-signal (δ A = 4.50, δ B = 4.34, JAB = 18.1 Hz, CH220), 2.43 (s, 3 H, CH312). 
13C-NMR (100 MHz, DMSO-d6): δ [ppm] = 171.00 (s, CO2H21), 165.31 (s, CO2R7), 
152.23 (s, CO4), 149.97 (s, C5), 143.95 (s, CAr11), 136.29 (s, CAr13), 128.40 (s, CHAr), 
128.32 (s, CHAr), 127.83 (s, CHAr), 127.70 (s, CHAr), 127.45 (s, CHAr), 126.57 (s, CHAr), 
102.38 (s, C1), 65.27 (s, CH210), 53.04 (s, CH2), 43.99 (s, CH220), 15.70 (s, CH312). 
FAB – MS [m/z] (relative intensity): 381.2 (35%) [M + H]+, 321.2 (10%) [M – C2H3O2]+, 
289.1 (25%) [M – C7H7]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C211H2116O514N2, 381.1445; found, 
381.1146; Δ = 0.15 mmu. 
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 Biginelli acid 51 derived from 4-formylbenzoic acid, urea and ethyl 
acetoacetate 
 
In a 25 mL round bottom flask, finely powdered urea (1.50 g, 24.9 mmol, 1.50 eq.) and 
4-formylbenzoic acid (2.50 g, 16.6 mmol, 1.00 eq.) were suspended in 4 mL DMSO. 
Subsequently, ethyl acetoacetate (3.25 g, 24.9 mmol, 1.50 eq.) and 
4-methylbenzenesulfonic acid (p-TSA) (200 mg, 1.65 mmol, 0.10 eq.) were added. The 
resulting mixture was stirred at 110 °C for 48 h and subsequently at 40 °C for 24 h. 
Subsequently, the crude reaction mixture was diluted with ethanol and added dropwise 
into 300 mL water. The suspension was stirred for 1 h until a precipitate was formed. 
The precipitate was filtered off, crushed, washed with water (3 × 20 mL) and dried. 
Afterwards, the precipitate was washed with n-hexane (3 × 20 mL). After drying under 
reduced pressure in a desiccator over calcium chloride, the Biginelli acid 51 was 
obtained as a colorless solid (4.57 g, 15.1 mmol, 90.1%). 
IR (ATR):  [cm-1] = 3309.4 (br, 𝜈(O-H)), 3206.7 (br, 𝜈(N-H)), 3084.8 (br, 𝜈(N-H)), 
2971.9 (br, 𝜈(C-H), 1723.3 (s, 𝜈(C=O)), 1702.5 (s, 𝜈(C=O)), 1649.1 (s, 𝜈(C=O)), 1608.9 
(m), 1474.3 (m), 1419.7 (w), 1379.8 (w), 1317.7 (w), 1288.1 (w), 1225.0 (vs), 1170.0 
(m), 1087.6 (s), 1018.3 (m), 875.7 (w), 843.2 (w), 792.4 (m), 754.5 (s), 700.5 (m), 667.9 
(w), 638.1 (s), 568.9 (w), 527.2 (w), 501.4 (w), 466.9 (w), 408.5 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 12.90 (s, 1 H, CO2H21), 9.27 (s, 1 H, NH19), 
7.91 (d, J = 7.8 Hz, 2 H, CHAr15,17), 7.81 (s, 1 H, NH3), 7.35 (d, J = 7.9 Hz, 2 H, CHAr14,18), 
5.21 (d, J = 2.8 Hz, 1 H, CH2), 3.97 (q, J = 6.9 Hz, 2 H, CH210), 2.25 (s, 3 H, CH312), 
1.08 (t, J = 7.1 Hz, 3 H, CH313). 
13C-NMR (75 MHz, DMSO-d6): δ [ppm] = 167.13 (s, CO2H20), 165.24 (s, CO2R7), 
152.00 (s, CO4), 149.57 (s, C5), 148.91 (s, CAr11), 129.84 (s, CAr16), 129.66 (s, CHAr15, 
17), 126.56 (s, CHAr14,18), 98.71 (s, C1), 59.32 (s, CH210), 53.93 (s, CH2), 17.88 (s, 
CH312), 14.10 (s, CH313). 
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FAB – MS [m/z] (relative intensity): 305.1 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C151H1716O514N2, 305.1132; found, 
305.1131; Δ = 0.12 mmu. 
NMR spectral data is in accordance to earlier reported.[342] 
 
 Biginelli acid 52 derived from 4-formylbenzoic acid, urea and 
benzyl acetoacetate 
 
In a 25 mL round bottom flask finely powdered urea (1.50 g, 24.9 mmol, 1.50 eq.) and 
4-formylbenzoic acid (2.50 g, 16.6 mmol, 1.00 eq.) were suspended in 4 mL dimethyl 
sulfoxide. Subsequently, benzyl acetoacetate (3.84 g, 20.0 mmol, 1.20 eq.) and 
4-methylbenzenesulfonic acid (200 mg, 1.65 mmol, 0.10 eq.) were added. The 
resulting mixture was stirred at 110 °C for 48 h and subsequently at 40 °C for 24 h. 
Subsequently, the crude reaction mixture was diluted with ethanol and added dropwise 
into 300 mL water. The suspension was stirred for 1 h until a precipitate was formed. 
The precipitate was separated, washed with water (3 × 20 mL) and dried. Afterwards 
the precipitate was washed with n-hexane (3 × 20 mL). After drying in a desiccator 
over calcium chloride the Biginelli acid 52 was obtained as a colorless solid (5.55 g, 
15.2 mmol, 91.0%). 
IR (ATR):  [cm-1] = 3273.7 (br, 𝜈(O-H)), 3068.9 (br, 𝜈(N-H)), 2931.0 (w, 𝜈(C-H), 1678.3 
(s, 𝜈(C=O)), 1642.6 (s, 𝜈(C=O)), 1608.6 (m), 1466.5 (m), 1381.5 (m), 1325.2 (m), 
1275.3 (m), 1228.5 (s), 1090.8 (s), 1017.7 (w), 953.9 (w), 909.7 (w), 860.3 (w), 773.3 
(m), 738.2 (m), 694.8 (m), 665.2 (m), 642.2 (w), 577.3 (w), 518.3 (m), 504.9 (m), 452.8 
(w), 394.7 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.92 (s, 1 H, CO2H26), 9.35 (d, J = 1.4 Hz, 
1 H, NH19), 7.88 (d, J = 8.3 Hz, 3 H, CHAr), 7.85 – 7.83 (m, 1 H, NH3), 7.32 (d, J = 8.3 
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Hz, 2 H, CHAr14,18), 7.30 – 7.25 (m, 3 H, CHAr), 7.19 – 7.08 (m, 2 H, CHAr), 5.24 (d, J = 
3.2 Hz, 1 H, CH2), 5.15 – 4.90 (m, 2 H, CH210), 2.28 (s, 3 H, CH312). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 167.10 (s, CO2H25), 164.96 (s, CO2R7), 
151.83 (s, CO4), 149.76 (s, C5), 149.33 (s, CAr16), 136.46 (s, CAr11), 129.86 (s, CAr13), 
129.66 (s, CHAr), 128.28 (s, CHAr), 127.79 (s, CHAr), 127.66 (s, CHAr), 126.57 (s, CHAr), 
98.20 (s, C1), 64.91 (s, CH210), 53.87 (s, CH2), 17.95 (s, CH312). 
FAB – MS [m/z] (relative intensity): 367.1 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C201H1916O514N2, 367.1288; found, 
367.1289; Δ = 0.05 mmu. 
 
6.2.2.2 Passerini reactions of Biginelli acids 
 
 Passerini product 53 derived from Biginelli acid 51, tert-butyl 
isocyanide and heptanal 
 
In a tube vial, finely powdered Biginelli-acid 51 (300 mg, 986 µmol, 1.00 eq.) was 
dissolved in 0.5 mL dimethyl sulfoxide and diluted with 0.9 mL dichloromethane. 
Subsequently, heptanal (169 mg, 1.48 mmol, 205 µL, 1.50 eq.) and 
tert-butylisocyanide (123 mg, 1.48 mmol, 142 µL, 1.50 eq.) were added. The mixture 
was and stirred at room temperature for 2 d. Subsequently, the crude reaction mixture 
was added dropwise into a stirred mixture of 10 mL water and 10 mL dichloromethane. 
The aqueous phase was extracted with 10 mL dichloromethane three times. The 
combined organic phases were concentrated under reduced pressure. The 
concentrate was added dropwise into 30 mL of n-hexane/ethyl acetate (4:1) while 
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stirring. After stirring for 1 h, a precipitate was formed, which was separated, washed 
with 30 mL n-hexane three times and dried under reduced pressure. The Passerini 
product 53 was obtained as a colorless solid (332 mg, 661 µmol, 67.1%). 
IR (ATR):  [cm-1] = 3292.8 (br, 𝜈(N-H)), 3086.2 (br, 𝜈(N-H)), 2926.6 (m, 𝜈(C-H), 1704.6 
(vs, 𝜈(C=O)), 1645.3 (s, 𝜈(C=O)), 1607.6 (w), 1554.3 (w), 1453.5 (m), 1426.2 (m), 
1407.4 (w), 1364.5 (w), 1312.9 (m), 1262.7 (m), 1219.1 (vs), 1179.6 (w), 1099.6 (s), 
1017.2 (w), 949.2 (w), 868.2 (w), 825.6 (w), 763.5 (m), 706.7 (m), 654.5 (m), 605.5 (w), 
522.6 (w), 456.2 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 9.29 (s, 1 H, NH34), 7.94 (d, J = 7.8 Hz, 2 H, 
CHAr32,30), 7.84 (s, 1 H, NH18), 7.63 (s, 1 H, NH3), 7.39 (d, J = 7.8 Hz, 2 H, CHAr29,33), 
5.22 (s, 1 H, CH17), 4.98 (s, 1 H, CH1), 3.98 (q, J = 6.9 Hz, 2 H, CH25), 2.26 (s, 3 H, 
CH327), 1.86 – 1.60 (m, 2 H, CH215), 1.43 – 1.16 (m, 19 H, CH2+CH37-9), 1.09 (t, J = 6.9 
Hz, 4 H, CH328), 0.93 – 0.74 (m, 3 H, CH310). 
13C-NMR (75 MHz, DMSO-d6): δ [ppm] = 168.51 (s, CONR2), 165.16 (s, CO2R22), 
164.92 (s, CO2R35), 151.92 (s, CO19), 150.10 (s, C20), 148.97 (s, CAr26), 129.62 (s, 
CHAr30,32), 128.67 (s, CAr31), 126.66 (s, CHAr29,33), 98.57 (s, C16), 74.04 (s, CH1), 59.29 
(s, CH225), 53.90 (s, CH17), 50.22 (s, C4), 31.65 (s, CH2), 31.12 (s, CH2), 28.45 (s, CH37-
9), 28.36 (s, CH2), 24.63 (s, CH2), 22.00 (s, CH2), 17.82 (s, CH327), 14.08 (s, CH328), 
13.91 (s, CH310). 
FAB – MS [m/z] (relative intensity): 502.3 (30%) [M + H]+, 456.3 (10%) [M – C2H5O]+, 
287.1 (100%) [Fragment A]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C271H4016O614N3, 502.2912; found, 
502.2911; Δ = 0.08 mmu. 
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 Passerini product 54 derived from Biginelli acid 52, tert-butyl 
isocyanide and heptanal 
 
In a tube vial, finely powdered Biginelli-acid 52 (300 mg, 819 µmol, 1.00 eq.) was 
dissolved in 1.5 mL dimethyl sulfoxide and diluted with 1.5 mL dichloromethane. 
Subsequently, heptanal (140 mg, 1.23 mmol, 171 µL, 1.50 eq.) and tert-
butylisocyanide (102 mg, 1.23 mmol, 118 µL, 1.50 eq.) were added. The mixture was 
stirred at room temperature for 4 d. Subsequently, the crude reaction mixture was 
added dropwise into a stirred mixture of 10 mL water and 10 mL ethyl acetate. The 
aqueous phase was extracted with 10 mL ethyl acetate three times. The combined 
organic phases were concentrated under reduced pressure. The concentrate was 
purified via column chromatography employing silica gel and eluting with a gradual 
solvent mixture of ethyl acetate/c-hexane (1:3 → 1:0). The Passerini product 54 was 
obtained as a colorless solid (103 mg, 182 µmol, 22.3%). 
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IR (ATR):  [cm-1] = 3233.8 (br, 𝜈(N-H)), 3089.1 (br, 𝜈(N-H)), 2926.9 (m, 𝜈(C-H), 2858.2 
(w, 𝜈(C-H), 1697.2 (s, 𝜈(C=O)), 1639.5 (s, 𝜈(C=O)), 1523.2 (w), 1453.7 (m), 1380.0 
(w), 1314.7 (w), 1261.5 (s), 1219.1 (vs), 1074.3 (s), 1017.6 (w), 859.8 (w), 825.0 (w), 
794.6 (w), 753.0 (w), 696.2 (m), 651.6 (w), 586.2 (w), 524.7 (w), 491.7 (w), 438.9 (w).  
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 9.35 (s, 1 H, NH33), 7.90 (d, J = 7.4 Hz, 2 H, 
CHAr29,31), 7.85 (s, 1 H, NH17), 7.64 (s, 1 H, NH3), 7.34 (d, J = 8.0 Hz, 2 H, CHAr28,32), 
7.26 (d, J = 4.4 Hz, 3 H, CHAr), 7.17 – 7.08 (m, 2 H, CHAr), 5.25 (d, J = 2.8 Hz, 1 H, 
CH16), 5.07 – 4.94 (m, 3 H, CH1 + CH224), 2.28 (s, 3 H, CH326), 1.91 – 1.66 (m, 2 H, 
CH214), 1.45 – 1.13 (m, 19 H, CH36-8 + CH2), 0.84 (d, J = 6.4 Hz, 3 H, CH39). 
13C-NMR (75 MHz, DMSO-d6): δ [ppm] = 168.50 (s, CONR2), 164.91 (s, CO2R34), 
151.71 (s, CO18), 149.85 (s, CAr25), 149.80 (s, CO2R21), 136.45 (s, CAr27), 129.65 (s, 
CHAr29,31), 128.69 (s, CAr30), 128.26 (s, CHAr), 127.70 (s, CHAr), 127.63 (s, CHAr), 126.70 
(s, CHAr28,32), 98.05 (s, C15), 74.02 (s, CH1), 64.84 (s, CH224), 53.89 (s, CH16), 50.22 (s, 
C4), 31.65 (s, CH2), 31.13 (s, CH2), 28.45 (s, CH36-8), 28.34 (s, CH2), 24.64 (s, CH2), 
21.99 (s, CH2), 17.90 (s, CH326), 13.92 (s, CH39). 
FAB – MS [m/z] (relative intensity): 564.3 (20%) [M + H]+, 456.3 (15%) [M – C7H7O]+, 
349.1 (80%) [Fragment A]+, 214.0 (10%) [Fragment B]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C321H4216O614N3, 564.3068; found, 
564.3069; Δ = 0.09 mmu. 
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 Passerini product 55 derived from Biginelli acid 51, cyclohexyl 
isocyanide and 2-phenylpropanal 
 
In a tube vial, finely powdered Biginelli-acid 51 (300 mg, 986 µmol, 1.00 eq.) was 
dissolved in 0.3 mL dimethyl sulfoxide with 2.00 mL dichloromethane. Subsequently, 
2-phenylpropanal (172 mg, 1.28 mmol, 1.30 eq.) and then cyclohexyl isocyanide 
(139 mg, 1.28 mmol, 1.30 eq.) were added. The mixture was stirred at room 
temperature for 3 d. Subsequently, the crude reaction mixture was concentrated under 
reduced pressure and purified via column chromatography employing silica gel and 
eluting with a gradual solvent mixture of ethyl acetate/c-hexane (1:2 → 1:0). The 
Passerini product 55 was obtained as a colorless solid (536 mg, 969 µmol, 98.3%). 
Rf = 0.37 in ethyl acetate 
IR (ATR):  [cm-1] = 3270.2 (br, 𝜈(N-H)), 2929.4 (w, 𝜈(C-H)), 2853.0 (w, 𝜈(C-H)), 1701.9 
(vs, 𝜈(C=O)), 1642.7 (vs, 𝜈(C=O)), 1536.9 (w), 1449.3 (w), 1367.3 (w), 1266.6 (m), 
1220.8 (vs, 𝜈(COOR)), 1085.3 (vs, 𝜈(COOR)), 1017.3 (m), 761.3 (m), 699.4 (s), 652.2 
(w), 526.0 (w), 459.2 (w). 
1H-NMR (600 MHz, DMSO-d6): δ [ppm] = 9.26 (d, J = 14.0 Hz, 1 H, NH5), 8.03 (t, J = 
7.1 Hz, 0.5 H, NH33a), 7.95 (dd, J = 8.3, 1.8 Hz, 1 H, CHAr13,11a), 7.89 (d, J = 7.9 Hz, 
0.5 H, NH33b), 7.83 – 7.77 (m, 2 H, CHAr13,11b + NH3), 7.38 (dd, J = 16.3, 7.9 Hz, 2 H, 
CHAr), 7.33 (d, J = 8.2 Hz, 2 H, CHAr), 7.31 – 7.25 (m, 2 H, CHAr), 7.20 – 7.16 (m, 1 H, 
CHAr), 5.24 – 5.17 (m, 1 H, CH2), 5.14 (dd, J = 11.0, 3.6 Hz, 1 H, CH23), 3.98 (dq, J = 
14.0, 7.1 Hz, 2 H, CH217), 3.58 – 3.45 (m, 1 H, CH35), 3.43 – 3.28 (m, 1 H, CH24), 2.28 
– 2.21 (m, 3 H, CH39), 1.63 (m, 5 H, CH2c-hex), 1.31 (dd, J = 46.8, 6.5 Hz, 3 H, CH325), 
1.20 (dt, J = 14.2, 7.7 Hz, 5 H, CH2c-hex), 1.13 – 1.04 (m, 3 H, CH319). 
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13C-NMR (75 MHz, DMSO-d6): δ [ppm] = 166.91 (s, CONR32), 166.72 (s, CONR32), 
165.15 (s, CO2R20), 164.76 (s, CO2R20), 164.68 (s, CO2R16), 151.88 (s, CO4), 151.83 
(s, CO4), 150.14 (s, CAr12), 148.93 (s, C6), 142.60 (s, CAr26), 142.27 (s, CAr26), 129.69 
(s, CHAr), 129.52 (s, CHAr), 128.44 (s, CHAr), 128.30 (s, CHAr), 128.13 (s, CHAr), 128.10 
(s, CHAr), 127.78 (s, CHAr), 126.64 (s, CHAr), 126.56 (s, CHAr), 98.57 (s, C1), 98.51 (s, 
C1), 78.18 (s, CH23), 77.65 (s, CH23), 59.26 (s, CH217), 53.87 (s, CH2), 47.46 (s, CH35), 
41.15 (s, CH24), 40.98 (s, CH24), 32.25 (s, CH2c-hex), 32.13 (s, CH2c-hex), 25.14 (s, CH2c-
hex), 24.56 (s, CH2c-hex), 24.47 (s, CH2c-hex), 17.79 (s, CH39), 17.70 (s, CH325), 17.66 (s, 
CH325), 14.87 (s, CH325), 14.80 (s, CH325), 14.06 (s, CH319), 14.04 (s, CH319). 
FAB – MS [m/z] (relative intensity): 548.3 (40%) [M + H]+, 502.2 (5%) [M – C2H5O]+, 
303.1 (5%) [Fragment C]+, 287.1 (100%) [Fragment A – H]+, 244.1 (20%) [Fragment 
B]+, 183.1 (20%) [Fragment D]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C311H3816O614N3, 548.2755; found, 
548.2755; Δ = 0.05 mmu. 
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 Passerini product 56 derived from Biginelli-acid 49, iso-butyl 
aldehyde and tert-butyl isocyanide 
 
In a 5 mL round bottom flask, finely powdered Biginelli-acid 49 (500 mg, 1.57 mmol, 
1.20 eq.) was dissolved in a minimal amount of dimethyl sulfoxide (0.5 mL). 
Subsequently, iso-butyraldehyde (123 mg, 1.73 mmol, 157 µL, 1.10 eq.) and tert-butyl 
isocyanide (131 mg, 1.57 mmol, 150 µL) were added. The mixture was diluted with 
dichloromethane (0.5 mL) and stirred at room temperature for 6 h. Subsequently, a 
second portion of aldehyde (56.6 mg, 0.50 eq.) and isocyanide (65.3 mg, 0.50 eq.) 
were added. The resulting mixture was stirred for 3 d at room temperature. The crude 
reaction mixture was added dropwise into a stirred mixture of 50 mL water and 50 mL 
dichloromethane. The organic phase was separated, dried over sodium sulfate and 
concentrated under reduced pressure. The solid residue was purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of c-hexane and 
diethyl ether (1:0 → 0:1). The Passerini product 56 was obtained as a colorless solid 
(563 mg, 1.18 µmol, 75.6%). 
IR (ATR):  [cm-1] = 3316.3 (br, 𝜈(O-H)), 2964.6 (m, 𝜈(C-H)), 2161.3 (w), 1751.9 
(w, 𝜈(C=O)), 1681.3 (vs, 𝜈(C=O)), 1528.6 (s), 1454.1 (s), 1386.6 (m), 1309.8 (w), 
1178.0 (vs), 1104.3 (s), 1056.6 (m), 1015.2 (m), 940.6 (w), 760.3 (w), 698.2 (m). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.18 (dd, J = 15.1, 3.7 Hz, 1 H, NH3), 7.42 
(d, J = 32.9 Hz, 1 H, NH26), 7.34 – 7.22 (m, 5 H, CHAr10-14), 5.20 (t, J = 3.8 Hz, 1 H, 
CH2), 4.71 – 4.40 (m, 3 H, CH24 + CH220), 4.02 (q, J = 7.0, 2 H, CH217), 2.41 (s, 3 H, 
CH39), 2.15 – 1.90 (m, 1 H, CH23), 1.28 – 1.24 (m. 10 H, CH330,33,34), 1.10 (t, J = 7.1 
Hz, 3 H, CH319), 0.91 – 0.82 (m, 6 H, CH331,35), 0.74 (d, J = 6.8 Hz, 1 H).  
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13C-NMR (75 MHz, DMSO-d6): δ [ppm] = 172.59 (s), 169.00 (s, CO2R21), 168.98 (s, 
CO2R21), 167.45 (s, CONR25), 165.50 (s, CO2R16), 165.44 (s, CO2R16), 152.60 (s, CO4), 
152.43 (s, CO4), 149.06 (s, C6), 148.80 (s, C6), 143.98 (s, CAr8), 143.83 (s, CAr8), 128.41 
(s, CHAr10,14), 128.40 (s, CHAr10,14), 127.46 (s, CHAr12), 127.44 (s, CHAr12), 126.43 (s, 
CHAr11,13), 126.38 (s, CHAr11,13), 103.25 (s, C1), 103.12 (s, C1), 78.52 (s, CH24), 78.17 
(s, CH24), 59.72 (s, CH217), 59.68 (s, CH217), 53.02 (s, CH2), 52.93 (s, CH2), 50.39 (s, 
C27), 50.30 (s, C27), 49.74 (s, C), 44.18 (s, CH220), 31.24 (s), 30.04 (s, CH23), 29.88 (s, 
CH23), 28.46 (s, CH330,33,34), 28.37 (s, CH330,33,34), 28.35 (s, CH330,33,34), 19.21 (s, 
CH331,35), 18.59 (s, CH331,35), 18.55 (s, CH331,35), 16.95 (s, CH331,35), 16.78 (s, CH331,35), 
15.54 (s, CH39), 15.50 (s, CH39), 13.95 (s, CH319). 
FAB – MS [m/z] (relative intensity): 474.3 (100%) [M + H]+, 428.2 (30%) [M – C2H5O]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C251H3616O614N3, 474.2599; found, 
474.2600; Δ = 0.11 mmu. 
 
 Passerini product 57 derived from Biginelli-acid 49, undec-10-enal 
and tert-butyl isocyanide 
 
In a 5 mL round bottom flask, finely powdered Biginelli-acid 49 (500 mg, 1.57 mmol, 
1.20 eq.) was dissolved in 1 mL dimethyl sulfoxide/dichloromethane (1:1). 
Subsequently, undec-10-enal (344 mg, 2.04 mmol, 409 µL, 1.30 eq.) and 
tert-butylisocyanide (170 mg, 2.04 mmol, 196 µL) were added. The mixture was diluted 
with dichloromethane (0.5 mL) and stirred at room temperature for 8 h. Subsequently, 
a second portion of aldehyde (79.3 mg, 0.30 eq.) and isocyanide (39.2 mg, 0.30 eq.) 
were added to the mixture and stirred at room temperature for 3 d. The crude reaction 
mixture was added dropwise into a stirred emulsion of 50 mL water and 50 mL 
dichloromethane. The organic phase was separated, dried over sodium sulfate and 
dried under reduced pressure. The oily residue was purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of c-hexane and 
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diethyl ether (0:1 → 1:0). The Passerini product 57 was obtained as a colorless oil 
(893 mg, 1.56 mmol, 99.7%). 
IR (ATR):  [cm-1] = 3323.2 (br, 𝜈(N-H)), 2924.7 (m, 𝜈(C-H)), 2853.1 (w, 𝜈(C-H)), 1752.5 
(w, 𝜈(C=O)), 1681.5 (vs, 𝜈(C=O)), 1529.2 (m), 1453.7 (m), 1385.8 (m), 1364.8 (m), 
1309.4 (w), 1278.1 (w), 1257.7 (w), 1176.3 (vs), 1103.6 (s), 1056.2 (m), 941.7 (w), 
909.0 (w), 861.3 (w), 828.5 (w), 759.6 (m), 697.5 (s), 651.6 (w).  
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.16 (dd, J = 16.9, 3.6 Hz, 1 H, NH3), 7.43 
(d, J = 11.2 Hz, 1 H, NH25), 7.34 – 7.21 (m, 5 H, CHAr10-14), 5.84 – 5.73 (m, 1 H, CH34), 
5.19 (t, J = 3.5 Hz, 1 H, CH2), 5.02 – 4.91 (m, 2 H, CH233), 4.84 (t, J = 6.3 Hz, 1 H, 
CH23), 4.74 – 4.40 (m, 2 H, CH220), 4.06 – 3.96 (m, 2 H, CH217), 2.43 (d, J = 17.4 Hz, 3 
H, CH39), 2.00 (q, J = 6.9 Hz, 2 H, CH235), 1.69 – 1.61 (m, 2 H, CH242), 1.27 – 1.21 (m, 
21 H, CH329,31,32 + CH236-41), 1.14 – 1.07 (t, J = 7.1 Hz, 3 H, CH319). 
13C-NMR (100 MHz, DMSO-d6): δ [ppm] = 168.95 (s, CO2R21),), 168.88 (s, CO2R21),), 
168.14 (s, CONR24), 165.43 (s, CO2R16), 165.41 (s, CO2R16), 152.49 (s, CO4), 152.27 
(s, CO4), 148.84 (s, C6), 148.76 (s, C6), 144.05 (s, CAr8), 143.87 (s, CAr8), 138.79 (s, 
CH34), 128.38 (s, CHAr10,14), 128.34 (s, CHAr10,14), 127.41 (s, CHAr12), 126.49 (s, 
CHAr11,13), 126.38 (s, CHAr11,13), 114.60 (s, CH233), 103.21 (s, C1), 103.19 (s, C1), 74.31 
(s, CH23), 74.16 (s, CH23), 59.65 (s, CH217), 53.15 (s, CH2), 52.95 (s, CH2), 50.30 (s, 
C26), 50.26 (s, C26), 44.03 (s, CH220), 33.17 (s, CH235), 31.37 (s, CH242), 31.28 (s, 
CH242), 28.79 (s, CH2), 28.75 (s, CH2), 28.65 (s, CH2), 28.54 (s, CH2), 28.51 (s, CH2), 
28.45 (s), 28.34 (s, CH329,31,32), 28.24 (s, CH241), 26.32 (s, CH241), 24.31 (s,CH2), 24.27 
(s, CH241), 15.53 (s, CH39), 15.48 (s, CH39), 13.93 (s, CH319). 
FAB – MS [m/z] (relative intensity): 570.4 (55%) [M + H]+, 524.3 (35%) [M – C2H5O]+, 
492.3 (10%) [M – C6H5]+, 317.1 (65%) [Fragment A]+, 273.1 (35%) [Fragment B]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C321H4816O614N3, 570.3538; found, 
570.3538; Δ = 0.04 mmu. 
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 Passerini compound 58 derived from Biginelli acid 49, octanal and 
benzyl isocyanide. 
 
In a tube vial, finely powdered Biginelli-acid 49 (302 mg, 949 µmol, 1.00 eq.) was 
dissolved in 0.3 mL dimethyl sulfoxide and diluted with 1.0 mL dichloromethane. 
Subsequently, octanal (178 mg, 1.38 mmol, 217 µL, 1.40 eq.) and benzyl isocyanide 
(150 mg, 1.28 mmol, 156 µL, 1.30 eq.) were added. The mixture was stirred at room 
temperature for 3 d. The crude product was purified via column chromatography 
employing silica gel and eluting with a gradual solvent mixture of ethyl acetate and 
c-hexane (1:9 → 1:0). The Passerini product 58 was obtained as a white solid (405 mg, 
715 μmol, 76.2%). 
IR (ATR):  [cm-1] = 3279.1 (br, 𝜈(N-H)), 2922.5 (w, 𝜈(C-H)), 2852.7 (w, 𝜈(C-H)), 1737.0 
(w, 𝜈(C=O)), 1709.5 (m, 𝜈(C=O), 1681.3 (vs, 𝜈(C=O)), 1662.1 (vs, 𝜈(C=O)), 1613.8 (s, 
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𝜈(C=O)), 1541.4 (m), 1495.5 (w), 1453.4 (m), 1405.5 (m), 1373.3 (m), 1306.1 (m), 
1278.8 (w), 1253.4 (w), 1189.9 (vs, 𝜈(COOR), 1103.6 (m), 1080.3 (m), 1053.5 (s), 
936.8 (m), 859.4 (w), 821.1 (m), 763.8 (m), 695.3 (s), 607.3 (w), 482.9 (w), 407.5 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.55 (t, J = 5.9 Hz, 1 H, NH25), 8.17 (d, J = 
3.2 Hz, 1 H, NH3), 7.33 – 7.28 (m, 6 H, CHAr), 7.27 – 7.22 (m, 4 H, CHAr), 5.21 (d, J = 
3.2 Hz, 1 H, CH2), 5.04 – 4.97 (m, 1 H, CH23), AB-signal (δ A = 4.73, δ B = 4.51, JAB = 
17.5 Hz, 2 H, CH220), 2 H, CH220), 4.31 (d, J = 5.9 Hz, 2 H, CH226), 4.02 (q, J = 7.0 Hz, 
2 H, CH217), 2.39 (s, 3 H, CH39), 1.79 – 1.70 (m, 2 H, CH236), 1.34 – 1.20 (m, 13 H, 
CH2), 1.11 (t, J = 7.1 Hz, 3 H, CH319), 0.85 (t, J = 6.8 Hz, 3 H, CH330). 
13C-NMR (126 MHz, DMSO-d6): δ [ppm] = 169.24 (s, CO2R21), 169.01 (s, CONR24), 
165.43 (s, CO2R16), 152.44 (s, CO4), 148.75 (s, C1), 143.91 (s, CAr8), 139.79 (s, CAr29), 
139.11 (s), 128.39 (s, CHAr), 128.21 (s, CHAr), 128.12 (s, CHAr), 127.42 (s, CHAr), 
127.14 (s, CHAr), 126.98 (s, CHAr), 126.76 (s, CHAr), 126.60 (s, CHAr), 126.42 (s, CHAr), 
103.26 (s, C1), 74.13 (s, CH23), 71.00 (s, CH), 59.69 (s, CH217), 53.01 (s, CH2), 44.05 
(s, CH220), 41.83 (s, CH226), 31.31 (s, CH2), 31.19 (s, CH2), 31.08 (s, CH2), 28.85 (s, 
CH2), 28.66 (s, CH2), 28.49 (s, CH2), 24.58 (s, CH2), 24.37 (s, CH2), 22.07 (s, CH2), 
22.04 (s, CH2), 15.57 (s, CH39), 13.95 (s, CH330 or 19), 13.90 (s, CH330 or 19). 
FAB – MS [m/z] (relative intensity): 564.3 (90%) [M + H]+, 518.3 (35%) [M – C2H5O]+, 
317.1 (50%) [Fragment A]+, 301.1 (35%) [Fragment A – O]+, 273.1 (15%) [Fragment 
C]+, 259.1 (50%) [Fragment C – CH2]+, 246.2 (15%) [Fragment B]+ 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C231H2516O614N2, 425.1707; found, 425-
1705; Δ = 0.05 mmu. 
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 Passerini compound 59 derived from Biginelli acid 49, octanal and 
2-morpholinoethyl isocyanide. 
 
In a tube vial, finely powdered Biginelli-acid 49 (302 mg, 949 µmol, 1.00 eq.) was 
dissolved in 0.3 mL dimethyl sulfoxide and diluted with 1.5 mL dichloromethane. 
Subsequently, octanal (158 mg, 1.23 mmol, 193 µL, 1.30 eq.) and 2-morpholinoethyl 
isocyanide (186 mg, 1.32 mmol, 182 µL, 1.40 eq.) were added. The mixture was stirred 
at room temperature for 3 d. The reaction mixture was evaporated under reduced 
pressure. The crude product was purified via column chromatography employing silica 
gel and eluting with a gradual solvent mixture of ethyl acetate and c-hexane (0:1 → 
1:1) and finally with a solvent mixture of dichloromethane, methanol and triethylamine 
(90:5:5). The product containing fractions were dried under reduced pressure to yield 
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a viscous oil. The oil was suspended in 50 mL water, sonicated for 1 h and washed 
with 30 mL water (this washing was repeated three times). After drying under reduced 
pressure, the Passerini product 59 was obtained as a yellow solid (222 mg, 372 μmol, 
39.2%). 
IR (ATR):  [cm-1] = 3304.4 (br, 𝜈(N-H)), 2925.8 (w, 𝜈(C-H)), 2854.4 (w, 𝜈(C-H)), 1751.8 
(w, 𝜈(C=O)), 1675.6 (vs, 𝜈(C=O)), 1541.3 (w), 1493.8 (m), 1453.9 (s), 1384.2 (m), 
1307.5 (w), 1277.7 (w), 1258.5 (w), 1174.9 (vs), 1109.9 (s), 1055.6 (s), 939.9 (w), 862.8 
(w), 829.0 (m), 758.1 (s), 697.8 (w), 650.1 (w), 624.4 (w), 511.8 (w), 458.7 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.16 (dd, J = 21.1, 3.6 Hz, 1 H, NH3), 7.92 
(dt, J = 15.2, 5.7 Hz, 1 H, NH25), 7.40 – 7.11 (m, 5 H, CHAr), 5.19 (t, J = 3.5 Hz, 1 H, 
CH2), 4.93 (dt, J = 10.0, 5.0 Hz, 1 H, CH23), 4.79 – 4.44 (m, 2 H, CH220), 4.06 – 3.96 
(m, 2 H, CH217), 3.58 – 3.45 (m, 6 H, CH236+38,42), 3.26 – 3.12 (m, 2 H, CH235), 2.41 (d, 
J = 10.5 Hz, 3 H, CH39), 2.39 – 2.30 (m, 2 H, CH239,41), 1.76 – 1.63 (m, 2 H, CH234), 
1.34 – 1.15 (m, 12 H, CH2), 1.13 – 1.06 (m, 3 H, CH319), 0.85 (t, J = 6.8 Hz, 3 H, CH328). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.13 (s, CO2R20), 169.04 (s, CO2R20), 
168.78 (s, CONR24), 168.77 (s, CONR24), 165.44 (s, CO2R16), 165.42 (s, CO2R16), 
152.48 (s, CO4), 152.24 (s, CO4), 148.73 (s, C6), 148.59 (s, C6), 144.05 (s, CAr8), 143.89 
(s, CAr8), 128.40 (s, CHAr), 128.32 (s, CHAr), 127.42 (s, CHAr), 126.65 (s, CHAr), 126.51 
(s, CHAr), 126.43 (s, CHAr), 103.34 (s, C1), 103.27 (s, C1), 74.07 (s, CH23), 74.03 (s, 
CH23), 66.16 (s, CH236+38,42), 59.70 (s, CH217), 57.12 (s, CH239,41), 53.19 (s, CH2), 44.09 
(s, CH220), 43.88 (s, CH220), 35.73 (s, CH235), 31.37 (s, CH2), 31.30 (s, CH2), 31.12 (s, 
CH2), 28.56 (s, CH2), 28.50 (s, CH2), 28.48 (s, CH2), 24.29 (s, CH2), 24.27 (s, CH2), 
22.05 (s, CH2), 15.60 (s, CH39), 15.59 (s, CH39), 13.94 (s, CH328), 13.90 (s, CH328). 
FAB – MS [m/z] (relative intensity): 587.3 (100%) [M + H]+, 541.3 (15%) [M – C2H5O]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C311H4716O714N4, 587.3439; found, 
587.3441; Δ = 0.16 mmu. 
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 Passerini compound 60 derived from Biginelli acid 49, 
2-ethylbutanal and 1-pentyl isocyanide 
 
In a tube vial, finely powdered Biginelli-acid 49 (300 mg, 942 µmol, 1.00 eq.) was 
dissolved in 0.3 mL dimethyl sulfoxide and diluted with 1.0 mL dichloromethane. 
Subsequently, 2-ethylbutanal (200 mg, 2.00 mmol, 246 µL, 2.10 eq.) and 1-pentyl 
isocyanide (120 mg, 1.23 mmol, 155 µL, 1.30 eq.) were added. The mixture was stirred 
at room temperature for 3 d. The crude product was purified via column 
chromatography employing silica gel and eluting with a gradual solvent mixture of 
diethyl ether and c-hexane (0:1 → 5:1). The Passerini product 60 was obtained as a 
colorless solid (381 mg, 739 µmol, 78.5%). 
IR (ATR):  [cm-1] = 3304.9 (br, 𝜈(N-H)), 2958.8 (w, 𝜈(C-H), 2930.1 (w, 𝜈(C-H), 2872.3 
(w, 𝜈(C-H), 1752.2 (s, 𝜈(C=O)), 1681.1 (vs, 𝜈(C=O)), 1535.4 (m), 1455.7 (m), 1383.7 
(m), 1309.7 (w), 1278.3 (w), 1177.3 (vs), 1104.9 (m), 1055.6 (m), 940.8 (w), 830.3 (w), 
760.0 (w), 697.6 (w), 651.4 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.19 (dd, J = 32.9, 3.7 Hz, 1 H, NH3), 7.93 
(dt, J = 33.8, 5.7 Hz, 1 H, NH25), 7.34 – 7.22 (m, 5 H, CHAr), 5.20 (dd, J = 5.6, 3.8 Hz, 
1 H, CH2), 4.99 (dd, J = 17.2, 3.9 Hz, 1 H, CH23), 4.75 – 4.45 (m, 2 H, CH220), 4.02 (p, 
J = 7.0 Hz, 2 H, CH217), 3.14 – 2.99 (m, 2 H, CH226), 2.43 (d, J = 25.0 Hz. 3 H, CH39), 
1.78 – 1.66 (m, 1 H, CH32), 1.45 – 1.32 (m, 4 H, CH2), 1.33 – 1.15 (m, 6 H, CH2), 1.10 
(td, J = 7.1, 4.6 Hz, 3 H, CH319), 0.89 – 0.79 (m, 9 H, CH330,37). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.24 (s, CO2R21), 169.21 (s, CO2R21), 
168.37 (s, CONR24), 165.50 (s, CO2R16), 165.44 (s, CO2R16), 152.78 (s, CO4), 152.37 
(s, CO4), 148.78 (s, C6), 148.72 (s, C6), 144.00 (s, CAr8), 143.78 (s, CAr8), 128.45 (s, 
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CHAr), 128.39 (s, CHAr), 127.49 (s, CHAr), 127.45 (s, CHAr), 126.51 (s, CHAr), 126.40 
(s, CHAr), 103.42 (s, C1), 103.21 (s, C1), 75.13 (s, CH23), 75.02 (s, CH23), 59.76 (s, 
CH217), 59.69 (s, CH217), 53.16 (s, CH2), 52.92 (s, CH2), 44.34 (s, CH220), 44.12 (s, 
CH220), 42.53 (s, CH32), 42.51 (s, CH32), 38.34 (s, CH226), 28.62 (s, CH2), 28.57 (s, 
CH2), 28.48 (s, CH2), 28.46 (s, CH2), 21.80 (s, CH2), 21.44 (s, CH2), 21.26 (s, CH2), 
15.65 (s, CH39), 15.62 (s, CH39), 13.97 (s, CH319), 13.91 (s, CH319), 11.38 (s, CH330,37), 
11.33 (s, CH330,37), 11.26 (s, CH330,37). 
FAB – MS [m/z] (relative intensity): 516.3 (100%) [M + H]+, 470.2 (30%), [M – C2H5O]+, 
317.1 (35%) [Fragment A]+, 301.1 (35%) [Fragment A – O]+, 259.1 (45%) [Fragment 
C]+, 198.2 (30%) [Fragment B]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C281H4216O614N3, 516.3068; found, 
516.3069; Δ = 0.07 mmu. 
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6.2.2.3 Biginelli-Passerini one-pot tandem reaction 
 
 Biginelli-Passerini product 61 prepared in one-pot procedure from 
4-fluorobenzaldehyde, N-carbomoylglycine, ethyl acetoacetate and 
pentylisocyanide 
 
In a tube vial, finely powdered N-carbomoylglycine (500 mg, 4.23 mmol, 1.00 eq.), 
4-fourobenzaldehyde (1.57 g, 12.7 mmol, 3.00 eq.) and ethyl acetoacetate (551 mg, 
4.23 mmol, 1.00 eq.) were stirred at 110 °C for 24 h and subsequently at 80 °C for 
another 24 h. Subsequently, the crude reaction mixture was cooled to ambient 
temperature and diluted with 3 mL dichloromethane. Pentylisocyanide (617 mg, 
6.35 mmol, 1.50 eq.) was added while stirring. The resulting mixture was stirred for 3 d 
at room temperature. The reaction mixture was dried under reduced pressure and 
purified via column chromatography employing silica gel and eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (1:5 → 1:0) to yield the Biginelli-Passerini 
one-pot product 61 as a colorless solid (972 mg, 1.74 mmol, 41.1%). Note: impure 
fractions can be purified by precipitation from ethyl acetate in c-hexane and 
crystallization through slow evaporation of the solvents overnight in an open flask. 
Rf = 0.51 in ethyl acetate/c-hexane (2:1). 
IR (ATR):  [cm-1] = 3287.9 (br, 𝜈(N-H)), 3097.3 (br, 𝜈(N-H)), 2931.7 (w, 𝜈(C-H)), 2860.3 
(w, 𝜈(C-H)), 1737.5 (m, 𝜈(C=O)), 1682.1 (vs, 𝜈(C=O)), 1659.4 (vs), 1621.6 (s), 1602.6 
(s), 1556.4 (s), 1508.3 (vs), 1449.9 (m), 1411.3 (m), 1369.2 (m), 1308.4 (m), 1277.5 
(m), 1256.0 (m), 1188.6 (vs), 1157.4 (s), 1098.5 (m), 1055.2 (m), 1013.6 (w), 940.1 
(w), 806.4 (w), 758.7 (w), 648.2 (w), 579.8 (w), 515.6 (w).  
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1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.27 (q, J = 5.6 Hz, 1 H, NH25), 8.16 (dd, J = 
16.4, 3.4 Hz, 1 H, NH3), 7.54 – 7.50 (m, 2 H, CHAr), 7.35 (ddd, J = 31.1, 8.3, 5.6 Hz, 2 
H, CHAr), 7.23 (td, J = 8.8, 3.7 Hz, 2 H, CHAr), 7.17 – 7.06 (m, 2 H, CHAr), 5.92 (d, J = 
10.2 Hz, 1 H, CH23), 5.20 (t, J = 3.7 Hz, 1 H, CH2), 4.92 – 4.52 (m, 2 H, CH220), 4.07 – 
3.95 (m, 2 H, CH217), 3.10 – 2.98 (m, 2 H, CH229), 2.43 (d, J = 10.8 Hz, 3 H, CH39), 1.43 
– 1.33 (m, 2 H, CH2), 1.28 – 1.05 (m, 7 H, CH2 + CH319), 0.87 – 0.74 (m, 3 H, CH333). 
13C-NMR (126 MHz, DMSO-d6): δ [ppm] = 169.00 (s, CO2R21), 168.96 (s, CO2R21), 
167.29 (s, CONR24), 167.26 (s, CONR24), 165.37 (s, CO2R16), 165.36 (s, CO2R16), 
162.25 (d, J = 244.9 Hz, CFAr), 162.23 (d, J = 245.1 Hz, CFAr), 161.45 (d, J = 243.3 
Hz, CFAr), 161.42 (d, J = 243.4 Hz, CFAr), 152.16 (s, CO4), 152.01 (s, CO4), 148.92 (s, 
C6), 148.73 (s, C6), 140.36 (d, J = 2.9 Hz, CAr8), 140.19 (d, J = 3.0 Hz, CAr8), 131.85 (d, 
J = 2.9 Hz, CAr28), 131.76 (d, J = 2.9 Hz, CAr28), 129.63 (s, CHAr), 129.56 (s, CHAr), 
129.48 (s, CHAr), 128.69 (s, CHAr), 128.62 (s, CHAr), 128.54 (s, CHAr), 128.47 (s, CHAr), 
128.43 (s, CHAr), 128.37 (s, CHAr), 115.43 (s, CHAr), 115.25 (s, CHAr), 115.18 (s, CHAr), 
115.16 (s, CHAr), 115.01 (s, CHAr), 114.99 (s, CHAr), 114.71 (s, CHAr), 114.54 (s, CHAr), 
103.28 (s, C1), 103.16 (s, C1), 75.12 (s, CH23), 75.00 (s, CH23), 59.77 (s, CH217), 52.66 
(s, CH2), 52.44 (s, CH2), 43.91 (s, CH220), 43.74 (s, CH220), 38.39 (s, CH229), 38.36 (s, 
CH229), 28.79 (s, CH2), 28.56 (s, , CH2), 28.54 (s, CH2), 28.49 (s, CH2), 28.30 (s, CH2), 
21.73 (s, CH2), 15.61 (s, CH39), 13.97 (s, CH319), 13.95 (s, CH319), 13.84 (s, CH333), 
13.83 (s, CH333). 
19F-NMR (377 MHz, DMSO-d6): δ [ppm] = -117.49 (s, CFAr), -117.50 (s, CFAr), -119.43 
(s, CFAr), -119.49 (s, CFAr). 
FAB – MS [m/z] (relative intensity): 558.3 (80%) [M + H]+, 512.2 (40%) [M – C2H5O]+, 
335.1 (100%) [Fragment A]+, 222.1 (30%) [Fragment B]+, 136.0 (70%) [Fragment B – 
C5H12N]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C291H3416O614N319F2, 558.2410; found, 
558.2411; Δ = 0.11 mmu. 
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6.2.3 Synthetic procedures for chapter 4.3 
 
Additional data such as displayed NMR spectra and tandem-MS mass spectra can be 
found in the supplementary information of the previous publication and are included in 
the electronic version of this thesis on the CD.[209] 
 
6.2.3.1 Bifunctional components 
 
 11-ureidoundecanoic acid 
 
In a 100 mL round bottom flask equipped with a magnetic stir bar urea (4.47 g, 
74.5 mmol, 3.00 eq.) and 11-aminoundecanoic acid (5.00 g, 24.8 mmol, 1.00 eq.) were 
suspended in 15 mL dimethyl sulfoxide. The resulting mixture was stirred at 120 °C for 
2 h while adding 0.7 mL concentrated hydrochloric acid (37%) every 30 min. The clear 
solution was subsequently cooled to room temperature and stirred overnight. The 
suspension was diluted with 10 mL 1 M hydrochloric acid and the precipitate was 
filtered off. The solid was washed with water (3 × 20 mL), dried on the filter and 
subsequently washed with ice cold ethyl acetate/ethanol (1:1) (2 × 30 mL). The residual 
solvent was removed under reduced pressure. 11-ureidoundecanoic acid was 
obtained as a colorless solid (4.98 g, 20.6 mmol, 82.8%). 
Spectral data is in accordance to earlier reported.[343] 
IR (ATR):  [cm-1] = 3411.6 (m, 𝜈(O-H)), 3346.2 (br, 𝜈(N-H)), 3209.9 (br, 𝜈(N-H)), 
2917.3 (w, 𝜈(C-H)), 2848.3 (w, 𝜈(C-H)), 1707.0 (s, 𝜈(C=O)), 1665.8 (s, 𝜈(C=O)), 1553.9 
(vs), 1481.9 (m), 1466.3 (m), 1400.3 (m), 1379.6 (m), 1351.8 (m), 1297.4 (m), 1270.1 
(m), 1243.5 (m), 1209.0 (s), 1182.1 (s), 1121.1 (m), 974.0 (m), 899.1 (w), 776.0 (w), 
721.4 (w), 684.8 (w), 575.8 (s), 468.3 (m), 416.4 (w), 379.1 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 11.94 (s, 1 H, CO2H13), 5.89 (t, J = 5.7 Hz, 1 
H, NH14), 5.35 (s, 2 H, NH16), 2.92 (q, J = 6.5 Hz, 2 H, CH211), 2.18 (t, J = 7.3 Hz, 2 H, 
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CH22), 1.47 (t, J = 7.1 Hz, 2 H, CH23), 1.33 (t, J = 6.7 Hz, 2 H, CH210), 1.24 (s, 12 H, 
CH24-9). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 174.52 (s, CO2H1), 158.72 (s, CON2R15), 
38.86 (s, CH211), 33.69 (s, CH22), 30.01 (s, CH210), 29.02 (s, CH2), 28.89 (s, CH2), 28.83 
(s, CH2), 28.76 (s, CH2), 28.56 (s, CH2), 26.43 (s, CH2), 24.51 (s, CH23). 
FAB – MS [m/z] (relative intensity): 245.3 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C121H2516O314N2, 245.1860; found, 
245.1859; Δ = 0.09 mmu. 
 
 6-ureidohexanoic acid 
 
In a 250 mL round bottom flask equipped with a magnetic stir bar urea (13.7 g, 
228 mmol, 3.00 eq.) and 6-aminohexanoic acid (10.00 g, 76.2 mmol, 1.00 eq.) were 
suspended in 40 mL dimethyl sulfoxide. The resulting mixture was stirred at 120 °C for 
2 h while adding 2 mL concentrated hydrochloric acid (37%) every 30 min. The clear 
solution was subsequently stirred at 100 °C for 2 h, then 30 mL 1 M hydrochloric acid 
were added, and the mixture was left to stand over night at room temperature. The 
solid was filtrated and recrystallized from ethanol/water (98:2), washed with 20 mL ice 
cold ethanol three times and dried under reduced pressure. 6-ureidohexanoic acid was 
obtained as a colorless solid (9.51 g, 54.6 mmol, 71.6%). Note: additional product could 
be crystalized from the mother liquor upon concentration and cooling. 
IR (ATR):  [cm-1] = 3403.5 (m, 𝜈(O-H)), 3344.9 (br, 𝜈(N-H)), 3204.7 (br, 𝜈(N-H)), 
2946.4 (w, 𝜈(C-H)), 2870.8 (w, 𝜈(C-H)), 1896.3 (br), 1705.4 (s, 𝜈(C=O)), 1658.3 (s, 
𝜈(C=O)), 1555.2 (vs), 1476.4 (m), 1449.8 (w), 1402.0 (s), 1374.3 (s), 1296.3 (m), 
1242.7 (m), 1194.3 (m), 1152.0 (w), 1101.3 (s), 1050.0 (m), 982.6 (s), 898.5 (w), 846.6 
(w), 776.7 (w), 728.8 (w), 681.1 (w), 567.3 (m), 531.9 (m), 414.4 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.03 (s, 1 H, CO2H13), 5.91 (t, J = 5.8 Hz, 1 
H, NH7), 5.37 (s, 2 H, NH9), 3.02 – 2.79 (m, 2 H, CH26), 2.18 (t, J = 7.4 Hz, 2 H, CH22), 
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1.48 (p, J = 7.4 Hz, 2 H, CH23), 1.34 (dq, J = 11.0, 6.8, 6.2 Hz, 2 H CH25), 1.24 (qd, J 
= 7.5, 3.2 Hz, 2 H, CH24). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 174.53 (s, CO2H1), 158.78 (s, CON2R8), 
33.71 (s, CH22), 29.80 (s, CH25), 26.02 (s, CH24), 24.34 (s, CH23). 
EI – MS [m/z] (relative intensity): 174.2 (80%) [M + H]+, 130.1 (100%) [M – CH3NO]+, 
115.1 (90%) [M – CH4N2O]+, 101.1 (80%) [M – C2H5N2O]+, 87.1 (100%) [Fragment A 
or B]+. 
HRMS – EI [m/z]: [M + H]+ calculated for 12C71H1416O314N2, 174.1004; found, 174.1005; 
Δ = 0.04 mmu. 
 
 
 Trans-1,4-diformamido cyclohexane obtained from trans-1,4-
diamino cyclohexane and ethylformate 
 
In a 250 mL round-bottom flask equipped with a reflux condenser and a magnetic stir 
bar trans-1,4-diamino cyclohexane (6.00 g, 52.5 mmol, 1.00 eq.) was mixed with ethyl 
formate (77.8 g, 84.6 mL, 1.05 mol, 20.0 eq.) and heated under reflux overnight (70 °C 
temperature set) while stirring. The reaction mixture was dried under reduced 
pressure. The resulting formamide was obtained as a grey solid (8.93 g, 52.5 mmol, 
99.8%). 
Spectral data is in accordance to earlier reported.[344] 
IR (ATR):  [cm-1] = 3267.1 (br, 𝜈(N-H)), 3066.3 (br, 𝜈(N-H)), 2952.0 (w, 𝜈(C-H)), 2933.3 
(w, 𝜈(C-H)), 2882.5 (w, 𝜈(C-H)), 2855.1 (w, 𝜈(C-H)), 1648.4 (vs, 𝜈(C=O)), 1545.5 (s), 
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1444.6 (m), 1390.5 (s), 1336.9 (m), 1253.1 (m), 1219.6 (m), 1097.0 (w), 1078.9 (m), 
967.6 (w), 904.4 (m), 760.0 (s), 719.4 (s), 562.8 (w), 443.3 (w), 411.4 (s). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 8.03 – 7.93 (m, 2 H, NH7,8), 7.91 (s, 2 H, 
CHO11,13), 3.60 – 3.48 (m, 2 H, CH2,5), 1.83 – 1.71 (m, 4 H, CH21,3,4,6 axial), 1.41 – 1.10 
(m, 4 H, CH21,3,4,6 equatorial). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 159.93 (s, CONR12), 45.49 (s, CH2,5), 32.56 
(s, CH2), 30.71 (s, CH2). 
FAB – MS [m/z] (relative intensity): 341.2 (40%) [2 M + H]+, 171.0 (100%) [M + H]+, 
126.1 (20%) [M – CH2NO]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C81H1516O214N2, 171.1128; found, 
171.1125; Δ = 0.34 mmu. 
 
 Trans-1,4-diisocyano cyclohexane obtained from 
trans-1,4-diformamido cyclohexane  
 
Trans-1,4-diformamido cyclohexane (8.90 g, 52.3 mmol, 1.00 eq.) was suspended in 
a three necked round-bottom flask equipped with a dropping funnel, a thermometer, a 
condenser and a magnetic stir bar in 40 mL dichloromethane and diisopropylamine 
(44.9 g, 62.4 mL, 444 mmol, 8.50 eq.) was added while stirring. The mixture was 
cooled to 0 °C and phosphoryl chloride (22.5 g, 13.4 mL, 146 mmol, 2.80 eq.) was 
added dropwise at such a rate that the reaction temperature remained below 0 °C. The 
mixture was stirred for 2 h at room temperature, then added carefully in portions into 
200 mL ice-water containing 50 g potassium carbonate maintaining the temperature 
below 25 °C. The resulting emulsion was stirred for 30 min at room temperature. The 
organic layer was separated, the aqueous layer extracted three times with 50 mL 
dichloromethane and the combined organic layers were dried over potassium 
carbonate. Purification by column chromatography employing silica gel as stationary 
phase and eluting with a gradual solvent mixture of c-hexane/ethyl acetate (5:1 → 3:1) 
and concentration in vacuo yielded trans-1,4-diisocyano cyclohexane as a pale solid 
(2.99 g, 22.3 mmol, 42.6%). 
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Rf = 0.51 in c-hexane/ethyl acetate (3:1). Visualized via Seebach staining solution. 
Spectral data is in accordance to earlier reported.[344] 
IR (ATR):  [cm-1] = 2951.8 (m, 𝜈(C-H)), 2867.8 (w, 𝜈(C-H)), 2136.6 (vs, 𝜈(NC)), 1445.0 
(s), 1366.6 (m), 1354.5 (m), 1330.7 (s), 1217.5 (s), 1127.3 (m), 1007.2 (m), 970.9 (m), 
920.1 (vs), 861.4 (m), 836.1 (m), 672.5 (w), 499.4 (m), 419.5 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 3.94 – 3.74 (m, 2 H, CH2,5), 1.94 (d, J = 9.8 
Hz, 4 H, CH21,3,4,6 axial), 1.64 (tt, J = 8.8, 4.7 Hz, 4 H, CH2,1,3,4,6 equatorial). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 155.23 (t, J = 4.8 Hz, NC8,10), 49.30 (t, J = 
5.4 Hz, CH2,5), 27.87 (CH21,3,4,6). 
FAB – MS [m/z] (relative intensity): 134.1 (30%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C81H1014N2, 134.0838; found, 134.0840; 
Δ = 0.10 mmu. 
 
 p-Xylenediformamide obtained from p-xylenediamine and 
ethylformate 
 
In a 250 mL round-bottom flask equipped with a reflux condenser and a magnetic stir 
bar p-xylenediamine (4.00 g, 29.4 mmol, 1.00 eq.) was mixed with ethyl formate 
(43.5 g, 47.3 mL, 587 mol, 20.0 eq.) and heated under reflux overnight (85 °C 
temperature set) while stirring. The reaction mixture was died under reduced pressure. 
The formamide was obtained as a colorless solid (5.60 g, 99.2%, 29.0 mmol). 
Spectral data is in accordance to earlier reported.[344] 
IR (ATR):  [cm-1] = 3271.6 (br, 𝜈(N-H)), 3026.2 (br, 𝜈(N-H)), 2886.0 (w, 𝜈(C-H)), 1643.9 
(vs, 𝜈(C=O)), 1525.1 (s), 1459.3 (m), 1425.0 (m), 1374.9 (s), 1347.0 (s), 1212.7 (s), 
1109.5 (w), 1029.5 (w), 948.6 (w), 826.9 (w), 827.0 (m), 696.2 (s), 544.9 (s). 
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1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.50 (br s, 2 H, NH2,9), 8.13 (d, J = 1.5 Hz, 2 
H, CH16,18), 7.22 (s, 4 H, CHAr11,12,14,15), 4.28 (d, J = 6.1 Hz, 2 H, CH23,8). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 161.04 (s, CONR1,10), 137.66 (s, CAr7,13), 
127.37 (s, CHAr11,12,14,15), 40.50 (s, CH23,8). 
FAB – MS [m/z] (relative intensity): 385.2 (40%) [2 M + H]+, 193.1 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C101H1316O214N2, 193.0972; found, 
193.0973; Δ = 0.14 mmu. 
 
 p-Xylenediisocyanide obtained from p-xylenediformamide 
 
p-Xylenediformamide (5.50 g, 28.6 mmol, 1.00 eq.) was suspended in a three necked 
round-bottom flask equipped with a dropping funnel, a thermometer, a condenser and 
a magnetic stir bar in 40 mL dichloromethane and diisopropylamine (24.6 g, 34.2 mL, 
243 mmol, 8.50 eq.) was added while stirring. The mixture was cooled to 0 °C and 
phosphoryl chloride (12.2 g, 7.31 mL, 80.1 mmol, 2.80 eq.). The mixture was stirred 
for 1 h at room temperature, then added carefully in portions into 200 mL ice-water 
containing 50 g potassium carbonate maintaining the temperature below 25 °C. The 
resulting emulsion was stirred for 30 min at room temperature. The organic layer was 
separated, the aqueous layer extracted three times with 50 mL dichloromethane and 
the combined organic layers were dried over potassium carbonate. Purification by 
column chromatography employing silica gel as stationary phase and eluting with a 
gradual solvent mixture of c-hexane/ethyl acetate (5:1 → 3:1) and concentration in 
vacuo yielded p-xylenediisocyanide as a yellow solid (2.60 g, 16.7 mmol, 58.1%). 
Rf = 0.40 in c-hexane/ethyl acetate (3:1). Visualized via Seebach staining solution. 
Spectral data is in accordance to earlier reported.[344] 
IR (ATR):  [cm-1] = 2964.5 (m, 𝜈(C-H)), 2155.1 (vs, 𝜈(NC)), 1894.9 (w), 1632.0 (w), 
1517.9 (m), 1436.7 (s), 1420.6 (s), 1350.0 (m), 1331.8 (w), 1258.4 (m), 1127.3 (w), 
1019.5 (m), 971.3 (w), 949.5 (s), 785.9 (vs), 741.8 (s), 554.3 (m), 467.1 (vs). 
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1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.43 (s, 4 H, CHAr11,12,14,15), 4.89 – 4.88 (m, 
2 H, CH23,8). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 156.81 – 156.65 (t, J = 5.1 Hz, NC1,10), 
133.30 (s, CAr7,13), 127.34 (s, CHAr11,12,14,15), 44.83 – 44.33 (t, J = 6.5 Hz, CH23,8). 
FAB – MS [m/z] (relative intensity): 156.1 (50%) [M + H]+, 130.1 (70%) [M – CN]+, 116.1 
(100%) [M – CH2CN]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C101H814N2, 156.0682; found, 156.0682; 
Δ = 0.01 mmu. 
 
 N,N'-hexane-1,6-diformamide obtained from hexamethylene 
diamine and ethylformate 
 
A solution of hexamethylene diamine (10.0 g, 86.1 mmol, 1.00 eq.) in ethyl formate 
(150 g, 162 mL, 2.02 mol, 23.5 eq.) was heated under reflux overnight (70 °C 
temperature set). The reaction mixture was concentrated in vacuo. The diformamide 
was obtained as a colorless solid (14.9 g, 86.7 mmol, 98.9%). 
Rf = 0.30 in dichloromethane/methanol (9:1). Visualized via Seebach staining solution. 
Spectral data is in accordance to earlier reported.[66] 
IR (ATR)  [cm-1] = 3271.5 (br, 𝜈(N-H)), 3027.8 (vw, 𝜈(C-H)), 2942.8 (w, 𝜈(C-H)), 
2911.2 (w, 𝜈(C-H)), 2852.1 (w, 𝜈(C-H)), 1625.8 (m, 𝜈(C=O)), 1527.0 (m), 1474.7 (w), 
1460.3 (w), 1385.3 (m), 1236.2 (m), 1210.6 (w), 1082.6 (vw), 776.5 (w), 704.7 (m), 
460.9 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 7.97 (s, 4 H, NH6,10, CHO8,12), 3.05 (dd, 
J = 12.7, 6.4 Hz, 4 H, CH25,9), 1.36 (dd, J = 16.5, 10.3 Hz, 4 H, CH21,4), 1.27 (d, J = 
14.4 Hz, 4 H, CH22,3). 
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13C-NMR (126 MHz, CDCl3) δ [ppm] = 160.89 (s, CHO7,11), 37.01 (s, CH25,9), 28.97 (s, 
CH21,4), 26.02 (s, CH22,3). 
FAB-MS m/z (relative intensity): 345.3 (25%) [2 M + H]+, 173.1 (100%) [M + H]+, 100.1 
(5%) [Fragment A]+. 
HRMS–FAB (m/z): [M + H]+ calculated for 12C81H1716O214N2, 173.1285; found, 
173.1287; Δ = 0. 20 mmu. 
 
 
 1,6-Diisocyanohexane obtained from N,N'-hexane-1,6-diformamide 
 
N,N'-hexane-1,6-diformamide (14.0 g, 81.3 mmol, 1.00 eq.) was suspended in 175 mL 
dichloromethane and diisopropylamine (49.4 g, 68.8 mL, 487 mmol, 6.00 eq.) was 
added. The mixture was cooled to 0 °C and phosphoryl chloride (34.9 g, 21.3 mL, 
228 mmol, 2.80 eq.) was added dropwise at such a rate that the reaction temperature 
remained below 0 °C. The mixture was stirred for 2 d, then poured into 500 mL ice-
water containing 50 g potassium carbonate. The resulting emulsion was stirred for 
30 min at room temperature. The organic layer was separated, the aqueous layer 
extracted three times with 50 mL dichloromethane and the combined organic layers 
were dried over potassium carbonate and subsequently under reduced pressure. The 
batch was separated into two equal amounts and each was purified separately by 
column chromatography employing silica gel as stationary phase (c-hexane/ethyl 
acetate 5:1 → 1:1) yielding 1,6-diisocyanohexane as a yellowish oil (8.64 g, 63.4 mmol, 
78.0%). 
Rf = 0.52 in c-hexane/ethyl acetate (1:1). Visualized via Seebach staining solution. 
Spectral data is in accordance to earlier reported.[66] 
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IR (ATR)  [cm-1] = 2942.2 (m, 𝜈(C-H)), 2862.2 (w, 𝜈(C-H)), 2146.0 (m, 𝜈(NC)), 1452.9 
(s), 1350.8 (m), 1175.5 (w), 956.4 (m), 819.6 (s), 727.5 (m), 553.5 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 3.57 – 3.37 (m, 4 H, CH23,8), 1.60 (d, J = 2.1 
Hz, 4 H, CH24,7), 1.43 – 1.29 (m, 4 H, CH25,6). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 155.45 (t, J = 5.6 Hz, C1,10), 41.03 (t, 
J = 5.9 Hz, CH23,8), 28.20 (s, CH24,7), 24.90 (s, CH25,6). 
EI-MS m/z (relative intensity): 137.2 (100%) [M + H]+. 
HRMS–EI (m/z): [M]+ calculated for 12C81H1214N2, 136.0995; found, 136.0994; Δ = 0.10 
mmu. 
 
 Benzyl 6-hydroxyhexanoate 62 and discrete oligomers 63 – 66 
obtained from ε-caprolactone and benzyl alcohol 
 
In a 250 mL round bottom flask equipped with dropping funnel, a temperature controller 
and magnetic stir bar benzyl alcohol (28.4 g, 27.3 mL, 262 mmol, 5.00 eq.) was stirred 
with DBU (800 mg, 784 µL, 5.25 mmol, 0.10 eq.) at room temperature. Subsequently, 
ε-caprolactone (6.00 g, 5.56 mL, 52.5 mmol, 1.00 eq.) dissolved in 30 mL 
dichloromethane was slowly added dropwise to the stirring solution at room 
temperature. The reaction mixture was stirred for 1 d at 85 °C. TLC indicated complete 
conversion of ε-caprolactone. 
Distillation: Thermal stress will favor oligomer formation 
Exceeding benzyl alcohol was removed by distillation (0.01 mbar, 65 °C). The residue 
was adsorbed onto celite® and purified via column chromatography on silica gel eluting 
with a gradual solvent mixture of c-hexane and diethyl ether (6:1 → 0:1). The 
monomeric benzyl ester 62 was obtained as a clear oil (1.37 g, 6.16 mmol, 11.7%). 
Furthermore, discrete oligomers (n = 2 – 5) were obtained as clear oils. Dimer (626 mg, 
1.86 mol, 3.54%) 63, timer 64 (468 g, 1.04 mmol, 1.98%), tetramer 65 (267 mg, 
472 µmol, 0.9%), pentamer 66 (267 mg, 393 µmol, 0.7%). 
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Washing procedure: Milder than distillation, provides the monomer in higher yields 
The reaction mixture was diluted with 200 mL ethyl acetate. Exceeding benzyl alcohol 
was removed by extracting six times with 200 mL water (if necessary with addition of 
brine) and 100 mL brine once. The organic phase was dried under reduced pressure 
and purified via chromatography (adsorbed onto celite®) on silica gel eluting with a 
gradual solvent mixture of c-hexane and diethyl ether (6:1 → 0:1). The monomeric 
benzyl ester 62 was obtained as a clear oil (3.32 g, 14.5 mmol, 27.6%). 
Monomer 62: 
 
Rf = 0.47 in diethyl ether/c-hexane (4:1). Visualized via Seebach staining solution. 
IR (ATR):  [cm-1] = 3400.4 (br, 𝜈(O-H)), 3033.8 (w), 2935.6 (m, 𝜈(C-H)), 2864.0 
(w, 𝜈(C-H)), 1731.1 (vs, 𝜈(C=O)), 1497.6 (w), 1455.3 (m), 1417.3 (w), 1383.1 (w), 
1352.0 (m), 1259.0 (m), 1212.6 (s), 1149.9 (vs), 1073.9 (s), 1052.2 (s), 1026.5 (m), 
802.5 (s), 735.9 (vs), 696.3 (m), 578.9 (w), 498.1 (w), 452.8 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.49 – 7.24 (m, 5 H, CHAr10-14), 5.08 (s, 2 H, 
CH215), 4.35 (t, J = 5.2 Hz, 1 H, OH7), 3.40 – 3.32 (m, 2 H, CH26), 2.35 (t, J = 7.4 Hz, 2 
H, CH22), 1.54 (p, J = 7.4 Hz, 2 H, CH23), 1.40 (dq, J = 8.7, 6.1 Hz, 2 H, CH25), 1.33 – 
1.22 (m, 2 H, CH24). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 172.77 (s, CO2R1), 136.29 (s, CAr9), 128.42 
(s, CHAr), 127.96 (s, CHAr), 127.91 (s, CHAr), 65.28 (s, CH215), 60.51 (s, CH26), 33.52 
(s, CH22), 32.14 (s, CH25), 25.03 (s, CH24), 24.39 (s, CH23). 
FAB – MS [m/z] (relative intensity): 223.0 (100%) [M + H]+, 135.0 (15%) [Fragment A]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C131H1916O3, 223.1329; found, 223.1327; 
Δ = 0.17 mmu. 
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Dimer 63: 
 
Rf = 0.43 in diethyl ether/c-hexane (4:1). Visualized via Seebach staining solution. 
IR (ATR):  [cm-1] = 3431.4 (br, 𝜈(O-H)), 2936.2 (m, 𝜈(C-H)), 2863.1 (m, 𝜈(C-H)), 
1729.3 (vs, 𝜈(C=O)), 1497.7 (m), 1455.5 (w), 1385.1 (w), 1353.3 (w), 1154.6 (vs), 
1080.1 (m), 736.3 (m), 697.5 (s), 579.8 (w), 498.1 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.66 – 7.18 (m, 5 H, CHAr10-14), 5.08 (s, 2 H, 
CH215), 4.35 (t, J = 5.2 Hz, 1 H, OH23), 3.97 (t, J = 6.6 Hz, 2 H, CH26), 3.36 (td, J = 6.5, 
5.2 Hz, 2 H, CH222), 2.36 (t, J = 7.4 Hz, 2 H, CH22), 2.26 (t, J = 7.4 Hz, 2 H, CH218), 
1.62 – 1.46 (m, 6 H, CH23+5+19), 1.45 – 1.35 (m, 2 H, CH221), 1.35 – 1.21 (m, 4 H, 
CH24+20). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 172.89 (s, CO2R1 or 17), 172.66 (s, CO2R1 or 
17), 136.26 (s, CAr9), 128.40 (s, CHAr), 127.96 (s, CHAr), 127.90 (s, CHAr), 65.30 (s, 
CH215), 63.45 (s, CH26), 60.52 (s, CH222), 33.57 (s, CH218), 33.32 (s, CH22), 32.14 (s, 
CH221), 27.78 (s, CH2), 25.04 (s, CH2), 24.87 (s, CH2), 24.41 (s, CH2), 24.07 (s, CH2). 
FAB – MS [m/z] (relative intensity): 337.2 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C191H2916O5, 337.2015; found, 337.2014; 
Δ = 0.08 mmu. 
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Trimer 64: 
 
Rf = 0.39 in diethyl ether/c-hexane (4:1). Visualized via Seebach staining solution. 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 7.47 – 7.22 (m, 5 H, CHAr10-14), 5.08 (s, 2 H, 
CH215), 4.34 (t, J = 5.2 Hz, 1 H, OH31), 3.98 (t, J = 6.5 Hz, 4 H, CH2), 3.40 – 3.33 (m, 2 
H, CH230), 2.36 (t, J = 7.3 Hz, 2 H, CH22), 2.26 (td, J = 7.3, 3.4 Hz, 4 H, CH22+26), 1.69 
– 1.46 (m, 10 H, CH2), 1.47 – 1.36 (m, 2 H, CH229), 1.37 – 1.16 (m, 6 H, CH24+20+28). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 172.92 (s, CO2R), 172.82 (s, CO2R), 172.69 
(s, CO2R), 136.28 (s, CAr9), 128.42 (s, CHAr), 127.99 (s, CHAr), 127.92 (s, CHAr), 65.33 
(s, CH215), 63.52 (s, CH26 or 22), 63.48 (s, CH26 or 22), 60.54 (s, CH230), 33.59 (s, CH22 or 
18 or 26), 33.38 (s, CH22 or 18 or 26), 33.34 (s, CH22 or 18 or 26), 32.17 (s, CH2), 27.82 (s, CH2), 
27.80 (s, CH2), 25.06 (s, CH2), 24.90 (s, CH2), 24.44 (s, CH2), 24.11 (s, CH2), 24.09 (s, 
CH2), 20.77 (s, CH2). 
 
Tetramer 65: 
 
Rf = 0.34 in diethyl ether/c-hexane (4:1). Visualized via Seebach staining solution. 
IR (ATR):  [cm-1] = 3528.8 (br, 𝜈(O-H)), 2936.8 (m, 𝜈(C-H)), 2863.0 (w, 𝜈(C-H)), 1730.0 
(vs, 𝜈(C=O)), 1455.7 (m), 1388.0 (m), 1354.3 (m), 1158.8 (s), 1090.7 (m), 738.0 (w), 
698.3 (m), 580.7 (w), 387.8 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 7.77 – 7.00 (m, 5 H, CHAr10-14), 5.08 (s, 2 H, 
CH215), 4.33 (t, J = 5.1 Hz, 1 H, OH39), 3.98 (t, J = 6.5 Hz, 6 H, CH26+22+30), 3.40 – 3.33 
(m, 2 H, CH238), 2.36 (t, J = 7.4 Hz, 2 H, CH22), 2.32 – 2.22 (m, 6 H, CH218+26+34), 1.64 
– 1.45 (m, 14 H, CH2), 1.44 – 1.36 (m, 2 H, CH237), 1.36 – 1.21 (m, 8 H, CH24+20+28+36). 
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13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 172.90 (s, CO2R), 172.80 (s, CO2R), 172.67 
(s, CO2R),128.41 (s, CHAr), 127.97 (s, CHAr), 127.91 (s, CHAr), 65.31 (s, CH215), 63.50 
(s, CH26 or 22 or 30), 63.46 (s, CH26 or 22 or 30), 60.53 (s, CH238), 33.58 (s, CH218 or 26 or 34), 
33.32 (s, CH22), 32.16 (s, CH2), 27.80 (s, CH2), 25.05 (s, CH2), 24.89 (s, CH2), 24.42 
(s, CH2), 24.09 (s, CH2), 24.07 (s, CH2). 
FAB – MS [m/z] (relative intensity): 565.3 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C311H4816O9, 565.3337; found, 565.3375; 
Δ = 0.15 mmu. 
 
Pentamer 66: 
 
Rf = 0.30 in diethyl ether/c-hexane (4:1). Visualized via Seebach staining solution. 
IR (ATR):  [cm-1] = 3536.2 (br, 𝜈(O-H)), 2937.5 (m, 𝜈(C-H)), 2863.8 (w, 𝜈(C-H)), 1728.2 
(vs, 𝜈(C=O)), 1456.0 (m), 1388.8 (w), 1354.9 (m), 1156.7 (vs), 1090.4 (m), 736.5 (m), 
697.9 (m), 579.5 (w), 498.4 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 7.72 – 6.77 (m, 5 H, CHAr10-14), 5.08 (s, 2 H, 
CH215), 4.33 (t, J = 5.1 Hz, 1 H, OH47), 3.98 (t, J = 6.5 Hz, 8 H, CH26+22+30+38), 3.42 – 
3.33 (m, 2 H, CH246), 2.36 (t, J = 7.3 Hz, 2 H, CH22), 2.32 – 2.18 (m, 8 H, CH218+26+34+42), 
1.63 – 1.46 (m, 18 H, CH2), 1.44 – 1.36 (m, 2 H, CH245), 1.66 – 1.41 (m, 20 H, CH2), 
1.36 – 1.21 (m, 10 H, CH24+20+28+36+44). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 172.91 (s, CO2R), 172.81 (s, CO2R), 172.68 
(s, CO2R), 136.28 (s, CAr9), 128.42 (s, CHAr), 127.98 (s, CHAr), 127.92 (s, CHAr), 65.32 
(s, CH215), 63.52 (s, CH26 or 30 or 38), 63.48 (s, CH26 or 30 or 38), 60.54 (s, CH246), 33.59 (s, 
CH2), 33.38 (s, CH2), 33.33 (s, CH2), 32.17 (s, CH2), 27.81 (s, CH2), 25.06 (s, CH2), 
24.90 (s, CH2), 24.44 (s, CH2), 24.11 (s, CH2), 24.09 (s, CH2). 
FAB – MS [m/z] (relative intensity): 679.4 (100%) [M + H]+. 
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HRMS – FAB [m/z]: [M + H]+ calculated for 12C371H5916O11, 679.4057; found, 679.4056; 
Δ = 0.17 mmu. 
 
 C6-Benzylacetoacetate 68 derived from C6-benzylalcohol 62 and 
diketene acetone adduct 67 
 
In carousel tube vial equipped with a magnetic stir bar the monomer benzyl alcohol 62 
(200 mg, 900 µmol, 1.00 eq.) was dissolved in 2 mL dimethyl sulfoxide. Subsequently, 
diketene acetone adduct 67 (256 mg, 239 µL, 1.80 mmol, 2.00 eq. 900 µL) was added 
while stirring at room temperature. The reaction mixture was heated to 110 °C. 
Reduced pressure was applied to the reaction vial (300 mbar) every 30 min for 3 min 
until the boiling of acetone stopped. TLC indicated complete conversion of the benzyl 
alcohol 62. After completion of the reaction, the mixture was diluted with 30 mL diethyl 
ether and washed with 30 mL water twice and with 20 mL brine once. The combined 
organic phases were dried under reduced pressure and purified by flash column 
chromatography employing silica gel as stationary phase and eluting with ethyl 
acetate/c-hexane (1:2). The acetoacetate product 68 was obtained as a yellow oil 
(189 mg, 621 µmol, 69.0%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.45. Visualized via Seebach staining solution. 
IR (ATR):  [cm-1] = 2946.1 (m, 𝜈(C-H)), 1730.5 (vs, 𝜈(C=O)), 1647.9 (w), 1497.8 (w), 
1455.3 (w), 1413.9 (w), 1383.9 (w), 1358.4 (w), 1314.3 (m), 1234.5 (s), 1149.1 (vs), 
1104.9 (w), 1029.9 (w), 963.2 (w), 802.2 (w), 738.0 (s), 697.8 (s), 578.3 (w), 541.9 (w), 
497.5 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.55 – 7.07 (m, 5 H, CHAr12-16), 5.08 (s, 2 H, 
CH210), 4.02 (t, J = 6.5 Hz, 2 H, CH21), 3.58 (s, 2 H, CH218), 2.35 (t, J = 7.4 Hz, 2 H, 
CH28), 2.16 (s, 3 H, CH321), 1.61 – 1.50 (m, 4 H, CH22+4), 1.37 – 1.22 (m, 2 H, CH23). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 201.55 (s, CO20), 172.67 (s, CO2R6), 167.26 
(s, CO2R17), 136.27 (s, CAr11), 128.42 (s, CHAr), 127.97 (s, CHAr), 127.93 (s, CHAr), 
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65.32 (s, CH210), 64.24 (s, CH21), 49.57 (s, CH218), 33.32 (s, CH28), 30.05 (s, CH321), 
27.66 (s, CH22 or 8), 24.75 (s, CH23), 24.03 (s, CH22 or 4). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C171H2216O514N423Na1, 329.1359; found, 
329.1359; Δ = 0.05 mmu. 
 
 Pentamer-benzyl acetoacetate 69 derived from pentamer-benzyl 
alcohol 66 and diketene acetone adduct 67 
 
In a carousel tube vial equipped with a magnetic stir bar the benzyl alcohol 66 (197 mg, 
290 µmol, 1.00 eq.) was dissolved in 1.5 mL dimethyl sulfoxide. Subsequently, 
diketene acetone adduct 67 (82.5 mg, 77.1 µL, 580 mmol, 2.00 eq.) was added while 
stirring at room temperature. The reaction mixture was stirred at 90 °C for 1 h and at 
110 °C for three hours. Reduced pressure was applied to the reaction vial (300 mbar) 
every 30 min for a few seconds until the boiling of acetone stopped. TLC indicated 
complete conversion of the benzyl alcohol 66. After completion of the reaction, the 
mixture was diluted with 30 mL diethyl ether and washed with 30 mL water twice and 
with 20 mL brine once. The combined organic phases were dried under reduced 
pressure and purified via column chromatography employing silica gel as stationary 
phase and eluting with diethyl ether /c-hexane (2:1 → 3:1). The acetoacetate product 
69 was obtained as a yellow highly viscous oil (133 mg, 174 µmol, 60.1%). 
Rf = 0.59 in diethyl ether/c-hexane (4:1). 
IR (ATR):  [cm-1] = 2938.6 (s, 𝜈(C-H)), 2863.6 (m, 𝜈(C-H)), 1727.6 (vs, 𝜈(C=O)), 
1455.8 (w), 1417.6 (m), 1357.6 (m), 1233.5 (s), 1154.9 (vs), 1094.1 (s), 1039.8 (m), 
960.8 (m), 736.6 (m), 698.2 (w), 541.1 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 11.63 (s, 0.2 H, OH52 or 53, enol), 7.35 (s, 5 H, 
CHAr10-14), 5.08 (s, 2 H, CH215), 4.07 – 3.93 (m, 10 H, CH26+22+30+38+46), 3.58 (s, 1.8 H, 
CH250), 2.35 (t, J = 7.3 Hz, 2 H, CH22), 2.27 (t, J = 7.3 Hz, 8 H, CH218+26+34+42), 2.16 (s, 
3 H, CH354), 1.67 – 1.41 (m, 20 H, CH2), 1.38 – 1.16 (m, 10 H, CH24+20+28+36+44). 
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13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 201.51 (s, CO51), 172.78 (s, 
CO2R1+17+25+33+41), 167.26 (s, CO2R49), 136.27 (s, CAr9), 128.40 (s, CHAr), 127.96 (s, 
CHAr), 127.90 (s, CHAr), 65.31 (s, CH215), 64.24 (s, CH246), 63.50 (s, CH26+22+30+38), 
49.56 (s, CH250), 33.37 (s, CH218 or 26 or 35 or 42), 33.32 (s, CH218 or 26 or 35 or 42), 30.04 (s, 
CH354), 27.80 (s, CH2), 27.69 (s, CH2), 24.89 (s, CH2), 24.78 (s, CH2), 24.09 (s, CH2), 
24.07 (s, CH2), 24.05 (s, CH2). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C411H6216O1323Na1, 785.4088; found, 
785.4079; Δ = 0.88 mmu. 
 
6.2.3.2 Biginelli acids 
 
 Biginelli acid 70 derived from 11-ureidoundecanoic acid, 
benzaldehyde and benzyl acetoacetate 
 
In a 25 mL round bottom flask finely powdered 11-ureidoundecanoic acid (1.00 g, 
4.09 mmol, 1.00 eq.) and benzaldehyde (654 mg, 6.14 mmol, 626 µL, 1.50 eq.) were 
suspended in 4 mL dimethyl sulfoxide. Subsequently, benzyl acetoacetate (1.18 g, 
6.14 mmol, 1.06 mL, 1.50 eq.) and 4-methylbenzenesulfonic acid (49.1 mg, 409 µmol, 
0.10 eq.) were added. The resulting mixture was stirred under argon atmosphere at 
110 °C over night and at 80 °C for another 24 h. Subsequently, the crude reaction 
mixture was added extracted with 200 mL water and 100 mL dichloromethane. The 
aqueous phase was extracted with 50 mL dichloromethane three times. The combined 
organic phases were washed with 50 mL water and concentrated under reduced 
pressure. The resulting concentrate was diluted with 20 mL ethyl acetate/c-hexane 
(4:1) and left to crystallize overnight. The precipitate was filtered and washed three 
times with 20 mL ice cold ethyl acetate and dried under reduced pressure. The Biginelli 
acid 70 was obtained as a colorless solid (930 mg, 1.83 mmol, 44.9%). 
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IR (ATR):  [cm-1] = 3365.7 (br, 𝜈(N-H)), 2923.6 (w, 𝜈(C-H)), 2847.4 (w, 𝜈(C-H)), 1723.1 
(s, 𝜈(C=O)), 1682.5 (s, 𝜈(C=O)), 1656.8 (vs, 𝜈(C=O)), 1616.3 (m), 1418.2 (w), 1384.3 
(s), 1315.5 (s), 1289.3 (s), 1265.6 (m), 1243.8 (m), 1222.7 (m), 1196.9 (m), 1158.0 
(vs), 1087.6 (s), 1049.1 (m), 1011.0 (w), 827.9 (w), 719.2 (w), 770.0 (w), 752.1 (w), 
734.6 (m), 715.2 (m), 699.8 (s), 633.0 (s), 516.9 (w), 496.1 (w), 430.5 (w), 393.0 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 11.96 (s, 1 H, CO2H36), 7.95 (d, J = 3.9 Hz, 
1 H, NH3), 7.32 – 7.13 (m, 10 H, CHAr14-18 + 19-23), 5.17 (d, J = 3.8 Hz, 1 H, CH2), AB-
signal (δA = 5.09, δB = 5.05 JAB = 12.0 Hz, 2 H, CH210), 3.91 – 3.41 (m, 2 H, CH225), 
2.51 (underneath solvent signal, CH312), 2.18 (t, J = 7.4 Hz, 2 H, CH234), 1.47 (p, J = 
7.2 Hz, 2 H, CH233), 1.35 (dt, J = 6.7, 6.3 Hz, 2 H, CH226), 1.29 – 1.00 (m, 12 H, 
CH227-32). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 174.47 (s, CO2H36), 165.36 (s, CO2R7), 
152.62 (s, CO4), 150.51 (s, C5), 143.80 (s, CAr11), 136.35 (s, CAr13), 128.34 (s, CHAr), 
128.28 (s, CHAr), 127.78 (s, CHAr), 127.63 (s, CHAr), 127.29 (s, CHAr), 126.05 (s, CHAr), 
102.53 (s, C1), 65.16 (s, CH210), 52.24 (s, CH2), 41.58 (s, CH225), 33.67 (s, CH234), 
29.33 (s, CH2), 28.92 (s, CH2), 28.83 (s, CH2), 28.72 (s, CH2), 28.52 (s, CH2), 26.16 (s, 
CH2), 24.50 (s, CH233), 15.71 (s, CH312). 
FAB – MS [m/z] (relative intensity): 507.3 (100%) [M + H]+, 429.2 (20%) [M – C6H5], 
415.2 (50%) [M – C7H7], 399.2 (50%) [M – C7H7O], 371.2 (10%) [M – C7H7O2], 312.1 
(10%) [Fragment A]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C301H3916O514N2, 507.2853; found, 
507.2853; Δ = 0.07 mmu. 
 
 
Chapter    6    Experimental part 
 
204  
 Biginelli acid 71 derived from 11-ureidoundecanoic acid, 
4-methoxy benzaldehyde and benzyl acetoacetate 
 
In a 25 mL round bottom flask finely powdered 11-ureidoundecanoic acid (1.00 g, 
4.09 mmol, 1.00 eq.) and 4-methoxy benzaldehyde (835 mg, 6.14 mmol, 1.50 eq.) 
were suspended in 5 mL dimethyl sulfoxide. Subsequently, benzyl acetoacetate 
(1.17 g, 6.14 mmol, 1.50 eq.) and 4-methylbenzenesulfonic acid (49.1 mg, 409 µmol, 
0.10 eq.) were added. The resulting mixture was stirred at 110 °C over night. 
Subsequently, the crude reaction mixture was added extracted with 50 mL water and 
30 mL dichloromethane. The aqueous phase was extracted with 30 mL 
dichloromethane three times. The combined organic phases were dried under reduced 
pressure. The resulting oil was diluted with 20 mL ethyl acetate/c-hexane (6:1) and left 
to crystallize overnight at 7 °C. The precipitate was filtered and washed three times 
with 20 mL ice cold ethyl acetate and dried under reduced pressure. The washing 
solution was dried under reduced pressure and the crystallization procedure was 
repeated to recover additional product. The Biginelli acid 71 was obtained as a yellow 
solid (858 mg, 1.60 mmol, 39.2%). 
IR (ATR):  [cm-1] = 3366.3 (br, 𝜈(N-H)), 2922.8 (w, 𝜈(C-H)), 2848.9 (w, 𝜈(C-H)), 1723.3 
(s, 𝜈(C=O)), 1682.5 (vs, 𝜈(C=O)), 1657.7 (s), 1609.3 (m), 1586.8 (m), 1511.4 (s), 
1497.1 (m), 1454.0 (m), 1441.8 (s), 1419.7 (m), 1384.0 (w), 1315.8 (m), 1287.3 (w), 
1272.0 (s), 1244.6 (w), 1223.2 (w), 1196.5 (m), 1156.5 (m), 1107.4 (s), 1086.2 (m), 
1048.7 (m), 1031.8 (s), 1011.0 (w), 1000.0 (w), 967.0 (m), 897.2 (w), 861.1 (w), 831.8 
(w), 804.9 (m), 746.8 (w), 719.3 (w), 692.6 (w), 638.6 (w), 623.3 (w), 584.1 (m), 554.5 
(w), 530.8 (w), 508.4 (m), 454.2 (w), 427.3 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 11.93 (s, 1 H, CO2H36), 7.88 (d, J = 3.8 Hz, 
1 H, NH3), 7.38 – 7.25 (m, 3 H, CHAr19-23), 7.25 – 7.13 (m, 2 H, CHAr19-23), 7.09 (d, J = 
8.4 Hz, 2 H, CHAr15,17), 6.83 (d, J = 8.3 Hz, 2 H, CHAr14,18), 5.12 (d, J = 3.9 Hz, 1 H, 
CH2), 5.10 – 4.99 (m, 2 H, CH210), 3.90 – 3.76 (m, 1 H, CH225a), 3.72 (s, 3 H, OCH339), 
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3.53 – 3.40 (m, 1 H, CH225b), 2.50 (underneath solvent signal, CH312), 2.18 (t, J = 7.3 
Hz, 2 H, CH234), 1.48 (t, J = 7.1 Hz, 2 H, CH2), 1.38 – 1.02 (m, 14 H, CH2). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 174.48 (s, CO2H36), 165.40 (s, CO2R7), 158.49 
, 156.31 (s, CAr15,17), 152.64 (s, CO4), 150.21 (s, C5), 136.40 (s, CAr13), 135.92 (s, CAr16), 
128.28 (s, CHAr), 127.77 (s, CHAr), 127.60 (s, CHAr), 127.25 (s, CHAr), 113.63 (s, 
CHAr14,18), 102.86 (s, C1), 65.10 (s, CH210), 55.04 (s, OCH339), 51.64 (s, CH2), 41.55 (s, 
CH225), 33.66 (s, CH234), 29.37 (s, CH2), 28.99 (s, CH2), 28.87 (s, CH2), 28.78 (s, CH2), 
28.74 (s, CH2), 28.54 (s, CH2), 26.20 (s, CH2), 24.50 (s, CH233), 15.68 (s, CH312). 
FAB – MS [m/z] (relative intensity): 537.3 (100%) [M + H]+, 445.3 (80%) [M – C7H7], 
429.3 (50%) [M – C7H7O], 401.3 (20%) [M – C8H7O2]. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C311H4116O614N2, 537.2965; found, 
537.2666; Δ = 0.16 mmu. 
 
 Biginelli acid 72 derived from 11-ureidoundecanoic acid, 4-methyl 
benzaldehyde and benzyl acetoacetate 
 
In a 25 mL round bottom flask finely powdered 11-ureidoundecanoic acid (1.00 g, 
4.09 mmol, 1.00 eq.) and 4-methyl benzaldehyde (738 mg, 6.14 mmol, 1.50 eq.) were 
suspended in 5 mL dimethyl sulfoxide. Subsequently, benzyl acetoacetate (1.17 g, 
6.14 mmol, 1.50 eq.) and 4-methylbenzenesulfonic acid (49.1 mg, 409 µmol, 0.10 eq.) 
were added. The resulting mixture was stirred at 110 °C over night. Subsequently, the 
crude reaction mixture was added extracted with 50 mL water and 30 mL 
dichloromethane. The aqueous phase was extracted with 30 mL dichloromethane 
three times. The combined organic phases were dried under reduced pressure. The 
resulting oil was diluted with 20 mL diethyl ether and left to crystallize overnight at 7 °C. 
The precipitate was filtered and washed three times with 20 mL ice cold diethyl ether 
then with 20 mL c-hexane and dried under reduced pressure. The washing solution 
was dried under reduced pressure and the crystallization procedure was repeated to 
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recover additional product. The Biginelli acid 72 was obtained as a yellow solid 
(953 mg, 1.83 mmol, 44.7%). 
IR (ATR):  [cm-1] = 3367.0 (br, 𝜈(N-H)), 2922.4 (m, 𝜈(C-H)), 2849.5 (w, 𝜈(C-H)), 1723.8 
(m, 𝜈(C=O)), 1681.6 (s), 1660.1 (vs), 1617.4 (s), 1512.5 (w), 1421.2 (w), 1387.3 (m), 
1336.5 (m), 1317.4 (w), 1284.2 (m), 1243.3 (m), 1224.0 (w), 1197.0 (m), 1155.2 (s), 
1088.3 (m), 1040.6 (vs), 1001.1 (m), 804.0 (w), 776.9 (w), 754.4 (w), 719.6 (w), 697.6 
(w), 647.9 (m), 627.1 (w), 589.4 (w), 553.3 (w), 503.3 (m), 429.7 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 11.96 (s, 1 H, CO2H36), 7.90 (d, J = 3.9 Hz, 
1 H, NH3), 7.35 – 7.24 (m, 3 H, CHAr), 7.24 – 7.15 (m, 2 H, CHAr), 7.13 – 7.01 (m, 4 H, 
CHAr), 5.14 (d, J = 3.7 Hz, 1 H, CH2), 5.11 – 4.97 (m, 2 H, CH210), 3.94 – 3.38 (m, 2 H, 
CH225), 2.50 (underneath solvent signal, CH312), 2.26 (s, 3 H, CH338), 2.19 (t, J = 7.4 
Hz, 2 H, CH234), 1.60 – 1.37 (m, 4 H, CH2), 1.34 – 1.01 (m, 12 H, CH2). 
13C-NMR (75 MHz, DMSO-d6) δ [ppm] = 174.47 (s, CO2H36), 165.39 (s, CO2R7), 152.68 
(s, CO4), 150.35 (s, C5), 140.86 (s, CAr11), 136.41 (s, CAr13 or 16), 136.38 (s, CAr13 or 16), 
128.84 (s, CHAr), 128.28 (s, CHAr), 127.78 (s, CHAr), 127.64 (s, CHAr), 125.95 (s, CHAr), 
102.74 (s, C1), 65.13 (s, CH210), 51.88 (s, CH2), 41.53 (s, CH225), 33.66 (s, CH234), 
29.38 (s, CH2), 28.97 (s, CH2), 28.88 (s, CH2), 28.78 (s, CH2), 28.55 (s, CH2), 26.18 (s, 
CH2), 24.51 (s, CH2), 20.61 (s, CH338), 15.69 (s, CH312). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C311H4016O514N223Na1, 543.2829; found, 
543.2829; Δ = 0.02 mmu. 
 
 Biginelli acid 73 derived from 11-ureidoundecanoic acid, 
benzaldehyde and C6-benzyl acetoacetate 68 
 
In a 25 mL round bottom flask finely powdered 11-ureidoundecanoic acid (215 mg, 
881 µmol, 1.50 eq.) and benzaldehyde (93.5 mg, 881 µmol, 1.50 eq.) were dissolved 
in 2.5 mL dimethyl sulfoxide. Subsequently, C6-benzyl acetoacetate 68 (180 mg, 
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587 µmol, 1.00 eq.) and 4-methylbenzenesulfonic acid (49.1 mg, 409 µmol, 0.10 eq.) 
were added. The resulting mixture was stirred at 110 °C over night. TLC indicated 
complete conversion of the C6-benzyl acetoacetate 68. Subsequently, the crude 
reaction mixture was extracted with 50 mL water and 30 mL dichloromethane. The 
aqueous phase was extracted with 30 mL dichloromethane three times. The combined 
organic phases were dried under reduced pressure. The residue was adsorbed onto 
celite® and purified via column chromatography on silica gel eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (1:4 → 1:0). The Biginelli acid 73 was 
obtained as an orange oil (243 mg, 66.8%, 391 µmol). 
Rf in ethyl acetate/c-hexane (1:1) = 0.18. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3363.8 (br, 𝜈(CO2H, NH)), 2920.5 (vs, 𝜈(C-H)), 2851.0 (s, 𝜈(C-H)), 
1738.0 (s, 𝜈(C=O)), 1706.6 (vs, 𝜈(C=O)), 1455.1 (m), 1388.2 (m), 1230.2 (m), 1158.5 
(vs), 1090.3 (m), 966.5 (w), 860.3 (w), 799.7 (w), 751.7 (w), 696.6 (w), 463.1 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 12.00 (br s, 1 H, CO2H31), 8.06 (d, J = 4.0 
Hz, 0.2 H, NH3 minor), 7.93 (d, J = 3.8 Hz, 0.8 H, NH3 major), 7.43 – 7.16 (m, 10 H, CHAr14-
18 + 41-45), 5.16 (d, J = 3.9 Hz, 0.2 H, CH2 minor), 5.13 (d, J = 3.7 Hz, 0.8 H, CH2 major), 5.07 
(s, 1.5 H, CH239 major), 5.06 (s, 0.5 H, CH239 minor), 3.99 – 3.89 (m, 2 H, CH210), 3.88 – 
3.76 (m, 1 H, CH220a), 3.53 – 3.41 (m, 1 H, CH220b), 2.49 (s, 3 H, CH312), 2.25 (t, J = 
7.4 Hz, 2 H, CH229), 2.20 – 2.15 (m, 2 H, CH235), 1.55 – 1.41 (m, 6 H, CH2), 1.38 –1.01 
(m, 18 H, CH2). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 174.53 (s, CO2H30), 172.65 (s, CO2R36), 
172.58 (s, CO2R36), 165.78 (s, CO2R7), 165.65 (s, CO2R7), 153.31 (s, CO4), 152.64 (s, 
CO4), 149.94 (s, C5), 148.75 (s, C5), 143.95 (s, CAr11), 143.53 (s, CAr11), 136.29 (s, 
CAr40), 135.69 (s, CAr40), 128.67 (s, CHAr), 128.60 (s, CHAr), 128.44 (s, CHAr), 128.35 
(s, CHAr), 128.12 (s, CHAr), 128.00 (s, CHAr), 127.95 (s, CHAr), 127.34 (s, CHAr), 127.29 
(s, CHAr), 126.90 (s, CHAr), 126.07 (s, CHAr), 126.05 (s, CHAr), 104.54 (s, C1), 102.80 
(s, C1), 65.33 (s, CH239), 65.30 (s, CH239), 63.73 (s, CH210), 63.31 (s, CH210), 52.40 (s, 
CH2), 52.25 (s, CH2), 41.54 (s, CH220), 33.69 (s, CH229), 33.31 (s, CH235), 33.22 (s, 
CH235), 29.39 (s, CH2), 28.98 (s, CH2), 28.93 (s, CH2), 28.88 (s, CH2), 28.82 (s, CH2), 
28.80 (s, CH2), 28.77 (s, CH2), 28.69 (s, CH2), 28.67 (s, CH2), 28.56 (s, CH2), 28.52 (s, 
CH2), 27.82 (s, CH2), 27.77 (s, CH2), 26.21 (s, CH2), 25.88 (s, CH2), 25.05 (s, CH2), 
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24.89 (s, CH2), 24.53 (s, CH2), 24.51 (s, CH2), 24.00 (s, CH2), 20.79 (s, CH2), 15.63 (s, 
CH312). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C361H4816O714N223Na1, 643.3354; found, 
643.3354; Δ = 0.02 mmu. 
 
 Biginelli acid 74 derived from 6-ureidohexanoic acid, benzaldehyde 
and benzyl acetoacetate 
 
In a 10 mL round bottom flask finely powdered 6-ureidohexanoic acid (2.39 g, 
13.7 mmol, 1.00 eq.) and benzaldehyde (1.89 g, 17.8 mmol, 1.30 eq.) were suspended 
in 5 mL dimethyl sulfoxide. Subsequently, benzyl acetoacetate (3.43 g, 17.9 mmol, 
1.30 eq.) and 4-methylbenzenesulfonic acid (p-TSA) (236 mg, 1.37 mmol, 0.10 eq.) 
were added. The resulting mixture was stirred at 110 °C over night. Subsequently, the 
crude reaction mixture was diluted with 10 mL ethanol and precipitated in water. The 
water was decanted, and the sticky precipitate was dissolved in 50 mL ethyl acetate 
and extracted with 50 mL water. The combined aqueous phases were reextracted with 
50 mL ethyl acetate three times. The combined organic phases were washed with 
30 mL brine and dried under reduced pressure. The residue was recrystallized from 
ethanol. The Biginelli-acid 74 was obtained as a yellow solid (3.29 g, 7.54 mmol, 
54.9%). Note: additional product could be crystalized from the mother liquor upon 
concentration and cooling. 
IR (ATR):  [cm-1] = 3214.9 (m, 𝜈(O-H)), 3064.5 (br, 𝜈(N-H)), 2941.9 (w, 𝜈(C-H)), 1888.4 
(br), 1707.5 (vs, 𝜈(C=O)), 1651.2 (s, 𝜈(C=O)), 1620.2 (s), 1495.8 (w), 1454.6 (m), 
1419.7 (m), 1389.9 (m), 1358.9 (s), 1317.9 (m), 1292.3 (s), 1277.0 (s), 1246.5 (s), 
1221.1 (m), 1201.1 (s), 1189.4 (m), 1159.5 (s), 1115.7 (vs), 1091.1 (s), 1076.8 (s), 
1054.4 (m), 1027.8 (m), 975.8 (m), 925.4 (w), 879.2 (w), 851.6 (w), 832.2 (w), 757.8 
(w), 734.8 (w), 717.5 (m), 694.2 (w), 668.7 (w), 638.2 (w), 624.7 (w), 578.0 (w), 547.7 
(w), 501.8 (m), 482.4 (w), 460.9 (w), 434.2 (w), 409.0 (w). 
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1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.00 (s, 1 H, CO2H26), 7.96 (d, J = 3.8 Hz, 
1 H, NH3), 7.37 – 7.12 (m, 10 H, CHAr14-18 + 27-31), 5.18 (d, J = 3.8 Hz, 1 H, CH2), 5.13 – 
5.01 (m, 2 H, CH210), 3.91 – 3.42 (m, 2 H, CH220), 2.51 (s, 3 H, CH312), 2.13 (t, J = 7.4 
Hz, 2 H, CH224), 1.58 – 1.22 (m, 4 H, CH221+23), 1.22 – 1.05 (m, 2 H, CH222). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 174.33 (s, CO2H25), 165.32 (s, CO2R7), 
152.56 (s, CO19), 150.47 (s, C5), 143.78 (s, CAr11), 136.32 (s, CAr13), 128.35 (s, CHAr), 
128.26 (s, CHAr), 127.76 (s, CHAr), 127.61 (s, CHAr), 127.30 (s, CHAr), 126.05 (s, CHAr), 
102.47 (s, C1), 65.13 (s, CH210), 52.25 (s, CH2), 41.47 (s, CH220), 33.50 (s, CH224), 
28.98 (s, CH2), 25.66 (s, CH222), 24.11 (s, CH2), 15.64 (s, CH312). 
FAB – MS [m/z] (relative intensity): 473.2 (100%) [M + H]+, 359.2 (30%) [M – C6H5]+, 
345.2 (70%) [M – C7H7]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C251H2916O514N2, 437.2076; found, 
437.2077; Δ = 0.04 mmu. 
 
 Biginelli acid 75 derived from hydantoic acid, benzyl acetoacetate 
and 4-bromobenzaldehyde 
 
Finely powdered N-carbomoylglycine (2.50 g, 21.2 mmol, 1.20 eq.) and 
4-bromobenzaldehyde (3.27 g, 17.6 mmol, 1.00 eq.) were suspended in 6 mL dimethyl 
sulfoxide and 0.5 mL water in a 50 mL round bottom flask. Subsequently, benzyl 
acetoacetate (3.73 g, 19.4 mmol, 3.35 mL, 1.10 eq.) and p-toluene sulfonic acid 
(212 mg, 1.76 mmol, 0.10 eq.) were added. The resulting mixture was stirred at 110 °C 
for 18 h. Subsequently, the crude reaction mixture was diluted with 10 mL ethanol and 
added dropwise into 300 mL water while stirring. The sticky precipitate was collected 
and dissolved in 40 mL ethyl acetate. The aqueous phase was extracted with ethyl 
acetate (3 × 30 mL). The combined organic phases were washed with brine (3 × 30 mL) 
and dried over sodium sulfate. The solvent was evaporated under reduced pressure 
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and the precipitate was washed with c-hexane/ethyl acetate (2:1) (3 × 100 mL). The 
solid was dried in vacuo to yield the Biginelli acid 75 as a yellowish solid (5.04 g, 
1.09 mmol, 62.1%). 
Rf = 0.34 in ethanol. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3215.5 (br, 𝜈(O-H)), 3092.0 (br, 𝜈(N-H)), 2922.4 (w, 𝜈(C-H), 1689.9 
(vs, 𝜈(C=O)), 1617.2 (m), 1487.1 (w), 1427.3 (m), 1396.4 (m), 1379.4 (m), 1309.6 (m), 
1272.0 (w), 1247.2 (w), 1208.3 (m), 1191.8 (s), 1174.6 (s), 1105.4 (m), 1072.7 (w), 
1042.3 (m), 1009.9 (m), 960.7 (w), 821.2 (w), 756.6 (m), 741.0 (m), 696.2 (m), 638.8 
(w), 575.9 (w), 503.3 (m), 461.9 (w). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 12.94 (s, 1 H, CO2H22), 8.10 (d, J = 3.6 Hz, 1 
H, NH3), 7.46 (d, J = 8.4 Hz, 2 H, CHAr15,17), 7.33 – 7.19 (m, 5 H, CHAr24-28), 7.18 – 7.12 
(m, 2 H, CHAr14,18), 5.18 (d, J = 3.4 Hz, 1 H, CH2), 5.10 – 5.02 (AB-Signal, δA = 5.08, 
δB = 5.04, JAB = 15.0 Hz, 2 H, CH210), 4.51 – 4.31 (AB-Signal, δA = 4.49, δB = 4.33, 
J = 20.0 Hz, 2 H, CH220), 2.42 (s, 3 H, CH312). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 170.95 (s, CO2H22), 165.14 (s, CO2R7), 
152.03 (s, CO4), 150.39 (s, C5), 143.28 (s, CAr11), 136.24 (s, CAr13), 131.30 (s, 
CHAr15,17), 128.86 (s, CHAr), 128.32 (s, CHAr), 127.88 (s, CHAr), 127.74 (s, CHAr), 120.58 
(s, CAr16), 101.87 (s, C1), 65.29 (s, CH210), 52.51 (s, CH2), 43.98 (s, CH220), 15.73 (s, 
CH312). 
FAB – MS [m/z] (relative intensity): 461.0 (95%) [M + H]+, 459.0 (100%) [M + H]+, 369.0 
[M – C7H8]+, 367.0 [M – C7H8]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C211H2016O514N279Br1, 459.0550; found, 
459.0548; Δ = 0.21 mmu. 
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 Biginelli acid 76 derived from hydantoic acid, 
4-flourobenzaldehyde and benzyl acetoacetate 
 
In a 50 mL round bottom flask finely powdered N-carbomoylglycine (2.50 g, 21.2 mmol, 
1.20 eq.) and 4-fourobenzaldehyde (2.19 g, 17.6 mmol, 1.00 eq.) were suspended in 
6 mL dimethyl sulfoxide (3.00 M for 1.00 eq.). Subsequently, benzyl acetoacetate 
(3.73 g, 19.4 mmol, 3.35 mL, 1.10 eq.) and 4-methylbenzenesulfonic acid (212 mg, 
1.76 mmol, 0.10 eq.) were added. The resulting mixture was stirred at 110 °C for 6 h 
and subsequently at 80 °C for 48 h. The crude reaction mixture was diluted with 30 mL 
ethyl acetate and added dropwise into 100 mL water. The organic phase was washed 
with brine (3 × 50 mL). The combined aqueous phases were extracted with ethyl 
acetate (3 × 50 mL). The combined organic extracts were dried over sodium sulfate 
and concentrated under reduced pressure. The oily residue was added dropwise into 
200 mL of c-hexane and stirred for 2 h until a precipitate was formed. The precipitate 
was filtered off, crushed and washed with c-hexane (3 × 80 mL) and with 
c-hexane/ethyl acetate (9:1) (3 × 50 mL). The precipitate was dried under reduced 
pressure in a desiccator over calcium chloride yielding the Biginelli acid 76 as a 
colorless solid (4.26 g, 10.2 mmol, 60.7%). 
IR (ATR):  [cm-1] = 3204.7 (br, 𝜈(CO2-H)), 3056.6 (br, (𝜈(N-H)), 1708.5 (vs, 𝜈(C=O)), 
1642.7 (s, 𝜈(C=O)), 1602.6 (w, 𝜈(C=O)), 1508.0 (s), 1431.8 (m), 1402.2 (m), 1315.0 
(m), 1284.2 (w), 1232.5 (m), 1216.3 (s), 1180.6 (vs), 1117.3 (s), 1041.4 (m), 961.8 (m), 
839.0 (w), 774.5 (w), 748.0 (s), 699.5 (s), 678.2 (m), 646.5 (m), 599.1 (w), 581.2 (w), 
543.5 (w), 514.7 (w), 499,9 (w), 469.9 (w), 390.2 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.95 (s, 1 H, CO2H22), 8.09 (d, J = 3.5 Hz, 
1 H, NH3), 7.37 – 7.24 (m, 5 H, CHAr), 7.21 – 7.13 (m, 2 H, CHAr), 7.09 (t, J = 8.8 Hz, 2 
H, CHAr), 5.22 (d, J = 3.3 Hz, 1 H, CH2), 5.06 (d, J = 4.1 Hz, 1 H, CH210), 4.44 (dd, J = 
53.0, 18.2 Hz, 2 H, CH220), 2.44 (s, 3 H, CH312). 
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13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 171.04 (s, CO2H21), 165.24 (s, CO2Bn7), 
161.51 (d, J = 243.4 Hz, CFAr16), 152.11 (s, CO6), 150.15 (s, C5), 140.25 (s, CAr), 136.29 
(s, CAr), 128.72 (s, CHAr), 128.61 (s, CHAr), 128.34 (s, CHAr), 127.89 (s, CHAr), 127.74 
(s, CHAr), 115.26 (s, CHAr), 114.98 (s, CHAr), 102.32 (s, C1), 65.32 (s, CH210), 52.46 (s, 
CH2), 43.99 (s, CH220), 15.75 (s, CH312). 
19F-NMR (377 MHz, DMSO-d6): δ [ppm] = -119.43 (s, CFAr29). 
FAB – MS [m/z] (relative intensity): 399.2 [M + H]+ (100%), 307.1 [M – C7H7]+ (35%), 
263.1 [M – C8H7O2]+ (15%). 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C211H2016O514N219F1, 399.1351; found, 
399.1350; Δ = 0.08 mmu. 
 
 Biginelli acid 77 derived from hydantoic acid, benzyl acetoacetate 
and 4-methoxy benzaldehyde 
 
Finely powdered N-carbomoylglycine (2.50 g, 21.2 mmol, 1.20 eq.) and 
4-methoxybenzaldehyde (2.40 g, 17.6 mmol, 1.00 eq.) were suspended in 6 mL 
dimethyl sulfoxide in a 50 mL round bottom flask. Subsequently, benzyl acetoacetate 
(3.73 g, 19.4 mmol, 3.35 mL, 1.10 eq.) and p-toluene sulfonic acid (212 mg, 
1.76 mmol, 0.10 eq.) were added. The resulting mixture was stirred at 110 °C for 22 h. 
TLC indicated full conversion of the aldehyde. Subsequently, the crude reaction 
mixture was diluted with 10 mL ethanol and added dropwise into 400 mL water while 
stirring. The sticky precipitate was collected and dissolved in 40 mL ethyl acetate. The 
aqueous phase was extracted with ethyl acetate (3 × 30 mL). The combined organic 
phases were washed with 50 mL brine and dried over sodium sulfate. The solvent was 
evaporated under reduced pressure and the precipitate was washed with 
c-hexane/ethyl acetate (2:1) (5 × 30 mL). The solid was dried in vacuo to yield the 
Biginelli acid 77 as a yellowish solid. (3.29 g, 8.02 mmol, 45.4%). 
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Rf = 0.31 in ethanol. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR)  [cm-1] = 3284.7 (br, 𝜈(CO2H)), 3235.3 (br, 𝜈(N-H)), 3072.8 (w), 3009.1 (w), 
2937.1 (w, 𝜈(C-H)), 2840.4 (w), 2731.4 (w), 2513.4 (w), 2433.2 (w), 1705.1 
(vs, 𝜈(C=O)), 1647.5 (s, 𝜈(C=O)), 1606.3 (m, 𝜈(C=O)), 1511.7 (m, 𝜈(C=C)), 1454.1 (m), 
1413.0 (m), 1384.2 (m), 1316.3 (w), 1287.5 (m), 1248.4 (s), 1229.9 (m), 1213.5 (vs), 
1174.4 (vs), 1114.8 (m), 1059.2 (m), 1028.4 (m), 942.0 (m), 898.8 (w), 851.5 (w), 835.0 
(w), 800.1 (w), 785.7 (m), 771.3 (w), 750.7 (w), 730.2 (m), 695.2 (w), 680.8 (w), 654.0 
(w), 582.0 (w), 503.9 (m), 438.1 (w). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 12.91 (s, 1 H, CO2H22), 8.01 (d, J = 3.5 Hz, 1 
H, NH3), 7.35 – 7.25 (m, 3 H, CHAr25-27), 7.21 (s, 1 H, CHAr), 7.19 (s, 1 H, CHAr), 7.19 – 
7.15 (m, 2 H, CHAr24,28), 6.83 (d, J = 8.7 Hz, 2 H, CHAr15,17), 5.17 (d, J = 3.3 Hz, 1 H, 
CH2), 5.11 – 4.96 (m, 2 H, CH210), 4.52 – 4.32 (AB-Signal, δA = 4.50, δB = 4.43, 
JAB = 20.0 Hz, 2H, CH220), 3.72 (s, 3 H, OCH329), 2.42 (s, 3 H, CH312). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 171.06 (s, CO2H22), 165.39 (s, CO2R7), 
158.64 (s, CAr16),152.26 (s, CO4), 149.63 (s, C5), 136.35 (s, CAr13), 136.16 (s, CAr11), 
128.34 (s, CHAr), 127.86 (s, CHAr), 127.81 (s, CHAr), 127.70 (s, CHAr24,28), 113.72 (s, 
CHAr15,17), 102.73 (s, C1), 65.24 (s, CH210), 55.10 (s, OCH329), 52.46 (s, CH2), 43.98 (s, 
CH220), 15.71 (s, CH312). 
FAB-MS m/z (relative intensity): 411.2 (90%) [M + H]+, 319.1 (54%) [M – C7H7]+, 303.1 
(47%) [M – C7H7O]+, 275.1 (20%) [Fragment A]+, 213.0 (10%) [Fragment C + H]+, 136.0 
(28%) [Fragment B + H]+, 107.0 (10%) [C7H7O]+, 91.0 (100%) [C7H7]+. 
HRMS–FAB (m/z): [M + H]+ calculated for 12C221H2316O614N2, 411.1551; found, 
411.1550; Δ = 0.06 mmu. 
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 Biginelli acid 78 derived from hydantoic acid, benzyl acetoacetate 
and 4-methylbenzaldehyde 
 
Finely powdered N-carbomoylglycine (2.50 g, 21.2 mmol, 1.20 eq.) and 
4-methylbenzaldehyde (2.12 g, 17.6 mmol, 1.00 eq.) were suspended in 6 mL dimethyl 
sulfoxide in a 25 mL round bottom flask. Subsequently, benzyl acetoacetate (3.73 g, 
19.4 mmol, 3.35 mL, 1.10 eq.) and p-toluene sulfonic acid (212 mg, 1.76 mmol, 
0.10 eq.) were added. The resulting mixture was stirred at 110 °C for 4 d. TLC indicated 
full conversion of the aldehyde. Subsequently, the crude reaction mixture was diluted 
with 10 mL ethanol and added dropwise into 400 mL water while stirring. The sticky 
precipitate was collected and dissolved in 40 mL ethyl acetate. The aqueous phase 
was extracted with ethyl acetate (3 × 30 mL). The combined organic phases were 
washed with 50 mL brine and dried over sodium sulfate. The solvent was evaporated 
under reduced pressure and the precipitate was washed with c-hexane/ethyl acetate 
(2:1) (4 × 30 mL). The solid was dried in vacuo to yield the Biginelli acid 78 as a 
brownish solid (4.44 g, 11.3 mmol, 63.8%). 
Rf = 0.35 in ethanol. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR)  [cm-1] = 3290.9 (br, 𝜈(N-H)), 3239.4 (vw, 𝜈(N-H)), 3064.6 (vw), 3007.0 (vw), 
2984.4 (vw, 𝜈(C-H)), 2957.7 (vw, 𝜈(C-H)), 2922.7 (vw, 𝜈(C-H)), 2869.2 (vw, 𝜈(C-H)), 
1721.5 (s, 𝜈(C=O)), 1707.1 (vs, 𝜈(C=O)), 1645.4 (s, 𝜈(C=O)), 1633.1 (s, 𝜈(C=O)), 
1583.7 (w), 1511.7 (w), 1497.3 (w), 1454.1 (m), 1415.0 (m), 1382.1 (w), 1363.6 (w), 
1316.3 (w), 1285.5 (m), 1269.0 (w), 1227.9 (m), 1213.5 (vs), 1201.1 (vs), 1182.6 (vs), 
1174.4 (vs), 1116.8 (s), 1077.7 (w), 1059.2 (s), 1040.7 (w), 1028.4 (w), 1018.1 (m), 
979.0 (w), 944.0 (m), 898.8 (w), 874.1 (w), 853.5 (w), 826.8 (w), 783.6 (m), 771.3 (w), 
748.6 (m), 732.2 (m), 693.1 (w), 680.8 (m), 652.0 (m), 619.1 (w), 582.0 (w), 565.6 (w), 
545.1 (vw), 526.5 (w), 501.8 (w), 495.6 (m), 456.6 (w), 436.0 (w). 
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1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 12.91 (s, 1 H, CO2H22), 8.05 (dd, 
J = 22.6, 3.5 Hz, 1 H, NH3), 7.35 – 7.26 (m, 3 H, CHAr25-27), 7.16 (m, 4 H, CHAr), 7.07 
(d, J = 7.9 Hz, 2 H, CHAr), 5.17 (t, J = 3.4 Hz, 1 H, CH2), 5.05 (s, 2 H, CH210), 4.50 – 
4.31 (AB-Signal, δA = 4.48, δB = 4.33, JAB = 20.0 Hz, 2 H, CH220), 2.41 (s, 3 H, CH312), 
2.26 (s, 3 H, CH329). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 170.99 (s, CO2H22), 165.36 (s, CO2R7), 
152.27 (s, CO4), 149.80 (s, C5), 141.02 (s, CAr13), 136.62 (s, CAr16), 136.32 (s, CAr11), 
128.92 (s, CHAr), 128.32 (s, CHAr), 127.84 (s, CHAr), 127.71 (s, CHAr), 126.47 (s, CHAr), 
102.51 (s, C1), 65.24 (s, CH210), 52.66 (s, CH2), 44.00 (s, CH220), 20.69 (s, CH329), 
15.69 (s, CH312). 
FAB-MS m/z (relative intensity): 395.2 (46%) [M + H]+, 349.2 (6%) [M – CH2O]+, 303.1 
(36%) [M – C7H7]+, 287.1 (8%) [M – C7H7O]+. 259.1 (12%) [Fragment A]+, 136.0 (19%) 
[Fragment B]+, 91.0 (100%) [C7H7]+. 
HRMS–FAB (m/z): [M + H]+ calculated for 12C221H2316O514N2, 395.1601; found, 
395.1598; Δ = 0.32 mmu. 
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 Biginelli acid 79 derived from hydantoic acid, 4-(trifluoromethoxy) 
benzaldehyde and benzyl acetoacetate 
 
In a 25 mL round bottom flask finely powdered N-carbomoylglycine (1.73 g, 14.7 mmol, 
1.20 eq.) and 4-(trifluoromethoxy)benzaldehyde (2.32 g, 12.2 mmol, 1.74 mL, 1.00 eq.) 
were suspended in 3 mL dimethyl sulfoxide (4.7 M for 1.00 eq.). Subsequently, benzyl 
acetoacetate (2.81 g, 14.5 mmol, 2.53 mL) and 4-methylbenzenesulfonic acid 
(73.2 mg, 610 µmol, 0.05 eq.) were added. The resulting mixture was stirred at 110 °C 
for 4 h and subsequently at 80 °C over night. TLC indicated full conversion of the 
aldehyde. Subsequently, the crude reaction mixture was added dropwise into 250 mL 
water. The sticky precipitate was collected and dissolved in ethyl acetate. The aqueous 
phase was extracted with ethyl acetate (3 × 50 mL). The organic phases and the 
dissolved precipitate were combined and washed with water (2 × 30 mL) and 30 mL 
brine. After concentration under reduced pressure the yellow oil was stirred in 50 mL 
c-hexane/ethyl acetate (2:1) for 3 h until a precipitate was formed. The precipitate was 
filtered off and washed with c-hexane (3 × 30 mL) and dried under reduced pressure 
in a desiccator over calcium chloride to yield the Biginelli acid 79 as a colorless solid 
(3.86 g, 19.2 mmol, 68.1%). 
IR (ATR):  [cm-1] = 3091.2 (br, 𝜈(N-H)), 2948.3 (w, 𝜈(C-H), 2170.4 (vw), 1699.5 (vs, 
𝜈(C=O)), 1632.2 (s, 𝜈(C=O)), 1508.8 (m), 1429.6 (m), 1399.4 (m), 1386.4 (m), 1362.8 
(w), 1312.6 (w), 1265.2 (m), 1212.2 (m), 1199.6 (m), 1177.7 (vs), 1155.1 (vs), 1114.6 
(s), 1042.4 (m), 1017.9 (m), 962.3 (w), 927.1 (w), 890.0 (w), 862.2 (w), 844.1 (w), 793.5 
(w), 744.3 (m), 694.8 (w), 650.4 (s), 635.5 (m), 593.9 (w), 548.2 (w), 514.8 (w), 493.8 
(w), 460.2 (w), 413.8 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 12.96 (s, 1 H, CO2H22), 8.13 (d, J = 3.7 Hz, 
1 H, NH3), 7.49 – 7.37 (m, 2 H, CHAr), 7.35 – 7.23 (m, 5 H, CHAr), 7.13 (dd, J = 6.6, 3.0 
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Hz, 2 H, CHAr), 5.25 (d, J = 3.6 Hz, 1 H, CH2), 5.14 – 4.99 (m, 2 H, CH210), 4.57 – 4.29 
(m, 2 H, CH220), 2.44 (s, 3 H, CH312). 
13C-NMR (126 MHz, DMSO-d6): δ [ppm] = 170.98 (s, CO2H21), 165.12 (s, CO2R7), 
152.02 (s, CO4), 150.50 (s, Cq5), 147.57 (s, CAr16), 143.37 (s, CAr11), 136.26 (s, CAr13), 
128.57 (s, CHAr), 128.26 (s, CHAr), 127.86 (s, CHAr), 127.69 (s, CHAr), 121.05 (s, 
CHAr15,17), 120.09 (q, J = 256.1 Hz, CF331), 101.92 (s, Cq1), 65.31 (CH210), 52.48 (s, 
CH2), 43.99 (s, CH220), 15.74 (s, CH312). 
19F-NMR (471 MHz, DMSO-d6) δ [ppm] = -56.83 (s, CF3). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C221H2916O614N219F123Na1, 487.1087; found, 
487.1088; Δ = 0.09 mmu. 
 
 Biginelli acid 80 derived from hydantoic acid, 4-ethoxy 
benzaldehyde and benzyl acetoacetate 
 
In a 50 mL round bottom flask finely powdered N-carbomoylglycine (2.50 g, 21.2 mmol, 
1.20 eq.) and 4-ethoxy benzaldehyde (2.64 g, 17.6 mmol, 1.00 eq.) were suspended 
in 6 mL dimethyl sulfoxide (3.00 M for 1.00 eq.). Subsequently, benzyl acetoacetate 
(3.73 g, 19.4 mmol, 3.35 mL, 1.10 eq.) and 4-methylbenzenesulfonic acid (212 mg, 
1.76 mmol, 0.10 eq.) were added. The resulting mixture was stirred at 110 °C for 8 h 
and afterwards at 40 °C for 2 d. Subsequently, the crude reaction mixture was diluted 
with 10 mL ethanol and added dropwise into 100 mL water while stirring. The mixture 
was stirred for 30 min and extracted with ethyl acetate (4 × 50 mL). The combined 
organic phases were concentrated under reduced pressure and the residue was stirred 
in 100 mL diethyl ether for 30 min. The orange oil was separated, washed with diethyl 
ether (2 × 30 mL) and dried under reduced pressure to yield the Biginelli acid 80 as an 
orange solid (4.32 g, 10.2 mmol, 57.7%). 
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IR (ATR):  [cm-1] = 3241.4 (br, 𝜈(N-H)), 2980.0 (w, 𝜈(C-H), 1710.2 (s, 𝜈(C=O)), 1608.0 
(s, 𝜈(C=O)), 1509.0 (s), 1382.0 (m), 1306.7 (m), 1285.9 (m), 1238.1 (w), 1209.5 (w), 
1171.7 (s), 1111.4 (s), 1042.7 (m), 952.9 (w), 923.1 (w), 821.7 (w), 772.2 (w), 749.9 
(w), 735.6 (w), 695.8 (w), 640.8 (w), 615.6 (w), 591.9 (w), 497.9 (w), 466.0 (w), 417.0 
(w).  
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.90 (s, 1 H, CO2H22), 8.00 (d, J = 3.6 Hz, 
1 H, NH3), 7.33 – 7.26 (m, 3 H, CHAr), 7.22 – 7.14 (m, 4 H, CHAr), 6.84 – 6.74 (m, 2 H, 
CHAr15,17), 5.15 (d, J = 3.5 Hz, 1 H, CH2), 5.05 (s, 2 H, CH210), 4.43 – 4.40 (m, 2 H, 
CH220), 4.02 – 3.90 (m, 2 H, CH230), 2.42 (d, J = 8.8 Hz, 3 H, CH312), 1.34 – 1.27 (m, 3 
H, CH331). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 171.00 (s, CO2H21), 165.35 (s, CO2R7), 
157.86 (s, CAr16), 152.21 (s, CO4), 149.55 (s, C5), 136.32 (s, CAr13), 135.99 (s, CAr11), 
128.30 (s, CHAr), 127.81 (s, CHAr), 127.76 (s, CHAr), 127.66 (s, CHAr), 114.15 (s, 
CHAr15,17), 102.69 (s, C1), 65.20 (s, CH210), 62.97 (s, CH230), 52.42 (s, CH2), 43.94 (s, 
CH220), 15.67 (s, CH312), 14.65 (s, CH331). 
FAB – MS [m/z] (relative intensity): 425.2 (95%) [M + H]+, 379.2 (15%) [M – C2H5O]+, 
333.1 (100%) [M – C7H7]+, 303.1 (60%) [M – C8H9O]+, 289.1 (50%) [M – C8H7O2]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C231H2516O614N2, 425.1707; found, 
425.1705; Δ = 0.05 mmu. 
 
 Biginelli acid 81 derived from hydantoic acid, 
3,4-dimethoxybenzaldehyde and benzyl acetoacetate 
 
In a 25 mL round bottom flask finely powdered N-carbomoylglycine (4.00 g, 33.8 mmol, 
1.20 eq.) and 3,4-dimethoxy benzaldehyde (4.69 g, 28.2 mmol, 4.21 mL, 1.00 eq.) 
were suspended in 6 mL dimethyl sulfoxide. Subsequently, benzyl acetoacetate 
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(6.51 g, 33.8 mmol, 5.85 mL, 1.20 eq.) and 4-methylbenzenesulfonic acid (169 mg, 
1.42 mmol, 0.05 eq.) were added. The resulting mixture was stirred at 110 °C for 8 h 
and at 80 °C over night. Subsequently, the crude reaction mixture was added dropwise 
into 400 mL water while stirring. The suspension was stirred for 1 h until a sticky 
precipitate was formed. The precipitate was collected and dissolved in ethyl acetate. 
The aqueous phase was extracted with ethyl acetate (3 × 50 mL). The organic phases 
and the dissolved precipitate were combined and washed with water (2 × 30 mL) and 
30 mL brine. After concentration under reduced pressure the red oil was stirred in 
50 mL c-hexane/ethyl acetate (2:1) for 1 h until a precipitate was formed. The 
precipitate was filtered off and washed with c-hexane/ethyl acetate (2:1) (3 × 30 mL), 
c-hexane (2 × 30 mL) and dried under reduced pressure in a desiccator over calcium 
chloride to yield the Biginelli acid 81 as a colorless solid (7.73 g, 17.6 mmol, 62.3%). 
IR (ATR):  [cm-1] = 3239.6 (br, 𝜈(CO2H)), 2932.7 (w, 𝜈(C-H), 2161.3 (vw), 1959.1 (vw), 
1712.5 (s, 𝜈(C=O)), 1689.8 (s, 𝜈(C=O)), 1616.5 (m), 1512.8 (w), 1453.7 (w), 1419.7 
(m), 1381.8 (m), 1342.3 (w), 1305.9 (w), 1253.1 (m), 1236.3 (m), 1211.3 (m), 1187.3 
(s), 1140.0 (vs), 1105.3 (s), 1039.2 (m), 1024.3 (s), 955.3 (w), 918.9 (m), 871.5 (m), 
848.9 (w), 813.4 (w), 787.3 (m), 751.3 (s), 697.8 (s), 671.2 (m), 637.5 (w), 600.1 (w), 
570.1 (w), 525.2 (w), 503.2 (w), 457.8 (w), 425.8 (w), 407.7 (w). 
1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 12.93 (s, 1 H, CO2H22), 8.00 (d, J = 3.6 Hz, 
1 H, NH3), 7.37 – 7.25 (m, 4 H, CHAr), 7.26 – 7.14 (m, 2 H, CHAr), 6.93 – 6.74 (m, 3 H, 
CHAr), 5.18 (d, J = 3.5 Hz, 1 H, CH2), 5.06 (s, 2 H, CH210), 4.66 – 4.23 (m, 2 H, CH220), 
3.72 (s, 3 H, OCH3), 3.63 (s, 3 H, OCH3), 2.43 (s, 3 H, CH312). 
13C-NMR (75 MHz, DMSO-d6): δ [ppm] = 171.10 (s, CO2H21), 165.41 (s, CO2R7), 
152.17 (CO4), 149.59 (s, Cq5), 148.71 (s, CAr16), 148.22 (s, CAr15), 136.55 (s, CAr13), 
136.36 (s, CAr11), 128.32 (s, CHAr), 127.83 (s, CHAr), 127.64 (s, CHAr), 118.58 (s, CHAr), 
111.56 (s, CHAr), 110.42 (s, CHAr), 102.56 (s, Cq1), 65.25 (s, CH210), 55.56 (s, OCH330 
or 32), 55.34 (s, OCH330 or 32), 52.88 (s, CH2), 43.84 (CH220), 15.72 (s, CH312). 
ESI–MS [m/z] (relative intensity): 463.14746 (100%) [M + Na]+ calculated for 
12C231H2416O714N223Na1, 463.1475; found, 463.1475; Δ = 0.08 mmu. 
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 Biginelli acid 82 derived from 11-uredioundecanoic acid, 
p-tolualdehyde and pentamer-AA 69 
 
In a 10 mL round bottom flask finely powdered 11-ureidoundecanoic acid (52.8 mg, 
216 µmol, 1.50 eq.) and p-tolualdehyde (26.0 mg, 216 µmol, 1.50 eq.) were suspended 
in 1 mL dimethyl sulfoxide. Subsequently, pentamer-benzyl acetoacetate 69 (110 mg, 
144 µmol, 1.00 eq.) and 4-methylbenzenesulfonic acid (p-TSA) (2.48 mg, 14.4 µmol, 
0.10 eq.) were added. The resulting mixture was stirred at 80 °C for 3 h and at 100 °C 
over night. TLC indicated complete conversion of the pentamer-benzyl acetoacetate 
69. Subsequently, the crude reaction mixture was extracted with 50 mL water and 30 
mL dichloromethane. The residue was adsorbed onto celite® and purified via column 
chromatography on silica gel eluting with ethyl acetate/c-hexane (1:1) in order to 
remove impurities and unreacted starting materials and subsequently eluting with 
dichloromethane/methanol/triethylamine (97:3:1) in order to elute the desired product. 
The relevant fractions were concentrated under reduced pressure down to a volume 
of approximately 30 mL, washed with 20 mL water three times, dried over sodium 
sulfate and dried under reduced pressure to yield the Biginelli acid 82 as a yellow oil 
(94.3 mg, 86.5 µmol, 60.0%). 
IR (ATR):  [cm-1] = 3452.6 (m, 𝜈(O-H)), 2925.3 (s, 𝜈(C-H)), 2854.7 (m, 𝜈(C-H)), 1729.8 
(vs, 𝜈(C=O)), 1704.1 (s, 𝜈(C=O)), 1496.2 (m), 1455.9 (w), 1388.4 (s), 1356.3 (w), 
1157.4 (vs), 1090.5 (s), 784.6 (w), 736.6 (w), 698.1 (w), 605.5 (w), 510.6 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.02 (s, 1 H, CO2H71), 8.28 – 7.78 (m, 1 H, 
NH43), 7.59 – 6.97 (m, 9 H, CHAr10-14 + 54,55,57,58), 5.07 (s, 3 H, CH42 + CH215), 3.97 (td, 
J = 6.5, 1.9 Hz, 10 H, CH26,22,30,38,50), 3.89 – 3.40 (m, 2 H, CH260), 2.48 (s, 3 H, CH352), 
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2.40 – 2.31 (m, 3 H, CH2), 2.32 – 2.22 (m, 9 H, CH378 + CH2), 2.17 (dt, J = 9.0, 7.3 Hz, 
4 H, CH2), 1.63 – 1.35 (dt, J = 17.2, 7.6 Hz, 24 H, CH2), 1.35 – 1.04 (m, 16 H, CH2). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 174.44 (s, CO2H1), 172.73 (s, CO2R), 172.61 
(s, CO2R), 165.58 (s, CO2R1), 152.62 (s, CO44), 149.71 (s, C45), 140.95 (s, CAr), 137.29 
(s, CAr), 136.32 (s, CAr), 129.28 (s, CHAr), 129.08 (s, CHAr), 128.78 (s, CHAr), 128.36 
(s, CHAr), 127.92 (s, CHAr), 127.85 (s, CHAr), 125.92 (s, CHAr), 102.90 (s, C41), 65.26 
(s, CH215), 63.45 (s, CH2), 63.18 (s, CH2), 51.99 (s, CH42), 41.42 (s, CH260), 33.61 (s, 
CH2), 33.32 (s, CH2), 33.27 (s, CH2), 29.36 (s, CH2), 28.94 (s, CH2), 28.84 (s, CH2), 
28.80 (s, CH2), 28.78 (s, CH2), 28.76 (s, CH2), 28.73 (s, CH2), 28.68 (s, CH2), 28.51 (s, 
CH2), 27.75 (s, CH2), 26.15 (s, CH2), 24.84 (s, CH2), 24.46 (s, CH2), 24.04 (s, CH2), 
20.54 (s, CH378), 15.53 (s, CH352). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C611H9016O1514N223Na1, 1113.6239; found, 
1113.6240; Δ = 0.68 mmu. 
 
6.2.3.3 Monomers-NC 
 
 Monomer-NC 83 obtained from Biginelli acid 50, 
trans-1,4-diisocyanocyclohexane and octanal 
 
In a 50 mL round bottom flask trans-1,4-diisocyanocyclohexane (1.76 g, 13.1 mmol, 
5.00 eq.) was stirred in 8 mL dichloromethane under argon atmosphere, subsequently 
octanal (674 mg, 5.25 mmol, 2.00 eq.) was added. Finely powdered Biginelli acid 50 
(1.00 g, 2.62 mmol, 1.00 eq.) was suspended in 5 mL dichloromethane and dimethyl 
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sulfoxide was added dropwise until a solution was obtained. The dissolved Biginelli 
acid was added dropwise to the stirring diisocyanide/aldehyde mixture under argon 
atmosphere. The resulting reaction mixture was stirred at room temperature for 2 d. 
The crude mixture was dried under reduced pressure. The residue was adsorbed onto 
celite® and purified via column chromatography on silica gel eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (1:5 → 2:1). The monomer-NC 83 was 
obtained as a colorless solid (987 mg, 1.55 mmol, 58.7%). The exceeding diisocyanide 
could be recovered (1.19 g, 8.90 mmol, 84.4%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.38. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3306.3 (br, 𝜈(N-H)), 2925.8 (w, 𝜈(C-H)), 2855.9 (w, 𝜈(C-H)), 2138.8 
(m, 𝜈(NC)), 1750.9 (s, 𝜈(C=O)), 1677.5 (vs, 𝜈(C=O)), 1533.9 (s), 1453.3 (s), 1383.8 (s), 
1309.3 (m), 1276.1 (w), 1255.8 (m), 1171.3 (vs), 1104.0 (s), 1042.8 (m), 831.1 (w), 
755.1 (m), 696.0 (s), 653.7 (w), 583.2 (w), 493.6 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.18 (dd, J = 26.3, 3.6 Hz, 1 H, NH12), 7.79 
(dd, J = 23.0, 7.7 Hz, 1 H, NH9), 7.33 – 7.24 (m, 8 H, CHAr), 7.20 – 7.14 (m, 2 H, CHAr), 
5.23 (dd, J = 5.3, 4.1 Hz, 1 H, CH11), 5.12 – 5.02 (m, 2 H, CH226), 4.87 (dd, J = 10.7, 
5.9 Hz, 1 H, CH32), 4.77 – 4.43 (m, 2 H, CH229), 3.70 – 3.69 (m, 1 H, CH5), 3.61 – 3.53 
(m, 1 H, CH2), 2.45 (d, J = 17.6 Hz, 3 H, CH318), 2.07 – 1.98 (m, 2 H, CH24,6 axial), 1.77 
– 1.65 (m, 4 H, CH2), 1.63 – 1.53 (m, 2 H, CH24,6 equatorial), 1.35 – 1.16 (m, 12 H, CH2), 
0.85 (t, J = 6.8 Hz, 3 H, CH347). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 169.14 (s, CO2R30), 168.96 (s, CO2R30), 
168.14 (s, CONR33), 168.12 (s, CONR33), 165.22 (s, CO2R25), 165.19 (s, CO2R25), 
154.46 (s, NC8), 152.47 (s, CO13), 152.19 (s, CO13), 149.68 (s, C15), 149.56 (s, C15), 
143.82 (s, CAr17), 143.62 (s, CAr17), 136.19 (s, CAr28), 128.45 (s, CHAr), 128.41 (s, CHAr), 
128.30 (s, CHAr), 127.85 (s, CHAr), 127.68 (s, CHAr), 127.51 (s, CHAr), 126.56 (s, CHAr), 
126.45 (s, CHAr), 102.79 (s, C10), 102.77 (s, C10), 74.10 (s, CH32), 74.02 (s, CH32), 
65.34 (s, CH226), 59.77 (s), 53.14 (s, CH11), 52.92 (s, CH11), 50.49 (s, CH5), 45.85 (s, 
CH2), 44.19 (s, CH229), 43.99 (s, CH229), 31.28 (s, CH2), 31.21 (s, CH2), 31.12 (s, CH2), 
31.10 (s, CH2), 30.89 (s, CH2), 29.00 (s, CH2), 28.51 (s, CH2), 28.48 (s, CH2), 24.36 (s, 
CH2), 24.33 (s, CH2), 22.06 (s, CH2), 15.66 (s, CH318), 15.65 (s, CH318), 13.95 (s, 
CH347). 
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FAB – MS [m/z] (relative intensity): 643.4 (80%) [M + H]+, 616.3 (80%) [M – NC]+, 535.3 
(70%) [M – C7H7O]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C371H4716O614N4, 643.3490; found, 
643.3492; Δ = 0.15 mmu. 
 
 Monomer-NC 84 obtained from Biginelli acid 50, 
p-xylenediisocyanide and octanal 
 
In a 25 mL round bottom flask p-xylenediisocyanide (1.03 g, 6.57 mmol, 5.00 eq.) was 
stirred in 5 mL dichloromethane under argon atmosphere, subsequently octanal 
(337 mg, 2.63 mmol, 2.00 eq.) was added. Finely powdered Biginelli acid 50 (500 mg, 
1.31 mmol, 1.00 eq.) was suspended in 2 mL dichloromethane and dimethyl sulfoxide 
was added dropwise until a solution was obtained. The dissolved Biginelli acid was 
added dropwise to the stirring diisocyanide/aldehyde mixture under argon atmosphere. 
The resulting reaction mixture was stirred at room temperature for 2 d. The crude 
mixture was dried under reduced pressure. The residue was adsorbed onto celite® and 
purified via column chromatography on silica gel eluting with a gradual solvent mixture 
of ethyl acetate and c-hexane (0:1 → 1:1). The monomer-NC 84 was obtained as a 
colorless solid (659 mg, 1.10 mmol, 75.6%). The exceeding diisocyanide could be 
recovered (643 mg, 4.14 mmol, 78.4%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.30. Visualized via fluorescence quench and 
Seebach staining solution. 
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IR (ATR):  [cm-1] = 3297.3 (br, 𝜈(N-H)), 2925.5 (w, 𝜈(C-H)), 2854.9 (w, 𝜈(C-H)), 2148.4 
(w, 𝜈(NC)), 1739.5 (m, 𝜈(C=O)), 1707.0 (s, 𝜈(C=O)), 1680.9 (vs, 𝜈(C=O)), 1663.0 (vs, 
𝜈(C=O)), 1616.8 (s), 1535.5 (m), 1496.3 (w), 1455.2 (w), 1406.6 (m), 1373.9 (w), 
1306.8 (w), 1278.5 (w), 1254.1 (w), 1190.5 (m), 1170.4 (vs), 1105.3 (s), 1081.2 (s), 
1042.8 (m), 953.2 (s), 830.3 (m), 750.9 (s), 697.5 (m), 589.3 (s), 558.8 (m), 512.4 (m), 
431.1 (m). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.65 – 8.52 (m, 1 H, NH9), 8.18 (dd, J = 21.8, 
3.6 Hz, 1 H, NH12), 7.40 – 7.21 (m, 12 H, CHAr), 7.21 – 7.12 (m, 2 H, CHAr), 5.23 (t, J 
= 4.3 Hz, 1 H, CH11), 5.12 – 5.02 (m, 2 H, CH226), 4.99 (dt, J = 9.7, 4.9 Hz, 1 H, CH32), 
4.84 – 4.78 (m, 2 H, CH25), 4.78 – 4.48 (m, 2 H, CH229), 4.31 (d, J = 6.0 Hz, 2 H, CH22), 
2.43 (d, J = 16.4 Hz, 3 H, CH318), 1.81 – 1.67 (m, 2 H, CH236), 1.37 – 1.19 (m, 10 H, 
CH242-46), 0.85 (t, J = 6.4 Hz, 3 H, CH347).  
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 169.24 (s, CO2R30), 169.07 (s, CONR33), 
165.23 (s, CO2R25), 165.21 (s, CO2R25), 156.50 (s, NC8), 152.36 (s, CO13), 152.17 (s, 
CO13), 149.74 (s, C15), 149.61 (s, C15), 143.86 (s, CAr17), 143.71 (s, CAr17), 139.18 (s, 
CAr3), 136.22 (s, CAr28), 131.91 (s, CAr50), 128.45 (s, CHAr), 128.41 (s, CHAr), 128.31 (s, 
CHAr), 127.85 (s, CHAr), 127.69 (s, CHAr), 127.51 (s, CHAr), 127.48 (s, CHAr), 126.87 
(s, CHAr), 126.60 (s, CHAr), 126.50 (s, CHAr), 102.83 (s, C10), 102.75 (s, C10), 74.17 (s, 
CH32), 74.08 (s, CH32), 65.33 (s, CH226), 53.17 (s, CH11), 52.96 (s, CH11), 44.65 (s, 
CH25), 44.61 (s, CH25), 44.58 (s, CH25), 44.11 (s, CH229), 43.92 (s, CH229), 41.56 (s, 
CH22), 41.54 (s, CH22), 31.33 (s, CH236), 31.31 (s, CH236), 31.11 (s, CH2), 28.53 (s, 
CH2), 28.51 (s, CH2), 28.50 (s, CH2), 24.41 (s, CH2), 24.38 (s, CH2), 22.07 (s, CH2), 
15.67 (s, CH318), 15.65 (s, CH318), 13.95 (s, CH347). 
FAB – MS [m/z] (relative intensity): 665.4 (20%) [M + H]+, 638.3 (100%) [M – NC]+, 
557.3 (25%) [M – C7H7O]+, 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C391H4516O614N4, 665.3334; found, 
665.3335; Δ = 0.12 mmu.  
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 Monomer-NC 85 obtained from Biginelli acid 70, 
1,6-diisocyanohexane and octanal 
 
In a 50 mL round bottom flask 1,6-diisocyanohexane (807 g, 5.91 mmol, 5.00 eq.) was 
stirred in 3 mL dichloromethane under argon atmosphere, subsequently octanal 
(303 mg, 2.37 mmol, 2.00 eq.) was added. Finely powdered Biginelli acid 70 (600 mg, 
1.18 mmol, 1.00 eq.) was suspended in 3 mL dichloromethane and added to the 
stirring diisocyanide aldehyde mixture. The resulting reaction mixture was stirred at 
room temperature for 2 d under argon atmosphere. The crude mixture was dried under 
reduced pressure. The residue was adsorbed onto celite® and purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of ethyl acetate and 
c-hexane (1:3 → 1:1). The monomer-NC 85 was obtained as a yellow oil which 
crystalized to a colorless solid after several days (882 mg, 1.14 mmol, 96.6%). The 
exceeding diisocyanide could be recovered (617 mg, 4.54 mmol, 95.7%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.28. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3223.3 (br, 𝜈(N-H)), 3095.6 (br, 𝜈(N-H)), 2924.6 (m, 𝜈(C-H)), 
2852.8 (m, 𝜈(C-H)), 2146.7 (w, 𝜈(NC)), 1738.9 (m, 𝜈(C=O)), 1707.4 (vs, 𝜈(C=O)), 
1682.1 (vs), 1616.2 (s), 1550.2 (m), 1454.4 (m), 1415.7 (w), 1394.6 (m), 1372.7, 
1346.3 (m), 1323.1 (m), 1236.4 (s), 1195.1 (m), 1151.5 (s), 1097.9 (s), 1078.6 (m), 
1040.5 (m), 999.8 (w), 913.9 (w), 828.1 (s), 753.6 (m), 722.8 (m), 697.5 (vs), 652.5 (s), 
589.7 (m), 570.4 (w), 530.1 (m), 510.2 (m), 446.5 (w).  
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.94 (d, J = 3.8 Hz, 1 H, NH28), 7.91 (t, J = 
5.9 Hz, 1 H, NH9), 7.33 – 7.20 (m, 6 H, CHAr39-48), 7.19 – 7.14 (m, 4 H, CHAr39-48), 5.17 
(d, J = 3.8 Hz, 1 H, CH27), 5.13 – 5.01 (m, 2 H, CH235), 4.81 (t, J = 6.3 Hz, 1 H, CH11), 
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3.90 – 3.41 (m, 4 H, CH250 + CH25), 3.11 – 2.97 (m, 2 H, CH215), 2.50 (underneath 
DMSO signal, CH337), 2.34 (t, J = 7.3 Hz, 2 H, CH259), 1.69 – 1.61 (m, 2 H, CH22), 1.60 
– 1.41 (m, 6 H, CH2), 1.41 – 1.30 (m, 6 H), 1.30 – 1.01 (m, 22 H), 0.90 – 0.78 (m, 3 H, 
CH321). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.40 (s, CO2R25), 169.14 (s, CONR12), 
165.34 (s, CO2R32), 155.61 – 155.28 (m, NC8), 152.59 (s, CO29), 150.47 (s, C30), 
143.81 (s, CAr36), 136.34 (s, CAr38), 128.30 (s, CHAr), 128.26 (s, CHAr), 127.76 (s, CHAr), 
127.61 (s, CHAr), 127.26 (s, CHAr), 126.04 (s, CHAr), 102.53 (s, C26), 73.09 (s, CH11), 
65.14 (s, CH235), 52.24 (s, CH27), 41.57 (s, CH250), 41.33 – 40.90 (m, CH25), 38.08 (s, 
CH215), 33.42 (s, CH259), 31.41 (s, CH22), 31.12 (s, CH2), 29.33 (s, CH2), 28.92 (s, CH2), 
28.83 (s, CH2), 28.76 (s, CH2), 28.73 (s, CH2), 28.68 (s, CH2), 28.52 (s, CH2), 28.51 (s, 
CH2), 28.39 (s, CH2), 26.16 (s, CH2), 25.41 (s, CH2), 25.31 (s, CH2), 24.52 (s, CH2), 
24.40 (s, CH2), 22.04 (s, CH2), 15.68 (s, CH337), 13.90 (s, CH321). 
FAB – MS [m/z] (relative intensity): 771.5 (100%) [M + H]+, 663.5 (50%) [M – C7H7O]+, 
489.3 (70%) [Fragment A]+, 321.1 (55%) [Fragment B]+, 231.1 (30%) [Fragment B – 
C7H6]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C461H6716O614N4, 771.5055; found, 
771.5056; Δ = 0.05 mmu. 
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 Monomer-NC 86 obtained from Biginelli acid 71, 
1,6-diisocyanohexane and 2-ethylbutanal 
 
In a 50 mL round bottom flask 1,6-diisocyanohexane (1.01 g, 7.45 mmol, 5.00 eq.) was 
stirred in 4 mL dichloromethane, subsequently 2-ethylbutanal (300 mg, 2.98 mmol, 
2.00 eq.) was added. Finely powdered Biginelli acid 71 (800 mg, 1.49 mmol, 1.00 eq.) 
was suspended in 3 mL dichloromethane/dimethyl sulfoxide (4:1) and added to the 
stirring diisocyanide aldehyde mixture. The resulting reaction mixture was stirred at 
room temperature for 2 d under argon atmosphere. The crude mixture was dried under 
reduced pressure. The residue was adsorbed onto celite® and purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of ethyl acetate and 
c-hexane (1:5 → 2:1). The monomer-NC 86 was obtained as a yellow solid (702 mg, 
907 µmol, 60.9%). The exceeding diisocyanide could be recovered (673 mg, 
4.94 mmol, 83.3%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.51. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3323.6 (br, 𝜈(N-H)), 3089.2 (br, 𝜈(N-H)), 2928.1 (s, 𝜈(C-H)), 2854.3 
(m, 𝜈(C-H)), 2145.7 (w, 𝜈(NC)), 1736.4 (m, 𝜈(C=O)), 1708.5 (m, 𝜈(C=O)), 1682.4 (s), 
1610.5 (vs), 1535.9 (s), 1509.7 (m), 1463.4 (s), 1428.2 (m), 1392.9 (w), 1305.2 (w), 
1285.5 (m), 1240.8 (w), 1199.8 (m), 1175.3 (w), 1154.2 (s), 1096.3 (m), 1039.0 (m), 
998.4 (s), 960.6 (m), 914.9 (w), 846.1 (m), 795.7 (m), 777.4 (w), 755.6 (m), 724.5 (m), 
697.6 (s), 650.3 (m), 588.1 (w), 563.6 (w), 533.2 (m), 510.2 (w), 424.9 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 7.89 (t, J = 5.9 Hz, 1 H, NH9), 7.86 (d, J = 
3.9 Hz, 1 H, NH28), 7.32 – 7.30 (m, 3 H, CHAr), 7.20 – 7.16 (m, 2 H, CHAr), 7.09 (d, J = 
8.4 Hz, 2 H, CHAr39,43), 6.83 (d, J = 8.5 Hz, 2 H, CHAr40,42), 5.13 (d, J = 3.8 Hz, 1 H, 
CH27), 5.11 – 5.02 (m, 2 H, CH235), 4.91 (d, J = 4.3 Hz, 1 H, CH11), 3.85 (ddd, J = 14.7, 
8.5, 6.3 Hz, 1 H, CH250a), 3.72 (s, 3 H, OCH361), 3.52 – 3.41 (m, 3 H, CH250b+CH25), 
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3.11 – 3.00 (m, 2 H, CH22), 2.50 (underneath DMSO signal, CH337), 2.38 (t, J = 7.3 Hz, 
2 H, CH259), 1.68 (tt, J = 8.0, 3.9 Hz, 1 H, CH15), 1.59 – 1.30 (m, 8 H, CH2), 1.30 – 1.23 
(m, 4 H, CH2), 1.23 – 1.14 (m, 4 H, CH2), 1.10 (t, J = 7.2 Hz, 2 H, CH2), 0.84 (q, J = 7.8 
Hz, 6 H, CH317,63).  
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.51 (s, CO2R25), 168.83 (s, CONR12), 
165.38 (s, CO2R32), 158.48 (s, CAr41), 155.45 (t, J = 5.5 Hz, NC8), 152.61 (s, CO29), 
150.17 (s, C30), 136.38 (s, CAr38), 135.92 (s, CAr36), 128.27 (s, CHAr), 127.75 (s, CHAr), 
127.58 (s, CHAr), 127.23 (s, CHAr), 113.61 (s, CHAr40,42), 102.85 (s, C26), 74.08 (s, 
CH11), 65.08 (s, CH235), 55.02 (s, OCH361), 51.64 (s, CH27), 42.54 (s, CH11), 41.55 (s, 
CH250), 41.02 (t, J = 5.6 Hz, CH25), 38.14 (s, CH22), 33.48 (s, CH259), 29.36 (s, CH2), 
28.94 (s, CH2), 28.85 (s, CH2), 28.76 (s, CH2), 28.74 (s, CH2), 28.66 (s, CH2), 28.39 (s, 
CH2), 26.18 (s, CH2), 25.40 (s, CH2), 25.34 (s, CH2), 24.41 (s, CH2), 21.75 (s, CH2), 
21.36 (s, CH2), 15.66 (s, CH337), 11.27 (s, CH317 or 63), 11.22 (s, CH317 or 63). 
FAB – MS [m/z] (relative intensity): 773.5 (80%) [M + H]+, 665.4 (70%) [M – C7H7O]+, 
535.3 (50%) [Fragment A]+, 519.3 (55%) [Fragment A – O]+, 351.1 (55%) [Fragment 
B]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C451H6516O714N4, 773.4853; found, 
773.4853; Δ = 0.03 mmu. 
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 Monomer-NC 87 obtained from Biginelli acid 72, 
1,6-diisocyanohexane and cyclohexane carbaldehyde 
 
In a 50 mL round bottom flask 1,6-diisocyanohexane (1.04 g, 7.68 mmol, 5.00 eq.) was 
stirred in 3 mL dichloromethane under argon atmosphere, subsequently 
cyclohexancarboxaldehyde (345 mg, 30.7 mmol, 2.00 eq.) was added. Finely 
powdered Biginelli acid 72 (800 mg, 1.54 mmol, 1.00 eq.) was suspended in 3 mL 
dichloromethane/dimethyl sulfoxide (4:1) and added dropwise to the stirring 
diisocyanide/aldehyde mixture. The resulting reaction mixture was stirred at room 
temperature for 2 d under argon atmosphere. The crude mixture was dried under 
reduced pressure. The residue was adsorbed onto celite® and purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of ethyl acetate and 
c-hexane (1:5 → 1:2). The monomer-NC 87 was obtained as a yellow solid (773 mg, 
1.53 µmol, 65.5%). The exceeding diisocyanide could be recovered (514 mg, 
3.77 mmol, 61.4%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.50. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3296.4 (br, 𝜈(N-H)), 3090.2 (br, 𝜈(N-H)), 2924.1 (s, 𝜈(C-H)), 2852.0 
(m, 𝜈(C-H)), 2146.4 (m, 𝜈(NC)), 1736.7 (m, 𝜈(C=O)), 1708.1 (vs, 𝜈(C=O)), 1681.4 (s), 
1615.5 (m), 1541.0 (w), 1452.9 (w), 1422.0 (w), 1391.9 (w), 1363.4 (m), 1336.3 (m), 
1322.0 (w), 1302.8 (m), 1274.5 (m), 1233.9 (m), 1194.6 (m), 1146.0 (s), 1095.9 (vs), 
1039.6 (s), 985.7 (m), 913.6 (w), 843.8 (w), 776.9 (w), 755.4 (m), 721.4 (m), 696.6 (s), 
650.8 (m), 590.0 (m), 554.2 (w), 521.5 (s), 507.4 (s), 429.0 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 7.89 – 7.85 (m, 2 H, NH9+28), 7.36 – 7.26 (m, 
3 H, CHAr), 7.23 – 7.13 (m, 2 H, CHAr), 7.11 – 7.01 (m, 4 H, CHAr), 5.14 (d, J = 3.8 Hz, 
1 H, CH27), 5.10 – 5.03 (m, 2 H, CH235), 4.66 (d, J = 5.4 Hz, 1 H, CH11), 3.89 – 3.80 
(m, 1 H, CH250a), 3.53 – 3.39 (m, 3 H, CH250b+CH25), 3.11 – 2.96 (m, 2 H, CH22), 2.49 
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(s, 3 H, CH337), 2.36 (td, J = 7.4, 2.4 Hz, 2 H, CH259), 2.26 (s, 3 H, CH360), 1.82 – 1.64 
(m, 4 H, CH2), 1.64 – 1.49 (m, 4 H, CH2), 1.48 – 0.99 (m, 22 H, CH2). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.46 (s, CO2R25), 168.26 (s, CONR12), 
165.37 (s, CO2R32), 155.60 – 155.21 (m, NC8), 152.66 (s, CO29), 150.30 (s, C30), 
140.86 (s, CAr36), 136.38 (s, CAr38 or 41), 136.36 (s, CAr36 or 41), 128.81 (s, CHAr), 128.26 
(s, CHAr), 127.76 (s, CHAr), 127.61 (s, CHAr), 125.94 (s, CHAr), 102.74 (s, C26), 77.03 
(s, CH11), 65.11 (s, CH235), 51.87 (s, CH27), 41.52 (s, CH250), 41.18 – 40.65 (m, CH25), 
38.05 (s, CH22), 33.39 (s, CH259), 29.36 (s, CH2), 28.93 (s, CH2), 28.86 (s, CH2), 28.77 
(s, CH2), 28.75 (s, CH2), 28.68 (s, CH2), 28.59 (s, CH2), 28.39 (s, CH2), 27.33 (s, CH2), 
26.16 (s, CH2), 25.70 (s, CH2), 25.50 (s, CH2), 25.37 (s, CH2), 25.31 (s, CH2), 24.40 (s, 
CH2), 20.59 (s, CH360), 15.67 (s, CH337). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C461H6416O614N423Na1, 791.4718; found, 
791.4717; Δ = 0.07 mmu. 
 
 Monomer-NC 88 obtained from Biginelli acid 73, 
1,6-diisocyanohexane and heptanal 
 
In a 25 mL round bottom flask 1,6-diisocyanohexane (164 mg, 1.21 mmol, 5.00 eq.) 
was stirred in 1 mL dichloromethane, subsequently heptanal (55.2 mg, 483 µmol, 
2.00 eq.) was added. Biginelli acid 73 (150 mg, 242 µmol, 1.00 eq.) was suspended in 
1 mL dichloromethane and added dropwise to the stirring diisocyanide aldehyde 
mixture. The resulting reaction mixture was stirred at room temperature for 3 d under 
argon atmosphere. The crude mixture was dried under reduced pressure. The residue 
was adsorbed onto celite® and purified via column chromatography on silica gel eluting 
with a gradual solvent mixture of ethyl acetate and c-hexane (1:2 → 1:0). The 
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monomer-NC 88 was obtained as a yellow oil (171 mg, 196 µmol, 81.3%). The 
exceeding diisocyanide could be recovered (13.7 mg, 119 µmol, 10.7%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.60. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3310.8 (br, 𝜈(N-H)), 2926.4 (s, 𝜈(C-H)), 2855.4 (s, 𝜈(C-H)), 2146.4 
(w, 𝜈(NC)), 1735.3 (s, 𝜈(C=O)), 1674.3 (vs, 𝜈(C=O)), 1619.6 (m), 1536.8 (m), 1495.3 
(m), 1454.7 (m), 1386.4 (m), 1234.0 (s), 1155.8 (s), 1088.0 (m), 829.7 (w), 733.6 (m), 
696.8 (w), 498.1 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.08 – 7.88 (m, 2 H, NH9+27), 7.66 – 7.18 (m, 
10 H, CHAr38-42+62-66), 5.16 (d, J = 3.9 Hz, 0.3 H, CH26 minor), 5.13 (d, J = 3.7 Hz, 0.7 H, 
CH26 major), 5.07 (s, 1.5 H, CH260 major), 5.06 (s, 0.5 H, CH260 minor), 4.81 (t, J = 6.3 Hz, 1 
H, CH11), 4.00 – 3.77 (m, 3 H, CH234+44a), 3.53 – 3.40 (m, 3 H, CH25+44b), 3.11 – 2.96 
(m, 2 H, CH22), 2.49 (s, 3 H, CH336), 2.34 (t, J = 7.5 Hz, 2 H, CH253), 2.25 (t, J = 7.4 Hz, 
2 H, CH256), 1.67 – 1.63 (m, 2 H, CH215), 1.56 – 1.51 (m, 4 H, CH2), 1.42 – 0.99 (m, 34 
H, CH2), 0.84 (t, J = 7.1, 3 H, CH322). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.61 (s, CO2R21 or 57), 172.44 (s, CO2R21 
or 57), 169.18 (s, CONR12), 165.75 (s, CO2R31), 165.62 (s, CO2R31), 155.52 – 155.37 (t, 
J = 5.5 Hz, NC8), 153.28 (s, CO28), 152.62 (s, CO28), 149.88 (s, C29), 148.70 (s, C29), 
143.94 (s, CAr35), 143.53 (s, CAr35), 136.28 (s, CAr61), 135.68 (s, CAr61), 128.65 (s, CHAr), 
128.41 (s, CHAr), 128.31 (s, CHAr), 127.97 (s, CHAr), 127.95 (s, CHAr), 127.91 (s, CHAr), 
127.25 (s, CHAr), 126.86 (s, CHAr), 126.04 (s, CHAr), 104.56 (s, C25), 102.81 (s, C25), 
73.12 (s, CH11), 65.30 (s, CH260), 65.27 (s, CH260), 63.70 (s, CH234), 63.29 (s, CH234), 
52.39 (s, CH26), 52.25 (s, CH26), 41.53 (s, CH244), 41.04 (t, J = 5.85 Hz, CH25), 38.10 
(s, CH22), 33.43 (s, CH253), 33.30 (s, CH256), 33.21 (s, CH2), 31.44 (s, CH215), 31.12 (s, 
CH2), 29.37 (s, CH2), 28.95 (s, CH2), 28.86 (s, CH2), 28.78 (s, CH2), 28.76 (s, CH2), 
28.70 (s, CH2), 28.63 (s, CH2), 28.51 (s, CH2), 28.40 (s, CH2), 28.24 (s, CH2), 27.75 (s, 
CH2), 26.19 (s, CH2), 25.88 (s, CH2), 25.43 (s, CH2), 25.32 (s, CH2), 25.03 (s, CH2), 
24.88 (s, CH2), 24.51 (s, CH2), 24.42 (s, CH2), 23.98 (s, CH2), 21.97 (s, CH2), 20.77 (s, 
CH2), 15.61 (s, CH336), 13.89 (s, CH322). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C511H7416O814N423Na1, 893.5400; found, 
893.5405; Δ = 0.54 mmu. 
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 Monomer-NC 89 obtained from Biginelli acid 74, 
1,6-diisocyanohexane and valeraldehyde 
 
In a 50 mL round bottom flask 1,6-diisocyanohexane (2.50 g, 18.3 mmol, 4.00 eq.) was 
stirred in 10 mL dichloromethane, subsequently pentanal (974 µL, 789 mg, 9.61 mmol, 
2.00 eq.) was added. Biginelli acid 74 (2.00 g, 4.58 mmol, 1.00 eq.) was suspended in 
3 mL dichloromethane and dimethyl sulfoxide was added dropwise until the Biginelli 
acid was fully dissolved, this solution was added dropwise to the stirring 
diisocyanide/aldehyde mixture. The resulting reaction mixture was degassed with 
argon and stirred at room temperature for 3 d under argon atmosphere. The crude 
mixture was dried under reduced pressure, the residue was adsorbed onto celite® and 
purified via column chromatography on silica gel eluting with a gradual solvent mixture 
of ethyl acetate and c-hexane (1:5 → 1:0). The monomer-NC 89 was obtained as a 
colorless, soft amorphous solid (2.54 g, 4.58 mmol, 84.1%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.57. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3320.6 (br, 𝜈(N-H)), 2934.9 (m, 𝜈(C-H)), 2862.0 (w, 𝜈(C-H)), 2147.4 
(w, 𝜈(NC)), 1736.0 (s, 𝜈(C=O)), 1681.0 (vs, 𝜈(C=O)), 1617.2 (s), 1534.4 (m), 1495.7 
(m), 1455.0 (s), 1372.4 (s), 1236.7 (vs), 1153.0 (s), 1111.4 (s), 1073.5 (s), 1044.0 (vs), 
1002.2 (m), 938.9 (w), 915.8 (w), 831.0 (w), 756.3 (w), 697.6 (s), 633.2 (w), 607.5 (w), 
516.9 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.96 (d, J = 3.8 Hz, 1 H, NH3), 7.93 (t, J = 
5.8 Hz, 1 H, NH38), 7.36 – 7.07 (m, 10 H, CHAr14-18 + 27-31), 5.18 (d, J = 3.7 Hz, 1 H, 
CH2), 5.14 – 4.97 (m, 2 H, CH210), 4.80 (dd, J = 7.2, 5.5 Hz, 1 H, CH33), 3.89 – 3.74 
(m, 1 H, CH220a), 3.57 – 3.40 (m, 3 H, CH246 + CH220b), 3.12 – 2.94 (m, 2 H, CH241), 
2.51 (s, 3 H, CH312), 2.31 – 2.25 (m, 2 H, CH224), 1.71 – 1.62 (m, 2 H, CH235), 1.62 – 
1.43 (m, 4 H, CH221+23), 1.44 – 1.20 (m, 10 H, CH2), 0.89 – 0.78 (m, 3 H, CH340). 
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13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.34 (s, CO2R25), 169.17 (s, CONR34), 
165.36 (s, CO2R7), 155.48 – 155.34 (m, NC7), 152.60 (s, CO19), 150.50 (s, C5), 143.85 
(s, CAr11), 136.36 (s, CAr13), 128.38 (s, CHAr), 128.30 (s, CHAr), 127.79 (s, CHAr), 127.65 
(s, CHAr), 127.32 (s, CHAr), 126.10 (s, CHAr), 102.55 (s, C1), 102.54 (s, C1), 73.18 (s, 
CH33), 65.17 (s, CH210), 52.30 (s, CH2), 41.51 (s, CH220), 41.15 – 40.90 (m, CH246), 
38.10 (s, CH241), 33.26 (s, CH224), 31.17 (s, CH235), 28.96 (s, CH2), 28.79 (s, CH2), 
28.39 (s, CH2), 26.79 (s, CH2), 25.55 (s, CH2), 25.42 (s, CH2), 25.32 (s, CH2), 24.03 (s, 
CH2), 20.76 (s, CH2), 15.68 (s, CH312), 13.82 (s, CH340). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C381H5016O614N423Na1, 681.3623; found, 
681.3624; Δ = 0.17 mmu. 
ESI – MS [m/z]: [2 M + Na]+ calculated for 12C761H10016O1214N823Na1, 1339.7353; found, 
1339.7371; Δ = 1.77 mmu. 
 
 Monomer-NC 90 obtained from Biginelli acid 50, 
1,6-diisocyanohexane and acetaldehyde 
 
In a 250 mL round bottom flask 1,6-diisocyanohexane (5.45 g, 40.0 mmol, 4.35 eq.) 
was stirred in 50 mL dichloromethane (0.17 M for 1.00 eq.), subsequently acetaldehyde 
(1,62 g, 3.68 mmol, 2.06 mL, 4.00 eq.) was added at 0 °C. Finely powdered Biginelli 
acid 50 (3.50 g, 9.20 mmol, 1.00 eq.) was dissolved in 6 mL dimethyl 
sulfoxide/dichloromethane (1:2) and added dropwise to the stirring mixture at room 
temperature. The resulting reaction mixture was stirred at room temperature for 5 d. 
The crude mixture concentrated under reduced pressure. The residue was purified via 
column chromatography on silica gel eluting with a gradual solvent mixture of ethyl 
acetate and c-hexane (0:1 → 1:0). The monomer-NC 90 was obtained as an 
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amorphous solid (3.01 g, 5.38 mmol, 58.5%). The exceeding diisocyanide could be 
recovered (1.25 g, 12.2 mmol, 30.5%). 
Rf = 0.38 in ethyl acetate. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3306.4 (br, 𝜈(N-H)), 2934.7 (m, 𝜈(C-H)), 2147.9 (br, 𝜈(N-C)), 
1752.1 (m, 𝜈(C=O)), 1675.8 (vs, 𝜈(C=O)), 1539.6 (m), 1495.5 (w), 1453.7 (s), 1383.8 
(m), 1308.0 (s), 1277.5 (m), 1257.3 (m), 1171.8 (vs), 1104.8 (s), 1041.5 (m), 938.5 (w), 
831.1 (w), 754.5 (m), 696.7 (s), 593.1 (w), 497.4 (w), 399.8 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.22 – 8.10 (m, 1 H, NH3), 7.95 (dt, J = 8.8, 
5.7 Hz, 1 H, NH25), 7.37 – 7.22 (m, 8 H, CHAr), 7.20 – 7.12 (m, 2 H, CHAr), 5.21 (t, J = 
3.4 Hz, 1 H, CH2), 5.06 (t, J = 3.0 Hz, 2 H, CH217), 5.03 – 4.94 (m, 1 H, CH23), 4.79 – 
4.44 (m, 2 H, CH217), 3.48 – 3.39 (m, 2 H, CH235), 3.13 – 3.00 (m, 2 H, CH230), 2.43 (d, 
J = 5.1 Hz, 3 H, CH39), 1.61 – 1.46 (m, 2 H, CH234), 1.44 – 1.14 (m, 10 H, CH2+CH329). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.41 (s, CONR24), 169.37 (s, CONR24), 
169.05 (s, CO2R21), 168.97 (s, CO2R21), 165.24 (s, CO2R16), 155.47 (t, J = 5.9 Hz, 
NC37), 155.43 (s, NC37), 155.40 (s, NC37), 152.30 (s, CO4), 152.14 (s, CO4), 149.77 (s, 
C6), 149.46 (s, C6), 143.87 (s, CAr8), 143.75 (s, CAr8), 136.23 (s, CAr19), 136.21 (s, CAr19), 
128.45 (s, CHAr), 128.41 (s, CHAr), 128.33 (s, CHAr), 127.85 (s, CHAr), 127.80 – 127.66 
(m, CHAr), 127.55 (s, CHAr), 126.62 (s, CHAr), 126.49 (s, CHAr), 102.87 (s, C1), 102.70 
(s, C1), 70.67 (s, CH23), 65.34 (s, CH217), 53.23 (s, CH2), 52.99 (s, CH2), 44.08 (s, 
CH220), 43.87 (s, CH220), 41.03 (dt, J = 5.9 Hz, 2.1 Hz, CH235), 38.22 (s, CH230), 28.75 
(s, CH231), 28.35 (s, CH234), 25.42 (s, CH233), 25.29 (s, CH232), 17.64 (s, CH329), 17.60 
(s, CH329), 15.71 (s, CH39), 15.65 (s, CH39). 
FAB – MS [m/z] (relative intensity): 561.3 (70%) [M + H]+, 435.2 (25%) [M – C7H7O]+, 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C311H3716O614N4, 561.2708; found, 
561.2709; Δ = 0.18 mmu. 
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 Monomer-NC 91 obtained from Biginelli acid 75, 
1,6-diisocyanohexane and lauric aldehyde 
 
In a 250 mL round bottom flask 1,6-diisocyanohexane (4.52 g, 3.32 mmol, 4.35 eq.) 
was stirred in 30 mL dichloromethane, subsequently lauric aldehyde (5.63 g, 
3.06 mmol, 4.00 eq.) was added. Finely powdered Biginelli acid 75 (3.50 g, 7.64 mmol, 
1.00 eq.) was dissolved in 10 mL dimethyl sulfoxide/dichloromethane (1:2) and added 
dropwise to the stirring mixture. The resulting reaction mixture was stirred at room 
temperature for 3 d. The crude mixture was dried under reduced pressure. The residue 
was purified via column chromatography on silica gel eluting with a gradual solvent 
mixture of ethyl acetate and c-hexane (0:1 → 1:1). The oily residue was dissolved in 
20 mL dichloromethane and dried under reduced pressure to yield the monomer-NC 
91 as a colorless, soft amorphous solid (2.99 g, 3.82 mmol, 50.0%). 
Rf = 0.29 in ethyl acetate/c-hexane (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3281.1 (br, 𝜈(N-H)), 2922.4 (w, 𝜈(C-H)), 2852.9 (w, 𝜈(C-H)), 2147.1 
(w, 𝜈(N-C)), 1733.8 (s, 𝜈(C=O)), 1685.3 (vs, 𝜈(C=O)), 1658.0 (s, 𝜈(C=O)), 1623.7 (m), 
1541.2 (m), 1486.9 (m), 1455.5 (w), 1410.8 (m), 1373.6 (w), 1307.8 (w), 1254.1 (w), 
1206.7 (vs), 1187.3 (s), 1168.4 (s), 1105.3 (s), 1071.0 (m), 1042.7 (m), 1009.1 (m), 
956.5 (m), 859.7 (w), 811.3 (w), 763.5 (m), 719.4 (w), 697.5 (w), 644.6 (w), 581.1 (w), 
502.8 (m), 435.3 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.22 (dd, J = 17.5, 3.7 Hz, 1 H, NH3), 8.00 – 
7.90 (m, 1 H, NH25), 7.49 – 7.43 (m, 2 H, CHAr), 7.33 – 7.27 (m, 3 H, CHAr), 7.21 (t, J 
= 7.9 Hz, 2 H, CHAr), 7.18 – 7.12 (m, 2 H, CHAr), 5.20 (t, J = 3.8 Hz, 1 H, CH2), 5.06 
(qd, J = 12.6, 1.8 Hz, 2 H, CH217), 4.92 – 4.87 (m, 1 H, CH23), 4.78 – 4.45 (m, 2 H, 
CH220), 3.49 – 3.40 (m, 2 H, CH234), 3.12 – 2.98 (m, 2 H, CH229), 2.45 (s) and 2.43 (s, 
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3 H, CH39), 1.76 – 1.62 (m, 2 H, CH228), 1.60 – 1.47 (m, 2 H, CH233), 1.43 – 1.12 (m, 
28 H, CH2), 0.89 – 0.81 (m, 3 H, CH352). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.06 (s, CONR24), 168.98 (s, CO2R20), 
168.63 (s, CO2R20), 165.03 (s, CO2Bn16), 165.01 (s, CO2Bn16), 155.51 (s, NC36), 
155.46 (s, NC36), 155.40 (s, NC36), 152.18 (s, CO4), 151.98 (s, CO4), 150.14 (s, C6), 
149.96 (s, C6), 143.14 (s, CAr8), 142.99 (s, CAr8), 136.14 (s, CAr19), 136.13 (s, CAr19), 
131.32 (s, CHAr), 131.27 (s, CHAr), 128.82 (s, CHAr), 128.75 (s, CHAr), 128.28 (s, CHAr), 
127.86 (s, CHAr), 127.70 (s, CHAr), 127.68 (s, CHAr), 120.60 (s, CAr12), 102.33 (s, C1), 
102.20 (s, C1), 74.18 (s, CH23), 74.12 (s, CH23), 65.34 (s, CH217), 52.59 (s, CH2), 52.41 
(s, CH2), 44.12 (s, CH220), 43.92 (s, CH220), 41.09 (s, CH234), 41.03 (s, CH234), 40.97 
(s, CH234), 38.16 (s, CH229), 31.29 (s, CH228), 29.01 (s, CH2), 29.00 (s, CH2), 28.89 (s, 
CH2), 28.85 (s, CH2), 28.82 (s, CH2), 28.72 (s, CH2), 28.56 (s, CH2), 28.38 (s, CH233), 
25.41 (s, CH2), 25.31 (s, CH2), 24.33 (s, CH2), 22.10 (s, CH2), 15.69 (s, CH39), 15.66 
(s, CH39), 13.95 (s, CH352). 
FAB – MS [m/z] (relative intensity): 779.4 (45%) [M(81Br) + H]+, 781.4 [M(79Br) + H]+ 
(40%), 673.3 (25%) [M(81Br) – C7H7O]+, 671.3 (30%) [M(79Br) – C7H7O]+, 457.0 
[Fragment A(81Br)]+ (45%), 457.0 [Fragment A(79Br)]+ (40%), 443.1 [Fragment A(81Br) 
– O]+ (35%), 441.1 [Fragment A(79Br) – O]+ (40%), 415.1 [Fragment A(81Br) – CO2]+ 
(10%), 413.1 [Fragment A(79Br) – CO2]+ (12%), 401.0 [Fragment B(81Br)]+ (13%), 
399.01 [Fragment B(79Br)]+ (12%). 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C411H5616O614N479Br1, 779.3378; found, 
779.3377; Δ = 0.10 mmu. 
Chapter    6    Experimental part 
 
  237 
 
 
 Monomer-NC 92 obtained from Biginelli acid 76, 
1,6-diisocyanohexane and cyclamen aldehyde 
 
In a 250 mL round bottom flask 1,6-diisocyanohexane (4.10 g, 30.1 mmol, 4.00 eq.) 
was stirred in 35 mL dichloromethane, subsequently cyclamen aldehyde (4.30 g, 
22.6 mmol, 3.00 eq.) was added. Finely powdered Biginelli acid 76 (3.00 g, 7.53 mmol, 
1.00 eq.) was dissolved in 6 mL dimethyl sulfoxide/dichloromethane (1:2) and added 
dropwise to the stirring mixture. The resulting reaction mixture was stirred at room 
temperature for 5 d. The crude mixture was dried under reduced pressure. The residue 
was purified via column chromatography on silica gel eluting with a gradual solvent 
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mixture of ethyl acetate and c-hexane (1:1 → 1:0), dry load adsorbed on celite®. The 
monomer-NC 92 was obtained as a yellow oil (2.75 g, 3.80 mmol, 50.5%). 
Rf = 0.32 in ethyl acetate/c-hexane (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3305.5 (br, 𝜈(N-H)), 2933.8 (w, 𝜈(C-H)), 2862.1 (w, 𝜈(C-H)), 2146.9 
(m, 𝜈(N-C)), 1750.6 (s, 𝜈(C=O)), 1681.8 (vs, 𝜈(C=O)), 1539.2 (m), 1507.4 (w), 1453.8 
(m), 1382.8 (w), 1309.2 (w), 1212.7 (s), 1172.1 (vs), 1097.5 (m), 1049.1 (m), 848.0 
(m), 753.1 (m), 697.2 (w), 597.0 (w), 503.8 (w). 
1H-NMR (600 MHz, DMSO-d6): δ [ppm] = 8.27 (ddd, J = 25.4, 24.2, 3.5 Hz, 1 H, NH3), 
7.96 (ddt, J = 50.1, 21.5, 5.7 Hz, 1 H, NH25), 7.36 – 7.25 (m, 5 H, CHAr), 7.22 – 7.06 
(m, 7 H, CHAr), 7.06 – 6.99 (m, 1 H, CHAr), 5.27 (d, J = 2.6 Hz, 1 H, CH2), 5.14 – 5.03 
(m, 2 H, CH217), 4.89 – 4.79 (m, 1 H, CH23), 4.78 – 4.51 (m, 2 H, CH220), 3.52 – 3.48 
(m, 2 H, CH234), 3.47 – 3.42 (m, 2 H, CH244), 3.10 (tdd, J = 16.1, 11.5, 6.2 Hz, 2 H, 
CH229), 2.87 – 2.70 (m, 2 H, CH51), 2.56 (d, J = 10.2 Hz, 2 H, CH39a), 2.48 – 2.43 (m, 1 
H, CH39b), 2.35 – 2.18 (m, 1 H, CH28), 1.66 – 1.50 (m, 4 H, CH2), 1.48 – 1.21 (m, 11 H, 
CH2), 1.24 – 1.09 (m, 10 H, CH2 + CH352,53), 0.81 – 0.76 (m, 3 H, CH343). 
13C-NMR (151 MHz, DMSO-d6): δ [ppm] = 169.06 (s, CO2R21), 169.04 (s, CO2R21), 
168.99 (s, Cq), 168.10 (s, Cq), 168.02 (s, Cq), 167.82 (s, Cq), 167.79 (s, Cq), 165.16 (s, 
CO2R16), 165.12 (s, CO2R16), 161.49 (d, J = 243.3 Hz, CFAr42), 155.52 (s, NC36), 155.45 
(s, NC36), 152.61 (s, CO4), 152.44 (s, CO4), 152.20 (s, CO4), 150.04 (s, CO4), 149.80 
(s, C6), 145.90 (s, CAr48), 140.02 (s, CAr8), 139.84 (s, CAr8), 137.09 (s, CAr), 136.93 (s, 
CAr19), 136.17 (s, CAr19), 129.14 (s, CHAr), 128.76 (s, CHAr), 128.55 (s, CHAr), 128.27 
(s, CHAr), 127.82 (s, CHAr), 127.63 (s, CHAr), 126.13 (s, CHAr), 115.22 (s, CHAr), 115.18 
(s, CHAr), 114.98 (s, CHAr), 102.72 (s, C1), 102.61 (s, C1), 77.57 (s, CH23), 75.64 (s, 
CH23), 65.33 (s, CH217), 52.41 (s, CH2), 52.28 (s, CH2), 52.20 (s, CH2), 44.51 (s, CH220), 
44.31 (s, CH220), 44.21 (s, CH220), 41.06 (s, CH234), 41.02 (s, CH234), 40.98 (s, CH234), 
38.31 (s, CH239), 38.22 (s, CH239), 36.93 (s, CH28), 36.69 (s, CH28), 32.98 (s, CH51), 
28.76 (s, CH2), 28.71 (s, CH2), 28.38 (s, CH2), 28.34 (s, CH2), 28.19 (s, CH2), 25.40 (s, 
CH2), 24.89 (s, CH2), 23.88 (s, CH2), 20.73 (s, CH2), 15.89 (s, CH39), 15.78 (s, CH39), 
15.72 (s, CH39), 15.22 (s, CH343), 15.11 (s, CH343), 14.06 (s, CH352,53), 13.99 (s, CH343), 
13.89 (s, CH343). 
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FAB – MS [m/z] (relative intensity): 725.3 (80%) [M + H]+, 629.3 (10%) [M – C6H4F]+, 
617.3 (70%) [M – C7H7O]+, 397.1 (90%) [Fragment A]+, 381.1 (100%) [Fragment A – 
O]+, 381.1 (90%) [Fragment A – C2H2O]+. 
19F-NMR (377 MHz, DMSO-d6): δ [ppm] = -119.35 (s, CFAr42), -119.35 (s, CFAr42), -
119.37 (s, CFAr42), -119.41 (s, CFAr42). 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C421H5016O614N419F1, 725.3709; found, 
725.3708; Δ = 0.12 mmu. 
 
 
 Monomer-NC 93 obtained from Biginelli acid 77, 
1,6-diisocyanohexane and 2-ethylbutanal 
 
1,6-diisocyanohexane (1.99 g, 14.6 mmol, 4.00 eq.) was stirred in 10 mL 
dichloromethane in a 100 mL round bottom flask, subsequently 2-ethylbutanal (1.46 g, 
14.6 mmol, 4.00 eq.) was added. Finely powdered Biginelli acid 77 (1.50 g, 3.65 mmol, 
1.00 eq.) was dissolved in 5 mL dimethyl sulfoxide/dichloromethane (1:4) and added 
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dropwise to the stirring mixture. The resulting reaction mixture was degassed with 
argon and stirred at room temperature for 36 h. The crude mixture was dried under 
reduced pressure. The residue was purified via column chromatography on silica gel 
eluting with a gradual solvent mixture of ethyl acetate and c-hexane (0:1 → 1:0). The 
oily residue dried in vacuo to yield the monomer-NC 93 as a colorless, soft amorphous 
solid (1.00 g, 1.55 mmol, 42.4%). 
Rf = 0.33 in c-hexane/ethyl acetate (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3313.54 (br, 𝜈(N-H)), 2961.8 (w, 𝜈(C-H)), 2935.0 (w, 𝜈(C-H)), 
2875.4 (w, 𝜈(C-H)), 2149.3 (w, 𝜈(NC)), 1752.4 (m, 𝜈(C=O)), 1678.3 (s, 𝜈(C=O)), 1536.4 
(w), 1511.7 (m), 1454.1 (m), 1384.2 (m), 1306.0 (w), 1281.4 (w), 1242.3 (s), 1172.3 
(vs), 1104.5 (s), 1028.4 (s), 1003.7 (w), 964.6 (w), 835.0 (w), 752.8 (m), 697.2 (m), 
654.0 (w), 584.1 (w), 508.0 (w). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.15 (dd, J = 42.9, 3.6 Hz, 1 H, NH3), 7.92 
(dt, J = 45.3, 5.6 Hz, 1 H, NH25), 7.35 – 7.25 (m, 3 H, CHAr), 7.22 – 7.11 (m, 4 H, CHAr), 
6.86 – 6.79 (m, 2 H, CHAr), 5.17 (dd, J = 6.8, 3.6 Hz, 1 H, CH2), 5.11 – 5.03 (m, 2 H, 
CH217), 4.99 (dd, J = 24.2, 3.9 Hz, 1 H, CH23), 4.75 – 4.46 (m, 2 H CH220), 3.72 (s, 3 H, 
OCH343), 3.48 – 3.39 (m, 2 H, CH235), 3.08 (m, 2 H, CH230), 2.45 (d, J = 31.6 Hz, 3 H, 
CH39), 1.82 – 1.63 (m, 1 H, CH29), 1.54 (d, J = 2.2 Hz, 2 H, CH234), 1.45 – 1.30 (m, 6 
H, CH2), 1.29 – 1.15 (m, 4 H, CH2), 0.94 – 0.69 (m, 6 H, CH346,47). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 169.25 (s, CO2R21), 169.21 (s, CO2R21), 
168.42 (s, CONR24), 165.32 (s, CO2Bn16), 165.25 (s, CO2Bn16), 158.66 (s, COMe12), 
158.63 (s, COMe12), 155.86 (t, J = 5.5 Hz, NC37), 152.71 (s, C4), 152.30 (s, C4), 149.36 
(s, C6), 149.26 (s, C6), 136.28 (s, CAr19), 135.91 (s, C8), 135.71 (s, C8), 128.31 (s, CHAr), 
127.86 (s, CHAr), 127.84 (s, CHAr), 127.75 (s, CHAr), 127.67 (s, CHAr), 127.65 (s, CHAr), 
127.64 (s, CHAr), 113.77 (s, CHAr), 113.72 (s, CHAr), 103.22 (s, C1), 103.02 (s, C1), 
75.14 (s, CH23), 75.05 (s, CH23), 65.30 (s, CH217), 65.25 (s, CH217), 55.10 (s, OCH343), 
52.46 (s, CH2), 52.25 (s, CH2), 44.37 (s, CH220), 44.17 (s, CH220), 42.51 (s, CH29), 42.48 
(s, CH29), 41.50 (t, J = 5.8 Hz, CH235), 38.26 (s, CH230), 28.74 (s, CH2), 28.69 (s, CH2), 
28.39 (s, CH234), 25.43 (s, CH2), 25.37 (s, CH2), 21.82 (s, CH2), 21.76 (s, CH2), 21.45 
(s, CH2), 21.26 (s, CH2), 15.72 (s, CH39), 15.68 (s, CH39), 11.39 (s, CH346,47), 11.34 (s, 
CH346,47), 11.27 (s, CH346,47). 
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FAB-MS m/z (relative intensity): 647.3 (13%) [M + H]+, 555.3 (3%) [M – C7H7]+, 539.3 
(15%) [M – C7H7O]+, 409.2 (20%) [Fragment A]+, 393.2 (26%) [Fragment A – O]+, 351.1 
(15%) [Fragment A – C2H2O2]+, 90.9 (100%) [C7H7]+. 
HRMS–FAB (m/z): [M + H]+ calculated for 12C361H4716O714N4, 647.3439; found, 
647.3441; Δ = 0.18 mmu. 
 
 
 Monomer-NC 94 obtained from Biginelli acid 78, 
1,6-diisocyanohexane and octanal 
 
1,6-diisocyanohexane (2.07 g, 15.2 mmol, 4.00 eq.) was stirred in 10 mL 
dichloromethane in a 100 mL round bottom flask, subsequently octanal (1.95 g, 
15.2 mmol, 4.00 eq.) was added. Finely powdered Biginelli acid 78 (1.50 g, 3.80 mmol, 
1.00 eq.) was dissolved in 6 mL dimethyl sulfoxide/dichloromethane (1:2) and added 
dropwise to the stirring mixture. The resulting reaction mixture was degassed with 
argon and stirred at room temperature for 2 d. The crude mixture was dried under 
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reduced pressure. The residue was purified via column chromatography on silica gel 
eluting with a gradual solvent mixture of ethyl acetate and c-hexane (0:1 → 2:1). The 
oily residue dried in vacuo to yield the monomer-NC 94 as a yellow, viscous liquid 
(1.72 g, 2.61 mmol, 68.9%). 
Rf = 0.36 in c-hexane/ethyl acetate (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3379.3 (vw), 3290.9 (br, 𝜈(N-H)), 3093.4 (vw), 3066.7 (vw), 3029.7 
(vw), 2951.5 (w, 𝜈(C-H)), 2926.8 (m, 𝜈(C-H)), 2856.9 (w, 𝜈(C-H)), 2147.3 (w, 𝜈(NC)), 
1744.1 (m, 𝜈(C=O)), 1709.2 (m, 𝜈(C=O)), 1682.4 (vs, 𝜈(C=O)), 1657.8 (vs, 𝜈(C=O)), 
1624.8 (m, 𝜈(C=O)), 1544.6 (w), 1513.8 (w), 1497.3 (vw), 1454.1 (m), 1443.8 (m), 
1413.0 (m), 1382.1 (m), 1306.0 (m), 1275. 2 (m), 1252.6 (m), 1205.3 (m), 1186.7 (vs), 
1170.3 (vs), 1145.6 (m), 1104.5 (s), 1044.8 (m), 985.2 (w), 966.7 (w), 935.8 (w), 884.4 
(vw), 855.6 (vw), 834.3 (vw), 822.7 (vw), 781.5 (w), 761.0 (m), 750.7 (m), 730.1 (m), 
697.2 (m), 654.0 (w), 598.5 (vw), 582.0 (w), 561.5 (vw), 534.7 (vw), 497.7 (w), 452.5 
(vw), 433.9 (vw). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.13 (dd, J = 27.9, 3.6Hz, 1 H, NH3), 7.93 (dt, 
J = 18.7, 5.7 Hz, 1 H, NH25), 7.30 (dd, J = 9.4, 5.6 Hz, 3 H, CHAr), 7.20 – 7.03 (m, 6 H, 
CHAr), 5.18 (dd, J = 6.1, 3.8 Hz, 1 H, CH2), 5.09 – 5.01 (m, 2 H, CH217), 4.90 (dd, 
J = 10.4, 5.1 Hz, 1 H, CH23), 4.81 – 4.42 (m, 2 H, CH220), 3.50 – 3.38 (m, 2 H, CH234), 
3.12 – 2.94 (m, 2 H, CH229), 2.43 (d, J = 13.4, 3 H, CH39), 2.26 (s, 3 H, CH342), 1.78 – 
1.63 (m, 2 H, CH2), 1.58 – 1.48 (d, J = 2.2 Hz, 2 H, CH2), 1.47 – 1.19 (m, 16 H, CH2), 
0.84 (t, J = 6.8 Hz 3H, CH348). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 169.24 (s, CO2R21), 169.15 (s, CO2R21), 
168.78 (s, CONR24), 165.35 (s, CO2Bn16), 165.32 (s, CO2Bn16), 155.52 (t, J = 5.2 Hz, 
NC36), 152.57 (s, C4), 152.31 (s, C4), 149.61 (s, C6), 149.43 (s, C6), 141.00 (s, CAr12), 
140.82 (s, CAr12), 136.74 (s, CAr19), 136.31 (C8), 129.03 (s, CHAr), 128.98 (s, CHAr), 
128.38 (s, CHAr), 127.92 (s, CHAr), 127.78 (s, CHAr), 127.76 (s, CHAr), 127.57 (s, CHAr), 
126.46 (s, CHAr), 103.07 (s, C1), 103.01 (s, C1), 74.25 (s, CH23), 74.18 (s, CH23), 65.38 
(s, CH217), 52.89 (s, CH2), 52.66 (s, CH2), 44.24 (s, CH220), 44.02 (s, CH220), 41.12 (dt, 
J = 5.8, 2.0 Hz, CH234), 38.26 (s, CH229), 31.43 (s, CH2), 31.37 (s, CH2), 31.21 (s, CH2), 
28.83 (s, CH2), 28.61 (s, CH2), 28.46 (s, CH2), 25.51 (s, CH2), 25.40 (s, CH2), 24.46 (s, 
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CH2), 22.15 (s, CH2), 20.85 (s, CH342), 15.74 (s, CH39), 15.61 (s, CH39), 14.02 (s, 
CH348). 
FAB-MS m/z (relative intensity): 659.4 (7%) [M + H]+, 393.2 (19%) [Fragment A]+, 377.2 
(10%) [Fragment A – O]+, 335.1 (16%) [Fragment A – C2H2O2]+, 303.1 (5%) [Fragment 
A – C7H7]+, 214.1 (4%) [Fragment A – 2 C7H7]+, 91.0 (100%) [C7H7]+. 
HRMS–FAB (m/z): [M + H]+ calculated for 12C381H5116O614N4, 659.3803; found, 
659.3805; Δ = 0.17 mmu. 
 
 
 Monomer-NC 95 obtained from Biginelli acid 79, 
1,6-diisocyanohexane and 4-methoxy benzaldehyde 
 
In a 50 mL round bottom flask 1,6-diisocyanohexane (1.47 g, 10.8 mmol, 5.00 eq.) was 
stirred in 3 mL dichloromethane, subsequently 4-methoxy benzaldehyde (586 mg, 
4.31 mmol, 2.00 eq.) was added. Biginelli-acid 79 (1.00 g, 2.15 mmol, 1.00 eq.) was 
suspended in 2 mL dichloromethane/dimethyl sulfoxide (3:1) and added dropwise to 
the stirring diisocyanide aldehyde mixture. The resulting reaction mixture was stirred 
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at room temperature for 7 d under argon atmosphere. The crude mixture was dried 
under reduced pressure. The residue was adsorbed onto celite® and purified via 
column chromatography on silica gel eluting with a gradual solvent mixture of ethyl 
acetate and c-hexane (1:4 → 1:0). The Passerini product 95 was obtained as a yellow 
solid (685 mg, 930 µmol, 43.2%). 
Rf in ethyl acetate = 0.51. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3303.8 (br, 𝜈(N-H)), 2937.2 (w, 𝜈(C-H)), 2148.2 (m, 𝜈(NC)), 1736.0 
(s, 𝜈(C=O)), 1682.4 (vs, 𝜈(C=O)), 1626.2 (s), 1540.0 (s), 1512.7 (m), 1454.5 (m), 
1374.0 (w), 1305.9 (vs), 1249.6 (vs), 1210.2 (vs), 1166.3 (vs), 1105.4 (s), 1042.1 (m), 
834.1 (m), 753.2 (w), 697.7 (w), 633.5 (w), 527.3 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.24 – 8.16 (m, 2 H, NH9+23), 7.45 – 7.08 (m, 
11 H, CHAr), 6.98 – 6.89 (m, 2 H, CHAr), 5.83 (d, J = 8.9 Hz, 1 H, CH11), 5.25 (t, J = 3.5 
Hz, 1 H, CH21), 5.15 – 4.98 (m, 2 H, CH230), 4.86 – 4.49 (m, 2 H, CH240), 3.75 (s, 3 H, 
OCH316), 3.39 (tt, J = 13.9, 7.4 Hz, 2 H, CH25), 3.13 – 2.97 (m, 2 H, CH29), 2.46 (d, J = 
4.4 Hz, 3 H, CH332), 1.53 – 1.42 (m, 2 H, CH220), 1.41 – 1.32 (m, 2 H, CH23), 1.32 – 
1.21 (m, 2 H, CH219), 1.21 – 1.10 (m, 2 H, CH218). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 169.01 (s, CO2R41), 168.94 (s, CO2R41), 
167.66 (s, CONR12), 167.61 (s, CONR12), 165.03 (s, CO2R30), 159.61 (s, CAr51), 159.56 
(s, CO2R41), 155.46 – 155.33 (m, CN8), 151.93 (s, CO26), 151.82 (s, C25), 150.00 (s, 
C25), 147.54 (s, CF348), 143.26 (s, CAr31), 143.09 (s, CAr31), 136.18 (s, CAr33), 136.16 (s, 
CAr33), 128.98 (s, CHAr), 128.87 (s, CHAr), 128.57 (s, CHAr), 128.47 (s, CHAr), 128.24 
(s, CHAr), 127.87 (s, CHAr), 127.85 (s, CHAr), 127.69 (s, CHAr), 127.65 (s, CHAr), 127.43 
(s, CHAr), 127.31 (s, CHAr), 121.32 (s, CHAr), 121.02 (s, CHAr), 113.81 (s, CHAr), 102.37 
(s, C21), 102.20 (s, C21), 75.67 (s, CH11), 75.54 (s, CH11), 65.35 (s, CH230), 55.16 (s, 
CH316), 55.14 (s, CH316), 52.63 (s, CH21), 52.46 (s, CH21), 43.97 (s, CH240), 43.82 (s, 
CH240), 41.08 – 40.85 (m, CH25), 38.21 (s, CH22), 28.67 (s, CH23), 28.35 (s, CH23), 
28.32 (s, CH220), 25.32 (s, CH219), 25.14 (s, CH218), 15.70 (s, CH332), 15.67 (s, CH332). 
19F-NMR (376 MHz, DMSO-d6) δ [ppm] = -61.17 (s, CF348a), -61.19 (s, CF348b). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C381H3916O814N419F323Na1, 759.2618; found, 
759.2607; Δ = 0.11 mmu. 
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ESI – MS [m/z]: [2 M + Na]+ calculated for 12C761H7816O1614N819F623Na1, 1495.5343; 
found, 1495.5348; Δ = 0.52 mmu. 
 
 Monomer-NC 96 obtained from Biginelli acid 80, 
1,6-diisocyanohexane and octanal 
 
In a 250 mL round bottom flask 1,6-diisocyanohexane (2.88 g, 21.2 mmol, 3.00 eq.) 
was stirred in 35 mL dichloromethane, subsequently octanal (3.62 g, 28.27 mmol, 4.00 
eq.) was added. Finely powdered Biginelli acid 80 (3.00 g, 7.07 mmol, 1.00 eq.) was 
dissolved in 8 mL dimethyl sulfoxide/dichloromethane (1:2) and added dropwise to the 
stirring mixture. The resulting reaction mixture was stirred at room temperature for 5 d 
under argon atmosphere. The crude mixture was dried under reduced pressure. The 
residue was adsorbed onto celite® and purified via column chromatography on silica 
gel eluting with a gradual solvent mixture of ethyl acetate/c-hexane (1:9 → 1:1). The 
monomer-NC 96 was obtained as a yellow oil (2.96 g, 4.31 mmol, 61.0%). The 
exceeding 1,6-diisocyanohexane could be recovered (1.04 g, 7.61 mmol, 54.0%). 
Rf = 0.61 in ethyl acetate/c-hexane (7:3). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3306.4 (br, 𝜈(N-H)), 2925.5 (m, 𝜈(C-H)), 2855.4 (w, 𝜈(C-H)), 2145.9 
(w, 𝜈(NC)), 1751.0 (w, 𝜈(C=O)), 1677.5 (vs, 𝜈(C=O)), 1608.9 (w), 1535.1 (w), 1508.9 
(m), 1453.6 (m), 1384.0 (m), 1305.3 (w), 1240.7 (w), 1172.5 (vs), 1106.1 (s), 1045.1 
(s), 923.0 (w), 862.9 (w), 751.5 (m), 696.7 (w), 652.7 (w), 583.3 (w), 509.3 (w), 449.3 
(w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.11 (dd, J = 22.3, 3.4 Hz, 1 H, NH3), 7.99 – 
7.88 (m, 1 H, NH36), 7.34 – 7.26 (m, 3 H, CHAr), 7.20 – 7.14 (m, 4 H, CHAr), 6.83 – 6.76 
(m, 2 H, CHAr), 5.16 (t, J = 4.1 Hz, 1 H, CH14), 5.10 – 5.00 (m, 2 H, CH221), 4.90 (dd, J 
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= 9.8, 6.1 Hz, 1 H, CH38), 4.78 – 4.43 (m, 2 H, CH25), 4.01 – 3.92 (m, 2 H, CH243), 3.52 
– 3.38 (m, 2 H, CH229), 3.05 (dt, J = 19.2, 6.6 Hz, 2 H, CH235), 2.43 (d, J = 10.3 Hz, 3 
H, CH315), 1.78 – 1.62 (m, 2 H, CH239), 1.62 – 1.46 (m, 3 H, CH231), 1.46 – 1.09 (m, 18 
H, CH2), 0.96 – 0.77 (m, 6 H, CH344+50). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.18 (s, CO2R6), 169.15 (s, CO2R6), 
169.07 (s, Cq), 168.68 (s, CONR40), 168.63 (s, CONR40), 165.28 (s, CO2R21), 165.24 
(s, CO2R21), 157.90 (s, CAr9), 155.51 (s, NC30), 155.47 (s, NC30), 155.40 (s, NC30), 
152.43 (s, CO2), 152.17 (s, CO2), 149.32 (s, C16), 149.13 (s, C16), 136.23 (s, CAr), 
135.90 (s, CAr), 135.71 (s, CAr), 128.28 (s, CHAr), 127.82 (s, CHAr), 127.70 (s, CHAr), 
127.67 (s, CHAr), 127.65 (s, CHAr), 114.18 (s, CHAr8,10), 114.13 (s, CHAr8,10), 103.15 (s, 
C17), 103.08 (s, C17), 74.15 (s, CH38), 74.10 (s, CH38), 65.27 (s, CH221), 62.97 (s, CH43), 
52.58 (s, CH14), 52.36 (s, CH14), 44.15 (s, CH25), 43.93 (s, CH25), 41.09 (s, CH229), 
41.04 (s, CH229), 40.98 (s, CH229), 38.18 (s, CH235), 31.43 (s, CH2), 31.35 (s, CH2), 
31.28 (s, CH2), 31.24 (s, CH2), 31.12 (s, CH2), 28.90 (s, CH2), 28.74 (s, CH2), 28.69 (s, 
CH2), 28.53 (s, CH2), 28.38 (s, CH2), 25.76 (s, CH2), 25.42 (s, CH2), 25.32 (s, CH2), 
24.54 (s, CH2), 24.38 (s, CH2), 22.06 (s, CH2), 20.75 (s, CH2), 15.66 (s, CH315), 15.63 
(s, CH315), 14.64 (s, CH344), 13.92 (s, CH350). 
FAB – MS [m/z] (relative intensity): 689.5 (45%) [M + H]+, 687.5 (30%) [M – H]+, 581.3 
(50%) [M – C7H7O]+. 
HRMS – FAB [m/z]: [M – H]+ calculated for 12C391H5116O714N4, 687.3752; found, 
687.3751; Δ = 0.17 mmu. 
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 Monomer-NC 97 obtained from Biginelli acid 52, 
1,6-diisocyanohexane and octanal 
 
In a 50 mL round bottom flask 1,6-diisocyanohexane (1.86 g, 13.6 mmol, 5.00 eq.) was 
stirred in 6 mL dichloromethane under argon atmosphere, subsequently octanal 
(699 mg, 5.45 mmol, 2.00 eq.) was added. Finely powdered Biginelli acid 52 (1.00 g, 
2.72 mmol, 1.00 eq.) was suspended in 5 mL dimethyl sulfoxide, diluted with 2 mL 
dichloromethane. The resulting reaction mixture was stirred at room temperature for 
4 d under argon atmosphere. The crude mixture was dried under reduced pressure. 
The residue was adsorbed onto celite® and purified via column chromatography on 
silica gel eluting with a gradual solvent mixture of ethyl acetate and c-hexane (1:3 → 
1:0). The monomer-NC 97 was obtained as a yellow solid (1.46 g, 2.31 mmol, 85.2%). 
The exceeding diisocyanide could be recovered (1.13 g, 8.30 mmol, 76.1%). 
Rf in ethyl acetate/ethanol (98:2) = 0.40. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] =3235.5 (br, 𝜈(N-H)), 3107.1 (br, 𝜈(N-H)), 2927.0 (w, 𝜈(C-H)), 2857.2 
(w, 𝜈(C-H)), 2147.1 (w, 𝜈(NC)), 1700.0 (vs, 𝜈(C=O)), 1639.3(vs, 𝜈(C=O)), 1609.0 (m), 
1537.1 (m), 1497.4 (m), 1454.4 (m), 1379.1 (w), 1314.9 (m), 1264.9 (m), 1220.6 (m), 
1178.5 (vs), 1085.0 (vs), 1017.8 (m), 949.9 (w), 912.6 (w), 860.5 (w), 824.8 (m), 754.2 
(w), 697.4 (w), 655.1 (s), 583.4 (w), 526.3 (w), 496.9 (w), 444.8 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 9.36 (d, J = 2.0 Hz, 1 H, NH43), 8.05 (t, J = 
5.7 Hz, 1 H, NH9), 7.93 (dd, J = 8.5, 2.1 Hz, 2 H, CHAr39,41), 7.85 (t, J = 2.7 Hz, 1 H, 
NH27), 7.36 (dd, J = 8.5, 2.3 Hz, 2 H, CHAr38,42), 7.32 – 7.22 (m, 3 H, CHAr44-48), 7.18 – 
7.11 (m, 2 H, CHAr44-48), 5.26 (d, J = 3.4 Hz, 1 H, CH26), 5.09 – 4.96 (m, 3 H, CH234 + 
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CH11), 3.46 (ddt, J = 6.6, 3.9, 1.9 Hz, 2 H, CH25), 3.11 – 3.03 (m, 2 H, CH22), 2.28 (s, 
3 H, CH336), 1.86 – 1.77 (m, 2 H, CH215), 1.63 – 1.49 (m, 2 H, CH224), 1.45 – 1.20 (m, 
16 H, CH222-24 + 16-20), 0.91 – 0.80 (m, 3 H, CH321). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 169.01 (s, CO2R12), 164.92 (s, CO2R31 or 
CONR12), 164.88 (s, CO2R31 or CONR12), 155.50 – 155.36 (m, NC8), 151.76 (s, CO28), 
149.94 (s, C29), 149.91 (s, C29), 149.84 (s, CAr40), 149.82 (s, CAr40), 136.45 (s, CAr37), 
136.44 (s, CAr37), 129.78 (s, CHAr), 128.56 (s, CHAr), 128.54 (s, CHAr), 128.27 (s, CHAr), 
128.25 (s, CHAr), 127.71 (s, CHAr), 127.65 (s, CHAr), 127.61 (s, CHAr), 126.63 , 98.08 
(s, C25), 98.07 (s, C25), 74.02 (s, CH11), 64.88 (s, CH234), 53.84 (s, CH26), 41.15 – 40.96 
(m, CH25), 38.20 (s, CH215), 31.55 (s, CH2), 31.17 (s, CH2), 28.79 (s, CH2), 28.60 (s, 
CH2), 28.54 (s, CH2), 28.39 (s, CH2), 25.43 (s, CH2), 25.35 (s, CH2), 24.59 (s, CH2), 
22.07 (s, CH2), 17.91 (s, CH2), 14.09 (s, CH336), 13.94 (s, CH321). 
FAB – MS [m/z] (relative intensity): 631.3 (50%) [M + H]+, 523.3 (30%) [M – C7H7O]+, 
349.1 (100%) [Fragment A]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C361H4716O614N4, 631.3490; found, 
631.3493; Δ = 0.30 mmu. 
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6.2.3.4 Model compounds and macromolecules 
 
 Passerini compound 98 obtained from Biginelli acid 49, 
1,6-diisocyanohexane and acetaldehyde 
 
In a 100 mL round bottom flask 1,6-diisocyanohexane (2.57 g, 18.8 mmol, 3.00 eq.) 
was dissolved in 40 mL dichloromethane. Subsequently, acetaldehyde (1.38 g, 31.4 
mmol, 5.00 eq.) was added at 0 °C. The Biginelli acid 49 (2.00 g, 6.28 mmol, 1.00 eq.) 
was dissolved in 10 mL dimethyl sulfoxide/dichloromethane (1:2) and added to the 
stirring solution dropwise at room temperature. After the complete addition, the 
reaction mixture was stirred for 4 days at room temperature. Subsequently the crude 
reaction mixture was concentrated under reduced pressure and added dropwise into 
a stirring emulsion of 70 mL water and 70 mL dichloromethane while stirring. The 
organic phase was separated, the aqueous phase was extracted with 20 mL ethyl 
acetate three times and the combined organic phases were dried over sodium sulfate 
and concentrated under reduced pressure. The oily residue was purified via column 
chromatography employing silica gel and eluting with a gradual solvent mixture of ethyl 
acetate and c-hexane (0:1 → 1:0). The Passerini product 98 was obtained as a yellow 
oil (1.56 g, 2.73 mmol, 43.5%). 
Rf = 0.48 in ethyl acetate. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3293.0 (br, 𝜈(N-H)), 2936.0 (br, 𝜈(C-H)), 2860.6 (br, 𝜈(C-H)), 
2147.2 (m, 𝜈(N-C)), 1752.6 (m, 𝜈(C=O)), 1675.9 (vs, 𝜈(C=O)), 1539.8 (m), 1452.6 (m), 
1372.2 (s), 1308.7 (m), 1176.1 (vs), 1095.3 (s), 1056.3 (m), 938.3 (w), 830.3 (w), 761.2 
(w), 698.7 (m). 
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1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.14 (dd, J = 9.2, 3.4 Hz, 1 H, NH3), 7.96 
(dd, J = 10.1, 4.8 Hz, 1 H, NH27), 7.38 – 7.18 (m, 5 H, CHAr10-14), 5.19 (s, 1 H, CH2), 
5.03 – 4.93 (m, 1 H, CH23), 4.72 – 4.49 (m, 2 H, CH220), 4.11 – 3.94 (m, 2 H, CH217), 
3.51 – 3.38 (m, 2 H, CH235), 3.12 – 3.00 (m, 2 H, CH230), 2.41 (d, J = 3.6 Hz, 3 H, CH39), 
1.62 – 1.45 (m, 2 H, CH234), 1.47 – 1.13 (m, 12 H, CH329 + CH2), 1.14 – 1.07 (m, 3 H, 
CH319). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.38 (s, CONR24), 169.35 (s, CONR24), 
169.08 (s, CO2R16), 168.98 (s, CO2R16), 165.45 (s, CO2R21), 155.47 (s, NC37), 155.42 
(s, NC37), 155.36 (s, NC37), 152.37 (s, CO4), 152.21 (s, CO4), 148.80 (s, C6), 148.48 
(s, C6), 144.08 (s, CAr8), 143.95 (s, CAr8), 128.40 (s, CHAr10,14), 128.36 (s, CHAr10,14), 
127.45 (s, CHAr12), 126.58 (s, CHAr13,11), 126.44 (s, CHAr13,11), 103.36 (s, C1), 103.19 
(s, C1), 70.63 (s, CH23), 70.61 (s, CH23), 59.71 (s, CH217), 53.31 (s, CH2), 53.04 (s, 
CH2), 44.04 (s, CH220), 43.82 (s, CH220), 41.10 (s, CH235), 41.08 (s, CH235), 41.05 (s, 
CH235), 41.03 (s, CH235), 40.99 (s, CH235), 40.97 (s, CH235), 38.22 (s, CH230), 38.20 (s, 
CH230), 28.74 (s, CH2), 28.35 (s, CH2), 25.42 (s, CH2), 25.29 (s, CH2), 20.75 (s, CH2), 
17.62 (s, CH329), 17.59 (s, CH329), 15.62 (s, CH39), 15.56 (s, CH39), 13.96 (s, CH319), 
13.94 (s, CH319). 
FAB – MS [m/z] (relative intensity): 499.1 (50%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C261H3516O614N4, 499.2551; found, 
499.2552; Δ = 0.09 mmu. 
 
 Compound 99 derived from Biginelli acid 50, Passerini compound 
98 and heptanal 
 
In a tube vial the Passerini compound 98 (200 mg, 401 µmol, 1.00 eq.) was suspended 
in 2 mL dichloromethane. Subsequently, heptanal (91.6 mg, 802 µmol, 2.00 eq.) and 
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the Biginelli acid 50 (229 mg, 602 µmol, 1.50 eq.) were added. Afterwards, 0.5 mL 
dimethyl sulfoxide were added dropwise while stirring until an orange solution was 
obtained. The reaction mixture was stirred at room temperature for 1 d. Subsequently, 
the crude reaction mixture was concentrated under reduced pressure and stirred with 
30 mL water and 30 mL dichloromethane. The organic phase was separated, dried 
over sodium sulfate and concentrated under reduced pressure. The oily residue was 
purified via column chromatography employing silica gel and eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane. The desired Passerini product 99 was 
obtained as a colorless solid (293 mg, 294 µmol, 73.5%). 
Rf = 0.41 in ethyl acetate. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3306.5 (br, 𝜈(N-H)), 2928.4 (br, 𝜈(C-H)), 2857.6 (br, 𝜈(C-H)), 
1751.5 (m, 𝜈(C=O)), 1676.8 (vs, 𝜈(C=O)), 1537.9 (m), 1453.3 (m), 1383.6 (m), 1308.7 
(w), 1172.3 (vs), 1102.9 (s), 1054.4 (m), 830.7 (w), 757.0 (w), 696.5 (s), 495.3 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.22 – 8.11 (m, 2 H, NH), 7.98 – 7.89 (m, 2 
H, NH), 7.36 – 7.21 (m, 13 H, CHAr), 7.18 – 7.13 (m, 2 H, CHAr), 5.24 – 5.17 (m, 2 H, 
CH), 5.10 – 5.02 (m, 2 H, CH), 5.03 – 4.95 (m, 1 H, CH), 4.93 – 4.85 (m, 1 H, CH), 
4.78 – 4.65 (m, 2 H, CH2), 4.54 – 4.43 (m, 2 H, CH2), 4.08 – 3.95 (m, 2 H, CH2), 3.12 
– 2.96 (m, 2 H, CH2), 2.44 (d, J = 12.7 Hz, 3 H, CH3), 2.40 (d, J = 5.8 Hz, 3 H, CH3), 
1.74 – 1.63 (m, 2 H, CH2), 1.35 (m, 7 H, CH2), 1.22 (dq, J = 14.3, 7.0 Hz, 14 H), 1.10 
(td, J = 7.1, 2.2 Hz, 3 H, CH3), 0.83 (t, J = 6.7 Hz, 3 H, CH3). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.32 (s, CONR24), 169.28 (s, CONR24), 
169.10 (s, CONR59), 169.03 (s, CO2R16), 168.96 (s, CO2R16), 168.62 (s, CO2R55), 
165.44 (s, CO2R51), 165.22 (s, CO2R21), 165.19 (s, CO2R21), 152.42 (s, CO4 or 39), 
152.37 (s, CO4 or 39), 152.20 (s, CO4 or 39), 152.17 (s, CO4 or 39), 149.69 (s, C6 or 41), 
149.56 (s, C6 or 41), 148.80 (s, C6 or 41), 148.50 (s, C6 or 41), 144.06 (s, C8 or 43), 143.95 (s, 
C8 or 43), 143.82 (s, C8 or 43), 143.65 (s, C8 or 43), 136.18 (s, CAr54), 128.43 (s, CHAr), 
128.40 (s, CHAr), 128.38 (s, CHAr), 128.35 (s, CHAr), 128.29 (s, CHAr), 128.29 (s, CHAr), 
127.83 (s, CHAr), 127.68 (s, CHAr), 127.44 (s, CHAr), 126.56 (s, CHAr), 126.44 (s, CHAr), 
103.34 (s, C1 or 36), 103.19 (s, C1 or 36), 102.80 (s, C1 or 36), 102.76 (s, C1 or 36), 74.12 (s, 
CH56), 74.04 (s, CH56), 70.59 (s, CH23), 65.32 (s, CH252), 59.72 (s, CH217), 53.29 (s, 
CH2 or 37), 53.13 (s, CH2 or 37), 53.04 (s, CH2 or 37), 52.91 (s, CH2 or 37), 44.15 (s, CH220 or 
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53), 44.03 (s, CH220 or 53), 43.95 (s, CH220 or 53), 43.82 (s, CH220 or 53), 38.25 (s, CH230, 35), 
31.32 (s, CH262), 31.30 (s, CH262), 31.04 (s, CH2), 28.89 (s, CH2), 28.17 (s, CH2), 25.87 
(s, CH2), 24.28 (s, CH2), 21.90 (s, CH2), 20.75 (s, CH2), 17.64 (s, CH329), 17.61 (s, 
CH329), 15.66 (s, CH39 or 44), 15.63 (s, CH39 or 44), 15.57 (s, CH39 or 44), 14.08 (s, CH319 or 
67), 13.96 (s, CH319 or 67), 13.94 (s, CH319 or 67), 13.88 (s, CH319 or 67). 
FAB – MS [m/z] (relative intensity): 993.4 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C541H6916O1214N6, 993.4968; found, 
993.4968; Δ = 0.01 mmu. 
 
 Carboxylic acid 100 via hydrogenolytic deprotection of 
compound 99 
 
In a 25 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 99 
(115 mg, 116µmol, 1.00 eq.) was dissolved in 5.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (10% Pd, 11.5 mg) was added to the solution. The 
resulting mixture was purged with argon and subsequently with hydrogen gas. The 
reaction was stirred for 3 d at room temperature under hydrogen atmosphere (balloon). 
The crude reaction mixture was filtered over celite® and flushed with 15 mL ethyl 
acetate/dichloromethane (1:1) three times. After evaporation of the solvents and drying 
under reduced pressure the acid 100 was obtained as a colorless solid (102 mg, 
112 µmol, 97.0%). 
IR (ATR):  [cm-1] = 3283.2 (br, 𝜈(N-H)), 2925.5 (w, 𝜈(C-H), 2856.2 (w, 𝜈(C-H), 1751.9 
(m, 𝜈(C=O)), 1671.0 (vs, 𝜈(C=O)), 1541.3 (m), 1453.5 (m), 1383.9 (s), 1308.5 (w), 
1177.1 (vs), 1096.4 (m), 1056.7 (w), 939.9 (w), 832.2 (w), 759.9 (w), 697.3 (s), 622.3 
(w), 464.4 (w), 386.4 (w). 
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1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 12.25 (br s, 1 H, CO2H52), 8.18 – 8.04 (m, 2 
H, NH2,38), 7.99 – 7.86 (m, 2 H, NH25, 58), 7.36 – 7.27 (m, 8 H, CHAr), 7.27 – 7.20 (m, 3 
H, CHAr), 5.18 (dd, J = 9.1, 4.2 Hz, 2 H, CH2,37), 4.98 (p, J = 6.7 Hz, 1 H, CH23), 4.90 
(dd, J = 11.8, 5.6 Hz, 1 H, CH56), 4.78 – 4.40 (m, 4 H, CH220,53), 4.06 – 3.96 (m, 2 H, 
CH217), 3.04 (tt, J = 12.6, 6.3 Hz, 4 H, CH230, 35), 2.45 – 2.38 (m, 6 H, CH39, 44), 1.69 (d, 
J = 5.8 Hz, 3 H, CH262), 1.35 (t, J = 8.2 Hz, 8 H, CH2+CH329), 1.31 – 1.14 (m, 17 H, 
CH2), 1.10 (td, J = 7.1, 2.2 Hz, 3 H, CH319), 0.89 – 0.79 (m, 3 H, CH367). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 169.31 (s, Cq), 169.28 (s, Cq), 169.21 (s, 
Cq), 169.10 (s, Cq), 169.03 (s, Cq), 168.95 (s, Cq), 168.64 (s, Cq), 167.23 (s, CO2H21), 
165.44 (s, CO2R16), 152.84 (s, CO4 or 39), 152.54 (s, CO4 or 39), 152.36 (s, CO4 or 39), 
152.20 (s, CO4 or 39), 148.79 (s, C6 or 41), 148.49 (s, C6 or 41), 144.03 (s, C8 or 43), 143.94 
(s, C8 or 43), 143.84 (s, C8 or 43), 128.40 (s, CHAr), 128.38 (s, CHAr), 128.35 (s, CHAr), 
128.32 (s, CHAr), 128.26 (s, CHAr), 127.44 (s, CHAr), 127.32 (s, CHAr), 127.30 (s, CHAr), 
126.57 (s, CHAr), 126.54 (s, CHAr), 126.42 (s, CHAr), 126.41 (s, CHAr), 103.95 (s, C1 or 
36), 103.34 (s, C1 or 36), 103.18 (s, C1 or 36), 74.05 (s, CH56), 70.59 (s, CH23), 70.55 (s, 
CH23), 59.70 (s, CH217), 53.29 (s, CH2 or 37), 53.03 (s, CH2 or 37), 44.13 (s, CH220 or 53), 
44.04 (s, CH220 or 53), 43.91 (s, CH220 or 53), 43.82 (s, CH220 or 53), 38.27 (s, CH230, 35), 
31.36 (s, CH262), 31.28 (s, CH262), 31.05 (s, CH2), 31.03 (s, CH2), 28.89 (s, CH2), 28.17 
(s, CH2), 25.88 (s, CH2), 24.28 (s, CH2), 21.90 (s, CH2), 17.65 (s, CH329), 17.61 (s, 
CH329), 15.62 (s, CH39 or 44), 15.57 (s, CH39 or 44), 15.52 (s, CH39 or 44), 15.49 (s, CH39 or 
44), 13.96 (s, CH319 or 67), 13.95 (s, CH319 or 67), 13.90 (s, CH319 or 67). 
FAB – MS [m/z] (relative intensity): 903.4 (100%) [M + H]+. 
HRMS – FAB [m/z]: [M + H]+ calculated for 12C471H6316O1214N6, 903.4498; found, 
903.4501; Δ = 0.21 mmu. 
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 Symmetric dimer-CO2Bn 101, obtained from sebacic acid, 
monomer-NC 90 and heptanal 
 
In a tube vial sebacic acid (265 mg, 1.31 mmol, 1.00 eq.) was dissolved in 4 mL 
dichloromethane/dimethyl sulfoxide (6:1). Subsequently, heptanal (522 mg, 
4.58 mmol, 3.50 eq.) and the monomer-NC 90 (2.20 g, 3.92 mmol, 3.00 eq.) were 
added. The reaction mixture was stirred at room temperature for 4 d and monitored via 
GPC. Subsequently, the crude reaction mixture was concentrated under reduced 
pressure. The oily residue was purified via column chromatography employing silica 
gel and eluting with a gradual solvent mixture of ethyl acetate and c-hexane (0:1 → 
1:0). The symmetric dimer 101 was obtained as a colorless solid (1.78 g, 1.15 mmol, 
88.0%). 
Rf = 0.50 in ethyl acetate. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3291.1 (br, 𝜈(N-H)), 2926.4 (m, 𝜈(C-H), 2954.6 (w, 𝜈(C-H), 1740.4 
(m, 𝜈(C=O)), 1654.9 (vs, 𝜈(C=O)), 1535.5 (s), 1496.0 (w), 1453.7 (m), 1382.4 (w), 
1307.8 (w), 1277.0 (w), 1256.4 (w), 1171.1 (vs), 1103.7 (s), 1042.1 (m), 963.3 (w), 
831.1 (w), 753.9 (w), 696.2 (s), 593.7 (w), 516.4 (w), 495.6 (w). 
1H-NMR (600 MHz, DMSO-d6): δ [ppm] = 8.15 (dd, J = 18.8, 3.6 Hz, 2 H, NH3), 7.93 
(ddd, J = 15.8, 11.0, 5.4 Hz, 4 H, NH25,40), 7.49 – 7.19 (m, 17 H, CHAr), 7.16 (dd, J = 
6.4, 2.7 Hz, 4 H, CHAr), 5.22 (t, J = 4.4 Hz, 2 H, CH2), 5.11 – 5.03 (m, 4 H, CH217), 4.99 
(dq, J = 13.9, 6.8 Hz, 2 H, CH23), 4.82 (t, J = 5.6 Hz, 2 H, CH38), 4.78 – 4.44 (m, 4 H, 
CH220), 3.12 – 2.96 (m, 8 H, CH229,34), 2.44 (d, J = 8.9 Hz, 6 H, CCH39), 2.35 (t, J = 7.3 
Hz, 4 H, CH235), 1.66 (s, 4 H, CH243), 1.51 (dd, J = 23.0, 16.1 Hz, 4 H, CH249), 1.44 – 
1.31 (m, 16 H, CH2+CH328), 1.32 – 1.13 (m, 38 H, CH2), 0.85 (t, J = 6.9 Hz, 6 H, CH348). 
13C-NMR (151 MHz, DMSO-d6): δ [ppm] = 172.40 (s, CO2R36), 169.30 (s, CONR24), 
169.26 (s, CONR24), 169.14 (s, CONR39), 168.97 (s, CO2R21), 168.90 (s, CO2R21), 
165.20 (s, CO2R16), 152.26 (s, CO4), 152.11 (s, CO4), 149.74 (s, C6), 149.45 (s, C6), 
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143.83 (s, CAr8), 143.72 (s, CAr8), 136.20 (s, CAr19), 136.18 (s, CAr19), 128.41 (s, CHAr), 
128.37 (s, CHAr), 128.29 (s, CHAr), 127.82 (s, CHAr), 127.70 (s, CHAr), 127.68 (s, CHAr), 
127.47 (s, CHAr), 126.59 (s, CHAr), 126.48 (s, CHAr), 102.83 (s, C1), 102.67 (s, C1), 
73.07 (s. CH38), 70.60 (s, CH23), 70.56 (s, CH23), 65.31 (s, CH217), 53.18 (s, CH2), 52.95 
(s, CH2), 44.06 (s, CH220), 43.86 (s, CH220), 38.27 (s, CH229 or 39), 38.25 (s, CH229 or 39), 
38.14 (s, CH229 or 39), 33.42 (s, CH235), 31.44 (s, CH243), 31.09 (s, CH2), 28.93 (s, CH2), 
28.58 (s, CH2), 28.36 (s, CH2), 28.20 (s, CH2), 25.86 (s, CH2), 24.48 (s, CH2), 24.39 (s, 
CH249), 21.94 (s, CH2), 17.63 (s, CH328), 17.60 (s, CH328), 15.68 (s, CH39), 15.62 (s, 
CH39), 13.87 (s, CH348). 
FAB – MS [m/z] (relative intensity): 1551.4 (100%) [M]+, 1443.5 (35%) [M – C7H7O]+. 
SEC–ESI–MS [m/z]: [M + Na]+ calculated for 12C861H11816O1814N823Na1, 1573.8456; 
found, 1573.8450; Δ = 0.60 mmu. 
 
 Symmetric dimer-CO2H 102, via hydrogenolytic deprotection of 
dimer-CO2Bn 101 
 
In a 25 mL round bottom flask equipped with a magnetic stir bar the symmetric dimer-
CO2Bn 101 (960 mg, 619 µmol, 1.00 eq.) was dissolved in 10.0 mL ethyl acetate. 
Subsequently, palladium on activated charcoal (20% Pd, 192 mg) was added to the 
solution. The solution was purged with argon and subsequently with hydrogen gas. 
The reaction was stirred at 40 °C for 5 h under hydrogen atmosphere (balloon) cooled 
to room temperature and 3 mL dichloromethane were added. The resulting solution 
was stirred for 3 d at room temperature under hydrogen atmosphere (balloon). TLC 
indicated complete conversion of the dimer-CO2Bn 101. The crude reaction mixture 
was filtered over celite®, and flushed with 50 mL ethyl acetate and 50 mL 
dichloromethane. After concentration under reduced pressure and drying in high 
vacuum the symmetric dimer-CO2H 102 was obtained as a colorless solid (834 mg, 
608 µmol, 98.3%). 
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IR (ATR):  [cm-1] = 3296.3 (br, 𝜈(N-H)), 2927.2 (m, 𝜈(C-H), 2854.2 (w, 𝜈(C-H), 1741.9 
(m, 𝜈(C=O)), 1659.2 (vs, 𝜈(C=O)), 1538.6 (s), 1454.2 (w), 1383.1 (w), 1177.4 (vs), 
1095.8 (m), 1029.2 (m), 937.9 (w), 848.5 (w), 760.5 (w), 697.4 (s), 621.2 (w), 494.8 
(w), 395.4 (w). 
1H-NMR (600 MHz, DMSO-d6): δ [ppm] = 12.21 (s, 2 H, CO2H18), 8.02 (dd, J = 20.3, 
3.5 Hz, 2 H, NH3), 7.91 – 7.84 (m, 4 H, NH25,40), 7.31 (dq, J = 9.7, 7.5 Hz, 8 H, CHAr), 
7.27 – 7.21 (m, 2 H, CHAr), 5.18 (s, 2 H. CH2), 4.99 (p, J = 6.9 Hz, 2 H, CH23), 4.84 – 
4.80 (m, 2 H, CH38), 4.72 – 4.39 (m, 4 H, CH20), 3.11 – 2.97 (m, 8 H, CH229,34), 2.41 (d, 
J = 9.2 Hz, 6 H, CH9), 2.34 (t, J = 7.3 Hz, 4 H, CH235), 1.65 (t, J = 15.8 Hz, 4 H, CH243), 
1.52 (dd, J = 13.9, 6.8 Hz, 4 H, CH249), 1.41 – 1.30 (m, 15 H, CH2+CH328), 1.32 – 1.20 
(m, 36 H, CH2), 0.85 (t, J = 6.9 Hz, 6 H, CH348). 
13C-NMR (151 MHz, DMSO-d6): δ [ppm] = 172.31 (s, CO2R36), 169.25 (s, CONR24), 
169.20 (s, CONR24), 169.07 (s, CONR39), 168.97 (s, CO2R21), 168.89 (s, CO2R21), 
167.18 (s, CO2H18), 152.65 (s, CO4), 152.49 (s, CO4), 147.93 (s, C6), 147.63 (s, C6), 
143.98 (s, CAr8), 143.88 (s, CAr8), 128.27 (s, CHAr10,14), 128.23 (s, CHAr10,14), 127.21 (s, 
CHAr12), 126.50 (s, CHAr11,13), 126.39 (s, CHAr11,13), 104.10 (s, C1), 103.98 (s, C1), 73.03 
(s, CH38), 70.46 (s, CH23), 70.42 (s, CH23), 53.24 (s, CH2), 53.01 (s, CH2), 44.00 (s, 
CH220), 43.83 (s, CH220), 38.25 (s, NHCH229 or 34), 38.22 (s, NHCH229 or 34), 38.11 (s, 
NHCH229 or 34), 33.38 (s, CH235), 31.38 (s, CH243), 31.01 (s, CH2), 28.86 (s, CH2), 28.83 
(s, CH2), 28.49 (s, CH2), 28.30 (s, CH2), 28.12 (s, CH2), 25.81 (s, CH2), 24.40 (s, CH2), 
24.32 (s, CH2), 21.85 (s, CH2), 17.55 (s, CH32), 17.52 (s, CH328), 15.50 (s, CH39), 15.42 
(s, CH39), 13.78 (s, CH348).  
FAB – MS [m/z] (relative intensity): 1393.4 (100%) [M – H + Na]+, 1370.8 (35%) [M]+, 
1353.4 (20%) [M – OH]+, 1285.0 (25%) [M – C6H14]+, 1027.4 (25%) [A + H]+, 245.1 
(100%) [B]+. 
SEC–ESI–MS [m/z]: [M + Na]+ calculated for 12C721H10616O1814N823Na1, 1393.7517; 
found, 1393.7507; Δ = 0.99 mmu. 
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 Symmetric dimer-CO2Bn 103, obtained from monomer-NC 85, 
sebacic acid and acetaldehyde 
 
In a 50 mL round bottom flask the monomer-NC 85 (727 mg, 943 µmol, 3.00 eq.) was 
stirred in 4 mL dichloromethane/dimethyl sulfoxide (3:1) subsequently and degassed 
with argon. Subsequently, acetaldehyde (55.4 mg, 1.25 mmol, 4.00 eq.) was added at 
0 °C. Finely powdered sebacic acid (63.6 mg, 1.18 mmol, 1.00 eq.) was added to the 
stirring isocyanide aldehyde mixture. The resulting reaction mixture was stirred at room 
temperature for 2 d under argon atmosphere. Additional acetaldehyde was added after 
12 h (55.4 mg, 1.25 mmol, 4.00 eq.). The crude mixture was dried under reduced 
pressure. The residue was adsorbed onto celite® and purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of ethyl acetate and 
c-hexane (0:1 → 1:1). The dimer-CO2Bn 103 was obtained as a colorless solid 
(369 mg, 201 µmol, 64.1%). The exceeding monomer-NC could be recovered (242 mg, 
193 µmol, 61.5%). 
Rf in ethyl acetate = 0.51. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3305.4 (br, 𝜈(N-H)), 2925.7 (m, 𝜈(C-H)), 2854.5 (w, 𝜈(C-H)), 1738.8 
(m, 𝜈(C=O)), 1664.4 (vs), 1618.4 (m), 1536.9 (m), 1495.9 (m), 1454.9 (m), 1387.0 (m), 
1235.7 (s), 1152.3 (s), 1089.6 (s), 1045.4 (m), 831.4 (m), 755.9 (m), 696.5 (s), 513.4 
(m). 
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1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.94 (d, J = 3.9 Hz, 2 H, NH40), 7.90 (td, J = 
5.8, 3.0 Hz, 4 H, NH9,17), 7.32 – 7.10 (m, 20 H, CHAr51-60), 5.17 (d, J = 3.8 Hz, 2 H, 
CH38), 5.12 – 5.00 (m, 4 H, CH247), 4.88 (q, J = 6.8 Hz, 2 H, CH15), 4.81 (t, J = 6.3 Hz, 
2 H, CH23), 3.92 – 3.39 (m, 4 H, CH271), 3.10 - 2.81 (m, 8 H, CH22,5), 2.50 (underneath 
DMSO signal, CH349), 2.38 – 2.27 (m, 8 H, CH213,71), 1.65 (d, J = 6.9 Hz, 4 H, CH227), 
1.58 – 1.43 (m, 10 H, CH2), 1.35 (q, J = 6.8 Hz, 4 H, CH2), 1.28 (d, J = 6.9 Hz, 6 H, 
CH319), 1.26 – 1.15 (m, 70 H, CH2), 0.87 – 0.80 (m, 6 H, CH333).  
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.40 (s, CO2R14 or 37), 172.21 (s, 
CO2R14 or 37), 169.74 (s, CONR16), 169.12 (s, CONR24), 165.34 (s, CO2R44), 152.60 (s, 
CO41), 150.50 (s, C42), 143.81 (s, CAr48), 136.35 (s, CAr50), 128.32 (s, CHAr), 128.28 (s, 
CHAr), 127.77 (s, CHAr), 127.63 (s, CHAr), 127.28 (s, CHAr), 126.05 (s, CHAr), 102.53 
(s, C38), 73.07 (s, CH23), 69.52 (s, CH15), 65.15 (s, CH247), 52.24 (s, CH39), 41.58 (s, 
CH262), 38.13 (s, CH22 or 5), 38.14 (s, CH22 or 5), 33.43 (s, CH213 or 71), 33.32 (s, 
CH213 or 71), 31.44 (s, CH227), 31.13 (s, CH2), 29.34 (s, CH2), 28.96 (s, CH2), 28.85 (s, 
CH2), 28.75 (s, CH2), 28.70 (s, CH2), 28.56 (s, CH2), 28.54 (s, CH2), 28.52 (s, CH2), 
28.40 (s, CH2), 28.35 (s, CH2), 26.18 (s, CH2), 25.83 (s, CH2), 24.53 (s, CH2), 24.42 (s, 
CH2), 24.28 (s, CH2), 22.05 (s, CH2), 17.70 (s, CH319), 15.69 (s, CH349), 13.91 (s, 
CH333). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C1061H15816O1814N823Na1, 1854.1586; found, 
1854.1629; Δ = 4.33 mmu. 
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 Symmetric dimer-CO2H 104 via hydrogenolytic deprotection of 
dimer-CO2Bn 103  
 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 103 
(230 mg, 123 µmol, 1.00 eq.) was dissolved in 4.00 mL tetrahydrofuran. Subsequently, 
palladium on activated charcoal (20% Pd, 23.0 mg) was added to the solution. The 
solution was purged with hydrogen gas every 30 minutes for 4 h and stirred for 3 d at 
45 °C under hydrogen atmosphere (balloon). The crude reaction mixture was filtered 
over celite® and flushed with 20 mL tetrahydrofuran three times and with 20 mL 
dichloromethane twice. After concentration under reduced pressure the residue was 
washed with 10 mL cold diethyl ether/ethyl acetate (4:1) three times. The solid was 
dried in high vacuum, yielding the carboxylic acid 104 as a colorless solid (204 mg, 
123 µmol, 98.5%). 
IR (ATR):  [cm-1] = 3293.7 (br, 𝜈(N-H)), 2925.6 (s, 𝜈(C-H)), 2854.1 (m, 𝜈(C-H)), 1738.8 
(m, 𝜈(C=O)), 1660.2 (vs, 𝜈(C=O)), 1538.4 (s), 1455.0 (m), 1385.9 (m), 1165.2 (m), 
1091.8 (s), 759.8 (m), 697.0 (w), 613.3 (w), 500.3 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.11 (s, 2 H, CO2H46), 7.94 – 7.80 (m, 6 H, 
7.89 (td, J = 5.8, 3.0 Hz, 4 H, NH9,17), 7.84 (d, J = 3.8 Hz, 2 H, NH40), 7.36 – 7.26 (m, 
5 H, CHAr51-55), 7.26 – 7.15 (m, 5 H, CHAr51-55), 5.13 (d, J = 3.8 Hz, 2 H, CH39), 4.88 (q, 
J = 6.8 Hz, 2 H, CH15), 4.81 (t, J = 6.3 Hz, 2 H, CH23), 3.84 (ddd, J = 14.6, 8.6, 6.3 Hz, 
2H), 3.92 – 3.35 (m, 4 H, CH262), 3.13 – 2.91 (m, 8 H, CH22+5), 2.47 (s, 6 H, CH349), 
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2.39 – 2.28 (m, 8 H, CH213+71), 1.65 (d, J = 7.3 Hz, 4 H, CH227), 1.51 (q, J = 6.7 Hz, 8 
H, CH212+70), 1.36 (t, J = 6.9 Hz, 8 H, CH23,36), 1.28 (d, J = 6.9 Hz, 6 H, CH319), 1.27 – 
1.03 (m, 56 H, CH2), 0.90 – 0.76 (m, 6 H, CH333). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.40 (s, CO2R14 or 37), 172.21 (s, 
CO2R14 or 37), 169.74 (s, CONR24), 169.13 (s, CONR16), 167.89 (s, CO2H44), 153.01 (s, 
CO41), 144.01 (s, CAr48), 128.24 (s, CHAr), 127.11 (s, CHAr), 126.02 (s, CHAr), 103.80 
(s, C38), 73.07 (s, CH23), 69.52 (s, CH15), 52.33 (s, CH39), 41.40 (s, CH262), 38.12 (s, 
CH22 or 5), 38.11 (s, CH22 or 5), 33.43 (s, CH213 or 71), 33.32 (s, CH213 or 71), 31.44 (s, 
CH227), 31.13 (s, CH2), 29.44 (s, CH2), 28.96 (s, CH2), 28.86 (s, CH2), 28.78 (s, CH2), 
28.71 (s, CH2), 28.55 (s, CH2), 28.54 (s, CH2), 28.51 (s, CH2), 28.40 (s, CH2), 28.35 (s, 
CH2), 26.19 (s, CH2), 25.83 (s, CH2), 24.52 (s, CH2), 24.42 (s, CH2), 24.28 (s, CH2), 
22.05 (s, CH2), 17.70 (s, CH319), 15.55 (s, CH349), 13.92 (s, CH333). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C921H14616O1814N823Na1, 1674.0647; found, 
1674.0686; Δ = 3.87 mmu. 
 
 Symmetric tetramer-CO2Bn 105, obtained from dimer-CO2H 102, 
monomer-NC 93 and lauric aldehyde 
 
In a tube vial the symmetric dimer-CO2H 102 (200 mg, 146 µmol, 1.00 eq.) was 
dissolved in 5 mL dichloromethane. Subsequently, the aldehyde (49.1 mg, 437 µmol, 
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3.00 eq.) and the monomer-NC 93 (283 mg, 437 µmol, 3.00 eq.) dissolved in 5 mL 
dichloromethane were added. The mixture was concentrated under reduced pressure 
down to a volume of 2 mL. The reaction mixture was stirred at room temperature for 3 
d. Subsequently, the crude reaction mixture was concentrated under reduced 
pressure. The oily residue was purified via column chromatography (dry loading, 
adsorbed onto celite®) employing silica gel as stationary phase and eluting with a 
gradual solvent mixture of ethyl acetate and c-hexane (1:2 → 1:0) for the elution of the 
monomer-NC 93. The exceeding monomer-NC 93 was almost fully recovered 
(92.3 mg, 501 µmol, 97.5%). The desired tetramer-CO2Bn 105 was eluted with ethyl 
acetate/ethanol (9:1). After concentration under reduced pressure and drying in high 
vacuum the symmetric tetramer-CO2Bn 105 was obtained as a colorless solid (397 
mg, 131 µmol, 89.7%). 
Rf in ethyl acetate/ethanol (9:1) = 0.77. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3303.5 (br, 𝜈(N-H)), 2926.0 (m, 𝜈(C-H), 2855.2 (w, 𝜈(C-H), 1748.0 
(m, 𝜈(C=O)), 1659.5 (vs, 𝜈(C=O)), 1536.5 (s), 1511.5 (m), 1454.8 (w), 1384.5 (w), 
1306.2 (m), 1244.4 (m), 1172.1 (vs), 1103.8 (s), 1039.0 (s), 939.4 (w), 830.5 (w), 754.9 
(w), 697.6 (m), 656.6 (w), 584.5 (w), 505.3 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.23 – 8.08 (m, 4 H, NH9,56), 7.99 – 7.84 (m, 
8 H, NH3,27,42,78), 7.40 – 7.11 (m, 24 H, CHAr), 6.82 (dd, J = 8.7, 3.8 Hz, 4 H. CHAr64,66), 
5.34 – 5.21 (m, 2 H, CH8), 5.19 – 5.14 (m, 2 H, CH55), 5.11 – 5.03 (m, 2 H, CH270), 5.03 
– 4.95 (m, 4 H, CH25,76), 4.88 – 4.78 (m, 4 H, CH1,40), 4.78 – 4.41 (m, 8 H, CH222,73), 
3.72 (s, 6 H, OCH398), 3.15 – 2.82 (m, 16 H, CH231,36,82,87), 2.49 – 2.41 (m, 12 H, 
CH315,63), 2.34 (t, J = 7.2 Hz, 4 H, CH237), 1.76 – 1.61 (m, 10 H, CH245,99+CH81), 1.56 – 
1.44 (m, 4 H, CH251), 1.41 – 1.31 (m, 29 H, CH2+CH330), 1.29 – 1.13 (m, 82 H, CH2), 
1.03 – 0.94 (m, 6 H, CH2), 0.93 – 0.68 (m, 24 H, CH350,95,97,109). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 172.36 (s, CO2R36), 169.30 (s, Cq), 169.26 
(s, Cq), 169.17 (s, Cq), 169.13 (s, Cq), 169.01 (s, Cq), 168.94 (s, Cq), 168.90 (s, Cq), 
168.33 (s, CONR77),165.28 (s, CO2Bn69), 165.21 (s, CO2Bn69), 164.87 (s, CO2R21), 
164.85 (s, CO2R21), 164.75 (s, CO2R21), 158.64 (s, CAr65), 158.61 (s, CAr65), 152.68 (s, 
CO10or57), 152.43 (s, CO10or57), 152.27 (s, CO10or57), 152.11 (s, CO10or57), 151.97 (s, 
CO10or57), 150.55 (s, Cq), 150.30 (s, Cq), 149.34 (s, C59), 149.23 (s, C59), 144.08 (s, 
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CAr14), 143.96 (s, CAr14), 143.73 (s, CAr), 143.64 (s, CAr), 136.26 (s, CAr72), 136.24 (s, 
CAr72), 135.93 (s, CAr61), 135.68 (s, CAr61), 128.46 (s, CHAr), 128.42 (s CHAr), 128.26 (s, 
CHAr16,20), 127.80 (s, CHAr), 127.78 (s, CHAr), 127.71 (s, CHAr), 127.64 (s, CHAr), 127.61 
(s, CHAr), 127.60 (s, CHAr), 126.73 (s, CHAr), 126.63 (s, CHAr), 126.51 (s, CHAr17,19), 
126.40 (s, CHAr17,19), 113.73 (s, CHAr64,66), 113.68 (s, CHAr64,66), 103.21 (s, C54), 103.00 
(s, C54), 102.35 (s, C7), 102.20 (s, C7), 75.10 (s, CH76), 74.99 (s, CH76), 73.29 (s, 
CH1+40), 73.06 (s, CH1+40), 70.57 (s, CH25), 65.26 (s, CH270), 65.20 (s, CH270), 55.06 (s, 
OCH398), 53.08 (s, CH8), 52.89 (s, CH8), 52.45 (s, CH55), 52.25 (s, CH55), 44.33 (s, 
CH222or73), 44.16 (s, CH222or73), 44.01 (s, CH222or73), 42.54 (s, CH81), 38.31 (s, 
CH231,36,82,87), 38.28 (s, CH231,36,82,87), 38.18 (s, CH231,36,82,87), 38.15 (s, CH231,36,82,87), 
33.42 (s, CH237), 31.57 (s, CH2), 31.45 (s, CH2), 31.31 (s, CH2), 31.10 (s, CH2), 29.01 
(s, CH2), 28.98 (s, CH2), 28.94 (s, CH2), 28.89 (s, CH2), 28.85 (s, CH2), 28.72 (s, CH2), 
28.60 (s, CH2), 28.38 (s, CH2), 28.22 (s, CH2), 25.87 (s, CH2), 24.49 (s, CH2), 24.39 (s, 
CH2), 22.10 (s, CH2), 21.95 (s, CH2), 21.81 (s, CH2), 21.77 (s, CH2), 21.44 (s, CH2), 
21.26 (s, CH2), 17.63 (s, CH330), 17.60 (s, CH330), 15.90 (s, CH315or62), 15.80 (s, 
CH315or62), 15.69 (s, CH362), 15.65 (s, CH362), 15.47 (s, CH315), 15.42 (s, CH315), 13.93 
(s, CH350,109), 13.86 (s, CH350,109), 11.36 (s, CH395,97), 11.31 (s, CH395,97), 11.25 (s, 
CH395,97). 
SEC–ESI–MS [m/z]: [M + Na]+ calculated for 12C1681H24616O3414N1623Na1, 3054.7905; 
found, 3054.8069; Δ = 16.4 mmu. 
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 Symmetric tetramer-CO2H 106, via hydrogenolytic deprotection of 
tetramer-CO2Bn 105 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the symmetric tetramer-
benzyl ester 105 (150 mg, 4.94 µmol, 1.00 eq.) was dissolved in 3.00 mL ethyl 
acetate/dichloromethane (1:1). Subsequently, palladium on activated charcoal 
(20 wt.%, 20.0 mg) was added to the solution. The solution was purged with argon for 
3 minutes and subsequently with hydrogen gas for 10 minutes. The reaction was stirred 
for 4 d at room temperature under hydrogen atmosphere (balloon). TLC indicated 
complete conversion of the tetramer-CO2Bn 105 (Rf in ethyl acetate/ethanol (9:1) = 
0.77). The crude reaction mixture was filtered over celite® and flushed with 50 mL 
dichloromethane three times and subsequently with 20 mL ethyl acetate. After 
concentration under reduced pressure and drying in high vacuum the symmetric 
tetramer-CO2H 106 was obtained as a colorless solid (131 mg, 46.0 µmol, 93.4%). 
IR (ATR):  [cm-1] = 3306.1 (br, 𝜈(N-H)), 2925.8 (m, 𝜈(C-H), 2854.2 (w, 𝜈(C-H), 1745.1 
(m, 𝜈(C=O)), 1652.0 (vs, 𝜈(C=O)), 1538.2 (s), 1511.7 (m), 1455.0 (w), 1377.8 (w), 
1246.9 (m), 1172.9 (vs), 1104.7 (s), 1031.7 (s), 831.5 (w), 758.6 (w), 698.7 (m), 632.2 
(w), 427.3 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 12.21 (br s, 1 H, CO2H71), 8.23 – 8.08 (m, 4 
H, NH9,56), 8.01 – 7.84 (m, 8 H, NH3,27,42,78), 7.41 – 7.15 (m, 14 H, CHAr), 6.85 (dd, J = 
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8.5, 4.9 Hz, 4 H, CHAr64,66), 5.36 – 5.21 (m, 2 H, CH8), 5.13 (dd, J = 8.3, 3.4 Hz, 2 H, 
CH55), 5.03 – 4.94 (m, 4 H, CH25,76), 4.87 – 4.79 (m, 4 H, CH1,40), 4.77 – 4.38 (m, 8 H, 
CH222,73), 3.71 (s, 6 H, OCH398), 3.09 – 2.86 (m, 16 H, CH31,36,82,87), 2.47 – 2.38 (m, 12 
H, CH315,63), 2.34 (t, J = 7.3 Hz, 4 H, CH237), 1.80 – 1.62 (m, 10 H, CH245,99+CH81), 1.56 
– 1.46 (m, 4 H, CH251), 1.40 – 1.32 (m, 29 H, CH2+CH330), 1.30 – 1.09 (m, 82 H, CH2), 
1.07 – 0.94 (m, 6 H, CH2), 0.89 – 0.68 (m, 24 H, CH350,95,97,109). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 172.36 (s, CO2R38), 169.30 (s, Cq), 169.26 
(s, Cq), 169.17 (s, Cq), 169.13 (s, Cq), 169.01 (s, Cq), 168.94 (s, Cq), 168.90 (s, Cq), 
168.33 (s, CONR77),165.28 (s, CO2Bn69), 165.21 (s, CO2Bn69), 164.87 (s, CO2R21), 
164.85 (s, CO2R21), 164.75 (s, CO2R21), 158.64 (s, CArOMe65), 158.61 (s, CArOMe65), 
152.68 (s, CO10or57), 152.43 (s, CO10or57), 152.27 (s, CO10or57), 152.11 (s, CO10or57), 
151.97 (s, CO10or57), 150.55 (s, C11), 150.30 (s, C11), 149.34 (s, C59), 149.23 (s, C59), 
144.08 (s, CAr14), 143.96 (s, CAr14), 143.73 (s, CAr), 143.64 (s, CAr), 136.26 (s, CAr72), 
136.24 (s, CAr72), 135.93 (s, CAr61), 135.68 (s, CAr61), 128.46 (s, CHAr), 128.42 (s CHAr), 
128.26 (s, CHAr16,20), 127.80 (s, CHAr), 127.78 (s, CHAr), 127.71 (s, CHAr), 127.64 (s, 
CHAr), 127.61 (s, CHAr), 127.60 (s, CHAr), 126.73 (s, CHAr), 126.63 (s, CHAr), 126.51 
(s, CHAr17,19), 126.40 (s, CHAr17,19), 113.73 (s, CHAr64,66), 113.68 (s, CHAr64,66), 103.21 
(s, C54), 103.00 (s, C54), 102.35 (s, C7), 102.20 (s, C7), 75.10 (s, CH76), 74.99 (s, CH76), 
73.29 (s, CH1+40), 73.06 (s, CH1+40), 70.57 (s, CH25), 65.26 (s, CH270), 65.20 (s, CH270), 
55.06 (s, OCH398), 53.08 (s, CH8), 52.89 (s, CH8), 52.45 (s, CH55), 52.25 (s, CH55), 
44.33 (s, CH222or73), 44.16 (s, CH222or73), 44.01 (s, CH222or73), 42.54 (s, CH81), 38.31 (s, 
CH231,36,82,87), 38.28 (s, CH231,36,82,87), 38.18 (s, CH231,36,82,87), 38.15 (s, CH231,36,82,87), 
33.42 (s, CH237), 31.57 (s, CH2), 31.45 (s, CH2), 31.31 (s, CH2), 31.10 (s, CH2), 29.01 
(s, CH2), 28.98 (s, CH2), 28.94 (s, CH2), 28.89 (s, CH2), 28.85 (s, CH2), 28.72 (s, CH2), 
28.60 (s, CH2), 28.38 (s, CH2), 28.22 (s, CH2), 25.87 (s, CH2), 24.49 (s, CH2), 24.39 (s, 
CH2), 22.10 (s, CH2), 21.95 (s, CH2), 21.81 (s, CH2), 21.77 (s, CH2), 21.44 (s, CH2), 
21.26 (s, CH2), 17.63 (s, CH330), 17.60 (s, CH330), 15.90 (s, CH315or62), 15.80 (s, 
CH315or62), 15.69 (s, CH362), 15.65 (s, CH362), 15.47 (s, CH315), 15.42 (s, CH315), 13.93 
(s, CH350,109), 13.86 (s, CH350,109), 11.36 (s, CH395,97), 11.31 (s, CH395,97), 11.25 (s, 
CH395,97). 
ESI–MS [m/z]: [M + 2 Na]2+ calculated for 12C1541H23416O3414N1623Na2, 1448.8429; 
found, 1448.8455.; Δ = 2.60 mmu. 
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 Symmetric tetramer-CO2Bn 107, obtained from the symmetric 
dimer-CO2H 102, monomer-NC 91 and cyclohexane carbaldehyde 
 
In a tube vial the symmetric dimer-CO2H 102 (160 mg, 119 µmol, 1.00 eq.) was 
dissolved in 5 mL dichloromethane. Subsequently, the aldehyde (46.7 mg, 419 µmol, 
3.50 eq.) and the monomer-NC 91 (278 mg, 356 µmol, 3.00 eq.) dissolved in 5 mL 
dichloromethane were added. The mixture was concentrated under reduced pressure 
down to a volume of 2 mL. The reaction mixture was stirred at room temperature for 
4 d. Subsequently, the crude reaction mixture was concentrated under reduced 
pressure. The oily residue was purified via column chromatography (dry loading, 
adsorbed onto celite®) employing silica gel as stationary phase and eluting with a 
gradual solvent mixture of ethyl acetate and c-hexane (1:3 → 1:0). The symmetric 
tetramer-CO2Bn 107 was obtained as a colorless solid (312 mg, 99.1 µmol, 83.3%). 
The exceeding monomer-NC 91 was recovered as a yellow oil (139 mg, 171 µmol, 
96.1%). 
Rf = 0.40 in ethyl acetate. Visualized via fluorescence quench and Seebach staining 
solution. 
IR (ATR):  [cm-1] = 3304.6 (br, 𝜈(N-H)), 2923.3 (s, 𝜈(C-H), 2852.6 (m, 𝜈(C-H), 1747.8 
(w, 𝜈(C=O)), 1655.2 (vs, 𝜈(C=O)), 1533.6 (s), 1451.1 (w), 1383.7 (m), 1307.9 (w), 
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1253.8 (w), 1169.2 (vs), 1098.9 (s), 1039.8 (w), 1009.4 (w), 830.7 (w), 756.6 (w), 697.6 
(m), 499.2 (w), 399.7 (w). 
1H-NMR (600 MHz, DMSO-d6): δ [ppm] = 8.22 – 8.12 (m, 4 H, NH10,62), 7.96 – 7.86 (m, 
7 H, NH3,28,43,84), 7.45 (t, J = 7.9 Hz, 1 H, CHAr), 7.41 – 7.24 (m, 16 H, CHAr), 7.24 – 
7.19 (m, 4 H, CHAr), 7.17 – 7.11 (m, 4 H, CHAr), 6.94 (s, 1 H, NH), 5.42 – 5.18 (m, 4 H, 
CH9,61), 5.15 – 4.95 (m, 6 H, CH276+CH29), 4.90 (dd, J = 10.5, 5.2 Hz, 2 H, CH82), 4.84 
– 4.80 (m, 2 H. CH42), 4.80 – 4.42 (m, 10 H, CH223,79 + CH1), 3.14 – 2.80 (m, 16 H, 
CH232,37,88,93), 2.50 – 2.40 (m, 12 H, CH316,68), 2.34 (t, J = 7.3 Hz, 4 H, CH238), 1.77 – 
1.58 (m, 12 H, CH2), 1.58 – 1.47 (m, 10 H, CH2), 1.35 (dd, J = 14.2, 6.0 Hz, 25 H, CH2 
+ CH331), 1.31 – 1.06 (m, 92 H, CH2), 1.10 – 0.90 (m, 8 H, CH2cyhex), 0.84 (t, J = 6.6 
Hz, 12 H, CH351,109). 
13C-NMR (151 MHz, DMSO-d6): δ [ppm] = 172.36 (s, CO2R39), 169.29 (s, CONR27), 
169.13 (s, CONR42), 169.01 (s, CO2R24), 168.93 (s, CO2R24), 168.56 (s, CO2R22), 
168.36 (s, CONR3), 165.01 (s, CO2R24), 164.99 (s, CO2R24), 164.89 (s, CO2R80), 
164.78 (s, CO2R80), 152.35 (s, CO11 or 63), 152.18 (s, CO11 or 63), 151.97 (s, CO11 or 63), 
150.12 (s, C65 or 13), 149.95 (s, C65 or 13), 143.13 (s, CAr15 or 67), 142.98 (s, CAr15 or 67), 
136.12 (s, CAr78), 136.10 (s, CAr78), 131.29 (s, CAr71), 131.24 (s, CAr71), 128.81 (s, 
CHAr69,73), 128.74 (s, CHAr69,73), 128.52 (s, CHAr), 128.49 (s, CHAr), 128.37 (s, CHAr), 
128.34 (s, CHAr), 128.25 (s, CHAr), 127.83 (s, CHAr), 127.68 (s, CHAr), 127.66 (s, CHAr), 
126.46 (s, CHAr), 126.37 (s, CHAr), 120.57 (s, CHAr), 120.56 (s, CHAr), 102.73 (s, C8), 
102.58 (s, C8), 102.33 (s, C60), 102.22 (s, C60), 77.08 (s), 74.15 (s, CH82), 74.08 (s, 
CH82), 73.06 (s, CH41), 70.59 (s, CH26), 70.57 (s, CH26), 70.54 (s, CH26), 65.32 (s, 
CH276), 52.99 (s, CH9), 52.76 (s, CH9), 52.59 (s, CH61), 52.41 (s, CH61), 44.13 (s, CH223 
or 79), 43.93 (s, CH223 or 79), 38.25 (s, CH232,37,88,93), 38.15 (s, CH232,37,88,93), 33.42 (s, 
CH238), 31.44 (s, CH245), 31.28 (s, CH287), 31.08 (s, CH249,107), 28.99 (s, CH2), 28.92 
(s, CH2), 28.88 (s, CH2), 28.83 (s, CH2), 28.80 (s, CH2), 28.70 (s, CH2), 28.58 (s, CH2), 
28.55 (s, CH2), 28.54 (s, CH2), 28.37 (s, CH2), 28.20 (s, CH2), 25.86 (s, CH247), 25.68 
(s, CH2), 25.51 (s, CH2), 25.43 (s, CH2), 24.47 (s, CH2), 24.38 (s, CH2), 24.31 (s, CH2), 
22.08 (s, CH2108), 21.93 (s, CH250), 17.61 (s, CH331), 17.58 (s, CH331), 15.91 (s, CH316 
or 68), 15.82 (s, CH316 or 68), 15.68 (s, CH316 or 68), 15.65 (s, CH316 or 68), 15.41 (s, CH316 or 
68), 15.35 (s, CH316 or 68), 13.91 (s, CH3109), 13.84 (s, CH351). 
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FAB – MS [m/z] (relative intensity): 3153.9 (95%) [M + H]+, [M – C2H5O]+, 2695.5 (10%) 
[Fragment A]+, 2500.9 (15%) [Fragment B]+, 1917.1 (25%) [Fragment C]+, 303.1 (60%) 
[M – C8H9O]+, 1351.3 (35%) [Fragment D]+. 
 
SEC–ESI–MS [m/z]: [M + 2 Na]2+ calculated for 12C721H10616O1814N823Na2, 1598.7898; 
found, 1598.7910; Δ = 1.23 mmu. 
 
6.2.3.5 Benzyl esters 
 
 Benzyl ester 108 derived from monomer-NC 85, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the monomer-NC 85 (120 mg, 156 µmol, 1.00 eq.) was 
stirred in 1 mL dichloromethane, subsequently octanal (39.9 mg, 311 µmol, 2.00 eq.) 
and stearic acid (88.5 mg, 311 µmol, 2.00 eq.) were added. The resulting reaction 
mixture was degassed with argon and stirred at room temperature for 4 d. The crude 
mixture was dried under reduced pressure. The residue was adsorbed onto celite® and 
purified via column chromatography on silica gel eluting with a gradual solvent mixture 
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of ethyl acetate and c-hexane (1:4 → 1:1). The benzyl ester 108 was obtained as a 
colorless solid (142 mg, 120 µmol, 77.2%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.44. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3291.7 (br, 𝜈(N-H)), 3093.8 (m), 2921.2 (vs, 𝜈(C-H)), 2851.8 (s, 
𝜈(C-H)), 1739.7 (m, 𝜈(C=O)), 1707.1 (s, 𝜈(C=O)), 1684.4 (vs, 𝜈(C=O)), 1657.2 (s), 
1619.3 (m), 1538.5 (m), 1455.1 (m), 1416.1 (m), 1395.7 (m), 1376.2 (w), 1346.5 (w), 
1322.4 (m), 1271.9 (m), 1215.5 (m), 1194.5 (m), 1153.1 (vs), 1098.5 (s), 1079.0 (m), 
1040.7 (m), 915.3 (w), 828.8 (w), 757.0 (m), 720.9 (m), 699.5 (vs), 652.5 (m), 589.5 
(w), 529.1 (m), 510.8 (m), 458.4 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 7.94 (d, J = 3.9 Hz, 1 H, NH58), 7.92 – 7.85 
(m, 2 H, NH7 + 9), 7.33 – 7.13 (m, 10 H, CHAr69-78), 5.17 (d, J = 3.8 Hz, 1 H, CH57), 5.14 
– 5.00 (m, 2 H, CH265), 4.81 (t, J = 6.3 Hz, 2 H, CH12 + 41), 3.91 – 3.41 (m, 2 H, CH280), 
3.09 – 2.93 (m, 4 H, CH214 + 45), 2.50 (underneath DMSO signal, CH367), 2.33 (td, J = 
7.3, 2.3 Hz, 4 H, CH221 + 89), 1.76 – 1.61 (m, 4 H, CH22 + 5), 1.61 – 1.43 (m, 4 H, CH2), 
1.43 – 1.32 (m, 4 H, CH2), 1.31 – 0.99 (m, 72 H, CH2), 0.90 – 0.78 (m, 9 H, 
CH338 + 39 + 51). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.37 (s, CO2R55), 170.33 (s, CO2R20), 
169.12 (s, CONR42 + 10), 165.34 (s, CO2R62), 152.60 (s, CO59), 150.50 (s, C60), 143.83 
(s, CAr66), 136.35 (s, CAr68), 128.32 (s, CHAr), 128.28 (s, CHAr), 127.78 (s, CHAr), 127.63 
(s, CHAr), 127.27 (s, CHAr), 126.07 (s, CHAr), 102.52 (s, C56), 73.07 (s, CH12 + 41), 65.16 
65.14 (s, CH265), 52.25 (s, CH57), 41.58 (s, CH280), 38.02 (s, CH214 + 45), 33.45 (s, 
CH221 + 89), 31.45 (s, CH22 + 5), 31.33 (s, CH2), 31.18 (s, CH2), 29.37 (s, CH2), 29.06 (s, 
CH2), 28.98 (s, CH2), 28.93 (s, CH2), 28.89 (s, CH2), 28.79 (s, CH2), 28.73 (s, CH2), 
28.58 (s, CH2), 28.43 (s, CH2), 28.40 (s, CH2), 26.21 (s, CH2), 25.76 (s, CH2), 24.56 (s, 
CH2), 24.43 (s, CH2), 22.12 (s, CH2), 22.09 (s, CH2), 20.78 (s, CH2), 15.68 (s, CH367), 
14.10 (s, CH338 + 39 + 51), 13.94 (s, CH338 + 39 + 51), 13.92 (s, CH338 + 39 + 51). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C721H11816O914N423Na1, 1205.8791; found, 
1205.8796; Δ = 0.54 mmu. 
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 Benzyl ester 109 derived from monomer-NC 86, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the isocyanide monomer 86 (100 mg, 129 µmol, 
1.00 eq.) was stirred in 2 mL dichloromethane, subsequently (33.2 mg, 258 µmol, 
2.00 eq.) and stearic acid (73.6 mg, 258 µmol, 2.00 eq.) were added. The resulting 
reaction mixture was degassed with argon and stirred at room temperature for 4 d. The 
crude mixture was dried under reduced pressure. The residue was adsorbed onto 
celite® and purified via column chromatography on silica gel eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (1:4 → 2:1). The benzyl ester 109 was 
obtained as a colorless solid (148 mg, 124 µmol, 96.2%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.42. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3282.9 (br, 𝜈(N-H)), 3091.4 (br, 𝜈(N-H)), 2919.9 (vs, 𝜈(C-H)), 
2850.9 (s, 𝜈(C-H)), 1742.7 (m, 𝜈(C=O)), 1709.6 (s, 𝜈(C=O)), 1682.6 (vs, 𝜈(C=O)), 
1656.4 (s), 1615.2 (m), 1539.1 (m), 1510.2 (w), 1464.7 (m), 1429.2 (m), 1392.2 (w), 
1285.2 (w), 1243.2 (s), 1197.6 (vs), 1154.6 (vs), 1097.0 (s), 1040.4 (m), 913.6 (w), 
846.2 (w), 777.9 (w), 754.2 (w), 722.3 (w), 696.8 (m), 650.9 (w), 589.6 (w), 534.1 (w), 
510.7 (w), 443.9 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.96 – 7.81 (m, 3 H, NH7+9+58), 7.29 (dd, J = 
5.1, 1.9 Hz, 3 H, CHAr), 7.21 – 7.13 (m, 2 H, CHAr), 7.12 – 7.04 (m, 2 H, CHAr), 6.86 – 
6.79 (m, 2 H, CHAr), 5.12 (d, J = 3.8 Hz, 1 H, CH57), 5.10 – 5.01 (m, 2 H, CH265), 4.91 
(d, J = 4.2 Hz, 1 H, CH41), 4.80 (t, J = 6.3 Hz, 1 H, CH12), 3.96 – 3.76 (m, 1 H, CH280a), 
3.71 (s, 3 H, OCH391), 3.58 – 3.38 (m, 1 H, CH280b), 3.14 – 2.93 (m, 4 H, CH22+5), 2.49 
(underneath DMSO signal, CH367), 2.35 (dt, J = 13.4, 7.2 Hz, 4 H, CH221+89), 1.71 – 
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1.59 (m, 3 H, CH214 + CH45), 1.59 – 1.45 (m, 4 H, CH223+88), 1.42 – 1.31 (m, 6 H, 
CH23+54+81), 1.28 – 1.13 (m, 54 H, CH2), 0.93 – 0.76 (m, 12 H, CH338+39+47,93). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.46 (s, CO2R55 or 10), 172.36 (s, CO2R55 
or 10), 169.10 (s, CONR42 or 10), 168.79 (s, CONR42 or 10), 165.37 (s, CO2R62), 158.48 (s, 
CAr71), 152.60 (s, CO59), 150.16 (s, C60), 136.38 (s, CAr68), 135.93 (s, CAr66), 128.27 (s, 
CHAr), 127.75 (s, CHAr), 127.58 (s, CHAr), 127.24 (s, CHAr), 113.60 (s, CHAr), 102.84 
(s, C56), 74.03 (s, CH41), 73.07 (s, CH12), 65.09 (s, CH265), 55.01 (s, OCH390), 51.64 (s, 
CH57), 42.58 (s, CH45), 41.56 (s, CH280), 38.09 (s, CH22 or 5), 38.05 (s, CH22 or 5), 33.50 
(s, CH221 or 89), 33.44 (s, CH221 or 89), 31.43 (s, CH2), 31.30 (s, CH2), 31.16 (s, CH2), 
29.38 (s, CH2), 29.03 (s, CH2), 29.00 (s, CH2), 28.96 (s, CH2), 28.90 (s, CH2), 28.80 (s, 
CH2), 28.71 (s, CH2), 28.68 (s, CH2), 28.56 (s, CH2), 28.54 (s, CH2), 28.42 (s, CH2), 
28.37 (s, CH2), 26.21 (s, CH2), 25.85 (s, CH2), 25.81 (s, CH2), 25.77 (s, CH2), 24.54 (s, 
CH2), 24.43 (s, CH2), 24.41 (s, CH2), 22.10 (s, CH2), 22.07 (s, CH2), 21.77 (s, CH2), 
21.38 (s, CH2), 15.66 (s, CH367), 13.92 (s, CH347 or 93), 13.90 (s, CH347 or 93), 11.28 (s, 
CH338 or 39), 11.24 (s, CH338 or 39). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C711H11616O1014N423Na1, 1207.8584; found, 
1207.8584; Δ = 0.03 mmu. 
 
 Benzyl ester 110 derived from monomer-NC 87, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the isocyanide monomer 87 (100 mg, 130 µmol, 
1.00 eq.) was stirred in 2 mL dichloromethane, subsequently octanal (33.3 mg, 
260 µmol, 2.00 eq.) and stearic acid (74.0 mg, 260 µmol, 2.00 eq.) were added. The 
resulting reaction mixture was degassed with argon and stirred at room temperature 
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for 4 d. The crude mixture was dried under reduced pressure. The residue was 
adsorbed onto celite® and purified via column chromatography on silica gel eluting with 
a gradual solvent mixture of ethyl acetate and c-hexane (1:4 → 1:1). The benzyl ester 
110 was obtained as a colorless solid (143 mg, 121 µmol, 93.5%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.70. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3293.9 (br, 𝜈(N-H)), 3088.1 (br, 𝜈(N-H)), 2921.7 (vs, 𝜈(C-H)), 
2851.8 (s, 𝜈(C-H)), 1740.1 (m, 𝜈(C=O)), 1708.6 (s, 𝜈(C=O)), 1681.7 (vs), 1657.4 (m), 
1617.1 (w), 1540.8 (m), 1465.6 (w), 1422.2 (w), 1391.5 (w), 1374.7 (w), 1336.5 (m), 
1321.6 (w), 1274.6 (m), 1234.5 (m), 1194.7 (m), 1151.8 (s), 1096.4 (m), 1040.7 (w), 
986.0 (w), 913.8 (w), 843.7 (w), 777.0 (w), 755.2 (w), 721.4 (w), 696.9 (m), 651.2 (w), 
590.3 (w), 554.4 (w), 521.6 (m), 447.4 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.93 – 7.76 (m, 3 H, NH7+9+54), 7.28 (dd, J = 
5.0, 1.9 Hz, 3 H, CHAr), 7.17 (dd, J = 6.7, 2.9 Hz, 2 H, CHAr), 7.10 – 6.98 (m, 5 H, 
CHAr70-74), 5.13 (d, J = 3.8 Hz, 1 H, CH53), 5.11 – 4.98 (m, 2 H, CH261), 4.81 (t, J = 7.1 
Hz, 1 H, CH12), 4.67 (d, J = 5.3 Hz, 1 H, CH41), 3.92 – 3.74 (m, 1 H, CH276a), 3.52 – 
3.39 (m, 1 H, CH276b), 3.12 – 2.89 (m, 4 H, CH22+5), 2.49 (s, 3 H, CH363), 2.34 (dt, J = 
7.7 Hz, J = 7.3 Hz, 4 H, CH221+85), 2.25 (s, 3 H, CH386), 1.78 – 1.58 (m, 4 H, CH2), 1.60 
– 0.95 (m, 75 H, CH2), 0.84 (t, J = 6.7 Hz, 6 H, CH338+39). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.38 (s, CO2R20 or 51), 172.30 (s, CO2R20 
or 51), 169.08 (s, CONR10), 168.21 (s, CONR42), 165.34 (s, CO2R58), 152.64 (s, CO55), 
150.25 (s, C56), 140.87 (s, CAr62), 136.34 (s, CAr64), 128.77 (s, CHAr), 128.23 (s, CHAr), 
127.73 (s, CHAr), 127.59 (s, CHAr), 125.94 (s, CHAr), 102.75 (s, C52), 76.97 (s, CH41), 
73.05 (s, CH12), 65.09 (s, CH261), 51.88 (s, CH53), 41.52 (s, CH276), 38.03 (s, CH22 or 5), 
38.00 (s, CH22 or 5), 33.44 (s, CH221 or 85), 33.41 (s, CH221 or 85), 31.42 (s, CH2), 31.29 (s, 
CH2), 31.15 (s, CH2), 29.38 (s, CH2), 29.02 (s, CH2), 28.96 (s, CH2), 28.89 (s, CH2), 
28.80 (s, CH2), 28.70 (s, CH2), 28.68 (s, CH2), 28.61 (s, CH2), 28.54 (s, CH2), 28.43 (s, 
CH2), 28.38 (s, CH2), 27.28 (s, CH2), 26.18 (s, CH2), 25.75 (s, CH2), 25.53 (s, CH2), 
25.41 (s, CH2), 24.53 (s, CH2), 24.40 (s, CH2), 22.08 (s, CH2), 22.05 (s, CH2), 20.57 (s, 
CH386), 15.65 (s, CH363), 13.88 (s, CH338 or 39), 13.86 (s, CH338 or 39). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C721H11616O914N423Na1, 1203.8635; found, 
1203.8637; Δ = 0.20 mmu.  
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 Benzyl ester 111 derived from monomer-NC 88, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the isocyanide monomer 88 (130 mg, 149 µmol, 
1.00 eq.) was stirred in 2 mL dichloromethane, subsequently octanal (38.3 mg, 
298 µmol, 2.00 eq.) and stearic acid (84.9 mg, 298 µmol, 2.00 eq.) were added. The 
resulting reaction mixture stirred at room temperature for 3 d under argon atmosphere. 
The crude mixture was dried under reduced pressure. The residue was adsorbed onto 
celite® and purified via column chromatography on silica gel eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (1:3 → 2:1). The benzyl ester 111 was 
obtained as a colorless oil (149 mg, 115 µmol, 77.6%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.67. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3270.6 (br, 𝜈(N-H)), 3092.7 (br, 𝜈(N-H)), 2918.9 (vs, 𝜈(C-H)), 
2850.3 (s, 𝜈(C-H)), 1741.7 (s, 𝜈(C=O)), 1680.1 (s, 𝜈(C=O)), 1656.1 (vs, 𝜈(C=O)), 
1564.0 (m), 1463.5 (m), 1383.0 (m), 1253.6 (m), 1233.4 (m), 1213.8 (m), 1191.2 (m), 
1161.0 (vs), 1088.3 (s), 805.8 (m), 722.5 (m), 696.7 (m), 503.9 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.93 (d, J = 3.8 Hz, 1 H, NH26), 7.89 (t, J = 
5.3 Hz, 2 H, NH7+9), 7.40 – 7.17 (m, 10 H, CHAr37-41+61-65), 5.15 (d, J = 3.9 Hz, 0.3 H, 
CH25 minor), 5.13 (d, J = 3.7 Hz, 0.7 H, CH25 major), 5.07 (s, 1.5 H, CH259 major), 5.06 (s, 
0.5 H, CH259 minor), 4.81 (t, J = 6.3 Hz, 2 H, CH10+68), 3.98 – 3.88 (m, 2 H, CH234), 3.88 
– 3.72 (m, 1 H, CH243a), 3.53 – 3.38 (m, 1 H, CH243b), 3.09 – 2.95 (m, 4 H, CH22+5), 2.48 
(s, 3 H, CH335), 2.33 (td, J = 7.3, 2.1 Hz, 4 H, CH252 or 55 or 77), 2.25 (t, J = 7.4 Hz, 2 H, 
CH252 or 55 or 77), 1.72 – 1.58 (m, 4 H, CH214+70), 1.57 – 1.41 (m, 10 H, CH2), 1.41 – 0.98 
(m, 90 H, CH2), 0.86 – 0.79 (m, 9 H, CH321+94+95). 
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13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.56 (s, CO2R20 or 56 or 76), 172.54 (s, 
CO2R20 or 56 or 76), 172.35 (s, CO2R20 or 56 or 76), 169.10 (s, CONR11+66), 165.71 (s, 
CO2R30), 165.58 (s, CO2R30), 153.27 (s, CO27), 152.58 (s, CO27), 149.83 (s, C28), 
143.94 (s, CAr34), 143.53 (s, CAr34), 136.26 (s, CAr60), 128.38 (s, CHAr), 128.27 (s, CHAr), 
127.94 (s, CHAr), 127.92 (s, CHAr), 127.89 (s, CHAr), 126.03 (s, CHAr), 102.80 (s, C24), 
73.06 (s, CH10+68), 65.29 (s, CH259), 65.25 (s, CH259), 63.26 (s, CH233), 52.38 (s, CH25), 
41.51 (s, CH243), 38.02 (s, CH22 or 5), 33.43 (s, CH252 or 55 or 77), 33.29 (s, CH252 or 55 or 77), 
33.19 (s, CH252 or 55 or 77), 31.44 (s, CH2), 31.30 (s, CH2), 31.16 (s, CH2), 31.11 (s, CH2), 
29.38 (s, CH2), 29.03 (s, CH2), 28.97 (s, CH2), 28.90 (s, CH2), 28.87 (s, CH2), 28.78 (s, 
CH2), 28.71 (s, CH2), 28.69 (s, CH2), 28.55 (s, CH2), 28.41 (s, CH2), 28.38 (s, CH2), 
28.25 (s, CH2), 27.75 (s, CH2), 26.20 (s, CH2), 25.76 (s, CH2), 25.02 (s, CH2), 24.87 (s, 
CH2), 24.54 (s, CH2), 24.50 (s, CH2), 24.41 (s, CH2), 23.97 (s, CH2), 22.10 (s, CH2), 
22.07 (s, CH2), 21.97 (s, CH2), 20.75 (s, CH2), 15.57 (s, CH335), 13.92 (s, CH321 or 94 or 
95), 13.90 (s, CH321 or 94 or 95), 13.86 (s, CH321 or 94 or 95). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C771H12616O1114N423Na1, 1305.9315; found, 
1305.9331; Δ = 1.58 mmu. 
 
 Benzyl ester 112 derived from monomer-NC 89, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the monomer-NC 89 (300 mg, 455 µmol, 1.00 eq.) was 
stirred in 3 mL dichloromethane, subsequently octanal (116 mg, 910 µmol, 2.00 eq.), 
stearic acid (194 mg, 683 µmol, 1.50 eq.) and a few droplets of dimethyl sulfoxide were 
added. The resulting reaction mixture was degassed with argon and stirred at room 
temperature for 3 d under argon atmosphere. The crude mixture was dried under 
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reduced pressure. The residue was adsorbed onto celite® and purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of ethyl acetate and 
c-hexane (1:2 → 2:1) and dried under reduced pressure to yield the benzyl ester 112 
as a colorless solid (396 mg, 369 µmol, 81.2%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.74. 
IR (ATR):  [cm-1] = 3269.5 (br, 𝜈(N-H)), 3093.2 (br, 𝜈(N-H)), 2919.3 (w, 𝜈(C-H)), 2850.2 
(w, 𝜈(C-H)), 1741.0 (s, 𝜈(C=O)), 1681.9 (s, 𝜈(C=O)), 1656.7 (vs), 1617.3 (m), 1539.7 
(m), 1495.9 (m), 1456.0 (w), 1372.4 (m), 1235.6 (s), 1191.7 (m), 1161.1 (vs), 1112.7 
(m), 1086.9 (w), 1045.4 (s), 938.4 (w), 830.1 (w), 755.9 (m), 723.8 (m), 697.0 (s), 633.7 
(w), 514.3 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 7.96 (d, J = 3.9 Hz, 1 H, NH54), 7.90 (q, J = 
5.4 Hz, 2 H, NH7+9), 7.32 – 7.12 (m, 10 H, CHAr65-69 + 77-81), 5.18 (d, J = 3.8 Hz, 1 H, 
CH53), 5.11 – 5.02 (m, 2 H, CH261), 4.84 – 4.78 (m, 2 H, CH12+41), 3.87 – 3.43 (m, 2 H, 
CH271), 3.03 (tq, J = 13.3, 6.6 Hz, 4 H, CH22+5), 2.51 (s, 3 H, CH363), 2.33 (t, J = 7.3 Hz, 
2 H, CH221 or 75), 2.28 (td, J = 7.4, 3.4 Hz, 2 H, CH221 or 75), 1.73 – 1.59 (m, 4 H, CH214+45), 
1.57 – 1.44 (m, 4 H, CH223+74), 1.42 – 1.31 (m, 6 H, CH272+3+50), 1.32 – 1.11 (m, 56 H, 
CH2), 0.84 (t, J = 6.7 Hz, 9 H, CH338+39+51). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.33 (s, CO2R20 or 76), 172.27 (s, CO2R20 
or 76), 169.10 (s, CONR10 + 42), 165.33 (s, CO2R58), 152.58 (s, CO55), 150.47 (s, C56), 
143.86 (s, CAr62), 136.34 (s, CAr64), 128.34 (s, CHAr), 128.27 (s, CHAr), 127.76 (s, CHAr), 
127.62 (s, CHAr), 127.28 (s, CHAr), 126.11 (s, CHAr), 102.55 (s, C52), 102.53 (s, C52), 
73.13 (s, CH12 or 41), 73.05 (s, CH12 or 41), 65.15 (s, CH261), 52.30 (s, CH53), 41.50 (s, 
CH271), 38.09 (s, CH22 + 50), 33.47 (s, CH221 or 75), 33.26 (s, CH221 or 75), 31.46 (s, CH2), 
31.34 (s, CH2), 31.20 (s, CH2), 29.08(s, CH2) , 29.06 (s, CH2), 29.02 (s, CH2), 29.00 (s, 
CH2), 28.98 (s, CH2), 28.95 (s, CH2), 28.76 (s, CH2), 28.74 (s, CH2), 28.61 (s, CH2), 
28.58 (s, CH2), 28.43 (s, CH2), 26.78 (s, CH2), 25.84 (s, CH2), 25.56 (s, CH2), 24.58 (s, 
CH2), 24.44 (s, CH2), 24.02 (s, CH2), 22.14 (s, CH2), 22.10 (s, CH2), 21.80 (s, CH2), 
15.66 (s, CH363), 13.92 (s, CH338 or 39 or 51), 13.90 (s, CH338 or 39 or 51), 13.79 (s, CH338 or 39 
or 51). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C641H10216O914N423Na1, 1093.7539; found, 
1093.7550; Δ = 1.10 mmu.  
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 Benzyl ester 113 derived from monomer-NC 90, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the monomer-NC 90 (120 mg, 214 µmol, 1.00 eq.) was 
stirred in 2 mL dichloromethane, subsequently octanal (54.9 mg, 428 µmol, 2.00 eq.) 
and stearic acid (91.3 mg, 311 µmol, 1.50 eq.) and one droplet of dimethyl sulfoxide 
were added. The resulting reaction mixture was degassed with Argon and stirred at 
room temperature for 5 d. The crude mixture was dried under reduced pressure. The 
residue was adsorbed onto celite® and purified via column chromatography on silica 
gel eluting with a gradual solvent mixture of ethyl acetate and c-hexane (1:1 → 1:0). 
The benzyl ester 113 was obtained as a colorless solid (166 mg, 171 µmol, 80.1%). 
Rf in ethyl acetate/c-hexane (5:1) = 0.47. 
IR (ATR):  [cm-1] = 3288.9 (br, 𝜈(N-H)), 2922.3 (vs, 𝜈(C-H)), 2852.7 (s, 𝜈(C-H)), 1736.3 
(s, 𝜈(C=O)), 1683.8 (vs, 𝜈(C=O)), 1661.0 (vs, 𝜈(C=O)), 1619.3 (m), 1543.3 (m), 1496.5 
(m), 1455.4 (w), 1408.1 (w), 1372.7 (m), 1307.4 (w), 1278.5 (w), 1254.5 (s), 1204.3 
(s), 1171.4 (vs), 1107.3 (m), 1044.2 (m), 963.0 (w), 883.5 (w), 831.7 (w), 762.0 (w), 
697.1 (s), 591.0 (w), 497.7 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.17 (dd, J = 16.2, 3.7 Hz, 1 H, NH51), 8.00 
– 7.86 (m, 2 H, NH7 + 9), 7.40 – 7.10 (m, 10 H, CHAr61-65 + 69-73), 5.21 (t, J = 4.3 Hz, 1 H, 
CH), 5.17 – 5.00 (m, 2 H, CH258), 5.01 – 4.95 (m, 1 H, CH44), 4.80 (t, J = 6.2 Hz, 1 H, 
CH15), 4.78 – 4.42 (m, 2 H, CH267), 3.02 (qq, J = 13.8, 6.7 Hz, 4 H, CH22+5), 2.43 (d, J 
= 7.6 Hz, 3 H, CH360), 2.38 – 2.28 (m, 2 H, CH224), 1.74 – 1.58 (m, 2 H, CH2), 1.58 – 
1.44 (m, 2 H, CH217), 1.44 – 1.35 (m, 4 H, CH2), 1.33 (dd, J = 6.9, 1.7 Hz, 3 H, CH347), 
1.22 (s, 46 H, CH2), 0.84 (td, J = 6.9, 2.2 Hz, 6 H, CH341+42). 
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13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.46 (s, CO2R23), 169.35 (s, CO2R48), 
169.30 (s, CO2R48), 169.17 (s, CONR13 or 45), 169.04 (s, CONR13 or 45), 168.97 (s, 
CONR13 or 45), 165.23 (s, CO2R55), 152.29 (s, CO2R52), 152.13 (s, CO2R52), 149.85 (s, 
C53), 149.54 (s, C53), 143.88 (s, CAr59), 143.76 (s, CAr59), 136.24 (s, CAr19), 136.21 (s, 
CAr19), 128.47 (s, CHAr), 128.43 (s, CHAr), 128.33 (s, CHAr), 127.98 (s, CHAr), 127.93 
(s, CHAr), 127.87 (s, CHAr), 127.75 (s, CHAr), 127.73 (s, CHAr), 127.53 (s, CHAr), 126.65 
(s, CHAr), 126.53 (s, CHAr), 126.23 (s, CHAr), 102.82 (s, C49), 102.64 (s, C49), 73.09 (s, 
CH15), 70.64 (s, CH44), 65.36 (s, CH258), 53.23 (s, CH50), 52.98 (s, CH50), 44.09 (s, 
CH267), 43.87 (s, CH267), 38.30 (s, CH22 or 5), 38.27 (s, CH22 or 5), 38.17 (s, CH22 or 5), 
33.48 (s, CH224), 31.48 (s, CH2), 31.36 (s, CH2), 31.22 (s, CH2), 29.11 (s, CH2), 29.09 
(s, CH2), 29.07 (s, CH2), 29.03 (s, CH2), 29.00 (s, CH2), 28.97 (s, CH2), 28.78 (s, CH2), 
28.75 (s, CH2), 28.63 (s, CH2), 28.58 (s, CH2), 28.43 (s, CH2), 25.91 (s, CH2), 24.62 (s, 
CH2), 24.48 (s, CH2), 22.17 (s, CH2), 22.14 (s, CH2), 17.70 (s, CH347), 17.67 (s, CH347), 
15.72 (s, CH360), 15.65 (s, CH360), 14.02 (s, CH341 or 42), 13.99 (s, CH341 or 42). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C571H8816O914N423Na1, 995.6449; found, 
995.6447; Δ = 0.20 mmu. 
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 Benzyl ester 114 derived from monomer-NC 91, stearic acid and 
octanal 
 
The monomer-NC 91 (200 mg, 256 µmol, 1.00 eq.) was stirred in 2 mL 
dichloromethane in a tube l, subsequently octanal (6.50 mg, 513 µmol, 2.00 eq.) and 
stearic acid (110 mg, 385 µmol, 1.50 eq.) were added. The resulting reaction mixture 
was stirred at room temperature for 3 d. The crude mixture was dried under reduced 
pressure. The residue was purified via column chromatography on silica gel eluting 
with a gradual solvent mixture of ethyl acetate and c-hexane (0:1 → 1:1) and dried in 
vacuo to yield the benzyl ester 114 (229 mg, 192 μmol, 75.0%). 
Rf = 0.27 in c-hexane/ethyl acetate (2:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3286.8 (br, 𝜈(N-H)), 3095.5 (br, 𝜈(N-H)), 2922.7 (vs, 𝜈(C-H)), 
2852.8 (s, 𝜈(C-H)), 1735.9 (s, 𝜈(C=O)), 1709.2 (m, 𝜈(C=O)), 1686.5 (vs,  𝜈(C=O)), 
1657.8 (vs, 𝜈(C=O)), 1624.8 (m, 𝜈(C=O)), 1546.7 (m), 1485.0 (w), 1456.2 (m), 1408.9 
(m), 1373.9 (m), 1308.1 (w), 1252.6 (m), 1207.3 (s), 1186.7 (s), 1166.2 (s), 1106.0 (m), 
1042.0 (m), 1026.3 (m), 1007.8 (m), 958.4 (w), 861.8 (w), 806.2 (w), 763.0 (m), 719.8 
(w), 697.2 (m), 647.9 (w), 582.0 (w), 501.8 (w), 429.8 (w). 
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1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8. 20 (dd, J = 22.0, 3.6 Hz, 1 H, NH3), 7.96 – 
7.85 (m, 2 H, NH25,36), 7.48 – 7.42 (m, 2 H, CHAr), 7.31 – 7.26 (m, 3 H, CHAr), 7.21 (t, 
J = 8.7 Hz, 2 H, CHAr), 7.14 (d, J = 3.3 Hz, 2 H, CHAr), 5.22 – 5.18 (m, 1 H, CH2), 5.11 
– 4.99 (AB-Signal, δA = 5.08, δB = 5.03, JAB = 15.0 Hz, 2 H, CH217), 4.90 (dt, 
J = 9.1, 4.6 Hz, 1 H, CH23), 4.83 – 4.79 (m, 1 H, CH55), 4.77 – 4.43 (m, 2 H, CH220), 
3.12 – 2.94 (m, 4 H, CH230,35), 2.44 (d, J = 11.6 Hz, 3 H, CH39), 2.34 (dt, 
J = 11.4, 6.3 Hz, 2 H, CH257), 1.70 (m, 5 H, CH2),1.49 (dt, J = 13.8, 6.7 Hz, 3 H, CH2), 
1.36 (d, J = 5.7 Hz, 5 H, CH2), 1.22 (s, 57 H, CH2,), 0.86 – 0.81 (m, 12 H, CH3). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 174.50 (s, CO2R64), 174.48 (s, CO2R64), 
172.39 (s, CONR53), 172.34 (s, CONR53), 169.13 (s, CO2R21), 169.05 (s, CO2R21), 
168.96 (s, CONR24), 168.56 (s, CONR24), 165.00 (s, CO2Bn16), 152.19 (s, C4), 151.98 
(s, C4), 150.17 (s, C6), 150.00 (s, C6), 143.15 (s, CAr8), 143.00(s, CAr8), 136.14 (s, CAr19), 
131.30 (s, CHAr), 131.25 (s, CHAr), 128.84 (s, CHAr), 128.76 (s, CHAr), 128.26 (s, CHAr), 
127.84 (s, CHAr)127.70 (s, CHAr), 127.68 (s, CHAr), 102.32 (s, C1), 102.21 (s, C1), 74.15 
(s, CH23), 74.09 (s, CH23), 73.06 (s, CH46), 65. 33 (s, CH217), 52.60 (s, CH2), 52. 42 (s, 
CH2), 44.13 (s, CH220), 44.03 (s, CH220), 38.16 (s, CH2), 38.07 (s, CH2), 33.67 (s, CH2), 
33.46 (s, CH2), 31.45 (s, CH2), 31.35 (s, CH2), 31.33 (s, CH2), 31.19 (s, CH2), 29.06 (s, 
CH2), 29.01 (s, CH2), 28.94 (s, CH2), 28.90 (s, CH2), 28.78 (s, CH2), 28.75 (s, CH2), 
28.63 (s, CH2), 28.60 (s, CH2), 28.57 (s, CH2), 28.41 (s, CH2), 25.82 (s, CH2), 25.79 (s, 
CH2), 24.57 (s, CH2), 24.51 (s, CH2), 24.43 (s, CH2), 24.35 (s, CH2), 22.13 (s, CH2), 
22.09 (s, CH2), 22.07 (s, CH2), 15.69 (s, CH39), 15.66 (s, CH39), 13.95 (s, CH3), 13.92 
(s, CH3), 13.90 (s, CH3). 
ESI–MS (m/z): [M + Na]+ calculated for 12C671H10779Br116O914N423Na1, 1213.7119; 
found, 1213.7199; Δ = 8.00 mmu. 
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 Benzyl ester 115 derived from monomer-NC 92, stearic acid and 
octanal 
 
The monomer-NC 92 (100 mg, 138 µmol, 1.00 eq.) was stirred in 1 mL 
dichloromethane in a 10 mL round bottom flask, subsequently octanal (35.4 mg, 
276 µmol, 2.00 eq.) and stearic acid (58.9 mg, 207 µmol, 1.50 eq.) were added. The 
resulting reaction mixture was degassed with argon and stirred at room temperature 
for 2 d. After 2 d reaction time the conversion was incomplete and additional monomer-
NC 92 (50.4 mg, 69,5 µmol, 0.50 eq.), octanal (24.6 mg, 191 µmol, 1.38 eq.) and 
stearic acid (42.3 mg, 148 µmol, 1.07 eq.) were added to the mixture and stirred at 
room temperature for 2 d. The crude mixture was dried under reduced pressure. The 
residue was purified via column chromatography on silica gel eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (0:1 → 1:1) and dried in vacuo to yield 
the benzyl ester 115 as a colorless oil (99.0 mg, 87.0 μmol, 41.9%). 
Rf = 0.67 in c-hexane/ethyl acetate (2:3). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3286.8 (br, 𝜈(N-H)), 2920.6 (vs, 𝜈(C-H)), 2852.8 (s, 𝜈(C-H)), 1738.0 
(m, 𝜈(C=O)), 1709.2 (m, 𝜈(C=O)), 1686.5 (vs,  𝜈(C=O)), 1657.7 (vs,  𝜈(C=O)), 1624.8 
(w,  𝜈(C=O)), 1612.5 (w,  𝜈(C=O)), 1583.7 (vw), 1540.5 (w), 1509.7 (m), 1456.2 (m), 
1413.0 (w), 1376.0 (m), 1306.0 (w), 1281.4 (w), 1242.3 (s), 1205.3 (s), 1172.3 (vs), 
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1104.5 (s), 1044.8 (m), 964.6 (vw), 925.5 (vw), 886.4 (vw), 857.6 (vw), 847.4 (vw), 
824.7 (vw), 802.1 (vw), 785.7 (vw), 761.0 (w), 721.9 (w), 697.2 (m), 652.0 (w), 614.9 
(vw), 592.3 (vw), 559.4 (vw), 534.7 (vw), 508.0 (vw), 444.2 (vw), 425.7 (vw). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.35 – 8.19 (m 1 H, NH3), 8.18 – 7.81 (m, 
2 H, NH25,35), 7.35 – 7.24 (m, 5 H, CHAr), 7.20 – 7.04 (m, 7 H, CHAr), 7.04 – 6.96 (m, 
1 H, CHAr), 5.24 (t, J = 8.0 Hz, 1 H, CH2), 5.13 – 5.01 (m, 2 H, CH217), 4.91 – 4.78 (m, 
2 H, CH23,45), 4.77 – 4.49 (m, 2 H, CH220), 3.16 – 2.96 (m, 4 H, CH229,34), 2.83 (dq, 
J = 6.6, 4.3 Hz, 1 H, CH80), 2.69 (t, J = 22.1 Hz, 2 H, CH242), 2.54 – 2.39 (m, 2 H, CH39), 
2.37 – 2.30 (m, 2 H, CH255), 2.29 – 2.21 (m, 1 H, CH28), 1.64 (d, J = 4.5 Hz, 2 H, CH2), 
1.55 – 1.46 (m, 2 H, CH2), 1.44 – 1.31 (m, 6 H, CH2), 1.22 (s, 32 H, CH2,), 1.18 – 1.16 
(m, 6 H, CH381,82), 0.92 – 0.73 (m, 9 H, CH353,72,74). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.39 (s, CO2R54), 169.15 (s, CO2R21), 
169.05 (s, CO2R21), 168.05 (s, CONR24 or CONR43), 167.97 (s, s, CONR24 or CONR43), 
167.78 (s, CONR24 or CONR43), 167.74 (s, CONR24 or CONR43), 165.16 (s, CO2Bn16), 
165.11 (s, CO2Bn16), 162.46 (s, CAr12), 160.53 (s, CAr12), 152.62 (s, C4), 152.44 (s, C4), 
152.30 (s, C4), 152.22 (s, C4), 150.14 (s, C6), 149.95 (s, C6), 149.88 (s, C6), 146.00 (s, 
CAr77), 145.89 (s, CAr77), 140.04 (s, CAr73), 139.86 (s, CAr73), 137.13 (s, CAr8), 136.98 (s, 
CAr8), 136.91 (s, CAr8), 136.18 (s, CAr19), 128.92 (dd, J = 10.7, 5.4 Hz, CHAr10,14), 128.52 
(dd, J = 11.5, 6.2 Hz, CHAr10,14), 128.29 (s, CHAr), 127.86 (s, CHAr), 127.83 (s, CHAr), 
127.73 (s, CHAr), 127.69 (s, CHAr), 127.68 (s, CHAr), 127.62 (s, CHAr), 126.17 (s, 
CHAr76,78), 126.13 (s, CHAr76,78), 115.23 (d, J = 3.9 Hz, CHAr11,13), 115.06 (d, J = 3.9 Hz, 
CHAr11,13), 102.71 (s, C1), 102.59 (s, C1), 77.58 (s, CH23), 77.52 (s, CH23), 75.69 (s, 
CH23), 75.52 (s, CH23), 73.06 (s, CH45), 65.36 (s, CH217), 65.32 (s, CH217), 52.41 (s, 
CH2), 52.28 (s, CH2), 52.20 (s, CH2), 44.51 (s, CH220), 44.31 (s, CH220), 44.21 (s, 
CH220), 38.26 (s, CH229,34), 38.12 (s, CH229,34), 36.94 (s, CH28), 36.77 (s, CH242), 36.70 
(s, CH242), 36.59 (m, CH242), 33.46 (s, CH255), 33.02 (s, CH80), 31.44 (s, CH2), 31.31 
(s, CH2), 31.16 (s, CH2), 29.04 (s, CH2), 28.98 (s, CH2), 28.92 (s, CH2), 28.73 (s, CH2), 
28.70 (s, CH2), 28.57 (s, CH2), 28.54 (s, CH2), 28.39 (s, CH2), 26.36 (s, CH2), 25.90 (s, 
CH2), 24.56 (s, CH2), 24.43 (s, CH2), 23.93 (s, CH381,82), 23.89 (s, CH381,82), 22.12 (s, 
CH2), 22.07 (s, CH2), 15.89 (s, CH39), 15.78 (s, CH39), 15.71 (s, CH39), 15.19 (s, CH374), 
15.08 (s, CH374), 14.09 (s, CH353 or 72), 13.94 (s, CH353 or 72), 13.91 (s, CH353 or 72). 
19F-NMR (400 MHz, DMSO-d6) δ [ppm] = -119.39 (s, F41), -119.40 (s, F41), -119.41 (s, 
F41), -119.45 (s, F41). 
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ESI–MS (m/z): [M + Na]+ calculated for 12C681H10116O914N419F123Na1, 1159.7445; found, 
1159.7449; Δ = 0.40 mmu. 
 
 Benzyl ester 116 derived from monomer-NC 83, stearic acid and 
octanal 
 
In a 5 mL round bottom flask the monomer-NC 83 (100 mg, 156 µmol, 1.00 eq.) was 
stirred in 2 mL dichloromethane, subsequently octanal (39.9 mg, 311 µmol, 2.00 eq.) 
and stearic acid (88.6 mg, 311 µmol, 2.00 eq.) were added. The resulting reaction 
mixture was degassed with argon and stirred at room temperature for 4 d. The crude 
mixture was dried under reduced pressure. The residue was adsorbed onto celite® and 
purified via column chromatography on silica gel eluting with a gradual solvent mixture 
of ethyl acetate and c-hexane (1:3 → 1:1) and dried under reduced pressure to yield 
the benzyl ester 116 as a colorless solid (128 mg, 121 µmol, 78.0%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.32. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3277.9 (br, 𝜈(N-H)), 2915.6 (vs, 𝜈(C-H)), 2848.4 (vs, 𝜈(C-H)), 
1737.3 (m, 𝜈(C=O)), 1688.2 (vs, 𝜈(C=O)), 1655.6 (s), 1624.9 (m), 1552.3 (m), 1462.5 
(m), 1409.6 (m), 1376.1 (m), 1298.1 (m), 1279.3 (w), 1259.7 (w), 1240.5 (w), 1205.1 
(s), 1187.2 (m), 1171.0 (m), 1108.3 (w), 1043.6 (m), 943.6 (m), 763.0 (m), 727.9 (m), 
696.3 (m), 592.4 (w), 549.7 (w), 505.2 (w), 449.7 (w). 
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1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.21 (dd, J = 32.7, 3.7 Hz, 1 H, NH42), 7.85 
– 7.68 (m, 2 H, NH7+9), 7.27 (m, 8 H, CHAr49-53), 7.19 – 7.12 (m, 2 H, CHAr49-53), 5.22 
(dd, J = 6.7, 3.7 Hz, 1 H, CH41), 5.12 – 5.00 (m, 2 H, CH256), 4.91 – 4.83 (m, 1 H, CH62), 
4.76 (t, J = 6.7 Hz, 1 H, CH12), 4.74 – 4.39 (m, 2 H, CH259), 3.56 – 3.43 (m, 2 H, CH2+5), 
2.44 (d, J = 16.9 Hz, 3 H, CH348), 2.32 (t, J = 7.2 Hz, 2 H, CH221), 1.75 – 1.60 (m, 9 H, 
CH2), 1.55 – 1.42 (m, 4 H, CH2), 1.31 – 1.15 (m, 88 H, CH2), 0.90 – 0.80 (m, 9 H, 
CH338 + 39 + 77). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.38 (s, CO2R20), 169.09 (s, CO2R60), 
168.88 (s, CO2R60), 168.49 (s, CONR10), 167.95 (s, CONR63), 167.92 (s, CONR63), 
165.21 (s, CO2R55), 165.18 (s, CO2R55), 152.54 (s, CO43), 152.21 (s, CO43), 149.68 (s, 
C45), 149.55 (s, C45), 143.81 (s, CAr47), 143.60 (s, CAr47), 136.17 (s, CAr58), 128.43 (s, 
CHAr), 128.38 (s, CHAr), 128.29 (s, CHAr), 127.83 (s, CHAr), 127.69 (s, CHAr), 127.48 
(s, CHAr), 126.55 (s, CHAr), 126.44 (s, CHAr), 102.80 (s, C40), 74.07 (s, CH62), 74.02 (s, 
CH62), 73.08 (s, CH12), 65.35 (s, CH256), 65.33 (s, CH256), 53.12 (s, CH41), 52.89 (s, 
CH41), 47.02 (s, CH2 or 5), 46.97 (s, CH2 or 5), 46.87 (s, CH2 or 5), 44.23 (s, CH259), 44.01 
(s, CH259), 33.66 (s, CH221), 31.42 (s, CH2), 31.32 (s, CH2), 31.17 (s, CH2), 31.12 (s, 
CH2), 31.10 (s, CH2), 30.83 (s, CH2), 30.80 (s, CH2), 29.37 (s, CH2), 29.05 (s, CH2), 
28.98 (s, CH2), 28.94 (s, CH2), 28.91 (s, CH2), 28.77 (s, CH2), 28.73 (s, CH2), 28.70 (s, 
CH2), 28.57 (s, CH2), 28.54 (s, CH2), 28.52 (s, CH2), 28.48 (s, CH2), 28.36 (s, CH2), 
24.56 (s, CH2), 24.51 (s, CH2), 24.47 (s, CH2), 24.34 (s, CH2), 24.31 (s, CH2), 22.12 (s, 
CH2), 22.08 (s, CH2), 22.06 (s, CH2), 15.68 (s, CH348), 15.67 (s, CH348), 13.96 (s, 
CH338 or 39 or 77), 13.95 (s, CH338 or 39 or 77), 13.93 (s, CH338 or 39 or 77). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C631H9816O914N423Na1, 1077.7226; found, 
1077.7230; Δ = 0.42 mmu. 
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 Benzyl ester 117 derived from monomer-NC 84, stearic acid and 
octanal 
 
In a 5 mL round bottom flask the isocyanide monomer 84 (100 mg, 155 µmol, 1.00 eq.) 
was stirred in 2 mL dichloromethane, subsequently octanal (39.8 mg, 310 µmol, 
2.00 eq.) and stearic acid (88.2 mg, 310 µmol, 2.00 eq.) were added. The resulting 
reaction mixture was degassed with argon and stirred at room temperature for 4 d. The 
crude mixture was dried under reduced pressure. The residue was adsorbed onto 
celite® and purified via column chromatography on silica gel eluting with a gradual 
solvent mixture of ethyl acetate and c-hexane (1:4 → 1:1). The benzyl ester 117 was 
obtained as a colorless solid (164 mg, 152 µmol, 98.2%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.41. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3281.8 (br, 𝜈(N-H)), 2917.1 (vs, 𝜈(C-H)), 2849.4 (s, 𝜈(C-H)), 1736.7 
(m, 𝜈(C=O)), 1686.1(vs, 𝜈(C=O)), 1660.5 (s), 1614.6 (m), 1538.9 (m), 1455.6 (m), 
1375.7 (m), 1307.7 (m), 1279.1 (m), 1256.3 (m), 1203.9 (s), 1169.3 (s), 1105.9 (m), 
1043.1 (m), 1027.1 (m), 962.0 (m), 833.0 (w), 763.5 (m), 720.5 (m), 696.7 (s), 590.2 
(w), 497.7 (w), 438.0 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.54 (dt, J = 11.5, 6.0 Hz, 1 H, NH9), 8.47 
(td, J = 6.1, 2.4 Hz, 1 H, NH7), 8.16 (dd, J = 21.3, 3.7 Hz, 1 H, NH40), 7.34 – 7.23 (m, 
8 H, CHAr), 7.20 – 7.08 (m, 6 H, CHAr), 5.22 (t, J = 4.5 Hz, 1 H, CH39), 5.12 – 5.01 (m, 
Chapter    6    Experimental part 
 
284  
2 H, CH254), 4.98 (dt, J = 7.5, 4.7 Hz, 1 H, CH60), 4.89 (dd, J = 7.3, 5.3 Hz, 1 H, CH10), 
4.83 – 4.45 (m, 2 H, CH257), 4.30 – 4.20 (m, 4 H, CH22+5), 2.43 (d, J = 16.5 Hz, 3 H, 
CH346), 2.35 (td, J = 7.3, 2.4 Hz, 2 H, CH219), 1.78 – 1.64 (m, 4 H, CH212+64), 1.62 – 
1.43 (m, 2 H, CH221), 1.42 – 1.05 (m, 50 H, CH2), 0.93 – 0.72 (m, 9 H, CH336+37+75). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.50 (s, CO2R18), 169.46 (CONR6), 169.18 
(s, CONR61), 168.95 (s, CO2R57), 168.92 (s, CO2R57), 165.22 (s, CO2R53), 165.19 (s, 
CO2R53), 152.34 (s, CO41), 152.16 (s, CO41), 149.75 (s, C43), 149.62 (s, C43), 143.85 
(s, CAr45), 143.70 (s, CAr45), 137.88 , 137.64 , 136.20 (s, CAr56), 136.19 (s, CAr56), 128.44 
(s, CHAr), 128.39 (s, CHAr), 128.30 (s, CHAr), 127.83 (s, CHAr), 127.68 (s, CHAr), 127.48 
(s, CHAr), 126.95 (s, CHAr), 126.58 (s, CHAr), 126.49 (s, CHAr), 102.81 (s, C38), 102.73 
(s, C38), 74.12 (s, CH60), 74.02 (s, CH60), 73.05 (s, CH10), 65.32 (s, CH254), 53.16 (s, 
CH39), 52.96 (s, CH39), 44.11 (s, CH257), 43.94 (s, CH257), 41.62 (s, CH22 or 5), 41.52 (s, 
CH22 or 5), 33.68 (s, CH219), 33.48 (s, CH219), 31.45 (s, CH2), 31.33 (s, CH212 or 64), 31.18 
(s, CH212 or 64), 31.14 (s, CH2), 29.05 (s, CH2), 29.03 (s, CH2), 28.93 (s, CH2), 28.78 (s, 
CH2), 28.74 (s, CH2), 28.59 (s, CH2), 28.53 (s, CH2), 28.41 (s, CH2), 24.62 (s, CH2), 
24.52 (s, CH2), 24.45 (s, CH2), 24.40 (s, CH2), 22.13 (s, CH2), 22.10 (s, CH2), 22.09 (s, 
CH2), 15.68 (s, CH346), 15.65 (s, CH346), 13.97 (s, CH336 or 37 or 75), 13.95 (s, 
CH336 or 37 or 75). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C651H9616O914N423Na1, 1099.7069; found, 
1099.7074; Δ = 0.50 mmu. 
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 Benzyl ester 118 derived from monomer-NC 93, stearic acid and 
octanal 
 
The monomer-NC 93 (150 mg, 232 µmol, 1.00 eq.) was stirred in 2 mL 
dichloromethane in a 10 mL round bottom flask, subsequently octanal (59.5 mg, 
464 µmol, 2.00 eq.) and stearic acid (99.0 mg, 348 µmol, 1.50 eq.) were added. The 
resulting reaction mixture was concentrated under reduced pressure, degassed with 
argon and stirred at room temperature for 1 d. The crude mixture was dried under 
reduced pressure. The residue was purified via column chromatography on silica gel 
eluting with a gradual solvent mixture of ethyl acetate and c-hexane (0:1 → 1:1) and 
dried in vacuo to yield the benzyl ester 118 (235 mg, 221 μmol, 95.4%). 
Rf = 0.55 in c-hexane/ethyl acetate (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3315.5 (br, 𝜈(N-H)), 2924.8 (s, 𝜈(C-H)), 2852.8 (m, 𝜈(C-H)), 1748.3 
(m, 𝜈(C=O)), 1682.4 (s, 𝜈(C=O)), 1653.6 (s, 𝜈(C=O)), 1583.7 (vw), 1540.5 (m), 1511.7 
(m), 1456.2 (m), 1415.0 (w), 1384.2 (m), 1306.0 (m), 1279.3 (m), 1244.3 (s), 1213.5 
(s), 1174.4 (vs), 1104.5 (m), 1040.7 (m), 1003.7 (m), 964.6 (vw), 935.8 (vw), 884.4 
(vw), 847.4 (vw), 830.9 (vw), 785.7 (vw), 752.8 (w), 730.1 (w), 697.2 (m), 654.0 (w), 
586.1 (vw), 553.2 (vw), 530.6 (vw), 508.0 (vw). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.14 (dd, J = 41.3, 3.6 Hz, 1 H, NH3), 7.90 (tt, 
J = 16.3, 5.6 Hz, 2 H, NH25,36), 7.33 – 7.26 (m, 3 H, CHAr), 7.16 (dt, J = 5.7, 5.1 Hz, 
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4 H, CHAr), 6.87 – 6.78 (m, 2 H, CHAr), 5.17 (dd, J = 7.9, 3.6 Hz, 1 H, CH2), 5.11 – 5.03 
(m, 2 H, CH217), 4.99 (dd, J = 24.3, 3.8 Hz, 1 H, CH23), 4.82 – 4.79 (m, 1 H, CH46), 4.75 
– 4.44 (m, 2 H CH220), 3.72 (s, 3 H, OCH342), 3.15 – 2.95 (m, 4 H, CH230,35), 2.45 (d, 
J = 32.7 Hz, 3 H, CH39), 2.37 – 2.30 (m, 2 H, CH256), 1.78 – 1.68 (m, 1 H, CH29), 1.65 
(d, J = 5.6 Hz, 2 H, CH2),1.53 (dd, J = 18.9, 12.2 Hz, 2 H, CH2), 1.44 – 1.31 (m, 7 H, 
CH2), 1.23 (s, 47 H, CH2,), 0.91 – 0.76 (m, 12 H, CH3). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.40 (s, CO2R55), 169.19 (s, CONR24 or 
CONR44 or CO2R21), 169.15 (s, CONR24 or CONR44 or CO2R21), 168.34 (s, CONR24 or 
CONR44 or CO2R21), 165.29 (s, CO2Bn16), 165.22 (s, CO2Bn16), 158.65 (s, COMe12), 
158.62 (s, COMe12), 152.69 (s, C4), 152.28 (s, C4), 149.38 (s, C6), 149.27 (s, C6), 
136.26 (s, CAr19), 135.94 (s, CAr8), 135.69 (s, CAr8), 128.28 (s, CHAr), 127.82 (s, CHAr), 
127.80 (s, CHAr), 127.73 (s, CHAr), 127.65 (s, CHAr), 127.62 (s, CHAr), 127.61 (s, CHAr), 
113.73 (s, CHAr), 113.69 (s, CHAr), 103.21 (s, C1), 103.00 (s, C1), 75.08 (s, CH23), 74.98 
(s, CH23), 73.07 (s, CH46), 65.28 (s, CH217), 65.21 (s, CH217), 55.06 (s, OCH343), 52.45 
(s, CH2), 52.24 (s, CH2), 44.36 (s, CH220), 44.16 (s, CH220), 42.55 (s, CH29), 42.52 (s, 
CH29), 38.28 (s, CH2), 38.14 (s, CH2), 33.45 (s, CH256), 31.45 (s, CH2), 31.32 (s, CH2), 
31.17 (s, CH2), 29.05 (s, CH2), 28.99 (s, CH2), 28.92 (s, CH2), 28.73 (s, CH2), 28.71 (s, 
CH2), 28.58 (s, CH2), 28.55 (s, CH2), 28.39 (s, CH2), 25.94 (s, CH2), 25.88 (s, CH2), 
24.56 (s, CH2), 24.43 (s, CH2), 22.12 (s, CH2), 22.08 (s, CH2), 21.82 (s, CH2), 21.77 (s, 
CH2), 15.70 (s, CH39), 15.66 (s, CH39), 13.94 (s, CH3), 13.91 (s, CH3), 11.37 (s, CH3), 
11.32 (s, CH3), 11.26 (s, CH3). 
FAB-MS m/z (relative intensity): 1059.9 (32%) [M + H]+, 951.8 (10%) [M – C7H7O]+, 
409.1 (34%) [Fragment A]+, 393.1 (34%) [Fragment A – O]+, 351.1 (50%) [Fragment A 
– C2H2O2]+, 303.1 (11%) [Fragment A – C7H7O]+, 275.1 (17%), 261.0 (8%) [Fragment 
B – C7H7]+, 163.0 (9%), 162.0 (54%), 90.9 (100%) [C7H7]+. 
HRMS–FAB (m/z): [M + H]+ calculated for 12C621H9916O1014N4, 1059.7356; found, 
1059.7353; Δ = 0.28 mmu. 
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 Benzyl ester 119 derived from monomer-NC 94, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the monomer-NC 94 (197 mg, 298 µmol, 1.00 eq.) was 
stirred in 1.2 mL dichloromethane, subsequently octanal (76.2 mg, 594 µmol, 2.00 eq.) 
and stearic acid (129 mg, 455 µmol, 1.50 eq.) were added. The resulting reaction 
mixture was stirred at room temperature for 1 d. Subsequently, the crude mixture was 
dried under reduced pressure. The residue was adsorbed onto celite® and purified via 
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column chromatography on silica gel eluting with a gradual solvent mixture of ethyl 
acetate and c-hexane (0:1 → 1:1) to yield the benzyl ester 119 as a pale highly viscous 
oil. (243 mg, 230 µmol, 75.4%). 
Rf = 0.46 in c-hexane/ethyl acetate (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3292.1 (w, 𝜈(N-H)), 2917.8 (s, 𝜈(C-H)), 2849.9 (s, 𝜈(C-H)), 1737.3 
(m, 𝜈(C=O)), 1687.5 (s, 𝜈(C=O)), 1660.5 (s), 1547.3 (m), 1455.7 (m), 1411.7 (w), 
1376.1 (m), 1307.1 (m), 1277.1 (m), 1258.0 (m), 1205.3 (s), 1170.0 (vs), 1106.7 (s), 
1043.5 (m), 963.9 (w), 843.9 (w), 800.8 (m), 765.9 (m), 721.2 (m), 697.0 (m), 588.8 
(w), 503.4 (m).  
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.12 (dd, J = 27.6, 3.6 Hz, 1 H, NH45), 7.96 
– 7.86 (m, 2 H, NH3+10), 7.31 – 7.27 (m, 3 H, CHAr), 7.18 – 7.11 (m, 4 H, CHAr), 7.10 – 
7.04 (m, 2 H, CHAr50,53), 5.17 (dd, J = 6.6, 3.6 Hz, 1 H, CH44), 5.12 – 5.00 (m, 2 H, 
CH258), 4.93 – 4.85 (m, 1 H, CH63), 4.81 (t, J = 6.3 Hz, 1 H, CH13), 4.76 – 4.41 (m, 2 H, 
CH259), 3.11 – 2.94 (m, 4 H, CH24,9), 2.43 (d, J = 14.5 Hz, 3 H, CH342), 2.36 – 2.30 (m, 
1 H, CH223a), 2.26 (s, 3 H, CH352), 2.17 (t, J = 7.4 Hz, 1 H, CH223b), 1.74 – 1.61 (m, 4 
H, CH215,64), 1.55 – 1.44 (m, 4 H, CH224), 1.35 – 1.33 (m, 6 H, CH24,9), 1.31 – 1.14 (m, 
68 H, CH2), 0.90 – 0.79 (m, 9 H, CH339,76,77). 
13C-NMR (126 MHz, DMSO-d6): δ [ppm] = 174.50 (s, CO2R21), 172.40 (s, CONR11), 
169.13 (s, CO2R60), 169.11 (s, CO2R60), 169.02 (s, CONR1), 168.61 (s, CONR1), 
165.24 (s, CO2R55), 165.21 (s, CO2R55), 152.48 (s, CO46), 152.22 (s, CO46), 149.53 (s, 
C41), 149.37 (s, C41), 140.91 (s, CAr51), 140.73 (s, CAr51), 136.60 (s, CAr48), 136.20 (s, 
CAr70), 128.93 (s, CHAr50,53), 128.88 (s, CHAr50,53), 128.28 (s, CHAr), 127.82 (s, CHAr), 
127.68 (s, CHAr), 127.67 (s, CHAr), 126.47 (s, CHAr49,54), 126.37 (s, CHAr49,54), 102.93 
(s, C43), 74.12 (s, CH63), 74.03 (s, CH63), 73.06 (s, CH13), 65.28 (s, CH258), 52.79 (s, 
CH44), 52.56 (s, CH44), 44.15 (s, CH259), 43.94 (s, CH259), 43.01 (s, CH), 38.19 (s, 
CH24,9), 38.10 (s, CH24,9), 33.67 (s, CH223), 33.45 (s, CH223), 31.45 (s, CH215,64), 31.32 
(s, CH2), 31.18 (s, CH2), 31.14 (s, CH2), 29.05 (s, CH2), 28.94 (s, CH2), 28.73 (s, CH2), 
28.52 (s, CH2), 28.39 (s, CH2), 25.84 (s, CH2), 24.56 (s, CH2), 24.51 (s, CH2), 24.43 (s, 
CH2), 24.38 (s, CH2), 22.12 (s, CH2), 22.09 (s, CH224), 20.66 (s, CH352), 15.65 (s, 
CH342), 15.62 (s, CH342), 13.95 (s, CH339,76,77), 13.92 (s, CH339,76,77). 
FAB – MS [m/z] (relative intensity): 1071.9 (10%) [M + H]+, 335.1 (20%) [Fragment A]+. 
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HRMS – FAB [m/z]: [M + H]+ calculated for 12C641H10316O914N4, 1071.76468; found, 
1071.7720; Δ = 0.28 mmu. 
 
 
 Benzyl ester 120 derived from monomer-NC 95, stearic acid and 
octanal 
 
In a 10 mL round bottom flask the monomer-NC 95 (300 mg, 407 µmol, 1.00 eq.) was 
stirred in 3 mL dichloromethane, subsequently octanal (104 mg, 814 µmol, 2.00 eq.), 
stearic acid (173 mg, 610 µmol, 1.50 eq.) and one droplet of dimethyl sulfoxide were 
added. The resulting reaction mixture was degassed with argon and stirred at room 
temperature for 7 d under argon atmosphere. The crude mixture was dried under 
reduced pressure. The residue was adsorbed onto celite® and purified via column 
chromatography on silica gel eluting with a gradual solvent mixture of ethyl acetate and 
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c-hexane (1:3 → 2:1) and dried under reduced pressure to yield the Passerini product 
120 as a colorless solid (333 mg, 289 µmol, 71.2%). 
Rf in ethyl acetate/c-hexane (2:1) = 0.71. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3306.9 (br, 𝜈(N-H)), 2924.0 (s, 𝜈(C-H)), 2853.9 (m, 𝜈(C-H)), 1740.1 
(s, 𝜈(C=O)), 1684.5 (vs, 𝜈(C=O)), 1540.0 (m), 1513.6 (s), 1456.5 (m), 1374.4 (w), 
1306.0 (vs), 1253.8 (vs), 1218.8 (vs), 1166.5 (vs), 1106.5 (s), 1042.7 (s), 833.6 (w), 
752.8 (w), 697.2 (w), 634.2 (m), 529.2 (w), 433.9 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 8.21 (d, J = 3.7 Hz, 1 H, NH23), 8.17 (t, J = 
3.3 Hz, 1 H, NH9), 7.88 (q, J = 5.6 Hz, 1 H, NH7), 7.46 – 7.07 (m, 11 H, CHAr), 6.92 (d, 
J = 8.7 Hz, 2 H, CHAr), 5.83 (d, J = 8.9 Hz, 1 H, CH11), 5.24 (t, J = 3.7 Hz, 1 H, CH21), 
5.16 – 4.94 (m, 2 H, CH230), 4.87 – 4.47 (m, 3 H, CH240 + CH54), 3.74 (s, 3 H, OCH316), 
3.11 – 2.90 (m, 4 H, CH22+5), 2.46 (d, J = 5.3 Hz, 3 H, CH332), 2.33 (t, J = 7.2 Hz, 2 H, 
CH271), 1.64 (s, 2 H, CH257), 1.58 – 1.44 (m, 2 H, CH273), 1.37 – 1.19 (m, 42 H, CH2), 
0.86 – 0.76 (m, 6 H, CH367+89). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.40 (s, CO2R69), 169.12 (s, CO2R41), 
168.94 (s, CO2R41), 168.88 (s, CONR8), 167.53 (s, CONR12), 165.01 (s, CO2R30), 
159.58 (s, CAr51), 159.54 (s, CAr51), 151.92 (s, CO26), 151.82 (s, CO26), 150.21 (s, C25), 
150.02 (s, C25), 147.53 (s, OCF348), 143.23 (s, CAr31), 143.07 (s, CAr31), 136.16 (s, 
CAr33), 136.14 (s, CAr33), 128.96 (s, CHAr), 128.86 (s, CHAr), 128.57 (s, CHAr), 128.46 
(s, CHAr), 128.22 (s, CHAr), 127.83 (s, CHAr), 127.68 (s, CHAr), 127.64 (s, CHAr), 127.46 
(s, CHAr), 127.34 (s, CHAr), 120.98 (s, CHAr), 113.78 (s, CHAr), 102.35 (s, C21), 102.20 
(s, C21), 75.64 (s, CH11), 75.49 (s, CH11), 73.06 (s, CH54), 65.33 (s, CH230), 55.13 (s, 
OCH316), 55.11 (s, OCH316), 52.62 (s, CH21), 52.46 (s, CH21), 43.96 (s, CH240), 43.83 
(s, CH240), 39.20 (s, CH22 or 5), 38.29 (s, CH22 or 5), 38.11 (s, CH22 or 5), 33.45 (s, CH271), 
31.44 (s, CH2), 31.30 (s, CH2), 31.15 (s, CH2), 29.03 (s, CH2), 29.01 (s, CH2), 28.97 (s, 
CH2), 28.90 (s, CH2), 28.86 (s, CH2), 28.71 (s, CH2), 28.69 (s, CH2), 28.56 (s, CH2), 
28.52 (s, CH2), 28.38 (s, CH2), 25.80 (s, CH2), 25.75 (s, CH2), 24.56 (s, CH2), 24.43 (s, 
CH2), 22.10 (s, CH2), 22.07 (s, CH2), 20.77, 15.69 (s, CH332), 15.66 (s, CH332), 13.94 
(s, CH367 or 89), 13.91 (s, CH367 or 89). 
19F-NMR (376 MHz, DMSO-d6) δ [ppm] = -61.19 (s, CF348a), -61.21 (s, CF348b). 
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ESI – MS [m/z]: [M + Na]+ calculated for 12C641H9116O1114N419F323Na1, 1171.6529; 
found, 1171.6543; Δ = 1.43 mmu. 
 
 Benzyl ester 121 derived from monomer-NC 96, stearic acid and 
octanal 
 
The monomer-NC 96 (100 mg, 145 µmol, 1.00 eq.) was stirred in 0.6 mL 
dichloromethane in a 10 mL round bottom flask, subsequently octanal (37.2 mg, 
290 µmol, 2.00 eq.) and stearic acid (61.9 mg, 218 µmol, 1.50 eq.) were added. The 
resulting reaction mixture was degassed with argon and stirred at room temperature 
for 2 d. The crude mixture was dried under reduced pressure. The residue was purified 
via column chromatography on silica gel eluting with a gradual solvent mixture of ethyl 
acetate and c-hexane (0:1 → 1:1) and dried in vacuo to yield the benzyl ester 121 as 
a colorless oil (82.7 mg, 75.1 μmol, 51.7%). 
Rf = 0.69 in c-hexane/ethyl acetate (2:3). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3288.8 (br, 𝜈(N-H)), 3105.8 (br, 𝜈(CO2H)), 2953.5 (m, 𝜈(C-H)), 
2920.6 (vs, 𝜈(C-H)), 2850.7 (s, 𝜈(C-H)), 1738.0 (m, 𝜈(C=O)), 1709.2 (m, 𝜈(C=O)), 
1686.5 (vs, 𝜈(C=O)), 1657.8 (vs, 𝜈(C=O)), 1626.9 (m, 𝜈(C=O)), 1610.4 (m, 𝜈(C=O)), 
1583.7 (w), 1540.5 (m), 1509.7 (m), 1456.3 (m), 1441.8 (m), 1415.0 (w), 1378.0 (m), 
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1328.7 (w), 1306.0 (m), 1281.4 (m), 1244.3 (s), 1205.3 (s), 1170.3 (vs), 1147.7 (m), 
1106.5 (s), 1044.8 (m), 983.1(w), 962.5 (w), 939.9 (w), 925.5 (w), 886.4 (vw), 857.6 
(vw), 847.4 (w), 824.7 (w), 800.1 (vw), 785.7 (w), 758.9 (w), 721.9 (m), 697.2 (m), 678.7 
(w), 652.0 (w), 612.9 (vw), 592.3 (w), 580.0 (w), 559.4 (vw), 532.7 (w), 503.9 (w), 442.2 
(vw), 425.7 (vw). 
1H-NMR (400 MHz, DMSO-d6) δ [ppm] = 8.10 (dd, J = 22.3, 3.5 Hz, 1 H, NH3), 7.98 – 
7.82 (m, 2 H, NH25,35), 7.33 – 7.23 (m, 3 H, CHAr), 7.22 – 7.06 (m, 4 H, CHAr), 6.89 – 
6.72 (m, 2 H, CHAr), 5.19 – 5.12 (m, 1 H, CH2), 5.10 – 4.99 (m, 2 H, CH217), 4.95 – 4.86 
(m, 1 H, CH23), 4.81 (t, J = 6.3 Hz, 1 H, CH45), 4.77 – 4.42 (m, 2 H, CH220), 3.98 (q, 
J = 6.9 Hz, 2 H, CH278), 3.14 – 2.88 (m, 4 H, CH229,34), 2.43 (d, J = 10.9 Hz, 3 H, CH39), 
2.33 (t, J = 7.2 Hz, 2 H, CH255a), 2.17 (t, J = 7.4 Hz, 2 H, CH255b),1.69 (dd, 
J = 15.4, 7.8 Hz, 4 H, CH2), 1.48 (dd, J = 15.8, 7.2 Hz, 4 H, CH2), 1.41 – 1.33 (m, 4 H, 
CH2), 1.30 (s, J = 7.1 Hz, 3 H, CH379), 1.26 – 1.13 (m, 52 H, CH2,), 0.87 – 0.78 (m, 9 
H, CH353,72,77). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 174.45 (s, CO2R54), 172.34 (s, CO2R21), 
169.12 (s, CONR24), 169.03 (s, CONR24), 168.60 (s, CONR43), 165.26 (s, CO2Bn16), 
165.22 (s, CO2Bn16), 157.89 (s, COEt12), 152.42 (s, C4), 152.16 (s, C4), 149.32 (s, C6), 
149.15 (s, C6), 136.22 (s, CAr19), 135.89 (CAr8), 135.70 (CAr8), 128.26 (s, CHAr), 127.79 
(s, CHAr), 127.69 (s, CHAr), 127.65 (s, CHAr), 127.63 (s, CHAr), 114.15 (s, CHAr), 114.10 
(s, CHAr), 103.13 (s, C1), 103.08 (s, C1), 74.11 (s, CH23), 74.04 (s, CH23), 73.05 (s, 
CH45), 65.25 (s, CH217), 62.95 (s, CH278), 52.60 (s, CH2), 52.35 (s, CH2), 44.15 (s, 
CH220), 43.90 (s, CH220), 38.19 (s, CH229 or 34), 38.10 (s, CH229 or 34), 33.66 (s, CH255), 
33.46 (s, CH255), 31.18 (s, CH2), 31.14 (s, CH2), 29.05 (s, CH2), 28.93 (s, CH2), 28.78 
(s, CH2), 28.73 (s, CH2), 28.59 (s, CH2), 28.55 (s, CH2), 28.40 (s, CH2), 25.83 (s, CH2), 
24.56 (s, CH2), 24.51 (s, CH2), 24.43 (s, CH2), 24.37 (s, CH2), 22.11 (s, CH2), 22.08 (s, 
CH2), 22.05 (s, CH2), 20.75 (s, CH2), 15.64 (s, CH39), 15.61 (s, CH39), 14.62 (s, CH379), 
14.08 (s, CH353 or 72 or 77), 13.91 (s, CH353 or 72 or 77), 13.89 (s, CH353 or 72 or 77). 
ESI–MS (m/z): [M + Na]+ calculated for 12C651H10416O1014N423Na1, 1123.7645; found, 
1123.7674; Δ = 2.90 mmu. 
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 Benzyl ester 122 derived from monomer-NC 97, stearic acid and octanal 
 
In a 10 mL round bottom flask the monomer-NC 97 (100 mg, 159 µmol, 1.00 eq.) was 
stirred in 1 mL dichloromethane, subsequently octanal (40.7 mg, 317 µmol, 2.00 eq.) 
and stearic acid (90.2 mg, 317 µmol, 2.00 eq.) were added. The resulting reaction 
mixture was degassed with argon and stirred at room temperature for 4 d. The crude 
mixture was dried under reduced pressure. The residue was adsorbed onto celite® and 
purified via column chromatography on silica gel eluting with a gradual solvent mixture 
of ethyl acetate and c-hexane (1:2 → 1:1). The benzyl ester 122 was obtained as a 
colorless solid (143 mg, 137 µmol, 78.6%). 
Rf in ethyl acetate/c-hexane (1:1) = 0.48. Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3286.5 (br, 𝜈(N-H)), 3097.2 (w, 𝜈(N-H)), 2922.5 (vs, 𝜈(C-H)), 
2853.0 (s, 𝜈(C-H)), 1702.1 (vs, 𝜈(C=O)), 1651.3 (vs, 𝜈(C=O)), 1539.1 (m), 1455.8 (m), 
1378.0 (m), 1264.3 (s), 1220.0 (vs), 1178.3 (m), 1088.1 (vs), 1018.3 (m), 861.6 (w), 
824.1 (m), 753.8 (m), 696.8 (m), 658.4 (m), 527.3 (w), 493.7 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 9.35 (d, J = 1.9 Hz, 1 H, NH73), 8.02 (t, J = 
5.8 Hz, 1 H, NH9), 7.95 – 7.88 (m, 3 H, CHAr69,71 + NH7), 7.86 (m, 1 H, NH57), 7.38 – 
7.31 (m, 2 H, CHAr68,72), 7.30 – 7.22 (m, 3 H, CHAr75-78), 7.16 – 7.10 (m, 2 H, CHAr75-78), 
5.25 (d, J = 3.3 Hz, 1 H, CH56), 5.10 – 4.97 (m, 3 H, CH264 + CH41), 4.81 (t, J = 6.3 Hz, 
1 H, CH12), 3.13 – 2.94 (m, 4 H, CH22 + 5), 2.33 (t, J = 7.3 Hz, 2 H, CH221), 2.28 (s, 3 H, 
CH366), 1.85 – 1.78 (m, 2 H, CH245), 1.69 – 1.62 (m, 2 H, CH214), 1.56 – 1.48 (m, 2 H, 
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CH223), 1.43 – 1.32 (m, 8 H, CH23,52-54), 1.32 – 1.14 (m, 58 H, CH2), 0.87 – 0.81 (m, 9 
H, CH338 + 39 + 51). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.34 (s, CO2R20), 169.11 (s, CONR10 or 42), 
168.93 (s, CONR10 or 42), 164.87 (s, CO2R61), 151.76 (s, CO58), 149.93 (s, CAr65 or 70), 
149.92 (s, CAr65 or 70), 149.83 (s, CAr65 or 70), 149.81 (s, CAr65 or 70), 136.43 (s, CAr67), 
129.76 (s, CHAr69,71), 128.55 (s, CHAr), 128.24 (s, CHAr), 128.22 (s, CHAr), 127.68 (s, 
CHAr), 127.64 (s, CHAr), 127.60 (s, CHAr), 126.59 (s, CHAr68,72), 98.06 (s, C55), 73.96 (s, 
CH41), 73.06 (s, CH12), 64.86 (s, CH264), 53.83 (s, CH56), 38.19 (s, CH2), 38.09 (s, CH2), 
33.46 (s, CH2), 31.59 (s, CH2), 31.45 (s, CH2), 31.33 (s, CH2), 31.20 (s, CH2), 31.19 (s, 
CH2), 29.06 (s, CH2), 28.99 (s, CH2), 28.94 (s, CH2), 28.74 (s, CH2), 28.64 (s, CH2), 
28.59 (s, CH2), 28.57 (s, CH2), 28.41 (s, CH2), 25.89 (s, CH2), 25.86 (s, CH2), 24.60 (s, 
CH2), 24.57 (s, CH2), 24.44 (s, CH2), 22.12 (s, CH2), 22.09 (s, CH2), 17.89 (s, CH366), 
13.92 (s, CH338 + 39 + 51), 13.91 (s, CH338 + 39 + 51). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C621H9816O914N423Na1, 1065.7226; found, 
1065.7230; Δ = 0.42 mmu. 
 
6.2.3.6 Carboxylic acids 
 
 Carboxylic acid 123 derived from benzyl ester 108 via 
hydrogenolytic deprotection 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 108 
(67.7 mg, 57.2 µmol, 1.00 eq.) was dissolved in 2.00 mL ethyl acetate. Subsequently, 
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palladium on activated charcoal (20% Pd, 20.0 mg) was added to the solution. The 
solution was purged with hydrogen gas for 5 minutes and stirred for 1 d at room 
temperature under hydrogen atmosphere (balloon). TLC indicated complete 
conversion of the benzyl ester 108. The crude reaction mixture was filtered over celite® 
and flushed with 20 mL ethyl acetate three times and with 20 mL dichloromethane 
twice. After concentration under reduced pressure and drying in high vacuum the 
carboxylic acid 123 was obtained as a colorless solid (62.0 mg, 56.7 µmol, 99.2%). 
IR (ATR):  [cm-1] = 3267.7 (br, 𝜈(N-H)), 2919.5 (vs, 𝜈(C-H)), 2850.9 (s, 𝜈(C-H)), 1743.9 
(m, 𝜈(C=O)), 1656.7 (vs, 𝜈(C=O)), 1541.2 (m), 1464.1 (m), 1385.1 (m), 1193.1 (m), 
1163.6 (s), 1091.6 (m), 759.5 (w), 721.6 (m), 696.6 (m), 621.4 (w), 514.2 (w), 458.8 
(w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 12.22 (s, 1 H, CO2H64), 7.92 – 7.78 (m, 3 H, 
NH7 + 9 + 58), 7.35 – 7.16 (m, 5 H, CHAr70-73), 5.14 (d, J = 3.7 Hz, 1 H, CH57), 4.82 (t, J = 
6.2 Hz, 2 H, CH12 + 41), 3.92 – 3.28 (m, 2 H, CH280), 3.09 – 2.94 (m, 4 H, CH214 + 45), 
2.47 (s, 3 H, CH367), 2.32 (q, J = 6.9 Hz, 4 H, CH221 + 89), 1.65 (dq, J = 10.3, 6.4 Hz, 4 
H, CH22 + 5), 1.50 (q, J = 7.4 Hz, 4 H, CH2), 1.35 (t, J = 6.7 Hz, 4 H, CH2), 1.30 – 1.05 
(m, 71 H, CH2), 0.83 (t, J = 6.7 Hz, 9 H, CH338 + 39 + 51). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.28 (s, CO2R20 or 55), 172.18 (s, 
CO2R20 or 55), 169.12 (s, CONR42 or 10), 169.10 (s, CONR42 or 10), 167.54 (s, CO2H64), 
153.04 (s, CO59), 148.54 (s, C60), 144.08 (s, CAr66), 128.18 (s, CHAr), 127.03 (s, CHAr), 
126.05 (s, CHAr), 104.18 (s, C56), 73.05 (s, CH12 or 41), 73.04 (s, CH12 or 41), 52.35 (s, 
CH57), 41.39 (s, CH280), 38.00 (s, CH214 + 45), 33.49 (s, CH221 or 89), 33.45 (s, CH221 or 89), 
31.49 (s, CH22 or 5), 31.40 (s, CH22 or 5), 31.25 (s, CH2), 31.23 (s, CH2), 29.50 (s, CH2), 
29.16 (s, CH2), 29.14 (s, CH2), 29.03 (s, CH2), 28.99 (s, CH2), 28.95 (s, CH2), 28.83 (s, 
CH2), 28.64 (s, CH2), 28.50 (s, CH2), 26.25 (s, CH2), 25.73 (s, CH2), 24.61 (s, CH2), 
24.59 (s, CH2), 24.45 (s, CH2), 22.17 (s, CH2), 22.12 (s, CH2), 15.50 (s, CH367), 13.86 
(s, CH338 + 39 + 51), 13.84 (s, CH338 + 39 + 51). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C65H11216O914N423Na1, 1115.8322; found, 
1115.8328; Δ = 0.61 mmu. 
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 Carboxylic acid 124 derived from benzyl ester 109 via 
hydrogenolytic deprotection 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 109 
(100 mg, 84.3 µmol, 1.00 eq.) was dissolved in 2.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20% Pd, 20.0 mg) was added to the solution. The 
solution was purged with hydrogen gas for 5 minutes and stirred for 1 d at room 
temperature under hydrogen atmosphere (balloon) while purging the first 4 h every 
30 min. TLC indicated complete conversion of the benzyl ester 109. The crude reaction 
mixture was filtered over celite® and flushed with 20 mL ethyl acetate three times and 
with 20 mL dichloromethane twice. After concentration under reduced pressure and 
drying in high vacuum the carboxylic acid 124 was obtained as a colorless solid 
(89.0 mg, 83.5 µmol, 98.9%). 
IR (ATR):  [cm-1] = 3272.1 (br, 𝜈(N-H, CO2H)), 2919.2 (vs, 𝜈(C-H)), 2850.4 (s, 𝜈(C-
H)), 1744.2 (s, 𝜈(C=O)), 1657.5 (vs, 𝜈(C=O)), 1537.9 (m), 1510.9 (m), 1463.8 (m), 
1382.9 (m), 1248.3 (s), 1164.1 (vs), 1091.3 (m), 1037.0 (w), 937.7 (w), 793.5 (w), 756.5 
(w), 721.3 (w), 618.7 (w), 591.3 8 (w), 502.1 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.18 (br s, 1 H, CO2H64), 7.92 – 7.84 (m, 2 
H, NH7+9), 7.76 (d, J = 3.8 Hz, 1 H, NH58), 7.12 (d, J = 8.7 Hz, 2 H, CHAr66,73), 6.84 (d, 
J = 8.7 Hz, 2 H, CHAr70,72), 5.07 (d, J = 3.7 Hz, 1 H, CH57), 4.91 (d, J = 4.2 Hz, 1 H, 
CH41), 4.81 (dd, J = 7.0, 5.9, 5.5 Hz, 1 H, CH12), 3.90 – 3.76 (m, 1 H, CH280a), 3.70 (s, 
3 H, OCH391), 3.61 – 3.14 (underneath water peak, CH280b), 3.11 – 2.93 (m, 4 H, 
CH22+5), 2.46 (s, 3 H, CH367), 2.35 (dt, J = 12.8, 7.2 Hz, 4 H, CH221+89), 1.75 – 1.59 (m, 
3 H, CH214+CH45), 1.58 – 1.47 (m, 4 H, CH223+88), 1.43 – 1.32 (m, 4 H, CH23+54), 1.31 
– 1.02 (m, 64 H, CH2), 0.90 – 0.74 (m, 12 H, CH338+39+47,93). 
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13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.43 (s, CO2R55), 172.33 (s, CO2R20), 
169.09 (s, CONR10), 168.77 (s, CONR42), 167.53 (s, CO2H64), 158.34 (s, CAr71), 153.04 
(s, CO59), 148.20 (s, C60), 136.15 (s, CAr66), 127.18 (s, CHAr66,73), 113.52 (s, CHAr70,72), 
104.49 (s, C56), 74.02 z(s, CH41), 73.05 (s, CH12), 54.98 (s, OCH391), 51.74 (s, CH57), 
42.58 (s, CH45), 41.34 (s, CH280), 38.10 (s, CH22 or 5), 38.05 (s, CH22 or 5), 33.49 (s, 
CH221 or 89), 33.43 (s, CH221 or 89), 31.42 (s, CH214), 31.29 (s, CH2), 31.15 (s, CH2), 29.47 
(s, CH2), 29.01 (s, CH2), 28.99 (s, CH2), 28.95 (s, CH2), 28.94 (s, CH2), 28.89 (s, CH2), 
28.83 (s, CH2), 28.70 (s, CH2), 28.67 (s, CH2), 28.54 (s, CH2), 28.42 (s, CH2), 28.37 (s, 
CH2), 26.21 (s, CH2), 25.81 (s, CH2), 25.77 (s, CH2), 24.52 (s, CH2), 24.42 (s, CH2), 
24.40 (s, CH2), 22.08 (s, CH2), 22.05 (s, CH2), 21.77 (s, CH2), 21.37 (s, CH2), 15.48 (s, 
CH367), 13.90 (s, CH338 or 39), 13.88 (s, CH338 or 39), 11.26 (s, CH343 or 93), 11.22 (s, CH343 
or 93). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C641H11016O1014N423Na1, 1117.8114; found, 
1117.8119; Δ = 0.47 mmu. 
 
 Carboxylic acid 125 derived from benzyl ester 110 via 
hydrogenolytic deprotection 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 110 
(100 mg, 84.6 µmol, 1.00 eq.) was dissolved in 2.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20% Pd, 20.0 mg) was added to the solution. The 
solution was purged with hydrogen gas for 5 minutes and stirred for 1 d at room 
temperature under hydrogen atmosphere (balloon) while purging every 30 minutes for 
the first four hours. TLC indicated complete conversion of the benzyl ester 110. The 
crude reaction mixture was filtered over celite® and flushed with 20 mL ethyl acetate 
Chapter    6    Experimental part 
 
298  
three times and with 20 mL dichloromethane twice. After concentration under reduced 
pressure and drying in high vacuum the carboxylic acid 125 was obtained as a 
colorless solid (90.8 mg, 83.2 µmol, 98.3%). 
IR (ATR):  [cm-1] = 3305.5 (br, 𝜈(N-H, CO2H)), 2922.0 (vs, 𝜈(C-H)), 2852.3 (s, 𝜈(C-
H)), 1741.0 (s, 𝜈(C=O)), 1660.9 (vs, 𝜈(C=O)), 1537.7 (s), 1453.0 (m), 1385.4 (m), 
1166.2 (m), 1092.7 (m), 987.6 (w), 844.3 (w), 762.4 (w), 720.6 (w), 620.3 (w), 585.4 
(w), 496.2 (w), 430.2 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.13 (s, 1 H, CO2H60), 7.88 (dt, J = 10.9, 
5.8 Hz, 2 H, NH7+9), 7.78 (d, J = 3.9 Hz, 1 H, NH54), 7.16 – 7.01 (m, 4 H, CHAr65,66,68,69), 
5.09 (d, J = 3.8 Hz, 1 H, CH53), 4.81 (t, J = 6.3 Hz, 1 H, CH12), 4.66 (d, J = 5.3 Hz, 1 H, 
CH41), 3.84 (dt, J = 14.7, 7.4 Hz, 1 H, CH276a), 3.56 – 3.19 (m, underneath water signal, 
CH276b), 3.12 – 2.92 (m, 4 H, CH22+5), 2.46 (s, 3 H, CH363), 2.34 (q, J = 7.5 Hz, 4 H, 
CH221+85), 2.24 (s, 3 H, CH386), 1.78 – 1.56 (m, 12 H, CH2), 1.56 – 1.47 (m, 4 H, CH2), 
1.43 – 1.30 (m, 4 H, CH2), 1.31 – 1.12 (m, 53 H, CH2), 1.14 – 0.97 (m, 4 H, CH2), 0.92 
– 0.75 (m, 6 H, CH338+39). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.40 (s, CO2R20), 172.33 (s, CO2R51), 
169.09 (s, CONR10), 168.22 (s, CONR42), 167.54 (s, CO2H58), 153.09 (s, CO55), 148.36 
(s, C56), 141.10 (s, CAr62), 136.10 (s, CAr67), 128.70 (s, CHAr65,69), 125.92 (s, CHAr66,68), 
104.38 (s, C52), 76.98 (s, CH41), 73.05 (s, CH12), 51.98 (s, CH53), 41.32 (s, CH276), 
38.05 (s, CH22 or 5), 38.02 (s, CH22 or 5), 33.44 (s, CH221 or 85), 33.41 (s, CH221 or 85), 31.29 
(s, CH2), 31.15 (s, CH2), 29.02 (s, CH2), 29.00 (s, CH2), 28.96 (s, CH2), 28.89 (s, CH2), 
28.70 (s, CH2), 28.55 (s, CH2), 27.29 (s, CH2), 26.20 (s, CH2), 25.81 (s, CH2), 25.79 (s, 
CH2), 25.78 (s, CH2), 25.75 (s, CH2), 25.72 (s, CH2), 25.53 (s, CH2), 25.41 (s, CH2), 
24.53 (s, CH2), 24.41 (s, CH2), 22.09 (s, CH2), 20.57 (s, CH386), 15.49 15.65 (s, CH363), 
13.90 (s, CH338 or 39), 13.88 (s, CH338 or 39). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C651H11016O914N423Na1, 1113.8165; found, 
1113.8167; Δ = 0.15 mmu. 
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 Carboxylic acid 126 derived from benzyl ester 111 via 
hydrogenolytic deprotection 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 111 
(100 mg, 77.9 µmol, 1.00 eq.) was dissolved in 3.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20 wt.% Pd, 20.0 mg) was added to the solution. The 
solution was purged with hydrogen gas for 10 minutes and stirred for 1 d at room 
temperature under hydrogen atmosphere (balloon). During the first 4 h the mixture was 
purged for 5 minutes every 30 minutes. TLC indicated complete conversion of the 
benzyl ester 111. The crude reaction mixture was filtered over celite® and flushed with 
30 mL ethyl acetate three times and with 30 mL dichloromethane three times. After 
concentration under reduced pressure and drying in high vacuum the carboxylic acid 
126 was obtained as a colorless solid (90.3 mg, 75.6 µmol, 97.2%). 
IR (ATR):  [cm-1] = 3272.7 (br, 𝜈(CO2H, N-H)), 3094.9 (br, 𝜈(N-H)), 2919.0 (vs, 𝜈(C-
H)), 2850.2 (s, 𝜈(C-H)), 1741.5 (s, 𝜈(C=O)), 1656.1 (vs, 𝜈(C=O)), 1541.3 (m), 1464.1, 
1386.9 (m), 1234.5 (s), 1192.2 (m), 1162.6 (vs), 1090.1 (s), 758.3 (m), 720.9 (m), 698.2 
(m). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 8.05 – 7.85 (m, 3 H, NH7+9+26), 7.34 – 7.16 
(m, 5 H, CHAr37-41), 5.13 (d, J = 3.9 Hz, 1 H, CH25), 4.80 (t, J = 6.3 Hz, 2 H, CH10+68), 
4.01 – 3.89 (m, 2 H, CH233), 4.01 – 3.89 (m, 1 H, CH243a), 3.35 (underneath water 
signal, CH243b), 3.13 – 2.95 (m, 4 H, CH22+5), 2.49 (s, 3 H, CH335), 2.33 (dt, J = 10.6, 
5.2 Hz, 4 H, CH252+77), 2.09 (t, J = 7.1 Hz, 2 H, CH255), 1.71 – 1.57 (m, 4 H, CH214+70), 
1.56 – 1.29 (m, 16 H, CH2), 1.31 – 1.06 (m, 70 H, CH2), 0.83 (t, J = 6.6 Hz, 9 H, 
CH321+94+95). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 174.44 (s, CO2H56), 172.43 (s, CO2R20 or 76), 
172.40 (s, CO2R20 or 76), 169.18 (s, CONR11+66), 165.64 (s, CO2R30), 165.13 (s, 
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CO2R30), 152.64 (s, CO27), 149.92 (s, C28), 144.00 (s, CAr34), 143.81 (s, CAr34), 128.36 
(s, CHAr), 127.30 (s, CHAr), 126.10 (s, CHAr), 103.16 (s, C24), 102.82 (s, C24), 73.10 (s, 
CH10+68), 63.55 (s, CH233), 63.39 (s, CH233), 52.44 (s, CH25), 52.12 (s, CH25), 41.57 (s, 
CH243), 38.05 (s, CH22+5), 33.59 (s, CH252 or 55 or 77), 33.49 (s, CH252 or 55 or 77), 33.47 (s, 
CH252 or 55 or 77), 31.52 (s, CH2), 31.50 (s, CH2), 31.40 (s, CH2), 31.26 (s, CH2), 31.21 (s, 
CH2), 29.45 (s, CH2), 29.14 (s, CH2), 29.08 (s, CH2), 29.03 (s, CH2), 29.01 (s, CH2), 
28.97 (s, CH2), 28.86 (s, CH2), 28.82 (s, CH2), 28.80 (s, CH2), 28.67 (s, CH2), 28.64 (s, 
CH2), 28.50 (s, CH2), 28.47 (s, CH2), 28.34 (s, CH2), 27.92 (s, CH2), 26.29 (s, CH2), 
25.81 (s, CH2), 25.78 (s, CH2), 25.06 (s, CH2), 24.63 (s, CH2), 24.58 (s, CH2), 24.48 (s, 
CH2), 24.13 (s, CH2), 22.20 (s, CH2), 22.16 (s, CH2), 22.07 (s, CH2), 15.61 (s, CH335), 
13.99 (s, CH321 or 94 or 95), 13.97 (s, CH321 or 94 or 95), 13.94 (s, CH321 or 94 or 95). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C701H12016O1114N423Na1, 1215.8846; found, 
1215.8851; Δ = 0.55 mmu. 
 
 Carboxylic acid 127 derived from benzyl ester 112 via 
hydrogenolytic deprotection 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 112 
(114 mg, 106 µmol, 1.00 eq.) was dissolved in 2.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20 wt.% Pd, 22.8 mg) was added to the solution. The 
solution was purged with hydrogen gas for 10 minutes and stirred for 1 d at room 
temperature under hydrogen atmosphere (balloon). During the first 4 h the mixture was 
purged with hydrogen for 5 minutes every 30 minutes. TLC indicated complete 
conversion of the benzyl ester 112. The crude reaction mixture was filtered over celite® 
and flushed with 50 mL ethyl acetate three times and with 50 mL dichloromethane 
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twice. After concentration under reduced pressure and drying in high vacuum the 
carboxylic acid 127 was obtained as a colorless solid (103 mg, 104 µmol, 98.7%). 
IR (ATR):  [cm-1] = 3290.3 (br, 𝜈(N-H)), 2922.4 (vs, 𝜈(C-H)), 2853.1 (s, 𝜈(C-H)), 1740.5 
(m, 𝜈(C=O)), 1659.8 (vs, 𝜈(C=O)), 1538.4 (m), 1455.9 (m), 1386.3 (m), 1161.8 (vs), 
1113.9 (s), 1073.5 (m), 833.0 (w), 759.9 (w), 697.2 (s), 612.6 (w), 515.2 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.17 (s, 1 H, CO2H58), 7.95 – 7.88 (m, 2 H, 
NH7+9), 7.87 (s, 1 H, NH54), 7.36 – 7.13 (m, 5 H, CHAr65-69), 5.14 (d, J = 3.8 Hz, 1 H, 
CH53), 4.87 – 4.77 (m, 2 H, CH12+41), 3.89 – 3.36 (m, 2 H, CH271), 3.02 (h, J = 6.7 Hz, 
4 H, CH22+5), 2.48 (s, 3 H, CH363), 2.36 – 2.20 (m, 6 H, CH221+72+75), 1.76 – 1.59 (m, 4 
H, CH214+45), 1.58 – 1.41 (m, 4 H, CH223+74), 1.42 – 1.32 (m, 4 H, CH2), 1.22 (s, 56 H, 
CH2), 0.89 – 0.75 (m, 9 H, CH338+39+51). 
13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.23 (s, CO2R20 or 76), 172.20 (s, CO2R20 
or 76), 169.11 (s, CONR10 or 42), 169.08 (s, CONR10 or 42), 167.53 (s, CO2H58), 153.04 (s, 
CO55), 148.53 (s, C56), 144.10 (s, CAr62), 128.23 (s, CHAr), 127.06 (s, CHAr), 126.08 (s, 
CHAr), 104.22 (s, C52), 73.12 (s, CH12 or 41), 73.02 (s, CH12 or 41), 52.39 (s, CH53), 41.30 
(s, CH271), 38.11 (s, CH22 + 5), 33.51 (s, CH221 or 75), 33.28 (s, CH221 or 75), 31.49 (s, CH2), 
31.39 (s, CH2), 31.23 (s, CH2), 29.15 (s, CH2), 29.12 (s, CH2), 29.10 (s, CH2), 29.02 (s, 
CH2), 28.82 (s, CH2), 28.65 (s, CH2), 28.62 (s, CH2), 28.50 (s, CH2), 26.79 (s, CH2), 
25.86 (s, CH2), 25.58 (s, CH2), 24.61 (s, CH2), 24.47 (s, CH2), 24.05 (s, CH2), 22.16 (s, 
CH2), 22.12 (s, CH2), 21.82 (s, CH2), 15.49 (s, CH363), 13.84 (s, CH338 or 39 or 51), 13.76 
(s, CH338 or 39 or 51). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C571H9616O914N423Na1, 1003.7070; found, 
1003.7072; Δ = 0.26 mmu. 
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 Carboxylic acid 128 derived from benzyl ester 113 via 
hydrogenolytic deprotection 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 113 
(150 mg, 154 µmol, 1.00 eq.) was dissolved in 2.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20 wt.% Pd, 30.0 mg) was added to the solution. The 
solution was purged with hydrogen gas for 10 minutes and stirred for 1 d at room 
temperature under hydrogen atmosphere (balloon). During the first 4 h the mixture was 
purged for 5 minutes every 30 minutes. TLC indicated complete conversion of the 
benzyl ester 113. The crude reaction mixture was filtered over celite® and flushed with 
20 mL ethyl acetate three times and with 20 mL dichloromethane twice. After 
concentration under reduced pressure and drying in high vacuum the carboxylic acid 
128 was obtained as a colorless solid (134 mg, 151 µmol, 98.5%). 
IR (ATR):  [cm-1] = 3296.7 (br, 𝜈(N-H)), 2918.7 (vs, 𝜈(C-H)), 2850.6 (s, 𝜈(C-H)), 1744.9 
(s, 𝜈(C=O)), 1660.0 (vs, 𝜈(C=O)), 1542.7 (m), 1455.6 (m), 1384.2 (m), 1301.0 (w), 
1181.6 (vs), 1097.2 (m), 1038.5 (w), 940.2 (w), 849.3 (w), 761.5 (w), 720.4 (w), 697.9 
(m), 646.2 (w), 621.9 (w), 498.3 (w). 
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.23 (s, 1 H, COH57), 8.08 (dd, J = 14.2, 
3.7 Hz, 1 H, NH51), 8.00 – 7.85 (m, 2 H, NH7+9), 7.42 – 7.14 (m, 5 H, CHAr61-65), 5.22 – 
5.13 (m, 1 H, CH50), 5.04 – 4.93 (m, 1 H, CH44), 4.81 (t, J = 6.3 Hz, 1 H, CH15), 4.76 – 
4.39 (m, 2 H, CH267), 3.15 – 2.88 (m, 4 H, CH22+5), 2.41 (d, J = 6.2 Hz, 3 H, CH360), 
2.34 (t, J = 7.2 Hz, 2 H, CH224), 1.65 (q, J = 7.3, 6.7 Hz, 2 H, CH217), 1.51 (q, J = 7.1 
Hz, 2 H, CH226), 1.41 – 1.30 (m, 7 H, CH2 + CH347), 1.30 – 1.18 (m, 46 H, CH2), 0.85 
(t, J = 6.7 Hz, 6 H, CH341+42). 
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13C-NMR (101 MHz, DMSO-d6) δ [ppm] = 172.37 (s, CO2R23), 169.32 (s, CO2R48), 
169.28 (s, CONR13 or 45), 169.12 (s, CONR13 or 45), 169.06 (s, CO2R23), 167.25 (s, 
CO2H55), 152.67 (CO52), 152.50 (CO52), 148.32 (s, C53), 148.24 (C53), 143.92 (s, CAr59), 
143.77 (s, CAr59), 128.36 (s, CHAr), 128.32 (s, CHAr), 127.31 (s, CHAr), 126.59 (s, CHAr), 
126.46 (s, CHAr), 103.98 (s, C49), 103.82 (s, C49), 73.05 (s, CH15), 70.53 (s, CH44), 
70.49 (s, CH44), 53.30 (s, CH50), 53.05 (s, CH50), 44.05 (s, CH267), 43.85 (s, CH267), 
38.30 (s, CH22 or 5), 38.27 (s, CH22 or 5), 38.17 (s, CH22 or 5), 33.48 (s, CH224), 31.46 (s, 
CH217), 31.33 (s, CH2), 31.18 (s, CH2), 29.06 (s, CH2), 29.04 (s, CH2), 29.00 (s, CH2), 
28.96 (s, CH2), 28.93 (s, CH2), 28.74 (s, CH2), 28.72 (s, CH2), 28.59 (s, CH2), 28.55 (s, 
CH2), 28.41 (s, CH2), 25.90 (s, CH2), 24.58 (s, CH226), 24.45 (s, CH2), 22.13 (s, CH2), 
22.09 (s, CH2), 17.65 (s, CH347), 17.62 (s, CH347), 15.57 (s, CH360), 15.50 (s, CH360), 
13.94 (s, CH341 or 42), 13.92 (s, CH341 or 42). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C501H8216O914N423Na1, 905.5974; found, 
905.5972; Δ = 0.23 mmu. 
 
 Carboxylic acid 129 derived from benzyl ester 115 via 
hydrogenolytic deprotection 
 
The benzyl ester 115 (66 mg, 58 µmol, 1.00 eq.) was dissolved in 0.9 mL ethyl acetate 
in a 10 mL round bottom flask. Subsequently, palladium on activated coal (20% Pd, 
12 mg) was added to the solution. The resulting mixture was purged with argon and 
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subsequently with hydrogen gas. The reaction was stirred for 1 d at room temperature 
under hydrogen atmosphere (balloon). The crude reaction mixture was filtered over 
celite® and flushed with 15 mL ethyl acetate/dichloromethane (1:1) three times. After 
evaporation of the solvents under reduced pressure and drying in vacuo the acid 129 
was obtained as a colorless solid (55.9 mg, 54.1 μmol, 92.1%). 
Rf = 0.15 in c-hexane/ethyl acetate (2:3). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3301.2 (br, 𝜈(NH)), 3089.3 (br, 𝜈(CO2H)), 2955.6 (m, 𝜈(CH)), 2922.7 
(vs, 𝜈(CH)), 2852.7 (s, 𝜈(CH)), 1746.2 (m, 𝜈(CO)), 1657.8 (vs, 𝜈(CO)), 1606.3 (m, 
𝜈(CO)), 1540. 5 (m), 1507.6 (m), 1456.2 (m), 1414.0 (w), 1382.1 (m), 1363.6 (w), 
1299.9 (w), 1275.2 (w), 1254.6 (w), 1178.5 (vs), 1110.6 (m), 1086.2 (m), 1067.4 (w), 
1048.9 (w), 1016.0 (w), 991.3 (w), 939.9 (vw), 859.7 (w), 851.5 (w), 837.1 (w), 802.2 
(vw), 763.0 (w), 719.8 (w), 637.6 (w), 580.0 (vw), 551.2 (w), 528.3 (vw), 497.7 (vw). 
1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 8.18 (ddd, J = 22.0, 19.4, 3.5 Hz, 1 H, NH3), 
8.08 – 7.80 (m, 2 H, NH23,33), 7.44 – 7.31 (m, 2 H, CHAr), 7.17 – 7.09 (m, 4 H, CHAr), 
7.09 – 7.05 (m, 1 H, CHAr), 7.04 – 6.99 (m, 1 H, CHAr), 5.26 – 5.20 (m, 1 H, CH2), 4.92 
– 4.78 (m, 2 H, CH21,38), 4.78 – 4.45 (m, 2 H, CH220), 3.16 – 2.96 (m, 4 H, CH227,32), 
2.83 (dt, J = 13.6, 6.7 Hz, 1 H, CH73), 2.72 (dd, J = 9.5, 4.7 Hz, 2 H, CH235), 2.53 – 2.43 
(m, 3 H, CH39), 2.32 (t, J = 7.1 Hz, 2 H, CH248), 1.65 (s, 2 H, CH2), 1.50 (d, J = 6.5 Hz, 
2 H, CH2), 1.45 – 1.31 (m, 5 H, CH2), 1.22 (s, 45 H, CH2), 1.17 (d, J = 6.9 Hz, 6 H, 
CH374,75), 0.87 – 0.80 (m, 6 H, CH346,65), 0.80 – 0.73 (m, 3 H, CH367). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.33 (s, CO2R47), 169.15 (s, CONR36), 
167.83 (s, s, CONR22), 167.79 (s, CONR22), 167.31 (s, CONR22), 167.27 (s, CONR22), 
165.10 (s, CO2H16), 165.03 (s, CO2H16), 162.40 (s, CAr12), 160.47 (s, CAr12), 153.19 (s, 
C4), 152.98 (s, C4), 152.75 (s, C4), 152.66 (s, C4), 148.36 (s, C6), 148.14 (s, C6), 148.08 
(s, C6), 145.99 (s, CAr70), 145.90 (s, CAr70), 145.86 (s, CAr70), 140.28 (s, CAr73), 140.09 
(s, CAr73), 140.02 (s, CAr73), 137.18 (s, CAr8), 137.02 (s, CAr8), 136.95 (s, CAr8), 129.01 
(s, CHAr69,71), 128.94 (s, CHAr69,71), 128.90 (s, CHAr69,71), 128.57 (s, CHAr), 128.50 (s, 
CHAr), 128.45 (s, CHAr), 128.44 (s, CHAr), 128.39 (s, CHAr), 126.18 (s, CHAr68,72), 126.16 
(s, CHAr68,72), 115.17 (d, J = 5.2 Hz, CHAr11,13), 115.00 (d, J = 4.9 Hz, CHAr11,13), 104.20 
(s, C1), 103.99 (s, C1), 77.51 (s, CH21), 77.46 (s, CH21), 75.63 (s, CH21), 75.49 (s, CH21), 
73.05 (s, CH38), 52.53 (s, CH2), 52.37 (s, CH2), 52.28 (s, CH2), 44.53 (s, CH220), 44.30 
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(s, CH220), 44.18 (s, CH220), 38.37 (s, CH227 or 32), 38.29 (s, CH227 or 32), 38.16 (s, 
CH227 or 32), 36.98 (s, CH235), 36.80 (s, CH235), 36.70 (s, CH235), 36.63 (m, CH235), 33.49 
(s, CH248), 33.05 (s, CH73), 31.47 (s, CH2), 31.36 (s, CH2), 31.20 (s, CH2), 29.10 (s, 
CH2), 29.08 (s, CH2), 29.05 (s, CH2), 28.78 (s, CH2), 28.61 (s, CH2), 28.58 (s, CH2), 
28.45 (s, CH2), 26.03 (s, CH2), 25.98 (s, CH2), 25.92 (s, CH2), 25.88 (s, CH2), 24.60 (s, 
CH2), 24.46 (s, CH2), 23.93 (s, CH374,75), 23.88 (s, CH374,75), 22.14 (s, CH2), 22.10 (s, 
CH2), 15.73 (s, CH39), 15.63 (s, CH39), 15.58 (s, CH39), 15.25 (s, CH367), 15.09 (s, 
CH367), 13.91 (s, CH346 or 65), 13.89 (s, CH346 or 65). 
19F-NMR (377 MHz, DMSO-d6) δ [ppm] = -119.70 (s, F34), -119.71 (s, F34), -119.72 (s, 
F34), -119.75 (s, F34). 
FAB-MS m/z (relative intensity): 1069.7 (60%) [M + Na]+, 1029.9 (10%) [M + H – F]+, 
291.0 (100%), [Fragment A]+. 
HRMS–FAB (m/z): [M + Na]+ calculated for 12C611H9516O914N419F123Na1, 1069.6975; 
found, 1069.6986; Δ = 1.09 mmu. 
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 Carboxylic acid 130 derived from benzyl ester 116 via 
hydrogenolytic deprotection 
 
In a 10 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 116 
(134 mg, 127 µmol, 1.00 eq.) was dissolved in 5.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20% Pd, 26.8 mg) was added to the solution. The 
solution was purged with argon for 5 minutes, subsequently with hydrogen gas for 
5 min and stirred for 1 d at room temperature under hydrogen atmosphere (balloon). 
TLC indicated complete conversion of the benzyl ester 116. The crude reaction mixture 
was filtered over celite® and flushed with 40 mL ethyl acetate three times and with 
30 mL dichloromethane twice. After concentration under reduced pressure and drying 
in high vacuum the carboxylic acid 130 was obtained as a colorless solid (119 mg, 
120 µmol, 94.4%). 
IR (ATR):  [cm-1] = 3276.3 (br, 𝜈(N-H)), 2916.5 (vs, 𝜈(C-H)), 2849.1 (s, 𝜈(C-H)), 1742.9 
(m, 𝜈(C=O)), 1672.9 (s, 𝜈(C=O)), 1655.1 (s), 1546.0 (m), 1454.8 (m), 1409.5 (m), 
1379.1 (m), 1298.7 (w), 1279.0 (w), 1259.8 (w), 1199.5 (s), 1109.9 (m), 940.8 (m), 
856.4 (w), 766.0 (m), 720.1 (m), 695.8 (m), 622.6 (w), 518.1 (w).  
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 12.12 (s, 1 H, CO2H57), 8.13 (dd, J = 37.2, 
3.7 Hz, 1 H, NH42), 7.85 – 7.67 (m, 2 H, NH7 + 9), 7.39 – 7.15 (m, 5 H, CHAr49-53), 5.18 
(t, J = 4.6 Hz, 1 H, CH41), 4.88 (dt, J = 9.4, 6.1 Hz, 1 H, CH62), 4.77 (t, J = 6.4 Hz, 1 H, 
CH12), 4.73 – 4.38 (m, 2 H, CH259), 3.53 – 3.43 (m, 2 H, CH2 + 5), 2.42 (d, J = 15.9 Hz, 
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3 H, CH348), 2.31 (t, J = 7.2 Hz, 2 H, CH221), 1.81 – 1.55 (m, 9 H, CH2), 1.49 (dt, J = 
20.3, 7.1 Hz, 4 H, CH2), 1.23 (s, 93 H, CH2), 0.85 (t, J = 6.8 Hz, 9 H, CH338 + 39 + 77). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 174.45 (s, CO2H57), 172.33 (s, CO2R20), 
169.21 (s, CO2R60), 168.97 s, CO2R60), 168.48 (s, CONR10), 167.98 (s, CONR10), 
167.93 (s, CONR63), 167.28 (s, CONR63), 153.00 (s, CO43), 152.62 (s, CO43), 148.05 
(s, C45), 147.88 (s, C45), 144.04 (s, CAr47), 143.81 (s, CAr47), 128.37 (s, CHAr), 128.31 
(s, CHAr), 127.31 (s, CHAr), 104.10 (s, C40), 104.05 (s, C40), 73.97 (s, CH62), 73.93 (s, 
CH62), 73.06 (s, CH12), 53.23 (s, CH41), 52.97 (s, CH41), 47.03 (s, CH2 or 5), 46.98 (s, 
CH2 or 5), 46.88 (s, CH2 or 5), 44.23 (s, CH259), 43.99 (s, CH259), 33.68 (s, CH221), 33.45 
(s, CH221), 31.43 (s, CH2), 31.34 (s, CH2), 31.19 (s, CH2), 31.16 (s, CH2), 31.12 (s, 
CH2), 30.82 (s, CH2), 29.08 (s, CH2), 29.02 (s, CH2), 28.97 (s, CH2), 28.95 (s, CH2), 
28.81 (s, CH2), 28.76 (s, CH2), 28.73 (s, CH2), 28.61 (s, CH2), 28.51 (s, CH2), 28.39 (s, 
CH2), 24.58 (s, CH2), 24.53 (s, CH2), 24.49 (s, CH2), 24.36 (s, CH2), 24.30 (s, CH2), 
22.14 (s, CH2), 22.09 (s, CH2), 22.08 (s, CH2), 15.53 (s, CH348), 15.50 (s, CH348), 13.94 
(s, CH338 or 39 or 77), 13.93 (s, CH338 or 39 or 77), 13.92 (s, CH338 or 39 or 77). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C561H9216O914N423Na1, 987.6757; found, 
987.6756; Δ = 0.05 mmu. 
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 Carboxylic acid 131 derived from benzyl ester 117 via 
hydrogenolytic deprotection 
 
In a 10 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 117 
(147 mg, 137 µmol, 1.00 eq.) was dissolved in 5.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20% Pd, 29.5 mg) was added to the solution. The 
solution was purged with hydrogen gas for 5 minutes and stirred for 1 d at 40 °C under 
hydrogen atmosphere (balloon). TLC indicated complete conversion of the benzyl 
ester 117. The crude reaction mixture was filtered over celite® and flushed with 20 mL 
ethyl acetate three times and with 20 mL dichloromethane twice. After concentration 
under reduced pressure and drying in high vacuum the carboxylic acid 131 was 
obtained as a colorless solid (130 mg, 131 µmol, 96.3%). 
IR (ATR):  [cm-1] = 3272.8 (br, 𝜈(N-H)), 2919.2 (s, 𝜈(C-H)), 2850.9 (m, 𝜈(C-H)), 1739.2 
(m, 𝜈(C=O)), 1710.3 (m), 1656.4 (vs, 𝜈(C=O)), 1620.5 (m), 1551.9 (m), 1495.1 (w), 
1455.0 (m), 1377.2 (m), 1302.5 (w), 1199.0 (vs), 1116.3 (m), 1026.1 (w), 938.0 (w), 
856.4 (w), 765.6 (m), 695.2 (m), 624.1 (w), 575.3 (w), 521.2 (w), 459.8 (w). 
1H-NMR (500 MHz, DMSO-d6): δ [ppm] = 12.24 (s, 1 H, CO2H55), 8.53 (dt, J = 11.7, 
6.0 Hz, 1 H, NH9), 8.47 (t, J = 6.0 Hz, 1 H, NH7), 8.08 (dd, J = 26.0, 3.6 Hz, 1 H, NH40), 
7.38 – 7.09 (m, 9 H, CHAr47-51 + 76-79,80), 5.19 (t, J = 4.0 Hz, 1 H, CH39), 4.99 (dd, J = 7.7, 
4.6 Hz, 1 H, CH60), 4.89 (dd, J = 7.5, 5.1 Hz, 1 H, CH10), 4.78 – 4.41 (m, 2 H, CH257), 
4.34 – 4.19 (m, 4 H, CH22+5), 2.41 (d, J = 15.9 Hz, 3 H, CH346), 2.35 (t, J = 7.2 Hz, 2 H, 
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CH219), 1.80 – 1.61 (m, 4 H, CH212+64), 1.59 – 1.43 (m, 2 H, CH221), 1.38 – 1.13 (m, 60 
H, CH2), 0.94 – 0.80 (m, 9 H, CH336 + 37 + 75). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.42 (s, CO2R18), 169.43 (s, CONR6), 
169.30 (s, CONR61), 169.28 (s, CONR61), 168.96 (s, CO2R58), 168.94 (s, CO2R58), 
167.31 (s, CO2H55), 167.30 (s, CO2H55), 152.80 (s, CO41), 152.57 (s, CO41), 147.94 (s, 
C43), 147.80 (s, C43), 144.09 (s, CAr45), 143.93 (s, CAr45), 137.88 (s, CAr3 or 78), 137.64 
(s, CAr3 or 78), 128.35 (s, CHAr), 128.31 (s, CHAr), 127.28 (s, CHAr), 126.97 (s, CHAr), 
126.95 (s, CHAr), 126.58 (s, CHAr), 126.46 (s, CHAr), 104.18 (s, C38), 104.13 (s, C38), 
74.04 (s, CH60), 73.96 (s, CH60), 73.03 (s, CH10), 53.28 (s, CH39), 53.06 (s, CH39), 44.07 
(s, CH257), 43.87 (s, CH257), 41.64 (s, CH22 or 5), 41.54 (s, CH22 or 5), 33.71 (s, CH219), 
33.50 (s, CH219), 31.46 (s, CH2), 31.36 (s, CH2), 31.21 (s, CH212 or 64), 31.17 (s, 
CH212 or 64), 29.10 (s, CH2), 29.07 (s, CH2), 29.05 (s, CH2), 28.98 (s, CH2), 28.83 (s, 
CH2), 28.78 (s, CH2), 28.62 (s, CH2), 28.55 (s, CH2), 28.46 (s, CH2), 24.64 (s, CH2), 
24.55 (s, CH2), 24.46 (s, CH2), 22.15 (s, CH2), 22.12 (s, CH2), 22.11 (s, CH2), 15.53 (s, 
CH346), 15.49 (s, CH346), 13.93 (s, CH336 or 37 or 75), 13.93 (s, CH336 or 37 or 75), 13.92 (s, 
CH336 or 37 or 75). 
ESI–MS [m/z]: [M + Na]+ calculated for 12C581H9016O914N423Na1, 1009.6600; found, 
1009.6604; Δ = 0.40 mmu. 
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 Carboxylic acid 132 derived from benzyl ester 118 via 
hydrogenolytic deprotection 
 
The benzyl ester 118 (130 mg, 124 µmol, 1.00 eq.) was dissolved in 3 mL ethyl acetate 
in a 25 mL round bottom flask. Subsequently, palladium on activated coal (20 wt.% Pd, 
20 mg) was added to the solution. The resulting mixture was purged with argon and 
subsequently with hydrogen gas. The reaction was stirred for 4 d at room temperature 
under hydrogen atmosphere (balloon). The crude reaction mixture was filtered over 
celite®, and flushed with 15 mL ethyl acetate/dichloromethane (1:1) three times. After 
evaporation of the solvents under reduced pressure and drying in vacuo the acid 132 
was obtained as a colorless solid (120 mg, 124 µmol, 99.8%). 
Rf = 0.21 in c-hexane/ethyl acetate (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3303.2 (br, 𝜈(NH)), 3083.1 (br, 𝜈(CO2H)), 2955.6 (m, 𝜈(CH)), 2922.7 
(vs, 𝜈(CH)), 2852.8 (m, 𝜈(CH)), 1746.2 (m, 𝜈(C=O)), 1668.0 (vs, 𝜈(C=O)), 1657.7 
(vs, 𝜈(C=O)), 1585.8 (w), 1538.5 (m), 1511.7 (m), 1456.2 (m), 1410.9 (w), 1384.2 (m), 
1304.0 (w), 1277.7 (m), 1246.4 (s), 1174.4 (vs), 1102.6 (m), 1032.5 (m), 1005.7 (w), 
929.9 (vw), 857.6 (w), 830.9 (w), 765.1 (w), 719.8 (w), 699.3 (vw), 633.5 (w), 588.2 
(w), 555.3 (vw), 528.6 (vw), 503.3 (vw), 466.9 (vw), 454.5 (vw). 
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1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 12.18 (s, 1 H, CO2H17), 8.05 (d, J = 46.2 Hz, 
1 H, NH3), 7.97 – 7.84 (m, 2 H, NH23,34), 7.21 (t, J = 7.8 Hz, 2 H, CHAr11,13), 6.85 (dd, 
J = 8.6, 5.2 Hz, 2 H, CHAr10,14), 5.12 (dd, J = 8.5, 3.4 Hz, 1 H, CH2), 4.99 (dd, 
J = 26.8, 3.8 Hz, 1 H, CH21), 4.86 – 4.78 (m, 1 H, CH39), 4.55 (ddd, 
J = 40.8, 24.4, 18.3 Hz, 2 H, CH218), 3.71 (s, 3 H, OCH335), 3.04 (m, 4 H, CH228,33), 2.42 
(d, J = 30.7 Hz, 3 H, CH39), 2.33 (m, 2 H, CH249), 1.78 – 1.68 (m, 1 H, CH27), 1.65 (d, 
J = 5.8 Hz, 2 H, CH2),1.60 – 1.46 (m, 3 H, CH2), 1.36 (dd, J = 13.3, 6.7 Hz, 7 H, CH2), 
1.23 (s, 41 H, CH2,), 0.93 – 0.76 (m, 12 H, CH3). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 172.44 (s, CO2R48), 169.33 (s, CO2R19), 
169.25 (s, CO2H16), 169.15 (s, CONR37), 168.38 (s, CONR22), 158.50 (s, COMe12), 
152.70 (s, C4), 150.21 (s, C6), 135.92 (s, C8), 127.69 (s, CHAr10,14), 127.59 (s, CHAr10,14), 
113.71 (s, CHAr11,13), 113.66 (s, CHAr11,13), 104.89 (s, C1), 104.54 (s, C1), 75.02 (s, 
CH21), 74.90 (s, CH21), 73.07 (s, CH39), 55.06 (s, OCH335), 52.54 (s, CH2), 44.35 (s, 
CH218), 44.12 (s, CH218), 42.55 (s, CH27), 38.29 (s, CH2), 38.14 (s, CH2), 33.44 (s, 
CH249), 31.44 (s, CH2), 31.30 (s, CH2), 31.16 (s, CH2), 29.02 (s, CH2), 28.96 (s, CH2), 
28.90 (s, CH2), 28.71 (s, CH2), 28.68 (s, CH2), 28.56 (s, CH2), 28.52 (s, CH2), 28.37 (s, 
CH2), 25.95 (s, CH2), 25.92 (s, CH2), 25.89 (s, CH2), 25.86 (s, CH2), 24.55 (s, CH2), 
24.42 (s, CH2), 22.11 (s, CH2), 22.07 (s, CH2), 21.84 (s, CH2), 21.75 (s, CH2), 21.48 (s, 
CH2), 20.78 (s, CH2), 15.48 (s, CH39), 14.10 (s, CH39), 13.97 (s, CH3), 13.94 (s, CH3), 
11.40 (s, CH3), 11.34 (s, CH3), 11.29 (s, CH3). 
FAB-MS m/z (relative intensity): 991.8 (13%) [M + Na]+, 951.8 (16%) [M – CH3]+, 649.5 
(6%) [Fragment B]+, 319.1 (97%) [Fragment A]+, 303.1 (91%) [Fragment A – O]+, 261.0 
(100%) [Fragment A – C2H2O2]+. 
HRMS–FAB (m/z): [M + Na]+ calculated for 12C551H9216O1014N423Na1, 991.6706; found, 
991.6704; Δ = 0.17 mmu. 
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 Carboxylic acid 133 derived from benzyl ester 119 via 
hydrogenolytic deprotection 
 
In a 25 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 119 
(120 mg, 113 µmol, 1.00 eq.) was dissolved in 3.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20 wt.% Pd/C, 24 mg) was added to the solution. The 
resulting mixture was purged with hydrogen gas and stirred for 18 h at room 
temperature under hydrogen atmosphere (balloon). The crude reaction mixture was 
filtered over celite® and flushed with 30 mL ethyl acetate/dichloromethane (1:1) three 
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times. After evaporation of the solvents and drying under reduced pressure the 
corresponding acid 133 was obtained as a colorless solid. (109 mg, 111 µmol, 99.4%). 
Rf = 0.46 in c-hexane/ethyl acetate (1:1). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR):  [cm-1] = 3292.1 (w, 𝜈(N-H)), 2917.8 (s, 𝜈(C-H)), 2849.9 (s, 𝜈(C-H)), 1737.3 
(m, 𝜈(C=O)), 1687.5 (s, 𝜈(C=O)), 1660.5 (s), 1547.3 (m), 1455.7 (m), 1411.7 (w), 
1376.1 (m), 1307.1 (m), 1277.1 (m), 1258.0 (m), 1205.3 (s), 1170.0 (vs), 1106.7 (s), 
1043.5 (m), 963.9 (w), 843.9 (w), 800.8 (m), 765.9 (m), 721.2 (m), 697.0 (m), 588.8 
(w), 503.4 (m).  
1H-NMR (400 MHz, DMSO-d6): δ [ppm] = 12.20 (br s, 1 H, CO2H56), 8.04 (dd, J = 25.7, 
3.6 Hz, 1 H, NH24), 7.91 (dt, J = 10.5, 5.2 Hz, 2 H, NH3,10), 7.22 – 7.15 (m, 2 H, 
CHAr52,50), 7.09 (dd, J = 8.0, 3.4 Hz, 2 H, CHAr49,53), 5.14 (t, J = 4.1 Hz, 1 H, CH41), 4.93 
– 4.87 (m, 1 H, CH60), 4.81 (t, J = 6.3 Hz, 1 H, CH13), 4.72 – 4.37 (m, 2 H, CH258), 3.13 
– 2.90 (m, 4 H, CH24,9), 2.40 (d, J = 11.0 Hz, 3 H, CH348), 2.33 (t, J = 7.2 Hz, 1 H, 
CH222a), 2.25 (s, 3 H, CH363), 2.17 (t, J = 7.4 Hz, 1 H, CH222b), 1.77 – 1.57 (m, 4 H, 
CH215,62), 1.57 – 1.42 (m, 4 H, CH224), 1.42 – 1.31 (m, 5 H, CH2), 1.31 – 1.11 (m, 80 H, 
CH2), 0.84 (t, J = 6.6 Hz, 12 H, CH339,69,70). 
13C-NMR (101 MHz, DMSO-d6): δ [ppm] = 174.49 (s, CO2R21), 172.38 (s, CONR11), 
169.23 (s, CO2R58), 169.14 (s, CO2R58), 168.65 (s, CONR1), 167.32 (s, CO2H55), 
152.94 (s, CO43), 152.64 (s, CO43), 147.86 (s, C45), 147.63 (s, C45), 141.12 (s, CAr51), 
140.93 (s, CAr51), 136.39 (s, CAr47), 128.88 (s, CHAr52,50), 128.83 (s, CHAr52,50), 126.46 
(s, CHAr49,54), 126.34 (s, CHAr49,54), 104.23 (s, C40), 74.05 (s, CH60), 73.95 (s, CH13), 
73.06 (s, CH13), 52.90 (s, CH41), 52.65 (s, CH41), 44.14 (s, CH257), 43.90 (s, CH257), 
38.21 (s, CH24,9), 38.12 (s, CH24,9), 33.69 (s, CH222), 33.47 (s, CH222), 31.46 (s, CH2), 
31.33 (s, CH2), 31.19 (s, CH2), 29.06 (s, CH2), 29.00 (s, CH2), 28.94 (s, CH2), 28.79 (s, 
CH2), 28.75 (s, CH2), 28.59 (s, CH2), 28.56 (s, CH2), 28.41 (s, CH2), 25.87 (s, CH2), 
24.57 (s, CH2), 24.52 (s, CH2), 24.44 (s, CH2), 24.39 (s, CH2), 22.13 (s, CH2), 22.09 (s, 
CH224), 20.77 (s, CH363), 20.65 (s, CH363), 15.51 (s, CH342), 15.47 (s, CH342), 13.95 (s, 
CH339,69,70), 13.93 (s, CH339,69,70). 
FAB – MS [m/z] (relative intensity): 981.9 (100%) [M + H]+, 935.8 (15%) [M -CO2H]+, 
697.4 (10%) [Fragment A]+, 977.6 (16%) [Fragment B]+, 245.0 (25%) [Fragment C – 
C2H2O2]+.  
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HRMS – FAB [m/z]: [M + H]+ calculated for 12C571H9716O914N4, 981.7520; found, 
981.7249; Δ = 0.08 mmu. 
 
 
 Carboxylic acid 134 derived from benzyl ester 120 via 
hydrogenolytic deprotection 
 
In a 5 mL round bottom flask equipped with a magnetic stir bar the benzyl ester 120 
(155 mg, 135 µmol, 1.00 eq.) was dissolved in 4.00 mL ethyl acetate. Subsequently, 
palladium on activated charcoal (20 wt.% Pd, 31.0 mg) was added to the solution. The 
solution was purged with hydrogen gas for 10 minutes and stirred for 1 d at room 
temperature under hydrogen atmosphere (balloon). During the first 2 h the mixture was 
purged with hydrogen for 5 minutes every 30 minutes. TLC indicated complete 
conversion of the benzyl ester 120. The crude reaction mixture was filtered over celite® 
and flushed with 50 mL ethyl acetate three times and with 50 mL dichloromethane 
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three times. After concentration under reduced pressure and drying in high vacuum 
the carboxylic acid 134 was obtained as a colorless solid (141 mg, 133 µmol, 98.5%). 
IR (ATR):  [cm-1] = 3280.3 (br, 𝜈(O-H)), 3087.3 (br, 𝜈(N-H)), 2917.4 (vs, 𝜈(C-H)), 
2850.0 (s, 𝜈(C-H)), 1745.1 (s, 𝜈(C=O)), 1713.0 (s, 𝜈(C=O)), 1644.0 (vs), 1612.2 (m), 
1553.2 (m), 1513.2 (m), 1464.7 (s), 1434.9 (m), 1403.1 (m), 1385.5 (m), 1246.8 (vs), 
1208.4 (s), 1162.0 (vs), 1120.7 (w), 1033.3 (w), 945.6 (w), 871.0 (w), 819.0 (w), 721.6 
(w), 681.5 (w), 629.0 (w), 518.2 (w), 433.7 (w). 
1H-NMR (400 MHz, DMSO-d6/CDCl3 8:2): δ [ppm] = 12.45 (s, 1 H, CO2H29), 8.00 (d, J 
= 3.6 Hz, 1 H, NH23), 7.88 – 7.77 (m, 2 H, NH7+9), 7.51 – 7.42 (m, 2 H, CHAr), 7.22 (d, 
J = 8.2 Hz, 2 H, CHAr), 7.18 – 7.11 (m, 2 H, CHAr), 6.84 – 6.77 (m, 2 H, CHAr), 5.20 (d, 
J = 3.6 Hz, 1 H, CH22), 4.81 (t, J = 6.3 Hz, 2 H, CH54), 4.56 – 4.21 (m, 2 H, CH240), 3.71 
(s, 3 H, OCH316), 3.01 (q, J = 6.6 Hz, 4 H, CH22+5), 2.41 (s, 3 H, CH332), 2.32 (t, J = 7.3 
Hz, 2 H, CH271), 1.72 – 1.62 (m, 2 H, CH257), 1.53 (t, J = 7.2 Hz, 2 H, CH273), 1.43 – 
1.32 (m, 6 H, CH2), 1.22 (s, 56 H, CH2), 0.90 – 0.80 (m, 6 H, CH367+89). 
13C-NMR (101 MHz, DMSO-d6/CDCl3 8:2) δ [ppm] = 172.19 (s, CO2R69), 170.89 (s, 
CO2R41), 170.19 (s, CONR8 or 12), 169.17 (s, CONR8 or 12), 167.07 (s, CO2H27), 157.73 
(s, CAr51), 152.33 (s, CO24), 148.62 (s, C25), 147.42 (s, OCF348), 143.33 (s, CAr31), 
129.69 (s, CHAr), 128.35 (s, CHAr), 128.31 (s, CHAr), 120.63 (s, CHAr), 113.36 (s, CHAr), 
103.15 (s, C21), 72.99 (s, CH54), 54.78 (s, OCH316), 52.50 (s, CH21), 43.71 (s, CH240), 
38.40 (s, CH22 or 5), 38.11 (s, CH22 or 5), 33.46 (s, CH271), 31.44 (s, CH2), 31.28 (s, CH2), 
31.14 (s, CH2), 29.02 (s, CH2), 28.98 (s, CH2), 28.89 (s, CH2), 28.69 (s, CH2), 28.56 (s, 
CH2), 28.54 (s, CH2), 28.42 (s, CH2), 25.91 (s, CH2), 25.83 (s, CH2), 24.52 (s, CH2), 
24.36 (s, CH2), 22.07 (s, CH2), 22.04 (s, CH2), 15.50 (s, CH332), 13.84 (s, CH367 or 89), 
13.81 (s, CH367 or 89). 
19F-NMR (376 MHz, DMSO-d6/CDCl3 8:2) δ [ppm] = -61.36 (s, CF348). 
ESI – MS [m/z]: [M + Na]+ calculated for 12C571H8516O1114N419F323Na1, 1081.6059; 
found, 1181.6064; Δ = 0.50 mmu. 
 
Chapter    6    Experimental part 
 
316  
 Carboxylic acid 135 derived from benzyl ester 121 via 
hydrogenolytic deprotection 
 
The benzyl ester 121 (49.5 mg, 45.0 µmol, 1.00 eq.) was dissolved in 0.9 mL ethyl 
acetate in a 10 mL round bottom flask. Subsequently, palladium on activated coal 
(20% Pd, 12 mg) was added to the solution. The resulting mixture was purged with 
argon and subsequently with hydrogen gas. The reaction was stirred for 3 d at room 
temperature under hydrogen atmosphere (balloon). The crude reaction mixture was 
filtered over celite® and flushed with 15 mL ethyl acetate/dichloromethane (1:1) three 
times. After evaporation of the solvents under reduced pressure and drying in vacuo 
the acid 135 was obtained as a colorless solid (42.3 mg, 41.9 μmol, 93.0%). 
Rf = 0.17 in c-hexane/ethyl acetate (2:3). Visualized via fluorescence quench and 
Seebach staining solution. 
IR (ATR)  [cm-1] = 3292.9 (br, 𝜈(N-H, CO2H)), 2951.5 (m, 𝜈(C-H)), 2916.5 (vs, 𝜈(C-
H)), 2884.7 (vs, 𝜈(C-H)), 1744.1 (m, 𝜈(C=O)), 1680.4 (s, 𝜈(C=O)), 1659.8 (s, 𝜈(C=O)), 
1612.5 (m, 𝜈(C=O)), 1583.7 (w), 1540.5 (m), 1511.7 (m), 1462.4 (m), 1437.7 (m), 
1408.9 (w), 1384.2 (m), 1330.7 (w), 1297.8 (m), 1279.3 (m), 1242.3 (m), 1201.1 (s), 
1174.4 (vs), 1114.8 (m), 1102.4 (m), 1048.9 (w), 1014.0 (w), 936.9 (w), 925.5 (w), 
890.6 (vw), 859.7 (w), 824.7 (vw), 761.0 (w), 719.8 (w), 689.0 (w), 639.6 (w), 608.8 
(w), 559.4 (vw), 534.7 (vw), 503.9 (vw), 452.5 (vw). 
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1H-NMR (500 MHz, DMSO-d6) δ [ppm] = 12.14 (s, 1 H, CO2H17), 8.01 (dd, 
J = 32.1, 3.5 Hz, 1 H, NH3), 7.95 – 7.85 (m, 2 H, NH23,33), 7.21 (dd, J = 13.0, 8.7 Hz, 2 
H, CHAr11,13), 6.82 (dd, J = 8.6, 5.1 Hz, 2 H, CHAr10,14), 5.12 (t, J = 4.3 Hz, 1 H, CH2), 
4.90 (dt, J = 10.8, 5.3 Hz, 1 H, CH21 or 38), 4.85 – 4.78 (m, 1 H, CH21 or 38), 4.78 – 4.35 
(m, 2 H, CH218), 3.97 (q, J = 7.0 Hz, 2 H, CH271), 3.04 (ddq, J = 19.4, 12.8, 6.4 Hz, 4 
H, CH227,32), 2.40 (d, J = 13.0 Hz, 3 H, CH39), 2.33 (t, J = 7.2 Hz, 2 H, CH248), 2.17 (t, 
J = 7.4 Hz, 1 H, CH248), 1.71 – 1.61 (m, 4 H, CH226.40), 1.55 – 1.44 (m, 2 H, CH250), 
1.35 (m, 4 H, CH2), 1.29 (t, J = 7.0 Hz, 3 H, CH372), 1.23 (s, 52 H, CH2), 0.84 (t, 
J = 6.8 Hz, 9 H, CH346,65,78). 
13C-NMR (126 MHz, DMSO-d6) δ [ppm] = 174.46 (s, CO2R47), 172.33 (s, CO2R47), 
169.28 (s, CO2R19), 169.12 (s, CONR22 or 36), 168.63 (s, CONR22 or 36), 167.33 (s, 
CO2H16), 167.30 (s, CO2H16), 157.79 (s, COEt12), 152.87 (s, CO4), 152.57 (s, CO4), 
147.69 (s, C6), 147.51 (s, C6), 136.11 (s, C8), 135.90 (s, C8), 127.76 (s, CHAr11,13), 
127.64 (s, CHAr11,13), 114.12 (s, CHAr10,14), 114.07 (s, CHAr10,14), 104.36 (s, C1), 74.04 
(s, CH21), 73.97 (s, CH21), 73.04 (s, CH38), 62.93 (s, CH271), 52.67 (s, CH2), 52.43 (s, 
CH2), 44.12 (s, CH218), 43.87 (s, CH218), 38.20 (s, CH27 or 32), 38.12 (s, CH27 or 32), 33.69 
(s, CH248), 33.48 (s, CH248), 31.46 (s, CH226 or 40), 31.35 (s, CH226 or 40), 31.20 (s, 
CH226 or 40), 31.16 (s, CH226 or 40), 29.09 (s, CH2), 28.96 (s, CH2), 28.82 (s, CH2), 28.77 
(s, CH2), 28.61 (s, CH2), 28.58 (s, CH2), 28.43 (s, CH2), 25.85 (s, CH2), 24.58 (s, CH2), 
24.53 (s, CH2), 24.45 (s, CH2), 24.39 (s, CH2), 22.14 (s, CH2), 22.10 (s, CH2), 15.50 (s, 
CH39), 15.47 (s, CH39), 14.64 (s, CH372), 13.91 (s, CH346 or 65 or 78), 13.88 (s, CH346 or 65 
or 78). 
FAB-MS m/z (relative intensity): 1033.9 (13%) [M + Na]+, 1011.9 (21%) [M + H]+, 333.1 
(92%) [Fragment A]+, 317.3 (62%) [Fragment A – O]+, 275.0 (100%) [Fragment A – 
C2H2O2]+. 
HRMS–FAB (m/z): [M + H]+ calculated for 12C581H9916O1014N4, 1011.7356; found, 
1011.7354; Δ = 0.16 mmu. 
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[277] J. Andréasson, U. Pischel, S. D. Straight, T. A. Moore, A. L. Moore, D. Gust, J. 
Am. Chem. Soc. 2011, 133, 11641–11648. 
[278] X.-J. Jiang, D. K. P. Ng, Angew. Chem. Int. Ed. 2014, 53, 10481–10484. 
[279] J. Chen, S. Zhou, J. Wen, Angew. Chem. Int. Ed. 2014, 54, 446–450. 
[280] C. P. Carvalho, Z. Domínguez, J. P. Da Silva, U. Pischel, Chem. Commun. 
2015, 51, 2698–2701. 
[281] D. Margulies, C. E. Felder, G. Melman, A. Shanzer, J. Am. Chem. Soc. 2007, 
129, 347–354. 
[282] G. Strack, M. Ornatska, M. Pita, E. Katz, J. Am. Chem. Soc. 2008, 130, 4234–
4235. 
[283] Z. Guo, W. Zhu, L. Shen, H. Tian, Angew. Chem. Int. Ed. 2007, 46, 5549–
5553. 
[284] W. Sun, C.-H. Xu, Z. Zhu, C.-J. Fang, C.-H. Yan, J. Phys. Chem. C 2008, 112, 
16973–16983. 
[285] Y. Liu, J. Ren, Y. Qin, J. Li, J. Liu, E. Wang, Chem. Commun. 2012, 48, 802–
804. 
[286] J. Halámek, T. K. Tam, S. Chinnapareddy, V. Bocharova, E. Katz, J. Phys. 
Chem. Lett. 2010, 1, 973–977. 
[287] T. Ratner, O. Reany, E. Keinan, ChemPhysChem 2009, 10, 3303–3309. 
[288] M. A. Palacios, E. Benito-Pena, M. Manesse, A. D. Mazzeo, C. N. LaFratta, G. 
M. Whitesides, D. R. Walt, Proc. Natl. Acad. Sci. 2011, 108, 16510–16514. 
[289] K.-W. Kim, V. Bocharova, J. Halámek, M.-K. Oh, E. Katz, Biotechnol. Bioeng. 
2011, 108, 1100–1107. 
[290] I. B. Burgess, L. Mishchenko, B. D. Hatton, M. Kolle, M. Lončar, J. Aizenberg, 
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7.2 Registers 
 
7.2.1 List of abbreviations 
 
Abbreviation Explanation 
1D One dimensional 
2D Two dimensional 
3CR Three-component reaction 
3D Three dimensional 
4CR Four-component reaction 
a priori Lat.: from the earlier 
a. u. Arbitrary unit 
ADMET Acyclic diene metathesis 
AES Advanced Encryption Standard 
AIBN Azobis(isobutyronitril) 
ATR Attenuated total reflection 
ATRP Atom Transfer Radical Polymerization 
BC Before Christ 
BINOL 1,1′-Bi-2-naphthol 
Bn Benzyl (~CH2C6H5) 
BOC tert-Butyloxycarbonyl 
Bp. Boiling point 
BQ para-Benzoquinone 
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br (IR) Broad 
br s (NMR) Broad singlet 
Cas Chemical abstracts service 
Cat. Catalyst 
CD Compact disk 
CDCl3 Deuterated chloroform  
CDI Carbonyldiimidazole 
CEM Chain ejection model 
cHex cyclo-Hexyl (~C6H11) 
CO2 Carbon dioxide 
COS Carbonyl sulfide 
COSY Correlation spectroscopy 
CRM Charged residue model 
CS2 Carbon disulfide 
CTA Chain transfer agent 
CTA Chain transfer agent 
CuMCR Copper-catalyzed multicomponent reaction 
d (NMR) Doublet 
DCC Dicyclohexylcarbodiimide 
DCM Dichloromethane 
DEPT Distortionless enhancement by polarization transfer. 
DFT Density functional theory 
DHMP 3,4-dihydropyrimidin-2(1H)-ones 
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DHP 1,4-dihydropyridines 
DMAP 4-(Dimethylamino)-pyridine 
DMPA 2,2-Dimethoxy-2-phenylacetophenone 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DRI Differential refractive index 
DSC Differential scanning calorimetry 
DTA Differential thermal analysis 
DVD Digital versatile disc 
e- Electron 
e.g. exempli gratia Lat.: for example 
EAA Ethyl acetoacetate 
ee Enantiomeric excess 
E-Factor Ecological factor 
EI Electron ionization 
EPO Erythropoietin 
eq. Equivalent 
ESI Electrospray ionization 
Et Ethyl (~C2H5) 
et al. et alii, et aliae, et alia. Lat.: and others 
etc. Et cetera Lat.: and other similar things 
EtOAc Ethyl acetate 
EtOH Ethanol 
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EWG Electron withdrawing group 
FAB Fast atom bombardment 
FRET fluorescence resonance energy transfer 
F-SPE Fluorous solid phase extraction 
F-tag Fluorous tagged  
FZK Forschungszentrum Karlsruhe 
GC-MS Gas chromatography - mass spectrometry 
GPC Gel permeation chromatography 
H+ Lewis or Brønsted acid 
H-bonded Hydrogen boned 
HCD Higher-energy collisional dissociation 
HESI Heated electrospray ionization  
HFIP Hexafluoro isopropanol 
HG-1 Hoveyda-Grubbs catalyst 1st generation 
HG-2 Hoveyda-Grubbs catalyst 2nd generation 
HIV Human immunodeficiency virus 
HMBC Heteronuclear multiple bond correlation 
HMQC Heteronuclear multiple quantum coherence 
HOAc Acetic acid 
HPLC High-performance liquid chromatography 
HRMS High resolution mass spectrometry 
HSQC Heteronuclear single quantum coherence 
i.e. id est Lat.: that is 
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iBu iso-Butyl (~CH2CH(CH3)2) 
IC50 Half maximal inhibitory concentration 
IEM Ion evaporation model 
in situ Lat.: on site, locally without isolation 
in vivo Lat.: within the living 
IR Infrared spectroscopy 
J (NMR) Coupling constant 
KIT Karlsruhe Institute of Technology 
KOH Potassium hydroxide 
LC Liquid chromatography 
LCST Lower critical solution temperature 
Ln Ligands 
m (IR) Medium 
m (NMR) Multiplet 
MAA Methyl acetoacetate 
MA-AA 2-(Methacryloyloxy)ethyl acetoacetate 
MALDI Matrix-assisted Laser Desorption/Ionization 
MCR Multicomponent reaction 
MeOH Methanol 
MIC Minimum inhibitory activity 
Monomer-NC Isocyanide-benzyl ester monomer 
Mp. Melting point 
mPEG Methoxypoly(ethylene glycol) 
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mPEG Poly(ethylene glycol) methyl ether 
MS Mass spectrometry 
NaOEt Sodium ethanolate 
NEt3 Triethylamine 
NH3 Ammonia 
NMP N-methyl-2-pyrrolidone 
NMR Nuclear magnetic resonance 
NOESY Nuclear Overhauser enhancement and exchange spectroscopy 
OTP One-time pad 
P.T. Proton transfer reaction 
Passerini-3CR Passerini three-component reaction 
Pd/C Palladium on activated charcoal 
Ph Phenyl (~C6H5) 
polyDHMP DHMP polymers 
PPh3 Triphenylphosphine 
ppm Parts per million 
prec. Precipitated 
PTFE Polytetrafluoroethylene 
p-TSA para-Toluenesulfonic acid 
q (NMR) Quartet 
quint. (NMR) Quintet 
r.t. Room temperature (approximately 23 °C) 
RAFT Reversible addition–fragmentation chain transfer 
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Rf Retention factor 
RI Refractive index 
RNA Ribonucleic acid 
RSA Rivest–Shamir–Adleman public-key cryptosystems 
s (IR) Strong 
s (NMR) Singlet (NMR) 
SEC Size-exclusion chromatography 
SMILES Simplified Molecular Input Line Entry Specification 
SPE Solid phase extraction 
t Time factor 
t (NMR) Triplett (NMR) 
TBD 1,5,7-Triazabicyclo[4.4.0]dec-5-ene 
tBu tert-Butyl (~C(CH3)3) 
tBuAA tert-Butyl acetoacetate 
tBuOK Potassium tert-butanoate 
TFFA Trifluoroacetic acid 
TG Thermo gravimetry 
TGA Thermo gravimetric analysis 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
TMS Trimethyl silane 
ToF Time-of-flight 
Ugi-4CR Ugi four-component reaction 
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Ugi-5CR Ugi five-component reaction 
UV Ultra violet 
UV/Vis Ultraviolet–visible spectroscopy 
VCI Verband der chemischen Industrie 
via Lat.: by way of, by means of, using 
vice versa Lat.: the other way around 
vs. Versus Lat.: against 
w (IR)  Weak 
X Conversion 
 
7.2.2 List of symbols 
 
Symbol Term  Dimension 
𝜈  Wavenumber 1 cm-1 
°C Degree centigrade 273.15 K 
Å Ångström 10-10 m 
amu Atomic mass unit 1 g∙mol-1 
Bit Basic unit of information 1 {1 or 0} 
Byte Unit of information 1 B = 8 bits 
cm Centimeter 10-2 m 
d Days 86400 s 
Da Dalton 1 g∙mol-1 
ĐM Dispersity ĐM = Mw/Mn 1 
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g Grams 1 g 
GB Gigabyte 109 byte 
h Hours 36000 s 
J Coupling constant 1 Hz = 1 s-1 
kDa Kilo Dalton  103 g∙mol-1 
kWh Kilowatt hours  3.6∙106 J 
M Molar mass 1 g∙mol-1 
m/z Mass-to-charge ratio 1 
MB Megabyte 106 byte 
mg Milligram 10-3 g 
min Minutes 60 s 
Mio. Million 103 
MJ Megajoule 106 J 
mL Milliliter 10-3 L = 10-6 m3 
mm Millimeter 10-3 m 
mmol Millimole 10-3 mol 
mmu Milli mass units 10-3 g∙mol-1 
Mn Number averaged molecular weight 1 g∙mol-1 
mol Mole 6.023∙10-23 particles 
Mw Mass averaged molecular weight 1 g∙mol-1 
n Amount of substance 1 mol 
N Normal 1 mol∙l-1 
nm Nanometer 10-9 m 
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s Second 1 s 
t Tons 106 g 
TB Terabyte 1012 byte 
Td 5% Decomposition temperature 1 ° C 
Tg Glass transition temperature 1 ° C 
Tm Melting temperature 1 ° C 
X Conversion 1 
Z Zetta 1021 
δ Chemical shift 1 ppm, 10-6 
μL Microliter 10-6 L = 10-9 m3 
μm Micrometer 10-6 m 
μmol Micromole 10-6 mol 
ρ Density 1 g∙cm-1 
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